
<html lang="en"     class="pb-page"  data-request-id="2195fe20-a0e6-442e-a8e2-1e53750cf75c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2020.63.issue-19;article:article:10.1021/acs.jmedchem.9b02057;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1–13)-NH2" /></meta><meta name="dc.Creator" content="Salvatore  Pacifico" /></meta><meta name="dc.Creator" content="Federica  Ferrari" /></meta><meta name="dc.Creator" content="Valentina  Albanese" /></meta><meta name="dc.Creator" content="Erika  Marzola" /></meta><meta name="dc.Creator" content="Joaquim Azevedo  Neto" /></meta><meta name="dc.Creator" content="Chiara  Ruzza" /></meta><meta name="dc.Creator" content="Girolamo  Calò" /></meta><meta name="dc.Creator" content="Delia  Preti" /></meta><meta name="dc.Creator" content="Remo  Guerrini" /></meta><meta name="dc.Description" content="Nociceptin/orphanin FQ (N/OFQ) controls different biological functions via selective stimulation of the N/OFQ peptide (NOP) receptor. The pleiotropic actions of N/OFQ may limit the development of N..." /></meta><meta name="Description" content="Nociceptin/orphanin FQ (N/OFQ) controls different biological functions via selective stimulation of the N/OFQ peptide (NOP) receptor. The pleiotropic actions of N/OFQ may limit the development of N..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 9, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b02057" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2020 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b02057" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b02057" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b02057" /></link>
        
    
    

<title>Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1–13)-NH2 | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b02057" /></meta><meta property="og:title" content="Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1–13)-NH2" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.9b02057/20210219/images/large/jm9b02057_0007.jpeg" /></meta><meta property="og:description" content="Nociceptin/orphanin FQ (N/OFQ) controls different biological functions via selective stimulation of the N/OFQ peptide (NOP) receptor. The pleiotropic actions of N/OFQ may limit the development of NOP ligands as innovative drugs in different therapeutic areas. The pharmacological concept of functional selectivity (aka biased agonism) might be useful for amplifying beneficial actions and/or counteracting side effects. Thus, molecules with large bias factors toward G protein or β arrestin are required for investigating the translational value of NOP biased modulation. Herein, the biased behavior of a heterogeneous library of NOP-targeting peptide derivatives was evaluated in vitro with the aim to provide possible insights into the structural determinants that govern the selective activation of G protein versus β-arrestin. Our results demonstrate that lipidation of N/OFQ(1–13)-NH2 is a useful strategy for obtaining G protein biased agonists for the NOP receptor." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b02057"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b02057">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b02057&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b02057&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b02057&amp;href=/doi/10.1021/acs.jmedchem.9b02057" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 19</span><span class="cit-fg-pageRange">, 10782-10795</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/19" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00499" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b02122" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1–13)-NH<sub>2</sub></span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Salvatore Pacifico</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Salvatore Pacifico</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemical and Pharmaceutical Sciences, University of Ferrara, Via Luigi Borsari 46, 44121 Ferrara, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Salvatore++Pacifico">Salvatore Pacifico</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3377-5107" title="Orcid link">http://orcid.org/0000-0002-3377-5107</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Federica Ferrari</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Federica Ferrari</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medical Sciences, Section of Pharmacology, University of Ferrara, Via Fossato di Mortara 17/19, 44121 Ferrara, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Federica++Ferrari">Federica Ferrari</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Valentina Albanese</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Valentina Albanese</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemical and Pharmaceutical Sciences, University of Ferrara, Via Luigi Borsari 46, 44121 Ferrara, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Valentina++Albanese">Valentina Albanese</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Erika Marzola</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Erika Marzola</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemical and Pharmaceutical Sciences, University of Ferrara, Via Luigi Borsari 46, 44121 Ferrara, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Erika++Marzola">Erika Marzola</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Joaquim Azevedo Neto</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Joaquim Azevedo Neto</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medical Sciences, Section of Pharmacology, University of Ferrara, Via Fossato di Mortara 17/19, 44121 Ferrara, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Joaquim+Azevedo++Neto">Joaquim Azevedo Neto</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Chiara Ruzza</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chiara Ruzza</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medical Sciences, Section of Pharmacology, University of Ferrara, Via Fossato di Mortara 17/19, 44121 Ferrara, Italy</div><div class="loa-info-affiliations-info">LTTA Laboratory for Advanced Therapies, Technopole of Ferrara, Via Fossato di Mortara 70, 44121 Ferrara, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chiara++Ruzza">Chiara Ruzza</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Girolamo Calò</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Girolamo Calò</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medical Sciences, Section of Pharmacology, University of Ferrara, Via Fossato di Mortara 17/19, 44121 Ferrara, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Girolamo++Cal%C3%B2">Girolamo Calò</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Delia Preti</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Delia Preti</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemical and Pharmaceutical Sciences, University of Ferrara, Via Luigi Borsari 46, 44121 Ferrara, Italy</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#7a1e1f16131b540a081f0e133a0f14131c1f54130e"><span class="__cf_email__" data-cfemail="4d292821242c633d3f2839240d3823242b28632439">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Delia++Preti">Delia Preti</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1075-3781" title="Orcid link">http://orcid.org/0000-0002-1075-3781</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Remo Guerrini</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Remo Guerrini</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemical and Pharmaceutical Sciences, University of Ferrara, Via Luigi Borsari 46, 44121 Ferrara, Italy</div><div class="loa-info-affiliations-info">LTTA Laboratory for Advanced Therapies, Technopole of Ferrara, Via Fossato di Mortara 70, 44121 Ferrara, Italy</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Remo++Guerrini">Remo Guerrini</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b02057&amp;href=/doi/10.1021%2Facs.jmedchem.9b02057" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 19</span><span class="cit-pageRange">, 10782–10795</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 9, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>11 December 2019</li><li><span class="item_label"><b>Published</b> online</span>9 September 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 October 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b02057" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b02057</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="https://acsopenscience.org/open-access/licensing-options/"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a><span class="article_header-cc-by"><a href="https://creativecommons.org/licenses/by/4.0/"><img src="/pb-assets/images/licensesLogos/OA_Icons_cc-1612971093887.svg" alt="CC: Creative Commons" /></img><span><strong>CC: </strong>Creative Commons</span></a><a href="https://creativecommons.org/licenses/by/4.0/"><img src="/pb-assets/images/licensesLogos/OA_Icons_by-1612971093257.svg" alt="BY: Credit must be given to the creator" /></img><span><strong>BY: </strong>Credit must be given to the creator</span></a></span></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b02057"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">751</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">3</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b02057" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1–13)-NH2&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Salvatore&quot;,&quot;last_name&quot;:&quot;Pacifico&quot;},{&quot;first_name&quot;:&quot;Federica&quot;,&quot;last_name&quot;:&quot;Ferrari&quot;},{&quot;first_name&quot;:&quot;Valentina&quot;,&quot;last_name&quot;:&quot;Albanese&quot;},{&quot;first_name&quot;:&quot;Erika&quot;,&quot;last_name&quot;:&quot;Marzola&quot;},{&quot;first_name&quot;:&quot;Joaquim&quot;,&quot;last_name&quot;:&quot;Azevedo Neto&quot;},{&quot;first_name&quot;:&quot;Chiara&quot;,&quot;last_name&quot;:&quot;Ruzza&quot;},{&quot;first_name&quot;:&quot;Girolamo&quot;,&quot;last_name&quot;:&quot;Calò&quot;},{&quot;first_name&quot;:&quot;Delia&quot;,&quot;last_name&quot;:&quot;Preti&quot;},{&quot;first_name&quot;:&quot;Remo&quot;,&quot;last_name&quot;:&quot;Guerrini&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;09&quot;,&quot;issue&quot;:&quot;19&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;10782-10795&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b02057&quot;},&quot;abstract&quot;:&quot;Nociceptin/orphanin FQ (N/OFQ) controls different biological functions via selective stimulation of the N/OFQ peptide (NOP) receptor. The pleiotropic actions of N/OFQ may limit the development of NOP ligands as innovative drugs in different therapeutic areas. The pharmacological concept of functional selectivity (aka biased agonism) might be useful for amplifying beneficial actions and/or counteracting side effects. Thus, molecules with large bias factors toward G protein or β arrestin are required for investigating the translational value of NOP biased modulation. Herein, the biased behavior of a heterogeneous library of NOP-targeting peptide derivatives was evaluated in vitro with the aim to provide possible insights into the structural determinants that govern the selective activation of G protein versus β-arrestin. Our results demonstrate that lipidation of N/OFQ(1–13)-NH2 is a useful strategy for obtaining G protein biased agonists for the NOP receptor.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b02057&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02057" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b02057&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02057" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b02057&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02057" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b02057&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b02057&amp;href=/doi/10.1021/acs.jmedchem.9b02057" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b02057" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b02057" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b02057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b02057%26sid%3Dliteratum%253Aachs%26pmid%3D32901477%26genre%3Darticle%26aulast%3DPacifico%26date%3D2020%26atitle%3DBiased%2BAgonism%2Bat%2BNociceptin%252FOrphanin%2BFQ%2BReceptors%253A%2BA%2BStructure%2BActivity%2BStudy%2Bon%2BN%252FOFQ%25281%25E2%2580%259313%2529-NH2%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D19%26spage%3D10782%26epage%3D10795%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/19" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/jmcmar.2020.63.issue-19/20201008/jmcmar.2020.63.issue-19.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.9b02057/20210219/images/medium/jm9b02057_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.9b02057/20210219/images/large/jm9b02057_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02057&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Nociceptin/orphanin FQ (N/OFQ) controls different biological functions <i>via</i> selective stimulation of the N/OFQ peptide (NOP) receptor. The pleiotropic actions of N/OFQ may limit the development of NOP ligands as innovative drugs in different therapeutic areas. The pharmacological concept of functional selectivity (aka biased agonism) might be useful for amplifying beneficial actions and/or counteracting side effects. Thus, molecules with large bias factors toward G protein or β arrestin are required for investigating the translational value of NOP biased modulation. Herein, the biased behavior of a heterogeneous library of NOP-targeting peptide derivatives was evaluated <i>in vitro</i> with the aim to provide possible insights into the structural determinants that govern the selective activation of G protein <i>versus</i> β-arrestin. Our results demonstrate that lipidation of N/OFQ(1–13)-NH<sub>2</sub> is a useful strategy for obtaining G protein biased agonists for the NOP receptor.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70370" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70370" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The peptide nociceptin/orphanin FQ (Phe-Gly-Gly-Phe-Thr-Gly-Ala-Arg-Lys-Ser-Ala-Arg-Lys-Leu-Ala-Asn-Gln, N/OFQ) is the endogenous ligand of the Gi coupled N/OFQ peptide (NOP) receptor.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> Previous structure–activity relationship studies, that have been recently reviewed,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> suggested that the N/OFQ N-terminal message domain (Phe-Gly-Gly-Phe) binds the NOP binding pocket while the address domain of the peptide (Thr-Gly-Ala-Arg-Lys-Ser-Ala-Arg-Lys-Leu-Ala-Asn-Gln) interacts with the second extracellular loop of the receptor. This proposal has been confirmed by the available NOP crystal structure studies.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> The N/OFQ-NOP receptor system regulates several biological functions, including locomotor activity, memory, emotional states, food intake, drug abuse, pain transmission, micturition, cough reflexes, and cardiovascular, respiratory, and immune functions.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> Thus, the NOP receptor is an attractive target for the development of innovative drugs, and there is now clinical evidence for possible indications of NOP ligands, including systolic hypertension for the partial agonist SER100,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> urinary incontinence due to overactive bladder for the full agonists N/OFQ and Rec 0438,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> pain for the mixed NOP/opioid receptor agonist cebranopadol,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> and depression for the antagonist BTRX-246040.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><div class="NLM_p">However, the pleiotropic effects exerted by N/OFQ and NOP agonists may be viewed as an obstacle in terms of drug development. To overcome this, the novel concept of functional selectivity or biased agonism might be useful.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10,11)</a> In fact, biased agonists are ligands able to stabilize different active conformations of the same receptor (<i>i.e.</i>, by promoting the interaction of the receptor with G protein better than arrestin or <i>vice versa</i>) thus eliciting distinct signaling patterns. In the opioid field, the observation that morphine displays a larger therapeutic index in β-arrestin 2 knockout mice<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12,13)</a> suggested that mu receptor agonists biased toward G protein may maintain analgesic efficacy while showing reduced side effects compared to classical opioid drugs; this proposal has been confirmed with different molecules as previously reviewed.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> However, recent genetic and pharmacological studies do not support this concept.<a onclick="showRef(event, 'ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17">(15−17)</a> Regarding the NOP receptor, few studies investigated the ability of ligands to discriminate between G proteins and arrestins.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18,19)</a> Very recently, a comparison of structurally distinct NOP receptor agonists demonstrated a clear dissociation between G protein-dependent signaling and receptor phosphorylation.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> However, the <i>in vivo</i> consequences of these differences are largely unknown; the only information available suggests that NOP ligands, producing similar effects on NOP/G protein interactions but showing different effects on β-arrestin 2 recruitment, elicited different actions on anxiety and mood.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><div class="NLM_p last">To investigate the potential of biased agonism in the NOP receptor field, molecules displaying a large bias factor toward G protein and toward arrestin are needed. Thus, the aim of this study was to investigate the effector-specific (G protein <i>vs</i> arrestin) structure–activity relationship of the NOP peptide ligand N/OFQ(1–13)-NH<sub>2</sub> (the smaller N/OFQ sequence acting as potent NOP full agonist<a onclick="showRef(event, 'ref3 ref22'); return false;" href="javascript:void(0);" class="ref ref3 ref22">(3,22)</a>) in order to identify NOP receptor biased agonists. The ability of known (compounds <b>1–38</b>) and novel (compounds <b>39–56</b>) N/OFQ(1–13)-NH<sub>2</sub> derivatives to promote NOP-G protein and NOP-arrestin interactions was investigated using a bioluminescence resonance energy transfer (BRET) assay. This assay originally set up for classical opioid receptors<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> has been then extended to the NOP receptor and validated using a large panel of standard NOP ligands.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Furthermore, novel NOP ligands have been more recently characterized using this NOP BRET assay, including the mixed NOP/opioid receptor agonists cebranopadol,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> DeNo,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and PWT2-[Dmt<sup>1</sup>]N/OFQ(1–13),<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and the NOP selective agonists AT-403<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and AT-090.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> To quantify biased signaling, the Black/Leff operational model that provides a quantifiable and scalable method to characterize ligand bias was used.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42182" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42182" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">All peptide derivatives listed in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>–<named-content content-type="anchor" rid="tbl2" type="simple"></named-content><named-content content-type="anchor" rid="tbl3" type="simple"></named-content><named-content content-type="anchor" rid="tbl4" type="simple"></named-content><a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> (<b>1–38</b>) have been obtained through standard solid phase peptide synthesis (SPPS) in analogy to previously reported procedures and as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Sectio">Experimental Sectio</a>n.<a onclick="showRef(event, 'ref29 ref30 ref31 ref32 ref33 ref34 ref35 ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref29 ref30 ref31 ref32 ref33 ref34 ref35 ref36 ref37 ref38">(29−38)</a> The chemical structures of unusual amino acids have been reported in Table S1 of the <a href="/doi/suppl/10.1021/acs.jmedchem.9b02057/suppl_file/jm9b02057_si_001.pdf" class="ext-link">Supporting Information</a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Effects of N/OFQ(1–13)-NH<sub>2</sub> and Its Ala Scan Derivatives in NOP/G Protein and NOP/β-Arrestin 2 Experiments</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">NOP/G protein</th><th class="rowsep1 colsep0" colspan="3" align="center">NOP/β-arrestin 2</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">pEC<sub>50</sub> (CL<sub>95%</sub>)</th><th class="colsep0 rowsep0" align="center">CR</th><th class="colsep0 rowsep0" align="center">α ± sem</th><th class="colsep0 rowsep0" align="center">pEC<sub>50</sub> (CL<sub>95%</sub>)</th><th class="colsep0 rowsep0" align="center">CR</th><th class="colsep0 rowsep0" align="center">α ± sem</th><th class="colsep0 rowsep0" align="center">bias factor (CL<sub>95%</sub>)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">N/OFQ(1–13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">8.80 (8.34–9.26)</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">1.00</td><td class="colsep0 rowsep0" align="left">8.26 (8.11–8.41)</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">1.00</td><td class="colsep0 rowsep0" align="left">0.00</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">[Ala<sup>1</sup>]N/OFQ(1–13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">Crc incomplete</td><td class="colsep0 rowsep0" align="left">∼700</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" colspan="3" align="center">inactive</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">[Ala<sup>2</sup>]N/OFQ(1–13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">6.36 (5.89–6.83)</td><td class="colsep0 rowsep0" align="left">275</td><td class="colsep0 rowsep0" align="left">0.54 ± 0.07<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" colspan="3" align="center">inactive</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">[Ala<sup>3</sup>]N/OFQ(1–13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">7.88 (6.79–8.96)</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">0.87 ± 0.02</td><td class="colsep0 rowsep0" align="left">7.54 (7.22–7.86)</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">0.65 ± 0.02<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">–0.21 (−0.96–0.55)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">[Ala<sup>4</sup>]N/OFQ(1–13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">Crc incomplete</td><td class="colsep0 rowsep0" align="left">∼1000</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" colspan="3" align="center">inactive</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">[Ala<sup>5</sup>]N/OFQ(1–13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">7.12 (6.61–7.64)</td><td class="colsep0 rowsep0" align="left">48</td><td class="colsep0 rowsep0" align="left">0.86 ± 0.02</td><td class="colsep0 rowsep0" align="left">6.13 (5.55–6.72)</td><td class="colsep0 rowsep0" align="left">135</td><td class="colsep0 rowsep0" align="left">0.72 ± 0.10<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">0.40 (−0.24–1.05)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">[Ala<sup>6</sup>]N/OFQ(1–13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">7.66 (6.59–8.72)</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">0.93 ± 0.04</td><td class="colsep0 rowsep0" align="left">7.10 (6.64–7.56)</td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">0.97 ± 0.04</td><td class="colsep0 rowsep0" align="left">0.04 (−0.60–0.67)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">[Ala<sup>8</sup>]N/OFQ(1–13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">Crc incomplete</td><td class="colsep0 rowsep0" align="left">∼1000</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" colspan="3" align="center">inactive</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">[Ala<sup>9</sup>]N/OFQ(1–13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">8.14 (6.88–9.41)</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">0.97 ± 0.04</td><td class="colsep0 rowsep0" align="left">7.77 (7.43–8.11)</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">1.03 ± 0.07</td><td class="colsep0 rowsep0" align="left">–0.15 (−0.79–0.49)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">[Ala<sup>10</sup>]N/OFQ(1–13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">9.25 (7.82–10.68)</td><td class="colsep0 rowsep0" align="left">0.35</td><td class="colsep0 rowsep0" align="left">0.94 ± 0.04</td><td class="colsep0 rowsep0" align="left">8.43 (7.91–8.95)</td><td class="colsep0 rowsep0" align="left">0.68</td><td class="colsep0 rowsep0" align="left">1.00 ± 0.04</td><td class="colsep0 rowsep0" align="left">–0.08 (−0.67–0.50)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">[Ala<sup>12</sup>]N/OFQ(1–13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">7.31 (6.41–8.22)</td><td class="colsep0 rowsep0" align="left">31</td><td class="colsep0 rowsep0" align="left">0.91 ± 0.04</td><td class="colsep0 rowsep0" align="left">6.85 (6.57–7.14)</td><td class="colsep0 rowsep0" align="left">26</td><td class="colsep0 rowsep0" align="left">0.99 ± 0.05</td><td class="colsep0 rowsep0" align="left">–0.15 (−0.78–0.49)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">[Ala<sup>13</sup>]N/OFQ(1–13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">7.91 (7.24–8.59)</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">0.96 ± 0.06</td><td class="colsep0 rowsep0" align="left">7.88 (7.75–8.01)</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">1.03 ± 0.05</td><td class="colsep0 rowsep0" align="left">–0.48 (−1.14–0.18)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last"><i>p</i> < 0.05 vs N/OFQ(1–13)NH<sub>2</sub> one-way ANOVA followed the Dunnett post hoc test. Data are expressed as the mean ± sem of five independent experiments made in duplicate; CR, concentration ratio; crc, concentration–response curve; CL<sub>95%</sub>, 95% confidence limits; sem, standard error of the mean.</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Effects of N/OFQ(1–13)-NH<sub>2</sub> and Its D Scan Derivatives in NOP/G Protein and NOP/β-Arrestin 2 Experiments</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">NOP/G protein</th><th class="rowsep1 colsep0" colspan="3" align="center">NOP/β-arrestin 2</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">pEC<sub>50</sub> (CL<sub>95%</sub>)</th><th class="colsep0 rowsep0" align="center">CR</th><th class="colsep0 rowsep0" align="center">α ± sem</th><th class="colsep0 rowsep0" align="center">pEC<sub>50</sub> (CL<sub>95%</sub>)</th><th class="colsep0 rowsep0" align="center">CR</th><th class="colsep0 rowsep0" align="center">α ± sem</th><th class="colsep0 rowsep0" align="center">bias factor (CL<sub>95%</sub>)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">N/OFQ(1–13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">8.37 (8.30–8.45)</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">1.00</td><td class="colsep0 rowsep0" align="left">8.02 (7.79–8.24)</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">1.00</td><td class="colsep0 rowsep0" align="left">0.00</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">[DPhe<sup>1</sup>]N/OFQ(1–13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">6.02 (5.36–6.69)</td><td class="colsep0 rowsep0" align="left">224</td><td class="colsep0 rowsep0" align="left">0.70 ± 0.03<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" colspan="3" align="center">crc incomplete</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">[DPhe<sup>4</sup>]N/OFQ(1–13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">5.99 (5.39–6.58)</td><td class="colsep0 rowsep0" align="left">240</td><td class="colsep0 rowsep0" align="left">0.79 ± 0.03<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" colspan="3" align="center">crc incomplete</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">[DThr<sup>5</sup>]N/OFQ(1–13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" colspan="3" align="center">crc incomplete</td><td class="colsep0 rowsep0" colspan="3" align="center">inactive</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">[DAla<sup>7</sup>]N/OFQ(1–13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">7.26 (7.01–7.52)</td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">0.95 ± 0.03</td><td class="colsep0 rowsep0" align="left">6.76 (6.56–6.96)</td><td class="colsep0 rowsep0" align="left">18</td><td class="colsep0 rowsep0" align="left">0.84 ± 0.03<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">0.21 (−0.28–0.70)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">[DArg<sup>8</sup>]N/OFQ(1–13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">7.03 (6.64–7.42)</td><td class="colsep0 rowsep0" align="left">22</td><td class="colsep0 rowsep0" align="left">0.95 ± 0.02</td><td class="colsep0 rowsep0" align="left">6.55 (6.31–6.79)</td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">0.79 ± 0.02<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">0.26 (−0.25–0.77)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">[DLys<sup>9</sup>]N/OFQ(1–13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">7.01 (6.85–7.17)</td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="left">0.94 ± 0.02</td><td class="colsep0 rowsep0" align="left">6.31 (6.00–6.62)</td><td class="colsep0 rowsep0" align="left">51</td><td class="colsep0 rowsep0" align="left">0.85 ± 0.06<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">0.24 (−0.25–0.73)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">[DSer<sup>10</sup>]N/OFQ(1–13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">7.80 (7.51–8.09)</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">1.08 ± 0.03</td><td class="colsep0 rowsep0" align="left">7.65 (7.49–7.80)</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">1.01 ± 0.03</td><td class="colsep0 rowsep0" align="left">–0.07 (−0.52–0.39)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">[DAla<sup>11</sup>]N/OFQ(1–13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">7.40 (7.03–7.78)</td><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left">1.07 ± 0.02</td><td class="colsep0 rowsep0" align="left">7.14 (7.01–7.27)</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">0.97 ± 0.04</td><td class="colsep0 rowsep0" align="left">0.14 (−0.31–0.60)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">[DArg<sup>12</sup>]N/OFQ(1–13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">7.63 (7.38–7.88)</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">1.06 ± 0.01</td><td class="colsep0 rowsep0" align="left">7.39 (7.21–7.57)</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">0.94 ± 0.04</td><td class="colsep0 rowsep0" align="left">0.26 (−0.19–0.71)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">[DLys<sup>13</sup>]N/OFQ(1–13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">8.34 (8.12–8.55)</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">1.07 ± 0.02</td><td class="colsep0 rowsep0" align="left">8.23 (8.12–8.34)</td><td class="colsep0 rowsep0" align="left">0.62</td><td class="colsep0 rowsep0" align="left">1.01 ± 0.04</td><td class="colsep0 rowsep0" align="left">0.03 (−0.42–0.48)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last"><i>p</i> < 0.05 vs N/OFQ(1–13)NH<sub>2</sub> one-way ANOVA followed by the Dunnett post hoc test. Data are expressed as the mean ± sem of five independent experiments made in duplicate.</p></div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Effects of N/OFQ(1–13)-NH<sub>2</sub> and Its Derivatives (Compounds <b>22</b>–<b>33</b>) in NOP/G Protein and NOP/β-Arrestin 2 Experiments</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">NOP/G protein</th><th class="rowsep1 colsep0" colspan="3" align="center">NOP/β-arrestin 2</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">pEC<sub>50</sub> (CL<sub>95%</sub>)</th><th class="colsep0 rowsep0" align="center">CR</th><th class="colsep0 rowsep0" align="center">α ± sem</th><th class="colsep0 rowsep0" align="center">pEC<sub>50</sub> (CL<sub>95%</sub>)</th><th class="colsep0 rowsep0" align="center">CR</th><th class="colsep0 rowsep0" align="center">α ± sem</th><th class="colsep0 rowsep0" align="center">bias factor (CL<sub>95%</sub>)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">N/OFQ(1–13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">8.70 (8.34–9.06)</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">1.00</td><td class="colsep0 rowsep0" align="left">8.28 (8.03–8.53)</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">1.00</td><td class="colsep0 rowsep0" align="left">0.00</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">[Cha<sup>1</sup>]N/OFQ(1–13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">8.93 (8.57–9.29)</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">1.08 ± 0.04</td><td class="colsep0 rowsep0" align="left">8.28 (7.88–8.67)</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">1.03 ± 0.05</td><td class="colsep0 rowsep0" align="left">0.20 (−0.36–0.76)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">[Leu<sup>1</sup>]N/OFQ(1–13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">8.19 (7.88–8.51)</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">1.06 ± 0.02</td><td class="colsep0 rowsep0" align="left">7.87 (7.69–8.04)</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">1.04 ± 0.06</td><td class="colsep0 rowsep0" align="left">–0.08 (−0.53–0.37)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">[Trp<sup>4</sup>]N/OFQ(1–13)-NH<sup>2</sup></td><td class="colsep0 rowsep0" align="left">7.63 (7.15–8.11)</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">1.01 ± 0.01</td><td class="colsep0 rowsep0" align="left">7.17 (7.00–7.33)</td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">0.77 ± 0.03<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">0.11 (−0.43–0.65)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">[D-Phe<sup>3</sup>]N/OFQ(1–13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" colspan="3" align="center">inactive</td><td class="colsep0 rowsep0" colspan="3" align="center">inactive</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">[D-Ala<sup>2</sup>]N/OFQ(1–13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">7.57 (7.28–7.86)</td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">1.03 ± 0.03</td><td class="colsep0 rowsep0" align="left">7.16 (6.94–7.34)</td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">0.95 ± 0.05</td><td class="colsep0 rowsep0" align="left">0.20 (−0.26–0.66)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">[Nphe<sup>1</sup>]N/OFQ(1–13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" colspan="3" align="center">inactive</td><td class="colsep0 rowsep0" colspan="3" align="center">inactive</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">[(<i>S</i>)βMeNphe<sup>1</sup>]N/OFQ(1–13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" colspan="3" align="center">inactive</td><td class="colsep0 rowsep0" colspan="3" align="center">inactive</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">[(pF)Phe<sup>4</sup>]N/OFQ(1–13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">9.34 (9.14–9.50)</td><td class="colsep0 rowsep0" align="left">0.2</td><td class="colsep0 rowsep0" align="left">1.08 ± 0.04</td><td class="colsep0 rowsep0" align="left">8.40 (8.11–8.69)</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">0.93 ± 0.04</td><td class="colsep0 rowsep0" align="left">0.59<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a> (0.13–1.05)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">[Phe<sup>1</sup>ψ(CH<sub>2</sub>–NH)Gly<sup>2</sup>]N/OFQ(1–13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">8.05 (7.66–8.44)</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">0.59 ± 0.03<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">Inactive</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">[Phe<sup>1</sup>ψ(CH<sub>2</sub>–S)Gly<sup>2</sup>]N/OFQ(1–13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" colspan="3" align="center">inactive</td><td class="colsep0 rowsep0" colspan="3" align="center">inactive</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">[Asn<sup>5</sup>]N/OFQ(1–13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">8.03 (7.45–8.60)</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">1.01 ± 0.03</td><td class="colsep0 rowsep0" align="left">7.56 (7.11–8.00)</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">1.03 ± 0.07</td><td class="colsep0 rowsep0" align="left">–0.12 (−0.59–0.35)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">[Val<sup>5</sup>]N/OFQ(1–13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">7.94 (7.47–8.42)</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">0.94 ± 0.05</td><td class="colsep0 rowsep0" align="left">7.38 (7.03–7.74)</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">0.93 ± 0.06</td><td class="colsep0 rowsep0" align="left">0.09 (−0.38–0.56)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last"><i>p</i> < 0.05 vs N/OFQ(1–13)NH<sub>2</sub> one-way ANOVA followed by the Dunnett post hoc test.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Statistically different from 0. Data are expressed as the mean ± sem of five independent experiments made in duplicate.</p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Antagonist Potency of N/OFQ(1–13)-NH<sub>2</sub> Derivatives in NOP/G Protein and NOP/β-arrestin 2 Experiments<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">p<i>A</i><sub>2</sub> (CL<sub>95%</sub>)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">NOP/G protein</th><th class="colsep0 rowsep0" align="center">NOP/β-arrestin 2</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">[Nphe<sup>1</sup>]N/OFQ(1–13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">7.51 (6.83–8.19)</td><td class="colsep0 rowsep0" align="left">7.13 (6.85–7.41)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">[(<i>S</i>)βMeNPhe<sup>1</sup>]N/OFQ(1–13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">7.86 (7.28–8.44)</td><td class="colsep0 rowsep0" align="left">7.67 (6.91–8.43)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">[Phe<sup>1</sup>ψ(CH<sub>2</sub>–NH)Gly<sup>2</sup>]N/OFQ(1–13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">8.23 (7.24–9.22)</td><td class="colsep0 rowsep0" align="left">7.83 (7.64–8.02)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">[Phe<sup>1</sup>ψ(CH<sub>2</sub>–S)Gly<sup>2</sup>]N/OFQ(1–13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">6.88 (6.00–7.76)</td><td class="colsep0 rowsep0" align="left">6.99 (6.86–7.12)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Data are expressed as the mean ± sem of five independent experiments made in duplicate.</p></div></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Effects of N/OFQ-NH<sub>2</sub> and Its Derivatives (Compounds <b>34–38</b>) in NOP/G Protein and NOP/β-Arrestin 2 Experiments<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">NOP/G protein</th><th class="rowsep1 colsep0" colspan="3" align="center">NOP/β-arrestin 2</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">pEC<sub>50</sub> (CL<sub>95%</sub>)</th><th class="colsep0 rowsep0" align="center" char=".">CR</th><th class="colsep0 rowsep0" align="center">α ± sem</th><th class="colsep0 rowsep0" align="center">pEC<sub>50</sub> (CL<sub>95%</sub>)</th><th class="colsep0 rowsep0" align="center" char=".">CR</th><th class="colsep0 rowsep0" align="center">α ± sem</th><th class="colsep0 rowsep0" align="center">bias factor (CL<sub>95%</sub>)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">N/OFQ(1–13)-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">8.08 (7.70–8.45)</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">1.00</td><td class="colsep0 rowsep0" align="left">8.01 (7.80–8.22)</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">1.00</td><td class="colsep0 rowsep0" align="left">0.00</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">[Aib<sup>7</sup>]N/OFQ-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">8.92 (8.68–9.17)</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td><td class="colsep0 rowsep0" align="left">1.08 ± 0.04</td><td class="colsep0 rowsep0" align="left">8.40 (8.25–8.55)</td><td class="colsep0 rowsep0" align="char" char=".">0.4</td><td class="colsep0 rowsep0" align="left">0.98 ± 0.05</td><td class="colsep0 rowsep0" align="left">0.46 (−0.08–1.01)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">[Aib<sup>11</sup>]N/OFQ-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">8.35 (7.84–8.86)</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="left">1.07 ± 0.03</td><td class="colsep0 rowsep0" align="left">8.21 (8.13–8.29)</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td><td class="colsep0 rowsep0" align="left">0.95 ± 0.03</td><td class="colsep0 rowsep0" align="left">0.29 (−0.20–0.79)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">[AC<sub>3</sub>C<sup>7</sup>]N/OFQ-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">7.67 (7.11–8.23)</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="left">1.13 ± 0.04</td><td class="colsep0 rowsep0" align="left">7.56 (7.40–7.73)</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="left">1.01 ± 0.04</td><td class="colsep0 rowsep0" align="left">0.40 (−0.11–0.90)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">[AC<sub>5</sub>C<sup>7</sup>]N/OFQ-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">8.10 (7.59–8.61)</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="left">1.11 ± 0.02</td><td class="colsep0 rowsep0" align="left">8.10 (7.86–8.34)</td><td class="colsep0 rowsep0" align="char" char=".">0.8</td><td class="colsep0 rowsep0" align="left">1.02 ± 0.03</td><td class="colsep0 rowsep0" align="left">0.08 (−0.41–0.58)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">[AC<sub>5</sub>C<sup>11</sup>]N/OFQ-NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">8.61 (8.20–9.03)</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td><td class="colsep0 rowsep0" align="left">1.09 ± 0.04</td><td class="colsep0 rowsep0" align="left">8.22 (8.08–8.35)</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td><td class="colsep0 rowsep0" align="left">1.05 ± 0.03</td><td class="colsep0 rowsep0" align="left">0.31 (−0.19–0.81)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Data are expressed as the mean ± sem of five independent experiments made in duplicate.</p></div></div></div><div class="NLM_p">In order to obtain the conjugated peptide derivatives reported in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Tables <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>, the sequence of N/OFQ(1–13)-NH<sub>2</sub> was initially elongated at the C-terminal position (for the obtainment of compounds <b>39–52</b>) or replaced at the 10–13 positions (for compounds <b>53–56</b>) with a cysteine residue. As described in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> (panel A), [Cys<sup>14</sup>]N/OFQ(1–14)-NH<sub>2</sub>, previously synthesized in SPPS, was efficiently reacted with various maleimide containing derivatives through a thiol-Michael reaction carried out in liquid phase conditions. The same approach has been used for the synthesis of peptides substituted with Cys in positions 10, 11, 12, and 13. Compounds <b>39–41</b> and <b>53–56</b> were obtained through the reaction of the cysteine-modified peptide precursors with a maleimide-functionalized fatty acid (<i>i.e.</i>, myristic, palmitic, and stearic acid). The latter compounds <b>62a–c</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, panel B) were prepared by a standard coupling reaction between the proper fatty acid and the <i>N</i>-(4-aminobutyl)maleimide derivative <b>61</b>.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.9b02057/20210219/images/medium/jm9b02057_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.9b02057/20210219/images/large/jm9b02057_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.9b02057/20210219/images/large/jm9b02057_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02057&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) NaHCO<sub>3</sub>, CH<sub>3</sub>CN/H<sub>2</sub>O, 5 min; (ii) HATU, DIPEA, DMF, 0 °C to rt, 12 h; (iii) WSC, HOBt, DMF, rt, 3 h; (iv) TFA/H<sub>2</sub>O/triethylsilane, rt, 3 h; and (v) Et<sub>3</sub>N, CH<sub>3</sub>CN, rt, 0.5 h.</p></p></figure><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Effects of N/OFQ(1–13)NH<sub>2</sub> and Its Derivatives from <b>39</b> to <b>48</b> in NOP/G Protein and NOP/β-Arrestin 2</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.9b02057/20210219/images/medium/jm9b02057_0003.gif" alt="" id="gr2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">Statistically different from 0. Data are expressed as the mean ± sem of five independent experiments made in duplicate.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Effects of N/OFQ(1–13)NH<sub>2</sub> and Compounds <b>40</b>, <b>49</b>–<b>56</b> in NOP/G Protein and NOP/β-Arrestin 2</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.9b02057/20210219/images/medium/jm9b02057_0004.gif" alt="" id="gr3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last"><i>p</i> < 0.05 vs N/OFQ one-way ANOVA followed by the Dunnett post hoc test.</p></div><div class="footnote" id="t7fn2"><sup><sup>b</sup></sup><p class="last">Statistically different from 0. Data are expressed as the mean ± sem of five independent experiments made in duplicate.</p></div></div><div></div></div><div class="NLM_p">Compounds <b>42–49</b>, <b>51</b>, and <b>52</b> were synthesized following a convergent scheme in which [Cys<sup>14</sup>]N/OFQ(1–14)-NH<sub>2</sub> was grafted <i>via</i> a thiol-Michael reaction to different pre-assembled peptide and non-peptide fragments (<b>65d–m</b>) prepared up front by solid phase synthesis and bearing at the N-terminal position a 4-(2,5-dioxo-2,5-dihydro-1<i>H</i>-pyrrol-1-yl)butanoic moiety (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, panel C).</div><div class="NLM_p">Moreover, compound <b>50</b> was obtained through the addition reaction of [Cys<sup>14</sup>]N/OFQ(1–14)-NH<sub>2</sub> to the cyclooctyl amine derivative <b>67</b> which was previously prepared using the active succinic ester-activated derivative of the butanoic maleimide and the cyclooctyl amine, as described in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> (panel D).</div><div class="NLM_p">Finally, the palmitoylated opioid peptides <b>57–59</b> in <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Tables <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a> were prepared from the corresponding [Cys<sup>8</sup>]dermorphin-NH<sub>2</sub>, [Cys<sup>8</sup>]deltorphin A-NH<sub>2</sub>, and [Cys<sup>6</sup>]Leu-enkephalin-NH<sub>2</sub> peptide derivatives, obtained in SPPS and coupled <i>via</i> thiol-Michael to the maleimide derivative of palmitic acid (<b>62b</b>).</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Effects of Dermorphin, Deltorphin A, Leu-Enkephalin, and Their C-Terminal Palmitoylate Analogues <b>57–59</b> in mu/G Protein and mu/β-Arrestin 2 Experiments</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.9b02057/20210219/images/medium/jm9b02057_0005.gif" alt="" id="gr4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup><sup>a</sup></sup><p class="last"><i>p</i> < 0.05 vs dermorphin, one-way ANOVA followed by the Dunnett post hoc test. Data are expressed as the mean ± sem of five independent experiments made in duplicate. RLuc, renilla luciferase.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Effects of Dermorphin, Deltorphin A, Leu-Enkephalin, and Their C-Terminal Palmitoylate Analogues <b>57–59</b> in Delta/G Protein and Delta/β-Arrestin 2 Experiments</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.9b02057/20210219/images/medium/jm9b02057_0006.gif" alt="" id="gr5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup><sup>a</sup></sup><p class="last">*: <i>p</i> < 0.05 vs deltorphin A , one-way ANOVA followed by the Dunnett post hoc test. *: statistically different from 0. Data are expressed as the mean ± sem of five independent experiments made in duplicate.</p></div></div><div></div></div><div class="NLM_p">As described above, the strategy for the synthesis of the new peptide conjugates <b>39–59</b> consisted of a convergent approach combining SPPS and a thiol-Michael conjugation reaction performed in liquid phase conditions. The overall process required the preparation of the target peptide sequence with an additional cysteine residue whose thiol function was exploited as anchoring point for the final derivatization. The fragments to be linked to the peptide sequence were independently synthesized (through SPPS or in liquid phase) and conveniently functionalized with a maleimide reactive group. The final thiol-Michael reaction was generally carried out in very mild conditions using only a small excess of the thiol reactant. As previously observed,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> this conjugation step confirmed its effectiveness, chemoselectivity, and utility because a complete conversion of the maleimide acceptor was detected within only 5 min of reaction, thus allowing an easy final purification of the desired products in quantitative yields. The methodology was particularly useful for the preparation of long peptide sequences or lipidated peptides that are problematic to be fully synthesized through SPPS because of solubility concerns. Moreover, this would require the use of an excess of lipidated Fmoc amino acids that are generally characterized by high costs.</div><div class="NLM_p last">Of note, the developed modular synthesis is particularly versatile and allows extending all modifications herein considered to be virtually any bioactive peptide sequence in which a cysteine residue can be added without compromising its pharmacological activity.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Pharmacology</h3><div class="NLM_p">In the first series of studies, we assessed in parallel experiments the ability to promote NOP/G protein and NOP/β-arrestin 2 interactions of N/OFQ(1–13)-NH<sub>2</sub>, of its Ala- (<b>1–11</b>; <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) and D-scan (<b>12–21</b>; <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) derivatives as well as of analogues modified either in the amino acid side chain or in the peptide bond (<b>22–33</b>; <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). N/OFQ(1–13)-NH<sub>2</sub> promoted NOP/G protein interactions in a concentration-dependent manner with high potency (pEC<sub>50</sub> 8.80). All Ala-scan derivatives showed similar maximal effects as N/OFQ(1–13)-NH<sub>2</sub> with the exception of [Ala<sup>2</sup>]N/OFQ(1–13)-NH<sub>2</sub> that behaved as a low potency partial agonist. Moreover, compounds replaced in positions 1, 4 and 8 displayed very low potency, being able to promote the NOP/G protein interaction only at micromolar concentrations. N/OFQ(1–13)-NH<sub>2</sub> stimulated the interaction of the NOP receptor with β-arrestin 2 in a concentration-dependent manner with high potency (pEC<sub>50</sub> 8.26). Ala-scan derivatives of N/OFQ(1–13)-NH<sub>2</sub> compounds <b>1–11</b> stimulated the interaction of the NOP receptor with β-arrestin 2, showing the same rank of potency as displayed in NOP/G protein experiments (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_p">Regarding NOP/G protein interactions, D-scan derivatives <b>12–21</b> displayed variable results depending on the position of the amino acid investigated. The inversion of the configuration of the chiral amino acids of the message domain produced drastic (>100-fold) reduction of potency. When the same modification was applied from the position 7 to 9, a moderate (>10-fold) reduction in potency was observed while modifications of the C-terminal of the peptide produced minor effects on peptide potency (<10-fold). Regarding NOP/β-arrestin 2 interactions, D-scan derivatives of N/OFQ(1–13)-NH<sub>2</sub> showed the same rank of potency as displayed in NOP/G protein experiments (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div><div class="NLM_p">As far as N/OFQ(1–13)-NH<sub>2</sub> analogues modified in the amino acid side chain of the message domain are concerned, all derivatives displayed full agonist activity at NOP/G protein with the exception of [Nphe<sup>1</sup>]N/OFQ(1–13)-NH<sub>2</sub> (<b>27</b>) that was devoid of efficacy. Moreover, the potency of these compounds was similar to that of N/OFQ(1–13)-NH<sub>2</sub> with the exception of [(pF)Phe<sup>4</sup>]N/OFQ(1–13)-NH<sub>2</sub> (<b>29</b>) that was 5-fold more potent and [Trp<sup>4</sup>]N/OFQ(1–13)-NH<sub>2</sub> (<b>24</b>) and [<span class="smallcaps smallerCapital">d</span>-Ala<sup>2</sup>]N/OFQ(1–13)-NH<sub>2</sub> (<b>26</b>) that were approximately 10-fold less potent. Finally, the replacement of the first peptide bond with Ψ(CH<sub>2</sub>–NH) (<b>30</b>) or Ψ(CH<sub>2</sub>–S) (<b>31</b>) caused reduction or elimination of peptide efficacy, respectively. Regarding NOP/β-arrestin 2 interactions, N/OFQ(1–13)-NH<sub>2</sub> analogues showed the same rank of potency as displayed in NOP/G protein experiments (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). The behavior of [(pF)Phe<sup>4</sup>]N/OFQ(1–13)-NH<sub>2</sub> (<b>29</b>) was however slightly different: in fact, as mentioned above, it displayed increased potency in NOP/G protein compared to N/OFQ(1–13)-NH<sub>2</sub> while similar potency in NOP/β-arrestin 2 experiments. This caused a small (3-fold) but statistically significant bias toward G protein for this NOP ligand.</div><div class="NLM_p">Compounds inactive as agonists were tested as antagonists against N/OFQ (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). 10 μM [Nphe<sup>1</sup>]N/OFQ(1–13)-NH<sub>2</sub> (<b>27</b>) antagonized N/OFQ stimulatory effects, showing similar p<i>A</i><sub>2</sub> values in NOP/G protein and NOP/β-arrestin 2 experiments. The addition of a methyl group on Nphe as in the [(<i>S</i>)βMeNphe<sup>1</sup>]N/OFQ(1–13)-NH<sub>2</sub> (<b>28</b>) produced a slight increase in potency with no changes in antagonist activity. [Phe<sup>1</sup>Ψ(CH<sub>2</sub>–NH)Gly<sup>2</sup>]N/OFQ(1–13)-NH<sub>2</sub> (<b>30</b>) behaved as partial agonist in NOP/G protein and as pure antagonist in NOP/β-arrestin 2 studies; its agonist potency for promoting NOP/G protein interactions and its antagonist potency for blocking NOP/β-arrestin 2 interactions were in the range 7.83–8.23. Finally, the substitution of the CH<sub>2</sub>–NH bond between Phe<sup>1</sup> and Gly<sup>2</sup> with CH<sub>2</sub>–S (compound <b>31</b>) caused a complete elimination of efficacy in NOP/G protein experiments that was however associated with an approximately 10-fold reduction in antagonist potency.</div><div class="NLM_p">As far as N/OFQ analogues modified in the address domain (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>), all derivatives displayed full agonist activity at NOP/G protein with minor modifications of potency: the most potent agonist was [Aib<sup>7</sup>]N/OFQ-NH<sub>2</sub> (<b>34</b>) and the least potent was [AC<sub>3</sub>C<sup>7</sup>]N/OFQ-NH<sub>2</sub> (<b>36</b>). Regarding NOP/β-arrestin 2 interactions, N/OFQ analogues showed the same rank of potency as displayed in NOP/G protein experiments.</div><div class="NLM_p">The above mentioned experiments were aimed at investigating the possible biased agonist activity of known N/OFQ analogues, including Ala- and D-scan derivatives<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29,30)</a> as well as peptides replaced in different amino acid positions or containing peptide bond modifications.<a onclick="showRef(event, 'ref31 ref32 ref33 ref34 ref35 ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref33 ref34 ref35 ref36 ref37 ref38">(31−38)</a> The results obtained with these peptides in the NOP/G protein BRET assay perfectly confirmed previous findings regarding the crucial role of the side chain of residues in positions 1, 2, 4, 8 and of the chirality of residues in positions 1, 4 and 5.<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29,30)</a> Moreover, as previously demonstrated, the first peptide bond and the benzyl moiety at the position 1 affect ligand efficacy,<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32,33)</a> while alpha helix inducing amino acids at the 7 and 11 positions<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36,37)</a> and the introduction of a fluorine atom in the para position of Phe<sup>4</sup> promote an increase of agonist potency.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div><div class="NLM_p">In addition, these experiments allowed appreciating features of some NOP peptide ligands not detected in previous studies. For instance, [(<i>S</i>)βMeNphe<sup>1</sup>]N/OFQ(1–13)-NH<sub>2</sub> (<b>28</b>) was slightly more potent than [Nphe<sup>1</sup>]N/OFQ(1–13)-NH<sub>2</sub> (<b>27</b>) both in NOP/G protein and NOP/β-arrestin 2 experiments while it was reported as equipotent in previous studies.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> [Phe<sup>1</sup>Ψ(CH<sub>2</sub>–S)Gly<sup>2</sup>]N/OFQ(1–13)-NH<sub>2</sub> (<b>31</b>) contrary to [Phe<sup>1</sup>Ψ(CH<sub>2</sub>–NH)Gly<sup>2</sup>]N/OFQ(1–13)-NH<sub>2</sub> (<b>30</b>) behaved as pure antagonist in NOP/G protein experiments; this has not been appreciated in previous bioassay experiments performed in the electrically stimulated mouse vas deferens possibly because of off-target agonist effects.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div><div class="NLM_p">Results obtained with these peptides in the NOP/β-arrestin 2 assay were virtually superimposable to those of the NOP/G protein assay with the exceptions of compounds <b>29</b> and <b>30</b>. In fact, compound <b>29</b> displayed a small (3-fold) but statistically significant bias toward G protein. On the other hand, compound <b>30</b> ([Phe<sup>1</sup>Ψ(CH<sub>2</sub>–NH)Gly<sup>2</sup>]N/OFQ(1–13)-NH<sub>2</sub>) in line with the previous findings<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> behaved as a partial agonist in NOP/G protein and as pure antagonist in NOP/β-arrestin 2 studies. This is an interesting feature, and compound <b>30</b> has been used as a pharmacological tool for performing initial studies on NOP functional selectivity that demonstrated that the action of a NOP ligand on emotional states is better predicted based on its β-arrestin 2 rather than G protein efficacy.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Apart from these exceptions, all modified peptides behaved as unbiased NOP receptor agonists. This result is somewhat unexpected because similar subtle chemical modifications were sufficient for generating biased agonists when applied to other peptide sequences, including angiotensin, apelin, glucagon-like peptide, and parathormone.<a onclick="showRef(event, 'ref40 ref41 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref40 ref41 ref42 ref43">(40−43)</a> It could be speculated that for the NOP receptor, the chemical requirements of peptide agonists for promoting the interaction of the receptor with G protein are very similar to those required for promoting receptor/arrestin interactions. However, we cannot exclude that future studies may eventually identify small chemical modifications of the primary sequence of N/OFQ which were able to produce strongly biased agonists for the NOP receptor.</div><div class="NLM_p">Collectively, the results obtained with the known N/OFQ derivatives demonstrated that their pharmacological activity was virtually identical in NOP/G protein and NOP/β-arrestin 2 experiments. In other words, all these compounds behaved, similarly to the natural peptide, as unbiased NOP agonists. Interestingly, a certain degree of biased agonism toward G protein has been detected in previous studies by investigating the pharmacological activity of tetrameric N/OFQ derivatives, including PWT2-N/OFQ<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and PWT2-[Dmt<sup>1</sup>]N/OFQ(1–13).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> These multimeric ligands can be considered as N/OFQ-related peptides modified with a rather hindered chemical group at the C-terminal.</div><div class="NLM_p">On these bases, we designed novel N/OFQ derivatives modified at the C terminus with various chemical moieties, including lipophilic (compounds <b>39–41</b>), hydrophilic (compound <b>42</b>), positively charged (compounds <b>43</b>, <b>44</b>), negatively charged (compounds <b>45</b>, <b>46</b>), and aromatic (compounds <b>47</b>, <b>48</b>) moieties. The results obtained with these novel compounds are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>. Compounds <b>39–41</b> displayed, compared to N/OFQ(1–13)-NH<sub>2</sub>, higher potency at NOP/G protein and lower potency at NOP/β-arrestin 2, thus behaving as agonists biased toward G protein. Similar results were obtained with positively charged peptides (compounds <b>43</b>, <b>44</b>) whose bias factor was however lower than that of compounds functionalized with fatty acid chains. A statistically significant bias toward G protein was also displayed by negatively charged peptides (compounds <b>45</b>, <b>46</b>), but their bias factor was low and associated with reduced agonist potency. Finally, C-terminal modification of N/OFQ(1–13)-NH<sub>2</sub> with hydrophilic neutral (compound <b>42</b>) or aromatic (compounds <b>47</b>, <b>48</b>) moieties did not produce significant changes in the pharmacological activity of the peptide.</div><div class="NLM_p">In order to further investigate the contribution toward G protein bias of positive charges and lipophilicity of C-terminal-modified N/OFQ(1–13)-NH<sub>2</sub> analogues, a second series of peptides was synthesized and tested, and the relative results are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>. Compound <b>49</b> characterized by a (Lys)<sub>6</sub> moiety displayed a larger increase in potency at NOP/G protein than NOP/β-arrestin 2 interactions, showing a statistically significant bias factor of approximately 10-fold. The use of a cyclic aliphatic moiety (compound <b>50</b>) or of chains generated using two (compound <b>51</b>) or three (compound <b>52</b>) amino undecanoic acids caused a similar reduction of NOP/G protein and NOP/β-arrestin 2 potency, thus producing unbiased NOP agonists. The shift of the position of the palmitoyl moiety produced different results depending on the substituted amino acid. In particular, similar results were obtained when the palmitoyl moiety has been located in position 14 (compound <b>40</b>) and 11 (compound <b>54</b>), while, when the same moiety was introduced in position 10 (compound <b>53</b>), 12 (compound <b>55</b>), and 13 (compound <b>56</b>), it produced a variable decrease in potency and a consistent decrease in the bias factor.</div><div class="NLM_p">The addition of neutral hydrophilic (<b>42</b>) or aromatic (<b>47</b>, <b>48</b>) moieties did not change the unbiased profile of the reference peptide. On the contrary, the addition of charged moieties particularly in the case of positively charged peptide sequences elicited a shift toward G protein biased agonism (<b>43</b><b>44</b>, and <b>49</b>). This effect was mainly due to an increase in agonist potency for receptor/G protein interactions associated with no changes for receptor/arrestin interactions. The higher bias was detected with compound <b>43</b> characterized by the dipeptide sequence Ala–Lys repeating for six times. However, similar results were obtained with compound <b>44</b> and <b>49</b> in which the charges were organized in different ways. Thus, for promoting G protein bias, the presence of C-terminal positive charges seems to be more important than their spatial distribution and orientation. Interestingly enough, the potent and selective NOP agonist UFP-112<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> that has an extra couple of positively charged residues (Arg<sup>14</sup>–Lys<sup>15</sup>) displayed a small but statistically significant G protein bias (0.71).<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Charged residues may promote receptor interactions <i>via</i> ionic bonds with acidic residues of which the second extracellular loop of the NOP receptor is rich.<a onclick="showRef(event, 'ref45 ref46 ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref45 ref46 ref47 ref48">(45−48)</a> This proposal has been corroborated by the results obtained in molecular modeling studies based on the crystal structure of the NOP receptor (see for details Figure 4e in a study by Thompson <i>et al.</i> 2012<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a>). As a speculative hypothesis, we might suggest that this mechanism is more effective for NOP conformations interacting with G proteins than for those interacting with arrestins.</div><div class="NLM_p">The most interesting results have been achieved by introducing lipophilic linear aliphatic moieties at the C-terminus of N/OFQ(1–13)-NH<sub>2</sub>. Small differences were obtained with chains of different lengths, that is, 14, 16, and 18 carbon atoms (compounds <b>39–41</b>). On the contrary, the linear structure of the chain seems to be important because compound <b>50</b>, with a cyclooctane ring, displayed reduced potency and behaved as an unbiased agonist. Moreover, the linear moieties must be fully aliphatic because their substitution with amphipathic sequences (compounds <b>51</b> and <b>52</b>) reduced their potencies and totally eliminated the biased profile. The importance of the palmitoylation site has been investigated with compounds <b>53–56</b>. The shift of the palmitoyl group from position 14 to positions 11, 10, 12, and 13 caused a progressive reduction of the G protein bias. For the last two compounds, it should be noted that the Cys residue needed for palmitoylation substituted positively charged amino acids (Arg<sup>12</sup> or Lys<sup>13</sup>) that are important for NOP binding, in agreement with previous results.<a onclick="showRef(event, 'ref29 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref29 ref30 ref31">(29−31)</a> Altogether these findings suggest that a linear aliphatic chain, particularly the palmitoyl group at the C-terminal of N/OFQ(1–13)-NH<sub>2</sub>, promoted a large (10–100 fold) G protein biased agonism because of increased NOP/G protein potency associated with a slight reduction of NOP/β-arrestin 2 potency. The mechanism by which C-terminal modifications of N/OFQ(1–13)-NH<sub>2</sub> promote biased agonism toward G protein is at present unknown. To the best of our knowledge, there is a single example of naturally occurring palmitoylated ligands for G protein-coupled receptors (GPCRs). Wnts are a family of proteins that must be palmitoylated to exert their biological effects through the activation of Frizzled receptors. Recent crystallographic studies demonstrated that Wnts use the fatty acid as a hotspot residue to engage their receptor.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> However, it is unlikely that such a mechanism might be relevant for the interaction of compound <b>40</b> with the NOP receptor because NOP and Frizzled receptors are phylogenetically very far from each other.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Moreover, it is noteworthy that compound <b>40</b> is structurally similar to pepducins, lipidated peptides of 10–20 amino acid residues with sequences derived from the receptor intracellular loops or C-terminus.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Pepducins, most probably acting intracellularly,<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> are able to modulate GPCR signaling, sometimes acting as biased agonists either toward G protein<a onclick="showRef(event, 'ref53 ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref53 ref54 ref55">(53−55)</a> or arrestin.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> However, it is unlikely that compound <b>40</b> acts as a pepducin. In fact, this peptide is palmitoylated at the C-terminus while pepducins are lipidated at their N-terminus. More importantly, there is no homology between the peptide sequence of compound 40 and those of the intracellular loops or the C-terminus of the NOP receptor.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> The lipophilicity of the palmitoyl moiety may favor the insertion of the peptide into the plasma membrane or it may directly interact with the NOP transmembrane domains. In both cases, this mechanism may favor G protein- rather than arrestin-preferring NOP active conformations.</div><div class="NLM_p">To gain insights into the mechanism of action of compounds <b>40</b> and <b>43</b>, their effects on NOP/G protein interactions were challenged with the NOP selective antagonist SB-612111<a onclick="showRef(event, 'ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref58 ref59">(58,59)</a> and compared to those obtained with the standard agonist N/OFQ(-1–13)-NH<sub>2</sub>. The antagonist did not produce any effect per se but elicited a rightward parallel shift of the concentration–response curve to N/OFQ(-1–13)-NH<sub>2</sub> without modifying the agonist maximal effect; a p<i>A</i><sub>2</sub> value of 8.05 (CL<sub>95%</sub> 7.74–8.37) was derived from these experiments. Similar results were obtained using compound <b>40</b> and <b>43</b> as NOP agonists; the p<i>A</i><sub>2</sub> values of SB-612111 calculated from these experiments were 7.95 (CL<sub>95%</sub> 7.43–8.47) and 7.77 (CL<sub>95%</sub> 7.32–8.21), respectively (see Figure S1 of the <a href="/doi/suppl/10.1021/acs.jmedchem.9b02057/suppl_file/jm9b02057_si_001.pdf" class="ext-link">Supporting Information</a>). Thus, SB-612111 competitively antagonized the effects of N/OFQ,<a onclick="showRef(event, 'ref19 ref60'); return false;" href="javascript:void(0);" class="ref ref19 ref60">(19,60)</a> N/OFQ(1–13)-NH<sub>2</sub>, and compounds <b>40</b> and <b>43</b>, showing similar p<i>A</i><sub>2</sub> values. This demonstrated that similar to N/OFQ and N/OFQ(1–13)-NH<sub>2</sub>, compounds <b>40</b> and <b>43</b> activate the NOP receptor by interacting with the orthosteric binding pocket that has been described at the atomic level in previous NOP/C-24<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> and NOP/SB-612111<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> crystal structure studies.</div><div class="NLM_p">Finally, in order to investigate whether the effects of palmitoylation of the peptide C-terminus are specific for N/OFQ and the NOP receptor or might influence the pharmacology of other opioid systems, this chemical modification has been applied to dermorphin, deltorphin A, and Leu-enkephalin,<a onclick="showRef(event, 'ref61 ref62'); return false;" href="javascript:void(0);" class="ref ref61 ref62">(61,62)</a> and the peptides evaluated at the mu (<a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>) and delta (<a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a></a>) opioid receptors. Dermorphin promoted mu receptor interactions with G protein and arrestin with similar potency while producing an incomplete concentration–response curve at the delta receptor. Opposite results were obtained with deltorphin A that promoted delta receptor interactions with G protein and arrestin with similar potency while eliciting stimulatory effects at the mu receptor only at micromolar concentrations. Leu-enkephalin produced similar stimulatory effects at mu and delta receptors, being slightly more potent on the latter. Palmitoylation of the C terminus of dermorphin (compound <b>57</b>) increased peptide potency both in mu/G protein and mu/β-arrestin 2 experiments. In addition, <b>57</b> was able to stimulate delta receptor interactions with both G protein and β-arrestin 2 although with lower potency compared to the mu receptor. Palmitoylation of the C terminus of deltorphin A (<b>58</b>) increased peptide potency in delta/G protein but not in delta/β-arrestin 2 studies, thus displaying a bias factor of 1.06. In addition, compound <b>58</b> was able to stimulate mu receptor interactions with both G protein and β-arrestin 2 although with lower potency compared to the delta/G protein experiments. Finally, when C-terminal palmitoylation was applied to Leu-enkephalin (compound <b>59</b>), it caused a large increase in receptor/G protein potency both at the mu and delta receptors. However, this was associated with a slight increase in mu/β-arrestin 2 potency and with a slight decrease in delta/β-arrestin 2 potency. Thus, compound <b>59</b> behaved as a G protein biased delta agonist with a bias factor of 1.70.</div><div class="NLM_p">Results obtained with reference opioid peptides confirmed previous findings:<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> dermorphin and deltorphin A behaved as selective agonists for the mu and delta receptors, respectively, while Leu-enkephalin displayed similar potency at both receptors. C-terminus palmitoylated peptides (compounds <b>57–59</b>) consistently displayed higher potency than their parent peptides in receptor/G protein experiments both at the mu and delta receptors. For the mu receptor, a similar increase in potency was also measured in receptor/β-arrestin 2 experiments; as a result, palmitoylated opioid peptides behaved as potent unbiased mu receptor agonists. On the contrary, for the delta receptor, the increase of receptor/G protein potency of palmitoylated peptides was associated with a slight decrease in receptor/β-arrestin 2 potency; as a consequence, palmitoylated deltorphin A (compound <b>58</b>) and Leu-enkephalin (compound <b>59</b>) behaved as potent G protein biased delta receptor agonists (bias factors 1.06 and 1.70, respectively).</div><div class="NLM_p last">Collectively the results obtained by the insertion of a palmitoyl moiety at the C-terminal of N/OFQ or opioid peptides consistently produced a rather large (10–100-fold) increase of agonist potency in receptor/G protein experiments. On the contrary, the effect of this chemical modification in receptor/β-arrestin 2 experiments was variable depending on the receptor under evaluation: increase in potency for the mu opioid receptor and no changes or little decrease in potency for the delta and NOP receptors. These combined actions make palmitoylated peptides, at least for these specific examples, G protein biased agonists for NOP and delta receptor and unbiased agonists for the mu receptors.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66886" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66886" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The present study was aimed at the identification of NOP receptor peptide biased agonists. Subtle chemical modifications in the N/OFQ(1–13)-NH<sub>2</sub> sequence even if able to produce large changes in ligand potency and/or efficacy did not provide useful information for the design of NOP biased agonists. Biased agonism toward G protein can be obtained by N/OFQ(1–13)-NH<sub>2</sub> C-terminal modifications with positively charged peptide sequences or linear aliphatic chains. The best results in terms of bias factors were obtained with the palmitoyl moiety. This chemical modification was also applied to mu and delta receptor peptide ligands; palmitoylated peptides consistently behaved as highly potent agonists for receptor/G protein interactions acting as G protein biased agonists for NOP and delta receptors and as unbiased agonists for the mu receptor. Further studies are needed to understand the mechanism by which C-terminal palmitoylation modulates the pharmacological profile of peptide agonists. Nevertheless, palmitoylation of biologically active peptides can be proposed as a chemical probe for generating highly potent agonists and in some cases G protein biased agonists. The availability of biased ligands together with solid knowledge of cell types and relative signaling pathways responsible for pathologies<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> are equally important to reduce translational gaps and eventually make functional selectivity a successful strategy in drug discovery.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12741" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12741" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Materials and Methods</h3><div class="NLM_p last">All chemicals, the resins for peptide synthesis, and Fmoc-protected amino acids were purchased from Bachem and Sigma-Aldrich, they were enantiopure and used as received. Peptides were synthesized according to published methods<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> using Fmoc/<i>t</i>-butyl chemistry with a Syro XP multiple peptide synthesizer (MultiSynTech GmbH, Witten Germany). Peptides were synthesized at a 0.11 mM scale on a Rink amide MBHA resin [4-(2′,4′-dimethoxyphenyl-Fmoc-aminomethyl)-phenoxyacetamido-norleucyl-MBHA resin; loading 0.55 mmol/g] as a solid support. Fmoc-amino acids (4-fold excess) were sequentially coupled to the growing peptide chain using DIPCDI/HOBt (<i>N</i>,<i>N</i>′-diisopropylcarbodiimide/1-hydroxybenzotriazole) (4-fold excess) as an activating mixture for 1 h at room temperature. Cycles of deprotection of Fmoc (40% piperidine/<i>N</i>,<i>N</i>-dimethylformamide) and coupling with the subsequent amino acids were repeated until the desired peptide-bound resin was obtained. Peptides were cleaved from the resin using the standard cleavage cocktail (95% TFA, 2.5% H<sub>2</sub>O, 2.5% triethylsilane) at room temperature for 3 h. After this time, peptides were treated with ice-cold diethyl ether and the precipitate was isolated by centrifugation. Analytical high-performance liquid chromatography (HPLC) analyses were performed on a Beckman 116 liquid chromatograph equipped with a Beckman 166 diode array detector. Analytical purity of the peptides was assessed using a XBridge C18 column (4.6 × 150 mm, 5 μm particle size) at a flow rate of 0.7 mL/min with a linear gradient from 100% of solvent A (H<sub>2</sub>O + 0.1% TFA) to 100% of solvent B (CH<sub>3</sub>CN + 0.1% TFA) over 25 min. All final compounds showed ≥95% purity when monitored at 220 nm, and their molecular weights were confirmed by a mass spectrometer ESI Micromass ZQ. High-resolution mass spectrometry (HRMS) analysis of final compounds (see the <a href="/doi/suppl/10.1021/acs.jmedchem.9b02057/suppl_file/jm9b02057_si_001.pdf" class="ext-link">Supporting Information</a>) was performed with an ESI-Q-TOF Nano HPLC-CHIP Cube Agilent 6520 instrument or with a Q Exactive Hybrid Quadrupole-Orbitrap (Thermo Fisher Scientific) spectrometer equipped with HESI-II (ESI). For the HRMS spectra, the samples were analyzed by dissolving them in a mixture H<sub>2</sub>O/CH<sub>3</sub>OH 3:7 with 0.1% of formic acid (see the <a href="/doi/suppl/10.1021/acs.jmedchem.9b02057/suppl_file/jm9b02057_si_001.pdf" class="ext-link">Supporting Information</a>). NMR spectroscopy was performed using a Varian 400 MHz instrument (s: singlet, d: doublet, dd: double doublet, t: triplet, and m: multiplet), and all experiments were performed in CDCl<sub>3</sub>. Crude peptides were purified on a reverse-phase Waters Prep 600 HPLC system equipped with a Jupiter column C18 (250 × 30 mm, 300 Å, 15 μm spherical particle size) eluted with solvent A (H<sub>2</sub>O + 0.1% TFA) and B (40% H<sub>2</sub>O in CH<sub>3</sub>CN + 0.1% TFA) at a flow rate of 20 mL/min. Gradient was programmed time by time taking into account the analytical HPLC profile of the crude peptide. For the elution of lipidated compounds, solvent B has been replaced with CH<sub>3</sub>CN + 0.1% TFA. Stock solutions of the tested compounds were made in bidistilled water (1 mM) and stored at −20 °C. All cell culture media and supplements were purchased from Invitrogen (Paisley, UK) or EuroClone (Milano, Italy). Native coelenterazine (CLZN, 5 mM, EtOH) was purchased from Synchem UG & Co. KG (Altenburg, Germany). SB-612111 was purchased from Tocris Bioscience (Brisol, UK). Stock solution of SB-612111 was made in dimethyl sulfoxide (10 mM) and stored at −20 °C.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Chemistry</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Synthesis of Compounds <b>62a–c</b></h4><div class="NLM_p">To a stirring solution of <b>60a–c</b> (1.0 mmol) in dimethylformamide (DMF) (2 mL) at 0 °C, hexafluorophosphate azabenzotriazole tetramethyl uronium (HATU) (1.2 equiv) and <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA) (2.0 equiv) were added. After 10 min, compound <b>61</b> (2.0 equiv), previously dissolved in DMF (2 mL) and DIPEA (2.0 equiv), was added dropwise. The reaction was stirred at room temperature for 16 h. After the solvent was evaporated under vacuum, the residue was dissolved in EtOAc (30 mL) and the organic layer was washed with 1 M HCl (30 mL), 5% NaHCO<sub>3</sub> (25 mL), and brine (10 mL). The organic phase was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub> and concentrated to dryness. The crude residue was purified <i>via</i> column chromatography using a mixture of EtOAc and petroleum ether as the eluent to give compounds <b>62a–c</b>.</div><div id="sec4_2_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i20" class="anchor-spacer"></div><h5 class="article-section__title" id="_i20"> <i>N</i>-(3-(2,5-Dioxo-2,5-dihydro-1<i>H</i>-pyrrol-1-yl)propyl)tetradecanamide (<b>62a</b>)</h5><div class="NLM_p last">White amorphous solid (yield 15%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 6.72 (s, 2H), 6.06 (m, 1H), 3.61 (t, <i>J</i> = 6.4 Hz, 2H), 3.21 (t, <i>J</i> = 7.4 Hz, 2H), 2.23 (m, 2H), 1.80 (m, 2H), 1.66 (m, 2H), 1.27 (m, 20H), 0.89 (t, <i>J</i> = 6.3 Hz, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 173.41, 171.19, 134.33, 94.74, 36.99, 35.99, 34.88, 32.01, 29.74, 29.59, 29.49, 28.40, 25.87, 22.78, 14.23. MS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>21</sub>H<sub>36</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 365.53; found, 365.32.</div></div><div id="sec4_2_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i21" class="anchor-spacer"></div><h5 class="article-section__title" id="_i21"> <i>N</i>-(3-(2,5-Dioxo-2,5-dihydro-1<i>H</i>-pyrrol-1-yl)propyl)palmitamide (<b>62b</b>)</h5><div class="NLM_p last">White amorphous solid (yield 37%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 6.74 (s, 2H), 6.00 (m, 1H), 3.60 (t, <i>J</i> = 6.7 Hz, 2H), 3.21 (m, 2H), 2.23 (t, <i>J</i> = 7.5 Hz, 2H), 1.78 (m, 4H), 1.66 (m, 2H), 1.29 (m, 22H), 0.89 (t, <i>J</i> = 6.8 Hz, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 173.41, 171.17, 134.30, 110.26, 37.01, 35.90, 34.87, 32.01, 29.61, 28.40, 25.85, 22.78, 14.23. MS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>23</sub>H<sub>40</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 393.58; found, 393.41.</div></div><div id="sec4_2_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> <i>N</i>-(3-(2,5-Dioxo-2,5-dihydro-1<i>H</i>-pyrrol-1-yl)propyl)stearamide (<b>62c</b>)</h5><div class="NLM_p last">White amorphous solid (yield 11%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 6.75 (s, 2H), 6.10 (m, 1H), 3.60 (t, <i>J</i> = 6.3 Hz, 2H), 3.22 (m, 2H), 2.24 (t, <i>J</i> = 7.8 Hz, 2H), 1.80 (m, 4H), 1.64 (m, 2H), 1.29 (m, 26H), 0.89 (t, <i>J</i> = 6.4 Hz, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 173.54, 171.19, 134.32, 36.97, 35.95, 34.88, 32.01, 29.62, 28.40, 25.86, 22.79, 14.23. MS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>25</sub>H<sub>44</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 421.64; found, 421.50.</div></div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> General Procedure for the Synthesis of <b>65d–m</b></h3><div class="NLM_p last">A solution of 4-(2,5-dioxo-2,5-dihydro-1<i>H</i>-pyrrol-1-yl)butanoic acid (<b>64</b>, 4.0 equiv),<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> EDAC (4.0 equiv), and HOBt (4.0 equiv) in DMF (3 mL) was added to the peptide-resin <b>63d–m</b> (1.0 equiv). The mixture was left stirring for 3 h, and the completion of the reaction was monitored <i>via</i> electrospray ionization–mass spectrometry (ESI-MS) after micro-cleavage of the product from the resin using the standard cleavage cocktail. Compounds were cleaved from the resin using the standard cleavage cocktail (95% TFA, 2.5% H<sub>2</sub>O, 2.5% triethylsilane) at room temperature for 3 h. After this time, the mixtures were treated with ice-cold diethyl ether, and the precipitate was isolated through centrifugation. The crude mixture was purified by preparative HPLC to give the desired derivatives <b>65d–m</b> (15–48% yields). All products were characterized by ESI-MS (see the <a href="/doi/suppl/10.1021/acs.jmedchem.9b02057/suppl_file/jm9b02057_si_001.pdf" class="ext-link">Supporting Information</a>).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Synthesis of <i>N</i>-Cyclooctyl-4-(2,5-dioxo-2,5-dihydro-1<i>H</i>-pyrrol-1-yl)butanamide (<b>67</b>)</h3><div class="NLM_p last">To a solution of the maleimidocarboxylic NHS-ester <b>66</b> (1.0 mmol)<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> in CH<sub>3</sub>CN, cyclooctylamine (1.0 equiv) and Et<sub>3</sub>N (1.0 equiv) were added at room temperature and the reaction was left stirring for 30 min. After the removal of the solvent, the crude residue was dissolved in EtOAc (50 mL) and the organic phase was washed with 1 M HCl (20 mL) and brine (20 mL). The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under vacuum. <b>67</b> was obtained after purification <i>via</i> column chromatography with a 2:1 mixture of EtOAc and petroleum ether. White amorphous solid (67% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 6.72 (s, 2H), 5.85 (m, 1H), 4.00 (m, 1H), 3.58 (t, <i>J</i> = 7.6 Hz, 2H), 2.12 (t, <i>J</i> = 7.0 Hz, 2H), 1.94 (m, 2H), 1.84 (m, 2H), 1.59 (m, 12H). <sup>13</sup>C NMR (CDCl<sub>3</sub>): δ 170.43, 169.74, 133.55, 48.83, 36.50, 33.27, 31.52, 26.64, 24.77, 24.46, 23.01. MS (ESI) <i>m</i>/<i>z</i>: calcd for C<sub>16</sub>H<sub>24</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 293.38; found, 293.49. <i>t</i><sub>R</sub> = 19.00.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> General Approach for the Synthesis of the N/OFQ Peptide Derivatives <b>39–59</b><i>via</i> Thiol-Michael Coupling</h3><div class="NLM_p last">To a solution of the maleimido compound (<b>62a–c</b>, <b>65d–m</b> and <b>67</b>, 10 μmol) and the appropriate peptide sequence functionalized with a cysteine residue (1.05 equiv) in CH<sub>3</sub>CN/H<sub>2</sub>O (2:1, 300 μL), 10 μL of a 5% aqueous solution of NaHCO<sub>3</sub> were added. After 5 min, the ESI-MS spectrum showed the completion of the reaction and the crude mixture was purified by preparative HPLC to give the desired derivatives <b>39–59</b>. All products were characterized by ESI-MS, and their purity degree (>95% at 220 nm) was evaluated by analytical HPLC (see the <a href="/doi/suppl/10.1021/acs.jmedchem.9b02057/suppl_file/jm9b02057_si_001.pdf" class="ext-link">Supporting Information</a>).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Pharmacology</h3><div id="sec4_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> BRET Assay</h4><div class="NLM_p">For this study, human embryonic kidney (HEK293) cells, permanently co-expressing the different pairs of fusion proteins NOP-RLuc/Gβ1-RGFP and NOP-RLuc/β-arrestin 2-RGFP, and SH-SY5Y cells stably, co-expressing the different pairs of fusion proteins mu-RLuc/Gβ1-RGFP and mu-RLuc/β-arrestin 2-RGFP or delta-RLuc/Gβ1-RGFP and delta-RLuc/β-arrestin 2-RGFP, were used. Cells were prepared and cultured, as described previously.<a onclick="showRef(event, 'ref19 ref23'); return false;" href="javascript:void(0);" class="ref ref19 ref23">(19,23)</a> Cells were grown in Dulbecco’s modified Eagle’s medium (DMEM)/HAMS F12 (1:1) supplemented with 10% fetal bovine serum, penicillin G (100 units/mL), streptomycin (100 μg mL<sup>–1</sup>), <span class="smallcaps smallerCapital">l</span>-glutamine (2 mM), fungizone (1 μg mL<sup>–1</sup>), geneticin (G418; 200 μg mL<sup>–1</sup>), and hygromycin B (100 μg mL<sup>–1</sup>) in a humidified atmosphere of 5% CO<sub>2</sub> at 37 °C. For G protein experiments, enriched plasma membrane aliquots from transfected cells were prepared by differential centrifugation; cells were detached with phosphate buffered saline (PBS)/EDTA solution (1 mM, pH 7.4 NaOH), then, after 5 min 500<i>g</i> centrifugation, Dounce-homogenized (30 strokes) in cold homogenization buffer (tris(hydroxymethyl)aminomethane 5 mM, EGTA 1 mM, DTT 1 mM, pH 7.4 HCl) in the presence of sucrose (0.32 M). Three following centrifugations were performed at 10 min 1000<i>g</i> (4 °C), and the supernatants were kept. Two 20 min 24,000<i>g</i> (4 °C) subsequent centrifugations (the second in the absence of sucrose) were performed for separating enriched membranes that, after discarding the supernatant, were kept in ultrapure water at −80 °C.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> The protein concentration in membrane preparations was determined using the QPRO-BCA kit (Cyanagen Srl, Bologna, IT) and the Ensight (PerkinElmer, Waltham, USA) in the spectrophotometer mode.</div><div class="NLM_p last">Luminescence in membranes was recorded in 96-well untreated white opaque microplates, while in whole cells, it was recorded in 96-well sterile poly-<span class="smallcaps smallerCapital">d</span>-lysine-coated white opaque microplates (PerkinElmer, Waltham, MA, USA) using the luminometer Victor 2030 (PerkinElmer, Waltham, MA, USA). For the determination of receptor/G protein interactions, membranes (3 μg of protein) prepared from cells co-expressing NOP (or mu or delta)/RLuc and Gβ1/RGFP were added to wells in DPBS. For the determination of receptor/β-arrestin 2 interactions, cells co-expressing NOP (or mu or delta)/RLuc and β-arrestin 2/RGFP were plated 24 h before the experiment in poly-<span class="smallcaps smallerCapital">d</span>-lysine-treated plates (100,000 cells/well). The cells were prepared for the experiment substituting the medium with PBS with MgCl<sub>2</sub> (0.5 mM) and CaCl<sub>2</sub> (0.9 mM). Coelenterazine at a final concentration of 5 μM was injected 15 min prior to reading the cell plate. Different concentrations of ligands in 20 μL of PBS–BSA 0.01% were added and incubated 5 min before reading luminescence. In antagonism experiments, antagonists (<b>27</b>, 10 μM; <b>28</b>, 10 μM; <b>30</b>, 1 μM; <b>31</b>, 1 μM; SB-612111, 10 nM) were incubated 15 min before adding N/OFQ(1–13)-NH<sub>2</sub>. The BRET ratio was measured 15 min after agonist injection. All experiments were performed at room temperature.</div></div><div id="sec4_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Data Analysis and Terminology</h4><div class="NLM_p">The pharmacological terminology adopted in this paper is consistent with IUPHAR recommendations.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> All data are expressed as the mean ± sem of five independent experiments made in duplicate. For potency values, 95% confidence limits (CL<sub>95%</sub>) were indicated. Ligand efficacy was expressed as intrinsic activity (α), calculated as the ratio between the <i>E</i><sub>max</sub> of the ligand and that of the standard agonist. Count per second (CPS) measured for the RGFP and RLuc light emitted using 510(10) and 460(25) filters (PerkinElmer, Waltham, MA), respectively, was used to calculate the BRET ratio. All data are expressed as the stimulated BRET ratio, that is, the ratio between CPS from RGFP and RLuc in the presence of ligands minus the BRET ratio in vehicle-treated wells. Maximal agonist effects were expressed as a fraction of the standard [N/OFQ(1–13)-NH<sub>2</sub> for NOP, deltorphin A for delta, dermorphin for mu] maximal effects which were determined in every assay plate. Agonist potencies are given as pEC<sub>50</sub>, that is, the negative logarithm to base 10 of the molar concentration of an agonist that produces 50% of the maximal effect of that agonist. Concentration–response curves to agonists were fitted to the classical four-parameter logistic nonlinear regression model<span class="NLM_disp-formula" id="ueq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.9b02057/20210219/images/medium/jm9b02057_m001.gif" alt="" id="_i29" /></img></span></div><div class="NLM_p">EC<sub>50</sub> is the concentration of agonist producing a 50% maximal response. Curves fitting were performed using PRISM 6.0 (GraphPad Software In., San Diego, USA). As listed in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>–<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>–<a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a>, ligand potency is expressed as a concentration ratio (CR), calculated as the ratio between the EC<sub>50</sub> of the ligand and that of the standard agonist.</div><div class="NLM_p">Antagonist potencies were derived from the Gaddum–Schild equation<span class="NLM_disp-formula" id="ueq2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.9b02057/20210219/images/medium/jm9b02057_m002.gif" alt="" id="_i30" /></img></span>assuming a slope value equal to unity, where CR indicates the ratio between agonist potency in the presence and absence of antagonist.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a></div><div class="NLM_p">Bias factors were calculated using N/OFQ(1–13)-NH<sub>2</sub> for NOP, dermorphin for mu, and deltorphin A for delta as standard unbiased ligand.</div><div class="NLM_p">The concentration–response curves of each compound were fitted to the Black–Leff operational model, described by Nagi and Pineyro<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a><span class="NLM_disp-formula" id="ueq3"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.9b02057/20210219/images/medium/jm9b02057_m003.gif" alt="" id="_i31" /></img></span>where [<i>A</i>] is the agonist concentration, the maximal response of the system is given by <i>E</i><sub>m</sub>, <i>n</i> is a fitting parameter for the slope, the affinity of the agonist is represented by the equilibrium dissociation constant of the agonist–receptor complex (<i>K</i><sub>A</sub>), and the efficacy of the agonist is defined by τ. τ and <i>K</i><sub>A</sub> are descriptive parameters of intrinsic efficacy and binding affinity and may be directly obtained by fitting the experimental data to the operational equation and can be expressed as “transduction coefficients” log(τ/<i>K</i><sub>A</sub>). The relative efficiency of agonists producing activation of any pathways can thus be quantified with a “normalized” transduction coefficient, namely Δlog(τ/<i>K</i><sub>A</sub>). Finally, the bias factors were calculated as difference between Δlog(τ/<i>K</i><sub>A</sub>) values for a given agonist between the pathways (G protein and β-arrestin 2)<span class="NLM_disp-formula" id="ueq4"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.9b02057/20210219/images/medium/jm9b02057_m004.gif" alt="" id="_i32" /></img></span></div><div class="NLM_p last">Bias factors are expressed as the mean of at least five independent experiments, and CL<sub>95%</sub> are indicated. Biased factor is considered to be statistically different from 0 when 0 is not included in CL<sub>95%</sub>. α values have been statistically analyzed with one-way analysis of variance (ANOVA) followed by the Dunnett post hoc test for multiple comparisons; <i>P</i> values less than 0.05 were considered to be statistically significant.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33"><a href="/doi/suppl/10.1021/acs.jmedchem.9b02057" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40312" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40312" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.9b02057?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b02057</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">ESI mass spectra of compounds <b>62a–c</b>, <b>65d–m</b>, <b>67</b>, and <b>39–59</b>; HPLC chromatograms of compounds <b>67</b> and <b>39–59</b>; HRMS profiles of final compounds; concentration–response curves to N/OFQ(1–13)-NH<sub>2</sub>, compounds <b>40</b> and <b>43</b> in the absence and presence of the NOP antagonist SB-612111; and chemical structures of unusual amino acids (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02057/suppl_file/jm9b02057_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b02057/suppl_file/jm9b02057_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02057/suppl_file/jm9b02057_si_001.pdf">jm9b02057_si_001.pdf (3.75 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02057/suppl_file/jm9b02057_si_002.csv">jm9b02057_si_002.csv (17.04 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b02057" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51085" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51085" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Delia Preti</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemical and Pharmaceutical Sciences, University of Ferrara, Via Luigi Borsari 46, 44121 Ferrara, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1075-3781" title="Orcid link">http://orcid.org/0000-0002-1075-3781</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#680c0d04010946181a0d1c01281d06010e0d46011c"><span class="__cf_email__" data-cfemail="0165646d68602f717364756841746f6867642f6875">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Salvatore Pacifico</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemical and Pharmaceutical Sciences, University of Ferrara, Via Luigi Borsari 46, 44121 Ferrara, Italy</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3377-5107" title="Orcid link">http://orcid.org/0000-0002-3377-5107</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Federica Ferrari</span> - <span class="hlFld-Affiliation affiliation">Department
of Medical Sciences, Section of Pharmacology, University of Ferrara, Via Fossato di Mortara 17/19, 44121 Ferrara, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Valentina Albanese</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemical and Pharmaceutical Sciences, University of Ferrara, Via Luigi Borsari 46, 44121 Ferrara, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Erika Marzola</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemical and Pharmaceutical Sciences, University of Ferrara, Via Luigi Borsari 46, 44121 Ferrara, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joaquim Azevedo Neto</span> - <span class="hlFld-Affiliation affiliation">Department
of Medical Sciences, Section of Pharmacology, University of Ferrara, Via Fossato di Mortara 17/19, 44121 Ferrara, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chiara Ruzza</span> - <span class="hlFld-Affiliation affiliation">Department
of Medical Sciences, Section of Pharmacology, University of Ferrara, Via Fossato di Mortara 17/19, 44121 Ferrara, Italy</span>; 
    <span class="hlFld-Affiliation affiliation">LTTA
Laboratory for Advanced Therapies, Technopole
of Ferrara, Via Fossato
di Mortara 70, 44121 Ferrara, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Girolamo Calò</span> - <span class="hlFld-Affiliation affiliation">Department
of Medical Sciences, Section of Pharmacology, University of Ferrara, Via Fossato di Mortara 17/19, 44121 Ferrara, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Remo Guerrini</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemical and Pharmaceutical Sciences, University of Ferrara, Via Luigi Borsari 46, 44121 Ferrara, Italy</span>; 
    <span class="hlFld-Affiliation affiliation">LTTA
Laboratory for Advanced Therapies, Technopole
of Ferrara, Via Fossato
di Mortara 70, 44121 Ferrara, Italy</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>S.P. and F.F. authors contributed equally.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13062" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13062" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">D.P. is supported by the grant FAR 2018 (Fondo di Ateneo per la Ricerca Scientifica, FAR1833745) of the University of Ferrara. S.P., F.F., D.P., G.C., and R.G. are supported by the grant PRIN 2015 (Prot. 2015WX8Y5B_002) from the Italian Ministry of Research and Education.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">BRET</td><td class="NLM_def"><p class="first last">bioluminescence resonance energy transfer</p></td></tr><tr><td class="NLM_term">BSA</td><td class="NLM_def"><p class="first last">bovine serum albumin</p></td></tr><tr><td class="NLM_term">DIPCDI</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>′-diisopropylcarbodiimide</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">CL<sub>95%</sub></td><td class="NLM_def"><p class="first last">95% confidence limits</p></td></tr><tr><td class="NLM_term">CLZN</td><td class="NLM_def"><p class="first last">coelenterazine</p></td></tr><tr><td class="NLM_term">CPS</td><td class="NLM_def"><p class="first last">count per second</p></td></tr><tr><td class="NLM_term">CR</td><td class="NLM_def"><p class="first last">concentration ratio</p></td></tr><tr><td class="NLM_term">CRC</td><td class="NLM_def"><p class="first last">concentration–response curve</p></td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Dulbecco’s modified Eagle’s medium</p></td></tr><tr><td class="NLM_term">DPBS</td><td class="NLM_def"><p class="first last">phosphate buffered saline</p></td></tr><tr><td class="NLM_term">DTT</td><td class="NLM_def"><p class="first last">dithiothreitol</p></td></tr><tr><td class="NLM_term">EDAC</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-dimethylaminopropyl)carbodiimide</p></td></tr><tr><td class="NLM_term">EGTA</td><td class="NLM_def"><p class="first last">ethylene glycol-bis(β-aminoethyl ether)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetra-acetic acid</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G protein-coupled receptor</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">hexafluorophosphate azabenzotriazole tetramethyl uronium</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">1-hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">MBHA resin</td><td class="NLM_def"><p class="first last">4-methylbenzhydrylamine resin</p></td></tr><tr><td class="NLM_term">NHS</td><td class="NLM_def"><p class="first last"><i>N</i>-hydroxy succinimide</p></td></tr><tr><td class="NLM_term">N/OFQ</td><td class="NLM_def"><p class="first last">nociceptin/orphanin FQ</p></td></tr><tr><td class="NLM_term">NOP</td><td class="NLM_def"><p class="first last">N/OFQ peptide</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate buffered saline</p></td></tr><tr><td class="NLM_term">PWT</td><td class="NLM_def"><p class="first last">peptide welding technology</p></td></tr><tr><td class="NLM_term">RGFP</td><td class="NLM_def"><p class="first last">recombinant green fluorescent protein</p></td></tr><tr><td class="NLM_term">RLuc</td><td class="NLM_def"><p class="first last">Renilla luciferase</p></td></tr><tr><td class="NLM_term">sem</td><td class="NLM_def"><p class="first last">standard error of the mean</p></td></tr><tr><td class="NLM_term">SPPS</td><td class="NLM_def"><p class="first last">solid phase peptide synthesis</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i37">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22561" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22561" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 70 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. G.</span></span> <span> </span><span class="NLM_article-title">The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">694</span>– <span class="NLM_lpage">710</span>, <span class="refDoi"> DOI: 10.1038/nrd2572</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1038%2Fnrd2572" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=18670432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptFOqsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=694-710&author=D.+G.+Lambert&title=The+nociceptin%2Forphanin+FQ+receptor%3A+a+target+with+broad+therapeutic+potential&doi=10.1038%2Fnrd2572"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential</span></div><div class="casAuthors">Lambert, David G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">694-710</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In this Review, Lambert describes the physiol. and potential clin. applications of nociceptin/orphanin FQ and its receptor.  This peptide-receptor system has been implicated in a wide range of biol. functions such as pain, drug abuse, cardiovascular control and immunity.  Identification of the enigmatic nociceptin/orphanin FQ peptide (N/OFQ) in 1995 represented the first successful use of reverse pharmacol. and led to deorphanization of the N/OFQ receptor (NOP).  Subsequently, the N/OFQ-NOP system has been implicated in a wide range of biol. functions, including pain, drug abuse, cardiovascular control and immunity.  Although this could be considered a hurdle for the development of pharmaceuticals selective for a specific disease indication, NOP represents a viable drug target.  This article describes potential clin. indications and highlights the current status of the very limited no. of clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuID92HZwUB7Vg90H21EOLACvtfcHk0li7BCSme9OKQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptFOqsL0%253D&md5=46c1952ed4a0ac1aa7779276bda5bba6</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd2572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2572%26sid%3Dliteratum%253Aachs%26aulast%3DLambert%26aufirst%3DD.%2BG.%26atitle%3DThe%2520nociceptin%252Forphanin%2520FQ%2520receptor%253A%2520a%2520target%2520with%2520broad%2520therapeutic%2520potential%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D694%26epage%3D710%26doi%3D10.1038%2Fnrd2572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Toll, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruchas, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calo’, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaveri, N. T.</span></span> <span> </span><span class="NLM_article-title">Nociceptin/orphanin FQ receptor structure, signaling, ligands, functions, and interactions with opioid systems</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">419</span>– <span class="NLM_lpage">457</span>, <span class="refDoi"> DOI: 10.1124/pr.114.009209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1124%2Fpr.114.009209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=26956246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A280%3ADC%252BC28josFaltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2016&pages=419-457&author=L.+Tollauthor=M.+R.+Bruchasauthor=G.+Calo%E2%80%99author=B.+M.+Coxauthor=N.+T.+Zaveri&title=Nociceptin%2Forphanin+FQ+receptor+structure%2C+signaling%2C+ligands%2C+functions%2C+and+interactions+with+opioid+systems&doi=10.1124%2Fpr.114.009209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems</span></div><div class="casAuthors">Toll Lawrence; Bruchas Michael R; Calo' Girolamo; Cox Brian M; Zaveri Nurulain T</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">419-57</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The NOP receptor (nociceptin/orphanin FQ opioid peptide receptor) is the most recently discovered member of the opioid receptor family and, together with its endogenous ligand, N/OFQ, make up the fourth members of the opioid receptor and opioid peptide family.  Because of its more recent discovery, an understanding of the cellular and behavioral actions induced by NOP receptor activation are less well developed than for the other members of the opioid receptor family.  All of these factors are important because NOP receptor activation has a clear modulatory role on mu opioid receptor-mediated actions and thereby affects opioid analgesia, tolerance development, and reward.  In addition to opioid modulatory actions, NOP receptor activation has important effects on motor function and other physiologic processes.  This review discusses how NOP pharmacology intersects, contrasts, and interacts with the mu opioid receptor in terms of tertiary structure and mechanism of receptor activation; location of receptors in the central nervous system; mechanisms of desensitization and downregulation; cellular actions; intracellular signal transduction pathways; and behavioral actions with respect to analgesia, tolerance, dependence, and reward.  This is followed by a discussion of the agonists and antagonists that have most contributed to our current knowledge.  Because NOP receptors are highly expressed in brain and spinal cord and NOP receptor activation sometimes synergizes with mu receptor-mediated actions and sometimes opposes them, an understanding of NOP receptor pharmacology in the context of these interactions with the opioid receptors will be crucial to the development of novel therapeutics that engage the NOP receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4KujB2a63gCEJCPKhJPuqfW6udTcc2eZ5Q9bPwrauzbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28josFaltw%253D%253D&md5=2a2c601fcd493fa3f67b0adee9259e02</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1124%2Fpr.114.009209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.114.009209%26sid%3Dliteratum%253Aachs%26aulast%3DToll%26aufirst%3DL.%26aulast%3DBruchas%26aufirst%3DM.%2BR.%26aulast%3DCalo%25E2%2580%2599%26aufirst%3DG.%26aulast%3DCox%26aufirst%3DB.%2BM.%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26atitle%3DNociceptin%252Forphanin%2520FQ%2520receptor%2520structure%252C%2520signaling%252C%2520ligands%252C%2520functions%252C%2520and%2520interactions%2520with%2520opioid%2520systems%26jtitle%3DPharmacol.%2520Rev.%26date%3D2016%26volume%3D68%26spage%3D419%26epage%3D457%26doi%3D10.1124%2Fpr.114.009209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Preti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caló, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span> <span> </span><span class="NLM_article-title">NOP-targeted peptide ligands</span>. <i>Handb. Exp. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>254</i></span>,  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">36</span>, <span class="refDoi"> DOI: 10.1007/164_2018_198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1007%2F164_2018_198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=30689091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmtlGltbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=254&publication_year=2019&pages=17-36&author=D.+Pretiauthor=G.+Cal%C3%B3author=R.+Guerrini&title=NOP-targeted+peptide+ligands&doi=10.1007%2F164_2018_198"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">NOP-Targeted Peptide Ligands</span></div><div class="casAuthors">Preti, Delia; Calo, Girolamo; Guerrini, Remo</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">254</span>
        (<span class="NLM_cas:issue">Nociceptin/Orphanin FQ Peptide Receptor</span>),
    <span class="NLM_cas:pages">17-36</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">1865-0325</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  The nociceptin/orphanin FQ (N/OFQ)-N/OFQ peptide (NOP) receptor system is widely distributed at both the peripheral and central level where it modulates important biol. functions with increasing therapeutic implications.  This chapter wants to provide a comprehensive and updated overview focused on the available structure-activity relationship studies on NOP receptor peptide ligands developed through different rational approaches.  Punctual modifications and cyclizations of the N/OFQ sequence have been properly combined furnishing potent NOP selective ligands with different pharmacol. activities (full and partial agonists, pure antagonists) and enhanced metabolic stability in vivo.  The screening of peptide libraries provided a second family of NOP ligands that have been successfully optimized.  Moreover, recent findings suggest the possibility to apply different multimerization strategies for the realization of multi-target NOP/opioid receptor ligands or tetrabranched N/OFQ derivs. with extraordinarily prolonged duration of action in vivo.  The diverse approaches led to the identification of important pharmacol. tools along with drug candidates currently in clin. development such as Rec 0438 (aka UFP-112) for the treatment of overactive bladder and SER 100 (aka ZP120) for the clin. management of systolic hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0uwIBk5Xr5LVg90H21EOLACvtfcHk0liYNukcww62KA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmtlGltbg%253D&md5=c89a7a0d238db175ec330a0ec2975150</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2F164_2018_198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F164_2018_198%26sid%3Dliteratum%253Aachs%26aulast%3DPreti%26aufirst%3DD.%26aulast%3DCal%25C3%25B3%26aufirst%3DG.%26aulast%3DGuerrini%26aufirst%3DR.%26atitle%3DNOP-targeted%2520peptide%2520ligands%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2019%26volume%3D254%26spage%3D17%26epage%3D36%26doi%3D10.1007%2F164_2018_198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vardy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapella, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>485</i></span>,  <span class="NLM_fpage">395</span>– <span class="NLM_lpage">399</span>, <span class="refDoi"> DOI: 10.1038/nature11085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1038%2Fnature11085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=22596163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC38XntF2jtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=485&publication_year=2012&pages=395-399&author=A.+A.+Thompsonauthor=W.+Liuauthor=E.+Chunauthor=V.+Katritchauthor=H.+Wuauthor=E.+Vardyauthor=X.-P.+Huangauthor=C.+Trapellaauthor=R.+Guerriniauthor=G.+Caloauthor=B.+L.+Rothauthor=V.+Cherezovauthor=R.+C.+Stevens&title=Structure+of+the+nociceptin%2Forphanin+FQ+receptor+in+complex+with+a+peptide+mimetic&doi=10.1038%2Fnature11085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic</span></div><div class="casAuthors">Thompson, Aaron A.; Liu, Wei; Chun, Eugene; Katritch, Vsevolod; Wu, Huixian; Vardy, Eyal; Huang, Xi-Ping; Trapella, Claudio; Guerrini, Remo; Calo, Girolamo; Roth, Bryan L.; Cherezov, Vadim; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">485</span>
        (<span class="NLM_cas:issue">7398</span>),
    <span class="NLM_cas:pages">395-399</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Members of the opioid receptor family of G-protein-coupled receptors (GPCRs) are found throughout the peripheral and central nervous system, where they have key roles in nociception and analgesia.  Unlike the classical' opioid receptors, δ, κ and μ (δ-OR, κ-OR and μ-OR), which were delineated by pharmacol. criteria in the 1970s and 1980s, the nociceptin/orphanin FQ (N/OFQ) peptide receptor (NOP, also known as ORL-1) was discovered relatively recently by mol. cloning and characterization of an orphan GPCR.  Although it shares high sequence similarity with classical opioid GPCR subtypes (∼60%), NOP has a markedly distinct pharmacol., featuring activation by the endogenous peptide N/OFQ, and unique selectivity for exogenous ligands.  Here we report the crystal structure of human NOP, solved in complex with the peptide mimetic antagonist compd.-24 (C-24), revealing at. details of ligand-receptor recognition and selectivity.  Compd.-24 mimics the first four amino-terminal residues of the NOP-selective peptide antagonist UFP-101, a close deriv. of N/OFQ, and provides important clues to the binding of these peptides.  The x-ray structure also shows substantial conformational differences in the pocket regions between NOP and the classical opioid receptors κ and μ, and these are probably due to a small no. of residues that vary between these receptors.  The NOP-compd.-24 structure explains the divergent selectivity profile of NOP and provides a new structural template for the design of NOP ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq0_U24fZ4r7Vg90H21EOLACvtfcHk0liYNukcww62KA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntF2jtbk%253D&md5=56819d10685f8a389710e9005d595d5b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnature11085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11085%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%2BA.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DChun%26aufirst%3DE.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DVardy%26aufirst%3DE.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DCalo%26aufirst%3DG.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructure%2520of%2520the%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520in%2520complex%2520with%2520a%2520peptide%2520mimetic%26jtitle%3DNature%26date%3D2012%26volume%3D485%26spage%3D395%26epage%3D399%26doi%3D10.1038%2Fnature11085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapella, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malfacini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caló, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">The importance of ligand-receptor conformational pairs in stabilization: spotlight on the N/OFQ G protein-coupled receptor</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">2291</span>– <span class="NLM_lpage">2299</span>, <span class="refDoi"> DOI: 10.1016/j.str.2015.07.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1016%2Fj.str.2015.07.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=26526853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslGltbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=2291-2299&author=R.+L.+Millerauthor=A.+A.+Thompsonauthor=C.+Trapellaauthor=R.+Guerriniauthor=D.+Malfaciniauthor=N.+Patelauthor=G.+W.+Hanauthor=V.+Cherezovauthor=G.+Cal%C3%B3author=V.+Katritchauthor=R.+C.+Stevens&title=The+importance+of+ligand-receptor+conformational+pairs+in+stabilization%3A+spotlight+on+the+N%2FOFQ+G+protein-coupled+receptor&doi=10.1016%2Fj.str.2015.07.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The Importance of Ligand-Receptor Conformational Pairs in Stabilization: Spotlight on the N/OFQ G Protein-Coupled Receptor</span></div><div class="casAuthors">Miller, Rebecca L.; Thompson, Aaron A.; Trapella, Claudio; Guerrini, Remo; Malfacini, Davide; Patel, Nilkanth; Han, Gye Won; Cherezov, Vadim; Calo, Girolamo; Katritch, Vsevolod; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2291-2299</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Understanding the mechanism by which ligands affect receptor conformational equil. is key in accelerating membrane protein structural biol.  In the case of G protein-coupled receptors (GPCRs), we currently pursue a brute-force approach for identifying ligands that stabilize receptors and facilitate crystallogenesis.  The nociceptin/orphanin FQ peptide receptor (NOP) is a member of the opioid receptor subfamily of GPCRs for which many structurally diverse ligands are available for screening.  We obsd. that antagonist potency is correlated with a ligand's ability to induce receptor stability (Tm) and crystallogenesis.  Using this screening strategy, we solved two structures of NOP in complex with top candidate ligands SB-612111 and C-35.  Docking studies indicate that while potent, stabilizing antagonists strongly favor a single binding orientation, less potent ligands can adopt multiple binding modes, contributing to their low Tm values.  These results suggest a mechanism for ligand-aided crystallogenesis whereby potent antagonists stabilize a single ligand-receptor conformational pair.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZK63i7P2bfLVg90H21EOLACvtfcHk0lh8Xisga8u1pQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslGltbbL&md5=ba984e9560d38b6a19a48d7fc4b7b231</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2015.07.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2015.07.024%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DR.%2BL.%26aulast%3DThompson%26aufirst%3DA.%2BA.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DMalfacini%26aufirst%3DD.%26aulast%3DPatel%26aufirst%3DN.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DCal%25C3%25B3%26aufirst%3DG.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DThe%2520importance%2520of%2520ligand-receptor%2520conformational%2520pairs%2520in%2520stabilization%253A%2520spotlight%2520on%2520the%2520N%252FOFQ%2520G%2520protein-coupled%2520receptor%26jtitle%3DStructure%26date%3D2015%26volume%3D23%26spage%3D2291%26epage%3D2299%26doi%3D10.1016%2Fj.str.2015.07.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kantola, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheinin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulbrandsen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meland, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smerud, K. T.</span></span> <span> </span><span class="NLM_article-title">Safety, tolerability, and antihypertensive effect of SER100, an opiate receptor-like 1 (ORL-1) partial agonist, in patients with isolated systolic hypertension</span>. <i>Clin. Pharmacol. Drug Dev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">584</span>– <span class="NLM_lpage">591</span>, <span class="refDoi"> DOI: 10.1002/cpdd.330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1002%2Fcpdd.330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=28032481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslymsLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2017&pages=584-591&author=I.+Kantolaauthor=M.+Scheininauthor=T.+Gulbrandsenauthor=N.+Melandauthor=K.+T.+Smerud&title=Safety%2C+tolerability%2C+and+antihypertensive+effect+of+SER100%2C+an+opiate+receptor-like+1+%28ORL-1%29+partial+agonist%2C+in+patients+with+isolated+systolic+hypertension&doi=10.1002%2Fcpdd.330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, Tolerability, and Antihypertensive Effect of SER100, an Opiate Receptor-Like 1 (ORL-1) Partial Agonist, in Patients With Isolated Systolic Hypertension</span></div><div class="casAuthors">Kantola, Ilkka; Scheinin, Mika; Gulbrandsen, Trygve; Meland, Nils; Smerud, Knut T.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology in Drug Development</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">584-591</span>CODEN:
                <span class="NLM_cas:coden">CPDDAH</span>;
        ISSN:<span class="NLM_cas:issn">2160-7648</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The purpose of the present trial was to evaluate safety, tolerability, and effect on systolic blood pressure (SBP) of SER100 in a small group of patients with isolated systolic hypertension (ISH) in treatment with at least 1 antihypertensive drug.  Eligible patients were randomized to either SER100 (10 mg) or placebo in a crossover design, and 2 doses were given s.c. (SC), 8 h apart, on 2 consecutive days.  On all treatment days patients were monitored with an ambulatory blood pressure measurement device for 12 daytime hours.  Seventeen patients completed treatment.  There were no serious or severe adverse events.  Relative to placebo SER100 induced an av. redn. of SBP during the 2 treatment days of 7.0 mm Hg (P = 0.0032), whereas the av. redn. of diastolic blood pressure (DBP) over the same period was 3.8 mm Hg (P = 0.0011).  For patients with ISH, this short-term cross-over study of SC SER100 demonstrated an acceptable safety profile and consistent, significant lowering of SBP and DBP.  As initial clin. proof of concept for a new class of drugs, a nociceptin agonist peptide, the results were encouraging and warrant further research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ_slehbrn6bVg90H21EOLACvtfcHk0lh8Xisga8u1pQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslymsLvN&md5=d913f92852f1eb924f0d2cf8e49811df</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fcpdd.330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcpdd.330%26sid%3Dliteratum%253Aachs%26aulast%3DKantola%26aufirst%3DI.%26aulast%3DScheinin%26aufirst%3DM.%26aulast%3DGulbrandsen%26aufirst%3DT.%26aulast%3DMeland%26aufirst%3DN.%26aulast%3DSmerud%26aufirst%3DK.%2BT.%26atitle%3DSafety%252C%2520tolerability%252C%2520and%2520antihypertensive%2520effect%2520of%2520SER100%252C%2520an%2520opiate%2520receptor-like%25201%2520%2528ORL-1%2529%2520partial%2520agonist%252C%2520in%2520patients%2520with%2520isolated%2520systolic%2520hypertension%26jtitle%3DClin.%2520Pharmacol.%2520Drug%2520Dev.%26date%3D2017%26volume%3D6%26spage%3D584%26epage%3D591%26doi%3D10.1002%2Fcpdd.330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Angelico, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barchielli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzeri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calo, G.</span></span> <span> </span><span class="NLM_article-title">Nociceptin/orphanin FQ and urinary bladder</span>. <i>Handb. Exp. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>254</i></span>,  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">365</span>, <span class="refDoi"> DOI: 10.1007/164_2018_182</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1007%2F164_2018_182" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=30430260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmtlGltbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=254&publication_year=2019&pages=347-365&author=P.+Angelicoauthor=M.+Barchielliauthor=M.+Lazzeriauthor=R.+Guerriniauthor=G.+Calo&title=Nociceptin%2Forphanin+FQ+and+urinary+bladder&doi=10.1007%2F164_2018_182"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Nociceptin/Orphanin FQ and Urinary Bladder</span></div><div class="casAuthors">Angelico, Patrizia; Barchielli, Marco; Lazzeri, Massimo; Guerrini, Remo; Calo, Girolamo</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">254</span>
        (<span class="NLM_cas:issue">Nociceptin/Orphanin FQ Peptide Receptor</span>),
    <span class="NLM_cas:pages">347-365</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">1865-0325</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Following identification as the endogenous ligand for the NOP receptor, nociceptin/orphanin FQ (N/OFQ) has been shown to control several biol. functions including the micturition reflex.  N/OFQ elicits a robust inhibitory effect on rat micturition by reducing the excitability of the afferent fibers.  After intravesical administration N/OFQ increases urodynamic bladder capacity and vol. threshold in overactive bladder patients but not in normal subjects.  Moreover daily treatment with intravesical N/OFQ for 10 days significantly reduced urine leakage episodes.  Different chem. modifications were combined into the N/OFQ sequence to generate Rec 0438 (aka UFP-112), a peptide NOP full agonist with high potency and selectivity and long-lasting duration of action.  Rec 0438 mimicked the robust inhibitory effects of N/OFQ on rat micturition reflex; its action is solely due to NOP receptor stimulation, does not show tolerance liability after 2 wk of treatment, and can be elicited by intravesical administration.  Collectively the evidence summarized and discussed in this chapter strongly suggests that NOP agonists are promising innovative drugs to treat overactive bladder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrLANrPTYpKbVg90H21EOLACvtfcHk0lh8Xisga8u1pQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmtlGltbY%253D&md5=20a4cc9f7056c78a0bad4e8743cf53f7</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2F164_2018_182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F164_2018_182%26sid%3Dliteratum%253Aachs%26aulast%3DAngelico%26aufirst%3DP.%26aulast%3DBarchielli%26aufirst%3DM.%26aulast%3DLazzeri%26aufirst%3DM.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DCalo%26aufirst%3DG.%26atitle%3DNociceptin%252Forphanin%2520FQ%2520and%2520urinary%2520bladder%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2019%26volume%3D254%26spage%3D347%26epage%3D365%26doi%3D10.1007%2F164_2018_182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. G.</span></span> <span> </span><span class="NLM_article-title">Nociceptin/orphanin FQ receptor ligands and translational challenges: focus on cebranopadol as an innovative analgesic</span>. <i>Br. J. Anaesth.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">1105</span>– <span class="NLM_lpage">1114</span>, <span class="refDoi"> DOI: 10.1016/j.bja.2018.06.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1016%2Fj.bja.2018.06.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=30336855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkvVGjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2018&pages=1105-1114&author=G.+Caloauthor=D.+G.+Lambert&title=Nociceptin%2Forphanin+FQ+receptor+ligands+and+translational+challenges%3A+focus+on+cebranopadol+as+an+innovative+analgesic&doi=10.1016%2Fj.bja.2018.06.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Nociceptin/orphanin FQ receptor ligands and translational challenges: focus on cebranopadol as an innovative analgesic</span></div><div class="casAuthors">Calo, G.; Lambert, D. G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Anaesthesia</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1105-1114</span>CODEN:
                <span class="NLM_cas:coden">BJANAD</span>;
        ISSN:<span class="NLM_cas:issn">1471-6771</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Opioids are characterised as classical (mu, delta, and kappa) along with the non-classical nociceptin/orphanin FQ (N/OFQ) receptor or NOP.  Targeting NOP has therapeutic indications in control of the cardiovascular and respiratory systems and micturition, and a profile as an antidepressant.  For all of these indications, there are translational human data.  Opioids such as morphine and fentanyl (activating the mu receptor) are the mainstay of pain treatment in the perioperative period, despite a challenging side-effect profile.  Opioids in general have poor efficacy in neuropathic pain.  Moreover, longer term use is assocd. with tolerance.  There is good evidence interactions between opioid receptors, and receptor co-activation can reduce side-effects without compromising analgesia; this is particularly true for mu and NOP co-activation.  Recent pharmaceutical development has produced a mixed opioid/NOP agonist, cebranopadol.  This new chem. entity is effective in animal models of nociceptive and neuropathic pain with greater efficacy in the latter.  In animal models, there is little evidence for respiratory depression, and tolerance (compared with morphine) only develops after long treatment periods.  There is now early phase clin. development in diabetic neuropathy, cancer pain, and low back pain where cebranopadol displays significant efficacy.  In 1996, N/OFQ was formally identified with an innovative analgesic profile.  Approx. 20 yr later, cebranopadol as a clin. ligand is advancing through the human trials process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYrn8LanDB8bVg90H21EOLACvtfcHk0lgHH5-W2qGoZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkvVGjtg%253D%253D&md5=bcc4df676d94a0250830edd3ea13c74e</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.bja.2018.06.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bja.2018.06.024%26sid%3Dliteratum%253Aachs%26aulast%3DCalo%26aufirst%3DG.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26atitle%3DNociceptin%252Forphanin%2520FQ%2520receptor%2520ligands%2520and%2520translational%2520challenges%253A%2520focus%2520on%2520cebranopadol%2520as%2520an%2520innovative%2520analgesic%26jtitle%3DBr.%2520J.%2520Anaesth.%26date%3D2018%26volume%3D121%26spage%3D1105%26epage%3D1114%26doi%3D10.1016%2Fj.bja.2018.06.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Witkin, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, W. J.</span></span> <span> </span><span class="NLM_article-title">Therapeutic approaches for NOP receptor antagonists in neurobehavioral disorders: clinical studies in major depressive disorder and alcohol use disorder with BTRX-246040 (LY2940094)</span>. <i>Handb. Exp. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>254</i></span>,  <span class="NLM_fpage">399</span>– <span class="NLM_lpage">415</span>, <span class="refDoi"> DOI: 10.1007/164_2018_186</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1007%2F164_2018_186" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=30701317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmtlGltbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=254&publication_year=2019&pages=399-415&author=J.+M.+Witkinauthor=T.+L.+Wallaceauthor=W.+J.+Martin&title=Therapeutic+approaches+for+NOP+receptor+antagonists+in+neurobehavioral+disorders%3A+clinical+studies+in+major+depressive+disorder+and+alcohol+use+disorder+with+BTRX-246040+%28LY2940094%29&doi=10.1007%2F164_2018_186"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic Approaches for NOP Receptor Antagonists in Neurobehavioral Disorders: Clinical Studies in Major Depressive Disorder and Alcohol Use Disorder with BTRX-246040 (LY2940094)</span></div><div class="casAuthors">Witkin, Jeffrey M.; Wallace, Tanya L.; Martin, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">254</span>
        (<span class="NLM_cas:issue">Nociceptin/Orphanin FQ Peptide Receptor</span>),
    <span class="NLM_cas:pages">399-415</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">1865-0325</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  BTRX-246040 (formerly LY2940094) was designed to test this hypothesis in the clinic.  A small clin. proof of concept study demonstrated efficacy of BTRX-246040 in MDD patients.  In this study, BTRX-246040 (40 mg, p.o.) significantly reduced neg. bias as assessed by the facial recognition test within 1 wk of treatment and decreased depression symptoms after 8 wk.  BTRX-246040 also reduced depression symptoms in a second trial with heavy alc. drinkers.  Given the comorbidity of MDD and alc. use disorder, a compd. with such effects in patients could be a valuable addn. to the medications available.  A proof of concept study showed efficacy of BTRX-246040 in reducing heavy drinking and increasing the probability of abstinence in individuals diagnosed with alc. dependence.  In addn., plasma levels of gamma-glutamyl transferase were decreased by BTRX-246040 compared to placebo control implying improvement in liver function.  Collectively, the clin. data reviewed within this chapter suggest that BTRX-264040 functions to normalize dysfunction in reward circuits.  The overall efficacy and safety of this compd. with a novel mechanism of action are encouraging of further clin. development.  BTRX-246040 is currently under development for MDD by BlackThorn Therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeAMk0S5iW1LVg90H21EOLACvtfcHk0lgHH5-W2qGoZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmtlGltbo%253D&md5=90e8b039b4d9a375f4d2c8a92f96353e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2F164_2018_186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F164_2018_186%26sid%3Dliteratum%253Aachs%26aulast%3DWitkin%26aufirst%3DJ.%2BM.%26aulast%3DWallace%26aufirst%3DT.%2BL.%26aulast%3DMartin%26aufirst%3DW.%2BJ.%26atitle%3DTherapeutic%2520approaches%2520for%2520NOP%2520receptor%2520antagonists%2520in%2520neurobehavioral%2520disorders%253A%2520clinical%2520studies%2520in%2520major%2520depressive%2520disorder%2520and%2520alcohol%2520use%2520disorder%2520with%2520BTRX-246040%2520%2528LY2940094%2529%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2019%26volume%3D254%26spage%3D399%26epage%3D415%26doi%3D10.1007%2F164_2018_186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luttrell, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maudsley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohn, L. M.</span></span> <span> </span><span class="NLM_article-title">Fulfilling the promise of “biased” G protein-coupled receptor agonism</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">579</span>– <span class="NLM_lpage">588</span>, <span class="refDoi"> DOI: 10.1124/mol.115.099630</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1124%2Fmol.115.099630" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=26134495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVCgs77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2015&pages=579-588&author=L.+M.+Luttrellauthor=S.+Maudsleyauthor=L.+M.+Bohn&title=Fulfilling+the+promise+of+%E2%80%9Cbiased%E2%80%9D+G+protein-coupled+receptor+agonism&doi=10.1124%2Fmol.115.099630"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Fulfilling the promise of "biased" G protein-coupled receptor agonism</span></div><div class="casAuthors">Luttrell, Louis M.; Maudsley, Stuart; Bohn, Laura M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">579-588</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The fact that over 30% of current pharmaceuticals target hepta-helical G protein-coupled receptors (GPCRs) attests to their tractability as drug targets.  Although GPCR drug development has traditionally focused on conventional agonists and antagonists, the growing appreciation that GPCRs mediate physiol. relevant effects via both G protein and non-G protein effectors has prompted the search for ligands that can "bias" downstream signaling in favor of one or the other process.  Biased ligands are novel entities with distinct signaling profiles dictated by ligand structure, and the potential prospect of biased ligands as better drugs has been pleonastically proclaimed.  Indeed, preclin. proof-of-concept studies have demonstrated that both G protein and arrestin pathway-selective ligands can promote beneficial effects in vivo while simultaneously antagonizing deleterious ones.  But along with opportunity comes added complexity and new challenges for drug discovery.  If ligands can be biased, then ligand classification becomes assay dependent, and more nuanced screening approaches are needed to capture ligand efficacy across several dimensions of signaling.  Moreover, because the signaling repertoire of biased ligands differs from that of the native agonist, unpredicted responses may arise in vivo as these unbalanced signals propagate.  For any given GPCR target, establishing a framework relating in vitro efficacy to in vivo biol. response is crucial to biased drug discovery.  This review discusses approaches to describing ligand efficacy in vitro, translating ligand bias into biol. response, and developing a systems-level understanding of biased agonism in vivo, with the overall goal of overcoming current barriers to developing biased GPCR therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp03ReQ3oHsSbVg90H21EOLACvtfcHk0lhNG6VK_uN8LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVCgs77N&md5=515e0ebeb7147efb48b9eca015905306</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1124%2Fmol.115.099630&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.115.099630%26sid%3Dliteratum%253Aachs%26aulast%3DLuttrell%26aufirst%3DL.%2BM.%26aulast%3DMaudsley%26aufirst%3DS.%26aulast%3DBohn%26aufirst%3DL.%2BM.%26atitle%3DFulfilling%2520the%2520promise%2520of%2520%25E2%2580%259Cbiased%25E2%2580%259D%2520G%2520protein-coupled%2520receptor%2520agonism%26jtitle%3DMol.%2520Pharmacol.%26date%3D2015%26volume%3D88%26spage%3D579%26epage%3D588%26doi%3D10.1124%2Fmol.115.099630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kenakin, T.</span></span> <span> </span><span class="NLM_article-title">New concepts in pharmacological efficacy at 7TM receptors: IUPHAR review 2</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>168</i></span>,  <span class="NLM_fpage">554</span>– <span class="NLM_lpage">575</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2012.02223.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1111%2Fj.1476-5381.2012.02223.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=22994528" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFKhsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2013&pages=554-575&author=T.+Kenakin&title=New+concepts+in+pharmacological+efficacy+at+7TM+receptors%3A+IUPHAR+review+2&doi=10.1111%2Fj.1476-5381.2012.02223.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">New concepts in pharmacological efficacy at 7TM receptors: IUPHAR Review 2</span></div><div class="casAuthors">Kenakin, Terry</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">554-575</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The present-day concept of drug efficacy has changed completely from its original description as the property of agonists that causes tissue activation.  The ability to visualize the multiple behaviors of seven transmembrane receptors has shown that drugs can have many efficacies and also that the transduction of drug stimulus to various cellular stimulus-response cascades can be biased towards some but not all pathways.  This latter effect leads to agonist "functional selectivity", which can be favorable for the improvement of agonist therapeutics.  However, in addn., biased agonist potency becomes cell type dependent with the loss of the monotonic behavior of stimulus-response mechanisms, leading to potential problems in agonist quantification.  This has an extremely important effect on the discovery process for new agonists since it now cannot be assumed that a given screening or lead optimization assay will correctly predict therapeutic behavior.  This review discusses these ideas and how new approaches to quantifying agonist effect may be used to circumvent the cell type dependence of agonism.  This article, written by a corresponding member of the International Union of Basic and Clin. Pharmacol. Committee on Receptor Nomenclature and Drug Classification (NC-IUPHAR), reviews our current understanding of the interaction of ligands with seven transmembrane receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN8xYts-AwKbVg90H21EOLACvtfcHk0lhNG6VK_uN8LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFKhsrc%253D&md5=0cf56bcf1a1ec26d67445795eca9d90b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.02223.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.02223.x%26sid%3Dliteratum%253Aachs%26aulast%3DKenakin%26aufirst%3DT.%26atitle%3DNew%2520concepts%2520in%2520pharmacological%2520efficacy%2520at%25207TM%2520receptors%253A%2520IUPHAR%2520review%25202%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D168%26spage%3D554%26epage%3D575%26doi%3D10.1111%2Fj.1476-5381.2012.02223.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raehal, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohn, L. M.</span></span> <span> </span><span class="NLM_article-title">Morphine side effects in beta-arrestin 2 knockout mice</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>314</i></span>,  <span class="NLM_fpage">1195</span>– <span class="NLM_lpage">1201</span>, <span class="refDoi"> DOI: 10.1124/jpet.105.087254</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1124%2Fjpet.105.087254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=15917400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvFSqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2005&pages=1195-1201&author=K.+M.+Raehalauthor=J.+K.+L.+Walkerauthor=L.+M.+Bohn&title=Morphine+side+effects+in+beta-arrestin+2+knockout+mice&doi=10.1124%2Fjpet.105.087254"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Morphine side effects in β-arrestin 2 knockout mice</span></div><div class="casAuthors">Raehal, Kirsten M.; Walker, Julia K. L.; Bohn, Laura M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">314</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1195-1201</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Morphine is a potent analgesic, yet, like most opioid narcotics, it exerts unwanted side effects such as constipation and respiratory suppression, thereby limiting its clin. utility.  Pharmacol. approaches taken to preserve the analgesic properties, while eliminating the unwanted side effects, have met with very limited success.  Here, we provide evidence that altering μ opioid receptor regulation may provide a novel approach to discriminate morphine's beneficial and deleterious effects in vivo.  We have previously reported that mice lacking the G protein-coupled receptor regulatory protein, β-arrestin 2, display profoundly altered morphine responses.  β-Arrestin 2 knockout mice have enhanced and prolonged morphine analgesia with very little morphine tolerance.  In this report, we examine whether the side effects of morphine treatment are also augmented in this animal model.  Surprisingly, the genetic disruption of opioid receptor regulation, while enhancing and prolonging analgesia, dramatically attenuates the respiratory suppression and acute constipation caused by morphine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGg-s6s4R0F7Vg90H21EOLACvtfcHk0lhNG6VK_uN8LA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvFSqsLw%253D&md5=0d3696e563ae3a6f6ce2cb2570cbb890</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.087254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.087254%26sid%3Dliteratum%253Aachs%26aulast%3DRaehal%26aufirst%3DK.%2BM.%26aulast%3DWalker%26aufirst%3DJ.%2BK.%2BL.%26aulast%3DBohn%26aufirst%3DL.%2BM.%26atitle%3DMorphine%2520side%2520effects%2520in%2520beta-arrestin%25202%2520knockout%2520mice%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D314%26spage%3D1195%26epage%3D1201%26doi%3D10.1124%2Fjpet.105.087254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bohn, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefkowitz, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gainetdinov, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peppel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, F. T.</span></span> <span> </span><span class="NLM_article-title">Enhanced morphine analgesia in mice lacking beta-arrestin 2</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">2495</span>– <span class="NLM_lpage">2498</span>, <span class="refDoi"> DOI: 10.1126/science.286.5449.2495</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1126%2Fscience.286.5449.2495" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10617462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmvVKg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=2495-2498&author=L.+M.+Bohnauthor=R.+J.+Lefkowitzauthor=R.+R.+Gainetdinovauthor=K.+Peppelauthor=M.+G.+Caronauthor=F.+T.+Lin&title=Enhanced+morphine+analgesia+in+mice+lacking+beta-arrestin+2&doi=10.1126%2Fscience.286.5449.2495"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced morphine analgesia in mice lacking β-arrestin 2</span></div><div class="casAuthors">Bohn, Laura M.; Lefkowitz, Robert J.; Gainetdinov, Raul R.; Peppel, Karsten; Caron, Marc G.; Lin, Fang-Tsyr</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">5449</span>),
    <span class="NLM_cas:pages">2495-2498</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The ability of morphine to alleviate pain is mediated through a heterotrimeric guanine nucleotide binding protein (G protein)-coupled heptahelical receptor (GPCR), the μ opioid receptor (μOR).  The efficiency of GPCR signaling is tightly regulated and ultimately limited by the coordinated phosphorylation of the receptors by specific GPCR kinases and the subsequent interaction of the phosphorylated receptors with β-arrestin 1 and β-arrestin 2.  Functional deletion of the β-arrestin 2 gene in mice resulted in remarkable potentiation and prolongation of the analgesic effect of morphine, suggesting that μOR desensitization was impaired.  These results provide evidence in vivo for the physiol. importance of β-arrestin 2 in regulating the function of a specific GPCR, the μOR.  Moreover, they suggest that inhibition of β-arrestin 2 function might lead to enhanced analgesic effectiveness of morphine and provide potential new avenues for the study and treatment of pain, narcotic tolerance, and dependence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSeiDXvYdnz7Vg90H21EOLACvtfcHk0ljubBAL1CL4KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmvVKg&md5=95f67b133e86422f385d1a7f8165d772</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1126%2Fscience.286.5449.2495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.286.5449.2495%26sid%3Dliteratum%253Aachs%26aulast%3DBohn%26aufirst%3DL.%2BM.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26aulast%3DGainetdinov%26aufirst%3DR.%2BR.%26aulast%3DPeppel%26aufirst%3DK.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26aulast%3DLin%26aufirst%3DF.%2BT.%26atitle%3DEnhanced%2520morphine%2520analgesia%2520in%2520mice%2520lacking%2520beta-arrestin%25202%26jtitle%3DScience%26date%3D1999%26volume%3D286%26spage%3D2495%26epage%3D2498%26doi%3D10.1126%2Fscience.286.5449.2495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siuda, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, R.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rominger, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Violin, J. D.</span></span> <span> </span><span class="NLM_article-title">Biased mu-opioid receptor ligands: a promising new generation of pain therapeutics</span>. <i>Curr. Opin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">84</span>, <span class="refDoi"> DOI: 10.1016/j.coph.2016.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1016%2Fj.coph.2016.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=27936408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFKjs73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2017&pages=77-84&author=E.+R.+Siudaauthor=R.+Carrauthor=D.+H.+Romingerauthor=J.+D.+Violin&title=Biased+mu-opioid+receptor+ligands%3A+a+promising+new+generation+of+pain+therapeutics&doi=10.1016%2Fj.coph.2016.11.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Biased mu-opioid receptor ligands: a promising new generation of pain therapeutics</span></div><div class="casAuthors">Siuda, Edward R.; Carr, Richard, III; Rominger, David H.; Violin, Jonathan D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">77-84</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Opioid chem. and biol. occupy a pivotal place in the history of pharmacol. and medicine.  Morphine offers unmatched efficacy in alleviating acute pain, but is also assocd. with a host of adverse side effects.  The advent of biased agonism at G protein-coupled receptors has expanded our understanding of intracellular signaling and highlighted the concept that certain ligands are able to differentially modulate downstream pathways.  The ability to target one pathway over another has allowed for the development of biased ligands with robust clin. efficacy and fewer adverse events.  In this review we summarize these concepts with an emphasis on biased mu opioid receptor pharmacol. and highlight how far opioid pharmacol. has evolved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnIOVY351osLVg90H21EOLACvtfcHk0ljubBAL1CL4KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFKjs73K&md5=f261dab2f2940cb828ec2db9f4d67f1c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2016.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2016.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DSiuda%26aufirst%3DE.%2BR.%26aulast%3DCarr%26aufirst%3DR.%26aulast%3DRominger%26aufirst%3DD.%2BH.%26aulast%3DViolin%26aufirst%3DJ.%2BD.%26atitle%3DBiased%2520mu-opioid%2520receptor%2520ligands%253A%2520a%2520promising%2520new%2520generation%2520of%2520pain%2520therapeutics%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2017%26volume%3D32%26spage%3D77%26epage%3D84%26doi%3D10.1016%2Fj.coph.2016.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kliewer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmiedel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christie, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, S.</span></span> <span> </span><span class="NLM_article-title">Morphine-induced respiratory depression is independent of beta-arrestin 2 signalling</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>177</i></span>,  <span class="NLM_fpage">2923</span>– <span class="NLM_lpage">2931</span>, <span class="refDoi"> DOI: 10.1111/bph.15004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1111%2Fbph.15004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=32052419" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjtFersLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2020&pages=2923-2931&author=A.+Kliewerauthor=A.+Gillisauthor=R.+Hillauthor=F.+Schmiedelauthor=C.+Baileyauthor=E.+Kellyauthor=G.+Hendersonauthor=M.+J.+Christieauthor=S.+Schulz&title=Morphine-induced+respiratory+depression+is+independent+of+beta-arrestin+2+signalling&doi=10.1111%2Fbph.15004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Morphine-induced respiratory depression is independent of β-arrestin2 signalling</span></div><div class="casAuthors">Kliewer, Andrea; Gillis, Alexander; Hill, Rob; Schmidel, Frank; Bailey, Chris; Kelly, Eamonn; Henderson, Graeme; Christie, MacDonald J.; Schulz, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">177</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2923-2931</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">GPCRs can signal through both G proteins and β-arrestin2.  For the μ-opioid receptor, early exptl. evidence from a single study suggested that G protein signalling mediates analgesia, whereas β-arrestin2 signalling mediates respiratory depression and constipation.  Consequently, for more than a decade, much research effort has been focused on developing biased μ-opioid agonists that preferentially target G protein signalling over β-arrestin signalling, as it was believed that such drugs would be analgesics devoid of respiratory depressant activity.  The present study was set up to re-examine opioid-induced respiratory depression in β-arrestin2 knockout mice.  To this end, a consortium was formed consisting of three different labs. located in different countries to evaluate independently opioid-induced respiratory depression.  Our consensus results unequivocally demonstrate that the prototypical μ-opioid agonist morphine as well as the potent opioid fentanyl do indeed induce respiratory depression and constipation in β-arrestin2 knockout mice in a dose-dependent manner indistinguishable from that obsd. in wild-type mice.  Our findings do not support the original suggestion that β-arrestin2 signalling plays a key role in opioid-induced respiratory depression and call into question the concept of developing G protein-biased μ-opioid receptor agonists as a strategy for the development of safer opioid analgesic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtInyxD8GRBbVg90H21EOLACvtfcHk0lhcsGShgt1Jjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjtFersLw%253D&md5=7913eb638bb57db9a7ed8d43aab61d48</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1111%2Fbph.15004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.15004%26sid%3Dliteratum%253Aachs%26aulast%3DKliewer%26aufirst%3DA.%26aulast%3DGillis%26aufirst%3DA.%26aulast%3DHill%26aufirst%3DR.%26aulast%3DSchmiedel%26aufirst%3DF.%26aulast%3DBailey%26aufirst%3DC.%26aulast%3DKelly%26aufirst%3DE.%26aulast%3DHenderson%26aufirst%3DG.%26aulast%3DChristie%26aufirst%3DM.%2BJ.%26aulast%3DSchulz%26aufirst%3DS.%26atitle%3DMorphine-induced%2520respiratory%2520depression%2520is%2520independent%2520of%2520beta-arrestin%25202%2520signalling%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2020%26volume%3D177%26spage%3D2923%26epage%3D2931%26doi%3D10.1111%2Fbph.15004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kliewer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmiedel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sianati, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bateman, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levitt, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christie, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, S.</span></span> <span> </span><span class="NLM_article-title">Phosphorylation-deficient G-protein-biased mu-opioid receptors improve analgesia and diminish tolerance but worsen opioid side effects</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">367</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-08162-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1038%2Fs41467-018-08162-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=30664663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC1MXntFeks7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=367&author=A.+Kliewerauthor=F.+Schmiedelauthor=S.+Sianatiauthor=A.+Baileyauthor=J.+T.+Batemanauthor=E.+S.+Levittauthor=J.+T.+Williamsauthor=M.+J.+Christieauthor=S.+Schulz&title=Phosphorylation-deficient+G-protein-biased+mu-opioid+receptors+improve+analgesia+and+diminish+tolerance+but+worsen+opioid+side+effects&doi=10.1038%2Fs41467-018-08162-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation-deficient G-protein-biased mu-opioid receptors improve analgesia and diminish tolerance but worsen opioid side effects</span></div><div class="casAuthors">Kliewer, A.; Schmiedel, F.; Sianati, S.; Bailey, A.; Bateman, J. T.; Levitt, E. S.; Williams, J. T.; Christie, M. J.; Schulz, S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">367</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Opioid analgesics are powerful pain relievers; however, over time, pain control diminishes as analgesic tolerance develops.  The mol. mechanisms initiating tolerance have remained unresolved to date.  We have previously shown that desensitization of the mu-opioid receptor and interaction with beta-arrestins is controlled by carboxyl-terminal phosphorylation.  Here we created knockin mice with a series of serine- and threonine-to-alanine mutations that render the receptor increasingly unable to recruit beta-arrestins.  Desensitization is inhibited in locus coeruleus neurons of mutant mice.  Opioid-induced analgesia is strongly enhanced and analgesic tolerance is greatly diminished.  Surprisingly, respiratory depression, constipation, and opioid withdrawal signs are unchanged or exacerbated, indicating that beta-arrestin recruitment does not contribute to the severity of opioid side effects and, hence, predicting that G-protein-biased mu-agonists are still likely to elicit severe adverse effects.  In conclusion, our findings identify carboxyl-terminal multisite phosphorylation as key step that drives acute mu-opioid receptor desensitization and long-term tolerance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaEj4ARbzSS7Vg90H21EOLACvtfcHk0lhcsGShgt1Jjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXntFeks7k%253D&md5=19fa2354d75d29b28503d21f63754d45</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-08162-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-08162-1%26sid%3Dliteratum%253Aachs%26aulast%3DKliewer%26aufirst%3DA.%26aulast%3DSchmiedel%26aufirst%3DF.%26aulast%3DSianati%26aufirst%3DS.%26aulast%3DBailey%26aufirst%3DA.%26aulast%3DBateman%26aufirst%3DJ.%2BT.%26aulast%3DLevitt%26aufirst%3DE.%2BS.%26aulast%3DWilliams%26aufirst%3DJ.%2BT.%26aulast%3DChristie%26aufirst%3DM.%2BJ.%26aulast%3DSchulz%26aufirst%3DS.%26atitle%3DPhosphorylation-deficient%2520G-protein-biased%2520mu-opioid%2520receptors%2520improve%2520analgesia%2520and%2520diminish%2520tolerance%2520but%2520worsen%2520opioid%2520side%2520effects%26jtitle%3DNat.%2520Commun.%26date%3D2019%26volume%3D10%26spage%3D367%26doi%3D10.1038%2Fs41467-018-08162-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gillis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gondin, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kliewer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alamein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manandhar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santiago, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritzwanker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmiedel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katte, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reekie, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimsey, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassiou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krasel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halls, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christie, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canals, M.</span></span> <span> </span><span class="NLM_article-title">Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists</span>. <i>Sci. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">eaaz3140</span>, <span class="refDoi"> DOI: 10.1126/scisignal.aaz3140</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1126%2Fscisignal.aaz3140" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=32234959" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2020&pages=eaaz3140&author=A.+Gillisauthor=A.+B.+Gondinauthor=A.+Kliewerauthor=J.+Sanchezauthor=H.+D.+Limauthor=C.+Alameinauthor=P.+Manandharauthor=M.+Santiagoauthor=S.+Fritzwankerauthor=F.+Schmiedelauthor=T.+A.+Katteauthor=T.+Reekieauthor=N.+L.+Grimseyauthor=M.+Kassiouauthor=B.+Kellamauthor=C.+Kraselauthor=M.+L.+Hallsauthor=M.+Connorauthor=J.+R.+Laneauthor=S.+Schulzauthor=M.+J.+Christieauthor=M.+Canals&title=Low+intrinsic+efficacy+for+G+protein+activation+can+explain+the+improved+side+effect+profiles+of+new+opioid+agonists&doi=10.1126%2Fscisignal.aaz3140"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.aaz3140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.aaz3140%26sid%3Dliteratum%253Aachs%26aulast%3DGillis%26aufirst%3DA.%26aulast%3DGondin%26aufirst%3DA.%2BB.%26aulast%3DKliewer%26aufirst%3DA.%26aulast%3DSanchez%26aufirst%3DJ.%26aulast%3DLim%26aufirst%3DH.%2BD.%26aulast%3DAlamein%26aufirst%3DC.%26aulast%3DManandhar%26aufirst%3DP.%26aulast%3DSantiago%26aufirst%3DM.%26aulast%3DFritzwanker%26aufirst%3DS.%26aulast%3DSchmiedel%26aufirst%3DF.%26aulast%3DKatte%26aufirst%3DT.%2BA.%26aulast%3DReekie%26aufirst%3DT.%26aulast%3DGrimsey%26aufirst%3DN.%2BL.%26aulast%3DKassiou%26aufirst%3DM.%26aulast%3DKellam%26aufirst%3DB.%26aulast%3DKrasel%26aufirst%3DC.%26aulast%3DHalls%26aufirst%3DM.%2BL.%26aulast%3DConnor%26aufirst%3DM.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DSchulz%26aufirst%3DS.%26aulast%3DChristie%26aufirst%3DM.%2BJ.%26aulast%3DCanals%26aufirst%3DM.%26atitle%3DLow%2520intrinsic%2520efficacy%2520for%2520G%2520protein%2520activation%2520can%2520explain%2520the%2520improved%2520side%2520effect%2520profiles%2520of%2520new%2520opioid%2520agonists%26jtitle%3DSci.%2520Signaling%26date%3D2020%26volume%3D13%26spage%3Deaaz3140%26doi%3D10.1126%2Fscisignal.aaz3140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mascarella, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spangler, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurevich, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarro, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruchas, M. R.</span></span> <span> </span><span class="NLM_article-title">Quantitative signaling and structure-activity analyses demonstrate functional selectivity at the nociceptin/orphanin FQ opioid receptor</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">502</span>– <span class="NLM_lpage">511</span>, <span class="refDoi"> DOI: 10.1124/mol.115.099150</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1124%2Fmol.115.099150" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=26134494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlyktLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2015&pages=502-511&author=S.+D.+Changauthor=S.+W.+Mascarellaauthor=S.+M.+Spanglerauthor=V.+V.+Gurevichauthor=H.+A.+Navarroauthor=F.+I.+Carrollauthor=M.+R.+Bruchas&title=Quantitative+signaling+and+structure-activity+analyses+demonstrate+functional+selectivity+at+the+nociceptin%2Forphanin+FQ+opioid+receptor&doi=10.1124%2Fmol.115.099150"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative signaling and structure-activity analyses demonstrate functional selectivity at the nociceptin/orphanin FQ opioid receptor</span></div><div class="casAuthors">Chang, Steven D.; Mascarella, S. Wayne; Spangler, Skylar M.; Gurevich, Vsevolod V.; Navarro, Hernan A.; Carroll, F. Ivy; Bruchas, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">502-511</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Pancreatic cancer has the lowest 5-yr survival rate of all major cancers despite decades of effort to design and implement novel, more effective treatment options.  In this study, we tested whether the dual phosphoinositide 3-kinase/mechanistic target of rapamycin inhibitor BEZ235 (BEZ) potentiates the antitumor effects of doxorubicin (DOX) against pancreatic cancer.  Cotreatment of BEZ235 with DOX resulted in dose-dependent inhibition of the phosphoinositide 3-kinase/mechanistic target of rapamycin survival pathway, which corresponded with an increase in poly ADP ribose polymerase cleavage.  Moreover, BEZ cotreatment significantly improved the effects of DOX toward both cell viability and cell death in part through reduced Bcl-2 expression and increased expression of the shorter, more cytotoxic forms of BIM.  BEZ also facilitated intracellular accumulation of DOX, which led to enhanced DNA damage and reactive oxygen species generation.  Furthermore, BEZ in combination with gemcitabine reduced MiaPaca2 cell proliferation but failed to increase reactive oxygen species generation or BIM expression, resulting in reduced necrosis and apoptosis.  Treatment with BEZ and DOX in mice bearing tumor xenographs significantly repressed tumor growth as compared with BEZ, DOX, or gemcitabine.  Addnl., in contrast to the enhanced expression seen in MiaPaca2 cells, BEZ and DOX cotreatment reduced BIM expression in H9C2 cardiomyocytes.  Also, the Bcl-2/Bax ratio was increased, which was assocd. with a redn. in cell death.  In vivo echocardiog. showed decreased cardiac function with DOX treatment, which was not improved by combination treatment with BEZ.  Thus, we propose that combining BEZ with DOX would be a better option for patients than current std. of care by providing a more effective tumor response without the assocd. increase in toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowdAZqtUuLx7Vg90H21EOLACvtfcHk0lhofAa-ArHG6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlyktLrI&md5=2bbd01f7e2c6b21e01a2406b69971eef</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1124%2Fmol.115.099150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.115.099150%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DS.%2BD.%26aulast%3DMascarella%26aufirst%3DS.%2BW.%26aulast%3DSpangler%26aufirst%3DS.%2BM.%26aulast%3DGurevich%26aufirst%3DV.%2BV.%26aulast%3DNavarro%26aufirst%3DH.%2BA.%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DBruchas%26aufirst%3DM.%2BR.%26atitle%3DQuantitative%2520signaling%2520and%2520structure-activity%2520analyses%2520demonstrate%2520functional%2520selectivity%2520at%2520the%2520nociceptin%252Forphanin%2520FQ%2520opioid%2520receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2015%26volume%3D88%26spage%3D502%26epage%3D511%26doi%3D10.1124%2Fmol.115.099150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malfacini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambrosio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gro’, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sbraccia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapella, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonora, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinton, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calo’, G.</span></span> <span> </span><span class="NLM_article-title">Pharmacological profile of nociceptin/orphanin FQ receptors interacting with G-proteins and beta-arrestins 2</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">e0132865</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0132865</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1371%2Fjournal.pone.0132865" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=26248189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFOisrzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0132865&author=D.+Malfaciniauthor=C.+Ambrosioauthor=M.+C.+Gro%E2%80%99author=M.+Sbracciaauthor=C.+Trapellaauthor=R.+Guerriniauthor=M.+Bonoraauthor=P.+Pintonauthor=T.+Costaauthor=G.+Calo%E2%80%99&title=Pharmacological+profile+of+nociceptin%2Forphanin+FQ+receptors+interacting+with+G-proteins+and+beta-arrestins+2&doi=10.1371%2Fjournal.pone.0132865"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological profile of nociceptin/orphanin FQ receptors interacting with G-proteins and β-arrestins 2</span></div><div class="casAuthors">Malfacini, D.; Ambrosio, C.; Gro, M. C.; Sbraccia, M.; Trapella, C.; Guerrini, R.; Bonora, M.; Pinton, P.; Costa, T.; Calo, G.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e0132865/1-e0132865/22</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Nociceptin/orphanin FQ (N/OFQ) controls several biol. functions by selectively activating an opioid like receptor named N/OFQ peptide receptor (NOP).  Biased agonism is emerging as an important and therapeutically relevant pharmacol. concept in the field of G protein coupled receptors including opioids.  To evaluate the relevance of this phenomenon in the NOP receptor, we used a bioluminescence resonance energy transfer technol. to measure the interactions of the NOP receptor with either G proteins or β-arrestin 2 in the absence and in presence of increasing concn. of ligands.  A large panel of receptor ligands was investigated by comparing their ability to promote or block NOP/G protein and NOP/arrestin interactions.  In this study we report a systematic anal. of the functional selectivity of NOP receptor ligands.  NOP/G protein interactions (investigated in cell membranes) allowed a precise estn. of both ligand potency and efficacy yielding data highly consistent with the known pharmacol. profile of this receptor.  The same panel of ligands displayed marked differences in the ability to promote NOP/β-arrestin 2 interactions (evaluated in whole cells).  In particular, full agonists displayed a general lower potency and for some ligands an inverted rank order of potency was noted.  Most partial agonists behaved as pure competitive antagonists of receptor/arrestin interaction.  Antagonists displayed similar values of potency for NOP/Gβ1 or NOP/β-arrestin 2 interaction.  Using N/OFQ as ref. ligand we computed the bias factors of NOP ligands and a no. of agonists with greater efficacy at G protein coupling were identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfT4SDzCFVILVg90H21EOLACvtfcHk0lhofAa-ArHG6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFOisrzP&md5=59067ccbe7155469015db1132c0e12cb</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0132865&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0132865%26sid%3Dliteratum%253Aachs%26aulast%3DMalfacini%26aufirst%3DD.%26aulast%3DAmbrosio%26aufirst%3DC.%26aulast%3DGro%25E2%2580%2599%26aufirst%3DM.%2BC.%26aulast%3DSbraccia%26aufirst%3DM.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DBonora%26aufirst%3DM.%26aulast%3DPinton%26aufirst%3DP.%26aulast%3DCosta%26aufirst%3DT.%26aulast%3DCalo%25E2%2580%2599%26aufirst%3DG.%26atitle%3DPharmacological%2520profile%2520of%2520nociceptin%252Forphanin%2520FQ%2520receptors%2520interacting%2520with%2520G-proteins%2520and%2520beta-arrestins%25202%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0132865%26doi%3D10.1371%2Fjournal.pone.0132865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moulédous, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Froment, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dasgupta, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Günther, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunori, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieffer, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toll, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruchas, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaveri, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, S.</span></span> <span> </span><span class="NLM_article-title">Agonist-selective NOP receptor phosphorylation correlates in vitro and in vivo and reveals differential post-activation signaling by chemically diverse agonists</span>. <i>Sci. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">eaau8072</span>, <span class="refDoi"> DOI: 10.1126/scisignal.aau8072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1126%2Fscisignal.aau8072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=30914485" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2019&pages=eaau8072&author=A.+Mannauthor=L.+Moul%C3%A9dousauthor=C.+Fromentauthor=P.+R.+O%E2%80%99Neillauthor=P.+Dasguptaauthor=T.+G%C3%BCntherauthor=G.+Brunoriauthor=B.+L.+Kiefferauthor=L.+Tollauthor=M.+R.+Bruchasauthor=N.+T.+Zaveriauthor=S.+Schulz&title=Agonist-selective+NOP+receptor+phosphorylation+correlates+in+vitro+and+in+vivo+and+reveals+differential+post-activation+signaling+by+chemically+diverse+agonists&doi=10.1126%2Fscisignal.aau8072"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.aau8072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.aau8072%26sid%3Dliteratum%253Aachs%26aulast%3DMann%26aufirst%3DA.%26aulast%3DMoul%25C3%25A9dous%26aufirst%3DL.%26aulast%3DFroment%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DP.%2BR.%26aulast%3DDasgupta%26aufirst%3DP.%26aulast%3DG%25C3%25BCnther%26aufirst%3DT.%26aulast%3DBrunori%26aufirst%3DG.%26aulast%3DKieffer%26aufirst%3DB.%2BL.%26aulast%3DToll%26aufirst%3DL.%26aulast%3DBruchas%26aufirst%3DM.%2BR.%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26aulast%3DSchulz%26aufirst%3DS.%26atitle%3DAgonist-selective%2520NOP%2520receptor%2520phosphorylation%2520correlates%2520in%2520vitro%2520and%2520in%2520vivo%2520and%2520reveals%2520differential%2520post-activation%2520signaling%2520by%2520chemically%2520diverse%2520agonists%26jtitle%3DSci.%2520Signaling%26date%3D2019%26volume%3D12%26spage%3Deaau8072%26doi%3D10.1126%2Fscisignal.aau8072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Asth, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzza, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malfacini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medeiros, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaveri, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavioli, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calo’, G.</span></span> <span> </span><span class="NLM_article-title">Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic-versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">434</span>– <span class="NLM_lpage">442</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2016.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1016%2Fj.neuropharm.2016.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=26867504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC28XivFKiur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2016&pages=434-442&author=L.+Asthauthor=C.+Ruzzaauthor=D.+Malfaciniauthor=I.+Medeirosauthor=R.+Guerriniauthor=N.+T.+Zaveriauthor=E.+C.+Gavioliauthor=G.+Calo%E2%80%99&title=Beta-arrestin+2+rather+than+G+protein+efficacy+determines+the+anxiolytic-versus+antidepressant-like+effects+of+nociceptin%2Forphanin+FQ+receptor+ligands&doi=10.1016%2Fj.neuropharm.2016.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic-versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands</span></div><div class="casAuthors">Asth, L.; Ruzza, C.; Malfacini, D.; Medeiros, I.; Guerrini, R.; Zaveri, N. T.; Gavioli, E. C.; Calo, G.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">434-442</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nociceptin/orphanin FQ (N/OFQ) receptor (NOP) agonists produce anxiolytic-like effects in rodents while antagonists promote antidepressant-like effects.  The aim of this study was to investigate the effect on anxiety and depression of NOP receptor partial agonists such as the peptides [F/G]N/OFQ(1-13)NH2 and UFP-113 and the non-peptide AT-090.  In vitro AT-090, UFP-113, and [F/G]N/OFQ(1-13)NH2 were tested for their ability to promote NOP/G-protein and NOP/β-arrestin 2 interaction, using a bioluminescence resonance energy transfer assay.  In vivo, they were tested in mice in the elevated plus maze (EPM) and in the forced swim (FST) tests.  NOP partial agonists effects were systematically compared to those of full agonists (N/OFQ and Ro 65-6570) and antagonists (UFP-101 and SB-612111).  In vitro, AT-090, UFP-113, and [F/G]N/OFQ(1-13)NH2 promoted NOP/G protein interaction, with maximal effects lower than those evoked by N/OFQ and Ro 65-6570.  AT-090 behaved as a NOP partial agonist also in inducing β-arrestin 2 recruitment, while UFP-113 and [F/G]N/OFQ(1-13)NH2 were inactive in this assay.  In vivo, AT-090 induced anxiolytic-like effects in the EPM but was inactive in the FST.  Opposite results were obtained with UFP-113 and [F/G]N/OFQ(1-13)NH2.  NOP ligands producing similar effects on NOP/G protein interaction (partial agonism) but showing different effects on β-arrestin 2 recruitment (partial agonism vs antagonism) elicited different actions on anxiety and mood.  These results suggest that the action of a NOP ligand on emotional states is better predicted based on its β-arrestin 2 rather than G-protein efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBoIUIFuXBjbVg90H21EOLACvtfcHk0ljlU6jboEg36Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XivFKiur8%253D&md5=07a5cd55a63a1822dc51970fe99e52f1</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2016.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2016.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DAsth%26aufirst%3DL.%26aulast%3DRuzza%26aufirst%3DC.%26aulast%3DMalfacini%26aufirst%3DD.%26aulast%3DMedeiros%26aufirst%3DI.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26aulast%3DGavioli%26aufirst%3DE.%2BC.%26aulast%3DCalo%25E2%2580%2599%26aufirst%3DG.%26atitle%3DBeta-arrestin%25202%2520rather%2520than%2520G%2520protein%2520efficacy%2520determines%2520the%2520anxiolytic-versus%2520antidepressant-like%2520effects%2520of%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520ligands%26jtitle%3DNeuropharmacology%26date%3D2016%26volume%3D105%26spage%3D434%26epage%3D442%26doi%3D10.1016%2Fj.neuropharm.2016.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calò, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neugebauer, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvadori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regoli, D.</span></span> <span> </span><span class="NLM_article-title">The mouse vas deferens: a pharmacological preparation sensitive to nociceptin</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>311</i></span>,  <span class="NLM_fpage">R3</span>– <span class="NLM_lpage">R5</span>, <span class="refDoi"> DOI: 10.1016/0014-2999(96)00563-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1016%2F0014-2999%2896%2900563-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=8884244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADyaK28XlsFWks78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=1996&pages=R3-R5&author=G.+Cal%C3%B2author=A.+Rizziauthor=G.+Bogoniauthor=V.+Neugebauerauthor=S.+Salvadoriauthor=R.+Guerriniauthor=C.+Bianchiauthor=D.+Regoli&title=The+mouse+vas+deferens%3A+a+pharmacological+preparation+sensitive+to+nociceptin&doi=10.1016%2F0014-2999%2896%2900563-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The mouse vas deferens: a pharmacological preparation sensitive to nociceptin</span></div><div class="casAuthors">Calo, Girolamo; Rizzi, Anna; Bogoni, Giovanni; Neugebauer, Vitold; Salvadori, Severo; Guerrini, Remo; Bianchi, Clementina; Regoli, Domenico</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">311</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">R3-R5</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The newly discovered neuropeptide, nociceptin (alias orphanin FQ), was tested for its potential direct effects, as well as for its ability to modify the elec. evoked contractions in several isolated organs suspended in vitro.  The elec. stimulated mouse vas deferens is a sensitive prepn. on which nociceptin exerts an inhibitory effect which is not affected by naloxone.  The mouse vas deferens is therefore proposed as a bioassay for nociceptin and related compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWqLkwn2Toz7Vg90H21EOLACvtfcHk0ljlU6jboEg36Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlsFWks78%253D&md5=3da5c3c35fc524d2b26dd1c1d359e594</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2896%2900563-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252896%252900563-8%26sid%3Dliteratum%253Aachs%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DBogoni%26aufirst%3DG.%26aulast%3DNeugebauer%26aufirst%3DV.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DBianchi%26aufirst%3DC.%26aulast%3DRegoli%26aufirst%3DD.%26atitle%3DThe%2520mouse%2520vas%2520deferens%253A%2520a%2520pharmacological%2520preparation%2520sensitive%2520to%2520nociceptin%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1996%26volume%3D311%26spage%3DR3%26epage%3DR5%26doi%3D10.1016%2F0014-2999%2896%2900563-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Molinari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vezzi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sbraccia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grò, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riitano, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambrosio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casella, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, T.</span></span> <span> </span><span class="NLM_article-title">Morphine-like opiates selectively antagonize receptor-arrestin interactions</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">12522</span>– <span class="NLM_lpage">12535</span>, <span class="refDoi"> DOI: 10.1074/jbc.m109.059410</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1074%2Fjbc.M109.059410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=20189994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvVGjtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=12522-12535&author=P.+Molinariauthor=V.+Vezziauthor=M.+Sbracciaauthor=C.+Gr%C3%B2author=D.+Riitanoauthor=C.+Ambrosioauthor=I.+Casellaauthor=T.+Costa&title=Morphine-like+opiates+selectively+antagonize+receptor-arrestin+interactions&doi=10.1074%2Fjbc.m109.059410"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Morphine-like Opiates Selectively Antagonize Receptor-Arrestin Interactions</span></div><div class="casAuthors">Molinari, Paola; Vezzi, Vanessa; Sbraccia, Maria; Gro, Cristina; Riitano, Daniela; Ambrosio, Caterina; Casella, Ida; Costa, Tommaso</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">12522-12535</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The addictive potential of opioids may be related to their differential ability to induce G protein signaling and endocytosis.  We compared the ability of 20 ligands (sampled from the main chem. classes of opioids) to promote the assocn. of μ and δ receptors with G protein or β-arrestin 2.  Receptor-arrestin binding was monitored by bioluminescence resonance energy transfer (BRET) in intact cells, where pertussis toxin expts. indicated that the interaction was minimally affected by receptor signaling.  To assess receptor-G protein coupling without competition from arrestins, we employed a cell-free BRET assay using membranes isolated from cells expressing luminescent receptors and fluorescent Gβ1.  In this system, the agonist-induced enhancement of BRET (indicating shortening of distance between the two proteins) was Gα-mediated (as shown by sensitivity to pertussis toxin and guanine nucleotides) and yielded data consistent with the known pharmacol. of the ligands.  We found marked differences of efficacy for G protein and arrestin, with a pattern suggesting more restrictive structural requirements for arrestin efficacy.  The anal. of such differences identified a subset of structures showing a marked discrepancy between efficacies for G protein and arrestin.  Addictive opiates like morphine and oxymorphone exhibited large differences both at δ and μ receptors.  Thus, they were effective agonists for G protein coupling but acted as competitive enkephalins antagonists (δ) or partial agonists (μ) for arrestin.  This arrestin-selective antagonism resulted in inhibition of short and long term events mediated by arrestin, such as rapid receptor internalization and down-regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgITOiZm3ElrVg90H21EOLACvtfcHk0lhnA2nbDMFXsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvVGjtL0%253D&md5=9e7042df0124343705535806173d7247</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.059410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.059410%26sid%3Dliteratum%253Aachs%26aulast%3DMolinari%26aufirst%3DP.%26aulast%3DVezzi%26aufirst%3DV.%26aulast%3DSbraccia%26aufirst%3DM.%26aulast%3DGr%25C3%25B2%26aufirst%3DC.%26aulast%3DRiitano%26aufirst%3DD.%26aulast%3DAmbrosio%26aufirst%3DC.%26aulast%3DCasella%26aufirst%3DI.%26aulast%3DCosta%26aufirst%3DT.%26atitle%3DMorphine-like%2520opiates%2520selectively%2520antagonize%2520receptor-arrestin%2520interactions%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D12522%26epage%3D12535%26doi%3D10.1074%2Fjbc.m109.059410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerlesi, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzza, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malfacini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianco, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapella, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calo’, G.</span></span> <span> </span><span class="NLM_article-title">Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonist</span>. <i>Pharmacol. Res. Perspect.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">e00247</span>, <span class="refDoi"> DOI: 10.1002/prp2.247</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1002%2Fprp2.247" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=28116100" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2016&pages=e00247&author=A.+Rizziauthor=M.+C.+Cerlesiauthor=C.+Ruzzaauthor=D.+Malfaciniauthor=F.+Ferrariauthor=S.+Biancoauthor=T.+Costaauthor=R.+Guerriniauthor=C.+Trapellaauthor=G.+Calo%E2%80%99&title=Pharmacological+characterization+of+cebranopadol+a+novel+analgesic+acting+as+mixed+nociceptin%2Forphanin+FQ+and+opioid+receptor+agonist&doi=10.1002%2Fprp2.247"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fprp2.247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprp2.247%26sid%3Dliteratum%253Aachs%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DCerlesi%26aufirst%3DM.%2BC.%26aulast%3DRuzza%26aufirst%3DC.%26aulast%3DMalfacini%26aufirst%3DD.%26aulast%3DFerrari%26aufirst%3DF.%26aulast%3DBianco%26aufirst%3DS.%26aulast%3DCosta%26aufirst%3DT.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DCalo%25E2%2580%2599%26aufirst%3DG.%26atitle%3DPharmacological%2520characterization%2520of%2520cebranopadol%2520a%2520novel%2520analgesic%2520acting%2520as%2520mixed%2520nociceptin%252Forphanin%2520FQ%2520and%2520opioid%2520receptor%2520agonist%26jtitle%3DPharmacol.%2520Res.%2520Perspect.%26date%3D2016%26volume%3D4%26spage%3De00247%26doi%3D10.1002%2Fprp2.247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bird, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerlesi, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malfacini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vezzi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molinari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micheli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mannelli, L. D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghelardini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calò, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. G.</span></span> <span> </span><span class="NLM_article-title">Characterisation of the novel mixed mu-NOP peptide ligand dermorphin-N/OFQ (DeNo)</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">e0156897</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0156897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1371%2Fjournal.pone.0156897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=27272042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslCqu7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=e0156897&author=M.+F.+Birdauthor=M.+C.+Cerlesiauthor=M.+Brownauthor=D.+Malfaciniauthor=V.+Vezziauthor=P.+Molinariauthor=L.+Micheliauthor=L.+D.+C.+Mannelliauthor=C.+Ghelardiniauthor=R.+Guerriniauthor=G.+Cal%C3%B2author=D.+G.+Lambert&title=Characterisation+of+the+novel+mixed+mu-NOP+peptide+ligand+dermorphin-N%2FOFQ+%28DeNo%29&doi=10.1371%2Fjournal.pone.0156897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Characterisation of the novel mixed mu-NOP peptide ligand dermorphin-N/OFQ (DeNo)</span></div><div class="casAuthors">Bird, Mark F.; Cerlesi, Maria Camilla; Brown, Mark; Malfacini, Davide; Vezzi, Vanessa; Molinari, Paola; Micheli, Laura; Mannelli, Lorenzo Di Cesare; Ghelardini, Carla; Guerrini, Remo; Calo, Girolamo; Lambert, David G.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e0156897/1-e0156897/22</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Introduction Opioid receptors are currently classified as Mu (μ), Delta (δ), Kappa (κ) plus the opioid related nociceptin/orphanin FQ (N/OFQ) peptide receptor (NOP).  Despite compelling evidence for interactions and benefits of targeting more than one receptor type in producing analgesia, clin. ligands are Mu agonists.  In this study we have designed a Mu-NOP agonist named DeNo.  The Mu agonist component is provided by dermorphin, a peptide isolated from the skin of Phyllomedusa frogs and the NOP component by the endogenous agonist N/OFQ.  Methods We have assessed receptor binding profile of DeNo and compared with dermorphin and N/ OFQ.  In a series of functional screens we have assessed the ability to (i) increase Ca2+ in cells coexpressing recombinant receptors and a the chimeric protein Gαqi5, (ii) stimulate the binding of GTPγ[35S], (iii) inhibit cAMP formation, (iv) activate MAPKinase, (v) stimulate receptor-G protein and arrestin interaction using BRET, (vi) elec. stimulated guinea pig ileum (gpI) assay and (vii) ability to produce analgesia via the intrathecal route in rats.  Results DeNo bound to Mu (pKi; 9.55) and NOP (pKi; 10.22) and with reasonable selectivity.  This translated to increased Ca2+ in Gαqi5 expressing cells (pEC50 Mu 7.17; NOP 9.69), increased binding of GTPγ[35S] (pEC50 Mu 7.70; NOP 9.50) and receptor-G protein interaction in BRET (pEC50 Mu 8.01; NOP 9.02). cAMP formation was inhibited and arrestin was activated (pEC50 Mu 6.36; NOP 8.19).  For MAPK DeNo activated p38 and ERK1/2 at Mu but only ERK1/2 at NOP.  In the gpI DeNO inhibited elec.-evoked contractions (pEC50 8.63) that was sensitive to both Mu and NOP antagonists.  DeNo was antinociceptive in rats.  Conclusion Collectively these data validate the strategy used to create a novel bivalent Mu-NOP peptide agonist by combining dermorphin (Mu) and N/OFQ (NOP).  This mol. behaves essentially as the parent compds. in vitro.  In the antonocicoeptive assays employed in this study DeNo displays only weak antinociceptive properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGf0rqpcJ8OrVg90H21EOLACvtfcHk0ljEpebO-qBAnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslCqu7nI&md5=5e929f3870f21dc463ccc60417dc59bd</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0156897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0156897%26sid%3Dliteratum%253Aachs%26aulast%3DBird%26aufirst%3DM.%2BF.%26aulast%3DCerlesi%26aufirst%3DM.%2BC.%26aulast%3DBrown%26aufirst%3DM.%26aulast%3DMalfacini%26aufirst%3DD.%26aulast%3DVezzi%26aufirst%3DV.%26aulast%3DMolinari%26aufirst%3DP.%26aulast%3DMicheli%26aufirst%3DL.%26aulast%3DMannelli%26aufirst%3DL.%2BD.%2BC.%26aulast%3DGhelardini%26aufirst%3DC.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26atitle%3DCharacterisation%2520of%2520the%2520novel%2520mixed%2520mu-NOP%2520peptide%2520ligand%2520dermorphin-N%252FOFQ%2520%2528DeNo%2529%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26spage%3De0156897%26doi%3D10.1371%2Fjournal.pone.0156897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cerlesi, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bird, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiguchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malfacini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzza, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span> <span> </span><span class="NLM_article-title">Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt<sup>1</sup>]N/OFQ(1-13)</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>794</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">126</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2016.11.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1016%2Fj.ejphar.2016.11.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=27871910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFGgtLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=794&publication_year=2017&pages=115-126&author=M.+C.+Cerlesiauthor=H.+Dingauthor=M.+F.+Birdauthor=N.+Kiguchiauthor=F.+Ferrariauthor=D.+Malfaciniauthor=A.+Rizziauthor=C.+Ruzzaauthor=D.+G.+Lambertauthor=M.-C.+Koauthor=G.+Caloauthor=R.+Guerrini&title=Pharmacological+studies+on+the+NOP+and+opioid+receptor+agonist+PWT2-%5BDmt1%5DN%2FOFQ%281-13%29&doi=10.1016%2Fj.ejphar.2016.11.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt1]N/OFQ(1-13)</span></div><div class="casAuthors">Cerlesi, Maria Camilla; Ding, Huiping; Bird, Mark F.; Kiguchi, Norikazu; Ferrari, Federica; Malfacini, Davide; Rizzi, Anna; Ruzza, Chiara; Lambert, David G.; Ko, Mei-Chuan; Calo, Girolamo; Guerrini, Remo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">794</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">115-126</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">An innovative chem. strategy named peptide welding technol. (PWT) has been developed for the facile synthesis of tetrabranched peptides. [Dmt1]N/OFQ(1-13)-NH2 acts as a universal agonist for nociceptin/orphanin FQ (N/OFQ) and classical opioid receptors.  The present study investigated the pharmacol. profile of the PWT deriv. of [Dmt1]N/OFQ(1-13)NH2 (PWT2-[Dmt1]) in several assays in vitro and in vivo after spinal administration in monkeys subjected to the tail withdrawal assay.  PWT2-[Dmt1] mimicked the effects of [Dmt1]N/OFQ(1-13)-NH2 displaying full agonist activity, similar affinity/potency and selectivity at human recombinant N/OFQ (NOP) and opioid receptors in receptor binding, stimulation of [35S]GTPγS binding, calcium mobilization in cells expressing chimeric G proteins, and BRET studies for measuring receptor/G-protein and receptor/β-arrestin 2 interaction.  In vivo in monkeys PWT2-[Dmt1] elicited dose-dependent and robust antinociceptive effects being more potent and longer lasting than [Dmt1]N/OFQ(1-13)-NH2.  The analgesic action of PWT2-[Dmt1] was sensitive to the NOP receptor antagonist J-113397, but not naltrexone.  Thus, the present study demonstrated that the tetrabranched deriv. of [Dmt1]N/OFQ(1-13)-NH2 obtained with the PWT technol. maintains the in vitro pharmacol. profile of the parent peptide but displays higher potency and longer lasting action in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaU2tLfW3W0LVg90H21EOLACvtfcHk0ljpRILvCs95IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFGgtLfI&md5=972be07440d904aa7463e15506271d23</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2016.11.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2016.11.026%26sid%3Dliteratum%253Aachs%26aulast%3DCerlesi%26aufirst%3DM.%2BC.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DBird%26aufirst%3DM.%2BF.%26aulast%3DKiguchi%26aufirst%3DN.%26aulast%3DFerrari%26aufirst%3DF.%26aulast%3DMalfacini%26aufirst%3DD.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DRuzza%26aufirst%3DC.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26aulast%3DKo%26aufirst%3DM.-C.%26aulast%3DCalo%26aufirst%3DG.%26aulast%3DGuerrini%26aufirst%3DR.%26atitle%3DPharmacological%2520studies%2520on%2520the%2520NOP%2520and%2520opioid%2520receptor%2520agonist%2520PWT2-%255BDmt1%255DN%252FOFQ%25281-13%2529%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2017%26volume%3D794%26spage%3D115%26epage%3D126%26doi%3D10.1016%2Fj.ejphar.2016.11.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malfacini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Journigan, B. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bird, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapella, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calo’, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaveri, N. T.</span></span> <span> </span><span class="NLM_article-title">In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403</span>. <i>Pharmacol. Res. Perspect.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">e00333</span>, <span class="refDoi"> DOI: 10.1002/prp2.333</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1002%2Fprp2.333" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2017&pages=e00333&author=F.+Ferrariauthor=D.+Malfaciniauthor=B.+V.+Journiganauthor=M.+F.+Birdauthor=C.+Trapellaauthor=R.+Guerriniauthor=D.+G.+Lambertauthor=G.+Calo%E2%80%99author=N.+T.+Zaveri&title=In+vitro+pharmacological+characterization+of+a+novel+unbiased+NOP+receptor-selective+nonpeptide+agonist+AT-403&doi=10.1002%2Fprp2.333"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fprp2.333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprp2.333%26sid%3Dliteratum%253Aachs%26aulast%3DFerrari%26aufirst%3DF.%26aulast%3DMalfacini%26aufirst%3DD.%26aulast%3DJournigan%26aufirst%3DB.%2BV.%26aulast%3DBird%26aufirst%3DM.%2BF.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26aulast%3DCalo%25E2%2580%2599%26aufirst%3DG.%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26atitle%3DIn%2520vitro%2520pharmacological%2520characterization%2520of%2520a%2520novel%2520unbiased%2520NOP%2520receptor-selective%2520nonpeptide%2520agonist%2520AT-403%26jtitle%3DPharmacol.%2520Res.%2520Perspect.%26date%3D2017%26volume%3D5%26spage%3De00333%26doi%3D10.1002%2Fprp2.333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kenakin, T.</span></span> <span> </span><span class="NLM_article-title">Biased receptor signaling in drug discovery</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">267</span>– <span class="NLM_lpage">315</span>, <span class="refDoi"> DOI: 10.1124/pr.118.016790</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1124%2Fpr.118.016790" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=30914442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvV2gtL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2019&pages=267-315&author=T.+Kenakin&title=Biased+receptor+signaling+in+drug+discovery&doi=10.1124%2Fpr.118.016790"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Biased receptor signaling in drug discovery</span></div><div class="casAuthors">Kenakin, Terry</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">267-315</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  A great deal of exptl. evidence suggests that ligands can stabilize different receptor active states that go on to interact with cellular signaling proteins to form a range of different complexes in varying quantities.  In pleiotropically linked receptor systems, this leads to selective activation of some signaling pathways at the expense of others (biased signaling).  This article summarizes the current knowledge about the complex components of receptor systems, the evidence that biased signaling is used in natural physiol. to fine-tune signaling, and the current thoughts on how this mechanism may be applied to the design of better drugs.  Although this is a fairly newly discovered phenomenon, theor. and exptl. data suggest that it is a ubiquitous behavior of ligands and receptors and to be expected.  Biased signaling is simple to detect in vitro and there are numerous methods to quantify the effect with scales that can be used to optimize this activity in structure-activity medicinal chem. studies.  At present, the major hurdle in the application of this mechanism to therapeutics is the translation of in vitro bias to in vivo effect; this is because of the numerous factors that can modify measures of bias in natural physiol. systems.  In spite of this, biased signaling still has the potential to justify revisiting of receptor targets previously thought to be intractable and also furnishes the means to pursue targets previously thought to be forbidden due to deleterious physiol. (as these may be eliminated through biased signaling).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomawYtBX53pbVg90H21EOLACvtfcHk0ljpRILvCs95IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvV2gtL3E&md5=ddf8cb5adb1dc14783bfc82a308fc70d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1124%2Fpr.118.016790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.118.016790%26sid%3Dliteratum%253Aachs%26aulast%3DKenakin%26aufirst%3DT.%26atitle%3DBiased%2520receptor%2520signaling%2520in%2520drug%2520discovery%26jtitle%3DPharmacol.%2520Rev.%26date%3D2019%26volume%3D71%26spage%3D267%26epage%3D315%26doi%3D10.1124%2Fpr.118.016790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dooley, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houghten, R. A.</span></span> <span> </span><span class="NLM_article-title">Orphanin FQ: receptor binding and analog structure activity relationships in rat brain</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">PL23</span>– <span class="NLM_lpage">PL29</span>, <span class="refDoi"> DOI: 10.1016/0024-3205(96)00261-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1016%2F0024-3205%2896%2900261-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=8684262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADyaK28XjsFGhsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1996&pages=PL23-PL29&author=C.+T.+Dooleyauthor=R.+A.+Houghten&title=Orphanin+FQ%3A+receptor+binding+and+analog+structure+activity+relationships+in+rat+brain&doi=10.1016%2F0024-3205%2896%2900261-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Orphanin FQ: receptor binding and analog structure activity relationships in rat brain</span></div><div class="casAuthors">Dooley, Colette T.; Houghten, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">PL23-PL29</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A tritiated form of orphanin FQ (a heptadecapeptide also known as Nociceptin) has been prepd.  This radioligand (33 Ci/mmole) was used to develop a radioreceptor assay using rat brain homogenates.  Binding was obsd. to be saturable, and analyses of the binding data indicate the presence of a single binding site with a dissocn. const. of 5 nM and Bmax of 535 fmoles/mg protein.  Thirty-four analogs of orphanin FQ, including a complete alanine "scan" of orphanin FQ, and truncation analogs from both the N- and C-terminals were synthesized and tested.  The data obtained indicate that the N-terminus plays a more crit. role in binding than the C-terminus and that residues 1, 2, 4, and 8 are essential for binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsICd529z6WbVg90H21EOLACvtfcHk0ljZVKs-0p5UzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjsFGhsL8%253D&md5=ff4ab4643920535ad6649137593f1b63</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2F0024-3205%2896%2900261-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0024-3205%252896%252900261-5%26sid%3Dliteratum%253Aachs%26aulast%3DDooley%26aufirst%3DC.%2BT.%26aulast%3DHoughten%26aufirst%3DR.%2BA.%26atitle%3DOrphanin%2520FQ%253A%2520receptor%2520binding%2520and%2520analog%2520structure%2520activity%2520relationships%2520in%2520rat%2520brain%26jtitle%3DLife%2520Sci.%26date%3D1996%26volume%3D59%26spage%3DPL23%26epage%3DPL29%26doi%3D10.1016%2F0024-3205%2896%2900261-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reinscheid, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ardati, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monsma, F. J.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Civelli, O.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship studies on the novel neuropeptide orphanin FQ</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>271</i></span>,  <span class="NLM_fpage">14163</span>– <span class="NLM_lpage">14168</span>, <span class="refDoi"> DOI: 10.1074/jbc.271.24.14163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1074%2Fjbc.271.24.14163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=8662940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADyaK28Xjs1Oit70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=14163-14168&author=R.+K.+Reinscheidauthor=A.+Ardatiauthor=F.+J.+Monsmaauthor=O.+Civelli&title=Structure-activity+relationship+studies+on+the+novel+neuropeptide+orphanin+FQ&doi=10.1074%2Fjbc.271.24.14163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship studies on the novel neuropeptide orphanin FQ</span></div><div class="casAuthors">Reinscheid, Rainer K.; Ardati, Ali; Monsma, Frederick J., Jr.; Civelli, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">14163-14168</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The heptadecapeptide orphanin FQ (OFQ) is an endogenous ligand to an opioid-like G protein-coupled receptor.  Although the primary structure of OFQ exhibits some similarity to the opioid peptides, OFQ is not recognized by opioid receptors nor does the OFQ receptor bind opioid ligands.  To investigate the structural determinants of this ligand/receptor selectivity, we conducted a systematic structure-activity study on OFQ to characterize which sites of the mol. are important for receptor activation.  Alanine- and D-amino acid-scanning mutagenesis revealed several residues in the amino-terminal half of OFQ which participate in both receptor binding and activation.  Most strikingly, the Phe1 position could be changed to a tyrosine without loss of biol. activity.  In addn., the OFQ receptor seemed to require recognition of the complete peptide mol. for activation.  These results indicate that the mode of interaction of OFQ with its receptor may be different from that of the opioid peptides with their resp. receptors and might therefore account for the obsd. selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkGdhen8JcfbVg90H21EOLACvtfcHk0ljZVKs-0p5UzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xjs1Oit70%253D&md5=e2b061b269da3ffe335aa8261ba431a4</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.24.14163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.24.14163%26sid%3Dliteratum%253Aachs%26aulast%3DReinscheid%26aufirst%3DR.%2BK.%26aulast%3DArdati%26aufirst%3DA.%26aulast%3DMonsma%26aufirst%3DF.%2BJ.%26aulast%3DCivelli%26aufirst%3DO.%26atitle%3DStructure-activity%2520relationship%2520studies%2520on%2520the%2520novel%2520neuropeptide%2520orphanin%2520FQ%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D14163%26epage%3D14168%26doi%3D10.1074%2Fjbc.271.24.14163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calo’, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazarus, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvadori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temussi, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regoli, D.</span></span> <span> </span><span class="NLM_article-title">Address and message sequences for the nociceptin receptor: a structure-activity study of nociceptin-(1-13)-peptide amide</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1789</span>– <span class="NLM_lpage">1793</span>, <span class="refDoi"> DOI: 10.1021/jm970011b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970011b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADyaK2sXjt1SqsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=1789-1793&author=R.+Guerriniauthor=G.+Calo%E2%80%99author=A.+Rizziauthor=C.+Bianchiauthor=L.+H.+Lazarusauthor=S.+Salvadoriauthor=P.+A.+Temussiauthor=D.+Regoli&title=Address+and+message+sequences+for+the+nociceptin+receptor%3A+a+structure-activity+study+of+nociceptin-%281-13%29-peptide+amide&doi=10.1021%2Fjm970011b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Address and Message Sequences for the Nociceptin Receptor: A Structure-Activity Study of Nociceptin-(1-13)-peptide amide</span></div><div class="casAuthors">Guerrini, Remo; Calo', Girolamo; Rizzi, Anna; Bianchi, Clementina; Lazarus, Lawrence H.; Salvadori, Severo; Temussi, Piero A.; Regoli, Domenico</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1789-1793</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nociceptin (NC) and some of its fragments as well as nociceptin-(1-13)-peptide amide NC(1-13)-NH2 and a series of its analogs were prepd. and tested in the mouse vas deferens to identify the sequences involved in the activation (message) and in the binding (address) of nociceptin to its receptor.  The NC receptor that inhibits the elec. evoked twitches of the mouse vas deferens was demonstrated to be distinct from the δ opioid receptor, since naloxone and Dmt-Tic-OH (a selective δ opioid receptor antagonist) block the δ opioid receptor but have no effect on the nociceptin receptor.  From structure-activity expts. suggest that (a) the entire sequence of NC may not be required for full biol. activities, since NC(1-13)-NH2 is as active as NC; (b) fragments of NC have however to be amidated as in NC(1-13)-NH2 to be protected from degrdn. by proteases; (c) cationic residues (as Arg8,12, Lys9,13) appear to play a functional role, since their replacement with Ala in the sequence of NC(1-13)-NH2 leads to inactivity; (d) the N-terminal tetrapeptide Phe-Gly-Gly-Phe is essential for activity: its full length and flexibility appear to be required for NC receptor activation and/or occupation; (e) Phe4 and not Phe1 appears to be the residue involved in receptor activation, since the replacement of Phe1 with Leu has no effect, while that of Phe4 leads to inactivity.  The data summarized in this paper indicate that the structural requirements of NC for occupation and activation of its receptor are different from that of opioids, particularly δ agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphC5NH2WPOFLVg90H21EOLACvtfcHk0lg9YAuJ2kzHRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjt1SqsL0%253D&md5=c3ca11cbac28740db5babed384a5ddde</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm970011b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970011b%26sid%3Dliteratum%253Aachs%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DCalo%25E2%2580%2599%26aufirst%3DG.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DBianchi%26aufirst%3DC.%26aulast%3DLazarus%26aufirst%3DL.%2BH.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DTemussi%26aufirst%3DP.%2BA.%26aulast%3DRegoli%26aufirst%3DD.%26atitle%3DAddress%2520and%2520message%2520sequences%2520for%2520the%2520nociceptin%2520receptor%253A%2520a%2520structure-activity%2520study%2520of%2520nociceptin-%25281-13%2529-peptide%2520amide%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D1789%26epage%3D1793%26doi%3D10.1021%2Fjm970011b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calo’, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigoni, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regoli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvadori, S.</span></span> <span> </span><span class="NLM_article-title">Structure-activity study of the nociceptin(1-13)-NH<sub>2</sub> N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">3360</span>– <span class="NLM_lpage">3366</span>, <span class="refDoi"> DOI: 10.1021/jm970805q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970805q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADyaK1cXkvF2nt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=3360-3366&author=G.+Calo%E2%80%99author=R.+Guerriniauthor=R.+Bigoniauthor=A.+Rizziauthor=C.+Bianchiauthor=D.+Regoliauthor=S.+Salvadori&title=Structure-activity+study+of+the+nociceptin%281-13%29-NH2+N-terminal+tetrapeptide+and+discovery+of+a+nociceptin+receptor+antagonist&doi=10.1021%2Fjm970805q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Study of the Nociceptin(1-13)-NH2 N-Terminal Tetrapeptide and Discovery of a Nociceptin Receptor Antagonist</span></div><div class="casAuthors">Calo, Girolamo; Guerrini, Remo; Bigoni, Raffaella; Rizzi, Anna; Bianchi, Clementina; Regoli, Domenico; Salvadori, Severo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3360-3366</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the present study, the minimal fragment sequence required to fully activate the nociceptin (NC) receptor, namely H-Phe-Gly-Gly-Phe-Thr-Gly-Ala-Arg-Lys-Ser-Ala-Arg-Lys-NH2 [NC(1-13)-NH2], was used as template for the design of a series of new compds.  Changes were made in the N-terminal tetrapeptide Phe-Gly-Gly-Phe, which has been shown to be essential for receptor occupation and activation.  The new compds. were tested for their ability to inhibit the elec. evoked contraction of the mouse vas deferens, a pharmacol. prepn. sensitive to NC.  Results obtained indicate that (a) the replacement of Gly2 or Gly3 with an arom. residue (Phe) of L or D chirality eliminates the ability of the peptide to occupy the NC receptor; (b) the distance between Phe1 and Phe4 of NC appears to be crit., since any alteration of it leads to a marked decrease or a total elimination of biol. activity; and (c) the insertion of a pseudopeptide bond between Phe1 and Gly2 maintains affinity but eliminates the ability of the peptide to activate the NC receptor and leads to antagonism.  The peptide [Phe1ψ(CH2-NH)Gly2]-NC(1-13)-NH2 acts as a selective NC receptor antagonist and is inactive on opioid receptors.  The results summarized in this paper confirm and extend our previous findings by showing that the structural requirements for NC binding to its receptor are clearly different from those of opioids; in addn., this structure-activity study has led to the identification of the first NC receptor selective antagonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogyRDk3ShRFLVg90H21EOLACvtfcHk0lg9YAuJ2kzHRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkvF2nt78%253D&md5=8b82c1e8f4e45c106afa365c3356787c</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm970805q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970805q%26sid%3Dliteratum%253Aachs%26aulast%3DCalo%25E2%2580%2599%26aufirst%3DG.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DBigoni%26aufirst%3DR.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DBianchi%26aufirst%3DC.%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DSalvadori%26aufirst%3DS.%26atitle%3DStructure-activity%2520study%2520of%2520the%2520nociceptin%25281-13%2529-NH2%2520N-terminal%2520tetrapeptide%2520and%2520discovery%2520of%2520a%2520nociceptin%2520receptor%2520antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D3360%26epage%3D3366%26doi%3D10.1021%2Fjm970805q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calo’, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigoni, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toth, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gessi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashiba, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borea, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomatis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvadori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regoli, D.</span></span> <span> </span><span class="NLM_article-title">Further studies on nociceptin-related peptides: discovery of a new chemical template with antagonist activity on the nociceptin receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">2805</span>– <span class="NLM_lpage">2813</span>, <span class="refDoi"> DOI: 10.1021/jm990075h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990075h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BD3cXksFOqsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2805-2813&author=R.+Guerriniauthor=G.+Calo%E2%80%99author=R.+Bigoniauthor=A.+Rizziauthor=K.+Varaniauthor=G.+Tothauthor=S.+Gessiauthor=E.+Hashibaauthor=Y.+Hashimotoauthor=D.+G.+Lambertauthor=P.+A.+Boreaauthor=R.+Tomatisauthor=S.+Salvadoriauthor=D.+Regoli&title=Further+studies+on+nociceptin-related+peptides%3A+discovery+of+a+new+chemical+template+with+antagonist+activity+on+the+nociceptin+receptor&doi=10.1021%2Fjm990075h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Further Studies on Nociceptin-Related Peptides: Discovery of a New Chemical Template with Antagonist Activity on the Nociceptin Receptor</span></div><div class="casAuthors">Guerrini, Remo; Calo, Girolamo; Bigoni, Raffaella; Rizzi, Anna; Varani, Katia; Toth, Geza; Gessi, Stefania; Hashiba, Eiji; Hashimoto, Yoshio; Lambert, David G.; Borea, Pier Andrea; Tomatis, Roberto; Salvadori, Severo; Regoli, Domenico</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2805-2813</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Three series of nociceptin (NC)-related peptides were synthesized and their abilities (i) to bind to the NC sites expressed in mouse forebrain membranes, (ii) to inhibit the elec. evoked contraction of the mouse vas deferens, and (iii) to inhibit forskolin-stimulated cAMP accumulation in Chinese hamster ovary cells expressing the human recombinant NC receptor (CHONCR) were investigated.  The compds. of the first series (a series) have an ordinary Xaa1-Gly2 bond, those of the second series (b series) have a Xaa1Ψ(CH2-NH)Gly2 pseudopeptide bond, and those of the third series (c series) have a peptoid (Nxaa1-Gly2) structure.  The affinity values measured in the binding assay and in the two functional assays with the compds. of the three series showed high levels of correlation.  Thus, (I) the compds. of the a series in which Phe1 was substituted with Tyr, Cha, or Leu acted as potent NC receptor agonists; (II) the b series compds. behaved as NC receptor antagonists in the mouse vas deferens and as full agonists in CHONCR cells with different potencies depending on the first amino acid residue, [Phe1Ψ(CH2-NH)Gly2]NC(1-17)NH2 and [Phe1Ψ(CH2-NH)Gly2]NC(1-13)NH2 being the most potent compds.; (III) the compds. of the third series were all inactive both as agonists and as antagonists with the exception of [Nphe1]NC(1-17)NH2 and [Nphe1]NC(1-13)NH2, which behaved as NC receptor antagonists both in the isolated tissue and in CHONCR cells (pKB 6.1-6.4).  In conclusion, this study demonstrates that chem. requirements for NC receptor agonists are different from those of antagonists.  Moreover, modifications of the steric orientation of the arom. residue Phe1 in the NC sequence as obtained with the pseudopeptide bond between Phe1 and Gly2 or with the displacement of the benzyl side chain by one atom, as in Nphe1, lead resp. to redn. or elimination of efficacy. Indeed, in contrast to [Phe1Ψ(CH2-NH)Gly2]NC(1-13)NH2 which has been reported to exhibit agonist activity in several assays involving either central or recombinant NC receptors, [Nphe1]NC(1-13)NH2 antagonizes the effect of NC at human recombinant NC receptors and in the mouse tail withdrawal assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFZxmx92b-YrVg90H21EOLACvtfcHk0liW6n2nr8KPzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXksFOqsLg%253D&md5=5aa116f7f4d37e32a7aebbbc078ff030</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm990075h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990075h%26sid%3Dliteratum%253Aachs%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DCalo%25E2%2580%2599%26aufirst%3DG.%26aulast%3DBigoni%26aufirst%3DR.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DToth%26aufirst%3DG.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DHashiba%26aufirst%3DE.%26aulast%3DHashimoto%26aufirst%3DY.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DTomatis%26aufirst%3DR.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DRegoli%26aufirst%3DD.%26atitle%3DFurther%2520studies%2520on%2520nociceptin-related%2520peptides%253A%2520discovery%2520of%2520a%2520new%2520chemical%2520template%2520with%2520antagonist%2520activity%2520on%2520the%2520nociceptin%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2805%26epage%3D2813%26doi%3D10.1021%2Fjm990075h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caló, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigoni, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zucchini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashiba, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toth, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borea, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvadori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regoli, D.</span></span> <span> </span><span class="NLM_article-title">Structure-activity studies of the Phe<sup>4</sup> residue of nociceptin(1-13)-NH<sub>2</sub>: identification of highly potent agonists of the nociceptin/orphanin FQ receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">3956</span>– <span class="NLM_lpage">3964</span>, <span class="refDoi"> DOI: 10.1021/jm010221v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm010221v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnsV2ksL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=3956-3964&author=R.+Guerriniauthor=G.+Cal%C3%B3author=R.+Bigoniauthor=D.+Rizziauthor=A.+Rizziauthor=M.+Zucchiniauthor=K.+Varaniauthor=E.+Hashibaauthor=D.+G.+Lambertauthor=G.+Tothauthor=P.+A.+Boreaauthor=S.+Salvadoriauthor=D.+Regoli&title=Structure-activity+studies+of+the+Phe4+residue+of+nociceptin%281-13%29-NH2%3A+identification+of+highly+potent+agonists+of+the+nociceptin%2Forphanin+FQ+receptor&doi=10.1021%2Fjm010221v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Studies of the Phe4 Residue of Nociceptin(1-13)-NH2: Identification of Highly Potent Agonists of the Nociceptin/Orphanin FQ Receptor</span></div><div class="casAuthors">Guerrini, Remo; Calo, Girolamo; Bigoni, Raffaella; Rizzi, Daniela; Rizzi, Anna; Zucchini, Marina; Varani, Katia; Hashiba, Eiji; Lambert, David G.; Toth, Geza; Borea, Pier Andrea; Salvadori, Severo; Regoli, Domenico</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3956-3964</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A total of 32 compds. was prepd. to investigate the functional role of Phe4 in NC(1-13)-NH2, the minimal sequence maintaining the same activity as the natural peptide nociceptin.  These compds. could be divided into three series in which Phe4 was replaced with residues that would (i) alter aromaticity or side chain length, (ii) introduce steric constraint, and (iii) modify the Ph ring.  Compds. were tested for biol. activity as (a) inhibitors of the elec. stimulated contraction of the mouse vas deferens; (b) competitors of the binding of [3H]-NC-NH2 to mouse brain membranes; and (c) inhibitors of forskolin-stimulated cAMP accumulation in CHO cells expressing the recombinant human OP4 receptor.  Results indicate that all compds. of the first and second series were inactive or very weak with the exception of [N(CH3)Phe4]NC(1-13)-NH2, which was only 3-fold less potent than NC(1-13)-NH2.  Compds. of the third series showed higher, equal, or lower potencies than NC(1-13)-NH2.  In particular, [(pF)Phe4]NC(1-13)-NH2 (pF) and [(pNO2)Phe4]NC(1-13)-NH2 (pNO2) were more active than NC(1-13)-NH2 by a factor of 5.  In the mVD, these compds. showed the following order of potency: (pF) = (pNO2) ≥ (pCN) > (pCl) > (pBr) > (pI) = (pCF3) = (pOCH3) > (pCH3) > (pNH2) = (pOH).  (oF) and esp. (mF) maintained high potencies but were less active than (pF).  Similar orders of potency were obsd. in binding competition and cAMP accumulation studies.  There was a strong (r2 ≥ 0.66) correlation between data obsd. in these assays.  Biol. activity data of compds. of the third series were plotted against some Hansch parameters that are currently used to quantify physicochem. features of the substituents.  In the three biol. assays agonist potency/affinity pos. correlates with the electron withdrawal properties of the groups in the p-position of Phe4 and inversely with their size.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEL-R6_28b97Vg90H21EOLACvtfcHk0liW6n2nr8KPzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnsV2ksL8%253D&md5=3176f57ec89f60f9c35a782a2fdc27c5</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm010221v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010221v%26sid%3Dliteratum%253Aachs%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DCal%25C3%25B3%26aufirst%3DG.%26aulast%3DBigoni%26aufirst%3DR.%26aulast%3DRizzi%26aufirst%3DD.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DZucchini%26aufirst%3DM.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DHashiba%26aufirst%3DE.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26aulast%3DToth%26aufirst%3DG.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DRegoli%26aufirst%3DD.%26atitle%3DStructure-activity%2520studies%2520of%2520the%2520Phe4%2520residue%2520of%2520nociceptin%25281-13%2529-NH2%253A%2520identification%2520of%2520highly%2520potent%2520agonists%2520of%2520the%2520nociceptin%252Forphanin%2520FQ%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D3956%26epage%3D3964%26doi%3D10.1021%2Fjm010221v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calo’, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigoni, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regoli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvadori, S.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship of [Nphe<sup>1</sup>]-NC-(1-13)-NH<sub>2</sub>, a pure and selective nociceptin/orphanin FQ receptor antagonist</span>. <i>J. Pept. Res.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">222</span>, <span class="refDoi"> DOI: 10.1111/j.1399-3011.2001.00820.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1111%2Fj.1399-3011.2001.00820.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=11298922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BD3MXisVCrsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2001&pages=215-222&author=R.+Guerriniauthor=G.+Calo%E2%80%99author=R.+Bigoniauthor=D.+Rizziauthor=D.+Regoliauthor=S.+Salvadori&title=Structure-activity+relationship+of+%5BNphe1%5D-NC-%281-13%29-NH2%2C+a+pure+and+selective+nociceptin%2Forphanin+FQ+receptor+antagonist&doi=10.1111%2Fj.1399-3011.2001.00820.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship of [Nphe1]-NC-(1-13)-NH2, a pure and selective nociceptin/orphanin FQ receptor antagonist</span></div><div class="casAuthors">Guerrini, R.; Calo', G.; Bigoni, R.; Rizzi, D.; Regoli, D.; Salvadori, S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Peptide Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">215-222</span>CODEN:
                <span class="NLM_cas:coden">JPERFA</span>;
        ISSN:<span class="NLM_cas:issn">1397-002X</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard International Publishers Ltd.</span>)
        </div><div class="casAbstract">A series of analogs of the ORL1 receptor antagonist [Nphe1]-NC(1-13)-NH2 was prepd. and tested for agonistic and antagonistic activities in the mouse vas deferens, a prepn. that shows high sensitivity to nociceptin and related peptides.  The purpose of this study was to det. the role of the arom. residue at the N-terminal for antagonism and eventually identify compds. with improved potency.  Results indicated that all 23 compds. are inactive as agonists, and the antagonistic potency of the initial template [Nphe1]-NC(1-13)-NH2 is high (pKB 6.43) compared with those of all other compds. except [(S)(βMe)Nphe1]NC(1-13)-NH2 (pKB 6.48).  The other 22 compds. can be divided into two groups: 10 show antagonistic potencies (pKB) ranging from 5.30 to 5.86, whereas the other 12 compds. are inactive.  This study clearly shows that the arom. ring of Nphe is very crit. for the interaction with the ORL1 receptor and can not be enlarged or sterically modified without significant loss of antagonistic potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV9CWs5k-Y5bVg90H21EOLACvtfcHk0lg-k2pUJTvL3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXisVCrsLs%253D&md5=3bbbed9f8b0017713e54e3f7dd2d4b9b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1111%2Fj.1399-3011.2001.00820.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1399-3011.2001.00820.x%26sid%3Dliteratum%253Aachs%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DCalo%25E2%2580%2599%26aufirst%3DG.%26aulast%3DBigoni%26aufirst%3DR.%26aulast%3DRizzi%26aufirst%3DD.%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DSalvadori%26aufirst%3DS.%26atitle%3DStructure-activity%2520relationship%2520of%2520%255BNphe1%255D-NC-%25281-13%2529-NH2%252C%2520a%2520pure%2520and%2520selective%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520antagonist%26jtitle%3DJ.%2520Pept.%2520Res.%26date%3D2001%26volume%3D57%26spage%3D215%26epage%3D222%26doi%3D10.1111%2Fj.1399-3011.2001.00820.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arduin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spagnolo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calò, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrà, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischetti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapella, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzola, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regoli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvadori, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with Cα,α-dialkylated amino acids</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">4434</span>– <span class="NLM_lpage">4443</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2007.04.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1016%2Fj.bmc.2007.04.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=17490886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlvFSjs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=4434-4443&author=M.+Arduinauthor=B.+Spagnoloauthor=G.+Cal%C3%B2author=R.+Guerriniauthor=G.+Carr%C3%A0author=C.+Fischettiauthor=C.+Trapellaauthor=E.+Marzolaauthor=J.+McDonaldauthor=D.+G.+Lambertauthor=D.+Regoliauthor=S.+Salvadori&title=Synthesis+and+biological+activity+of+nociceptin%2Forphanin+FQ+analogues+substituted+in+position+7+or+11+with+C%CE%B1%2C%CE%B1-dialkylated+amino+acids&doi=10.1016%2Fj.bmc.2007.04.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with Cα,α-dialkylated amino acids</span></div><div class="casAuthors">Arduin, Marika; Spagnolo, Barbara; Calo, Girolamo; Guerrini, Remo; Carra, Giacomo; Fischetti, Carmela; Trapella, Claudio; Marzola, Erika; McDonald, John; Lambert, David G.; Regoli, Domenico; Salvadori, Severo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4434-4443</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Previous structure-activity and NMR studies on nociceptin/orphanin FQ (N/OFQ) demonstrated that Aib substitution of Ala7 and/or Ala11 increases the peptide potency through an alpha helix structure induction mechanism.  On these bases we synthesized and evaluated pharmacol. in the mouse vas deferens assay a series of N/OFQ-NH2 analogs substituted in position 7 and 11 with Cα,α-disubstituted cyclic, linear and branched amino acids.  None of the 20 novel N/OFQ analogs produced better results than [Aib7]N/OFQ-NH2.  Thus, this substitution was combined with other chem. modifications known to modulate peptide potency and/or efficacy generating compd. 21 [Nphe1Aib7Arg14Lys15]N/OFQ-NH2 (coded as UFP-111), compd. 22 [(pF)Phe4Aib7Arg14Lys15]N/OFQ-NH2 (UFP-112) and compd. 23 [Phe1Ψ(CH2-NH)Gly2(pF)Phe4Aib7Arg14Lys15]N/OFQ-NH2 (UFP-113).  These novel peptides behaved as highly potent NOP receptor ligands showing full (UFP-112) and partial (UFP-113) agonist and pure antagonist (UFP-111) activities in a series of in vitro functional assays performed on pharmacol. prepns. expressing native as well as recombinant NOP receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6OBbZI6whX7Vg90H21EOLACvtfcHk0lg-k2pUJTvL3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlvFSjs74%253D&md5=79f4cf61ed759bcf4dcdc3cddaec20ac</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.04.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.04.026%26sid%3Dliteratum%253Aachs%26aulast%3DArduin%26aufirst%3DM.%26aulast%3DSpagnolo%26aufirst%3DB.%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DCarr%25C3%25A0%26aufirst%3DG.%26aulast%3DFischetti%26aufirst%3DC.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DMarzola%26aufirst%3DE.%26aulast%3DMcDonald%26aufirst%3DJ.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DSalvadori%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520of%2520nociceptin%252Forphanin%2520FQ%2520analogues%2520substituted%2520in%2520position%25207%2520or%252011%2520with%2520C%25CE%25B1%252C%25CE%25B1-dialkylated%2520amino%2520acids%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D4434%26epage%3D4443%26doi%3D10.1016%2Fj.bmc.2007.04.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenzano, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyle, D. J.</span></span> <span> </span><span class="NLM_article-title">Novel, potent ORL-1 receptor agonist peptides containing alpha-helix-promoting conformational constraints</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">5280</span>– <span class="NLM_lpage">5286</span>, <span class="refDoi"> DOI: 10.1021/jm0202021</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0202021" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BD38Xns1GhsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=5280-5286&author=C.+Zhangauthor=W.+Millerauthor=K.+J.+Valenzanoauthor=D.+J.+Kyle&title=Novel%2C+potent+ORL-1+receptor+agonist+peptides+containing+alpha-helix-promoting+conformational+constraints&doi=10.1021%2Fjm0202021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Novel, potent ORL-1 receptor agonist peptides containing α-helix-promoting conformational constraints</span></div><div class="casAuthors">Zhang, Chongwu; Miller, Wendy; Valenzano, Kenneth J.; Kyle, Donald J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5280-5286</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The ORL-1 receptor has recently been cloned and is implicated in a wide variety of physiol. and pathophysiol. processes.  Toward the goal of elucidating important features of the receptor-bound conformation of the endogenous ligand, nociceptin (NC), several conformationally constrained analogs were prepd.  Either α-aminoisobutyric acid (Aib) or N-methylalanine (MeAla) were inserted as replacement(s) for Ala7, Ala11, or Ala15 in the native NC sequence (FGGFTGARKSARKLANQ).  In vitro assays measuring human ORL-1 receptor affinity (competition binding against [3H] NC), functional potency ([35S]GTPγS), and efficacy (as compared to NC) were performed for each new peptide.  The receptor affinities of the Aib-contg. peptides generally matched NC, showing Ki's in the range of 0.1-0.5 nM.  By comparison, the receptor affinities of the MeAla-contg. peptides were significantly diminished.  Peptide 14 (FGGFTG[Aib]RKS[Aib]RKLANQ-NH2), which contains two constrained alanine residues (positions 7 and 11) and a C-terminal amide modification, was found to be a very potent agonist with Ki = 0.05 nM and EC50 = 0.08 nM in the human ORL-1 assays.  The data support a hypothesis that the receptor-bound form of NC might adopt an amphipathic helix in the "address" segment of the sequence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDAbEqzH3chbVg90H21EOLACvtfcHk0lgdExr4s5UcuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xns1GhsL8%253D&md5=5aa01a2ab064913448cb48e0b440de60</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm0202021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0202021%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DMiller%26aufirst%3DW.%26aulast%3DValenzano%26aufirst%3DK.%2BJ.%26aulast%3DKyle%26aufirst%3DD.%2BJ.%26atitle%3DNovel%252C%2520potent%2520ORL-1%2520receptor%2520agonist%2520peptides%2520containing%2520alpha-helix-promoting%2520conformational%2520constraints%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D5280%26epage%3D5286%26doi%3D10.1021%2Fjm0202021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zucchini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomatis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regoli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calo’, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvadori, S.</span></span> <span> </span><span class="NLM_article-title">Nociceptin/orphanin FQ(1-13)NH<sub>2</sub> analogues modified in the Phe<sup>1</sup>-Gly<sup>2</sup> peptide bond</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">365</span>– <span class="NLM_lpage">368</span>, <span class="refDoi"> DOI: 10.1016/s0960-894x(02)01004-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1016%2FS0960-894X%2802%2901004-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=12565930" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptFaltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=365-368&author=R.+Guerriniauthor=D.+Rizziauthor=M.+Zucchiniauthor=R.+Tomatisauthor=D.+Regoliauthor=G.+Calo%E2%80%99author=S.+Salvadori&title=Nociceptin%2Forphanin+FQ%281-13%29NH2+analogues+modified+in+the+Phe1-Gly2+peptide+bond&doi=10.1016%2Fs0960-894x%2802%2901004-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Nociceptin/orphanin FQ(1-13)NH2 analogs modified in the Phe1-Gly2 peptide bond</span></div><div class="casAuthors">Guerrini, Remo; Rizzi, Daniela; Zucchini, Marina; Tomatis, Roberto; Regoli, Domenico; Calo', Girolamo; Salvadori, Severo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">365-368</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The synthesis and pharmacol. activity of novel nociceptin/orphanin FQ (N/OFQ) analogs modified in the Phe1-Gly2 peptide bond are reported.  The aim of the present work was to elucidate the importance of this peptide bond for the N/OFQ receptor (NOP) interaction.  Our study indicates that the first peptide bond in N/OFQ is important but not crucial for interaction with the N/OFQ receptor; for instance, substitution with a methyleneoxy bond generates an agonist deriv. just 3-fold less potent than the ref. compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGwzawDwsbBLVg90H21EOLACvtfcHk0lgdExr4s5UcuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptFaltA%253D%253D&md5=37c81781cfed4cda5d40755775046e81</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2901004-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252901004-1%26sid%3Dliteratum%253Aachs%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DRizzi%26aufirst%3DD.%26aulast%3DZucchini%26aufirst%3DM.%26aulast%3DTomatis%26aufirst%3DR.%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DCalo%25E2%2580%2599%26aufirst%3DG.%26aulast%3DSalvadori%26aufirst%3DS.%26atitle%3DNociceptin%252Forphanin%2520FQ%25281-13%2529NH2%2520analogues%2520modified%2520in%2520the%2520Phe1-Gly2%2520peptide%2520bond%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D365%26epage%3D368%26doi%3D10.1016%2Fs0960-894x%2802%2901004-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pacifico, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albanese, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Illuminati, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fantinati, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzola, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neto, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturaro, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzza, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calò, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span> <span> </span><span class="NLM_article-title">Tetrabranched hetero-conjugated peptides as bifunctional agonists of the NOP and mu opioid receptors</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">2444</span>– <span class="NLM_lpage">2451</span>, <span class="refDoi"> DOI: 10.1021/acs.bioconjchem.9b00519</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.9b00519" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1KksL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2019&pages=2444-2451&author=S.+Pacificoauthor=V.+Albaneseauthor=D.+Illuminatiauthor=A.+Fantinatiauthor=E.+Marzolaauthor=F.+Ferrariauthor=J.+A.+Netoauthor=C.+Sturaroauthor=C.+Ruzzaauthor=G.+Cal%C3%B2author=D.+Pretiauthor=R.+Guerrini&title=Tetrabranched+hetero-conjugated+peptides+as+bifunctional+agonists+of+the+NOP+and+mu+opioid+receptors&doi=10.1021%2Facs.bioconjchem.9b00519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Tetrabranched Hetero-Conjugated Peptides as Bifunctional Agonists of the NOP and Mu Opioid Receptors</span></div><div class="casAuthors">Pacifico, Salvatore; Albanese, Valentina; Illuminati, Davide; Fantinati, Anna; Marzola, Erika; Ferrari, Federica; Neto, Joaquim Azevedo; Sturaro, Chiara; Ruzza, Chiara; Calo, Girolamo; Preti, Delia; Guerrini, Remo</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2444-2451</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The general aim of the work was the validation of a new synthetic methodol. designed for obtaining bifunctional heterotetrabranched peptide ligands.  Applying an easily accessible synthetic route, we provided a small series of heteromultimeric peptide conjugates targeting the nociceptin/orphanin FQ (N/OFQ) peptide receptors (NOP) and mu opioid receptors.  Among these, H-PWT1-N/OFQ-[Dmt1]dermorphin demonstrated a similar and high agonist potency at the NOP and mu receptors.  The achieved results confirmed the robustness of the approach that is extremely versatile and virtually applicable to different peptide sequences whose pharmacol. activity can be combined for generating dual acting multimeric compds.  These innovative pharmacol. tools will be extremely helpful for investigating the consequences of the simultaneous activation and/or blockage of different peptidergic receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom00_e11aupbVg90H21EOLACvtfcHk0liw8xDDj_xHlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1KksL3K&md5=643c7bb57212e5eed8193d852eb444fd</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.9b00519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.9b00519%26sid%3Dliteratum%253Aachs%26aulast%3DPacifico%26aufirst%3DS.%26aulast%3DAlbanese%26aufirst%3DV.%26aulast%3DIlluminati%26aufirst%3DD.%26aulast%3DFantinati%26aufirst%3DA.%26aulast%3DMarzola%26aufirst%3DE.%26aulast%3DFerrari%26aufirst%3DF.%26aulast%3DNeto%26aufirst%3DJ.%2BA.%26aulast%3DSturaro%26aufirst%3DC.%26aulast%3DRuzza%26aufirst%3DC.%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26aulast%3DPreti%26aufirst%3DD.%26aulast%3DGuerrini%26aufirst%3DR.%26atitle%3DTetrabranched%2520hetero-conjugated%2520peptides%2520as%2520bifunctional%2520agonists%2520of%2520the%2520NOP%2520and%2520mu%2520opioid%2520receptors%26jtitle%3DBioconjugate%2520Chem.%26date%3D2019%26volume%3D30%26spage%3D2444%26epage%3D2451%26doi%3D10.1021%2Facs.bioconjchem.9b00519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J.</span></span> <span> </span><span class="NLM_article-title">Biased ligands of G protein-coupled receptors (GPCRs): structure-functional selectivity relationships (SFSRs) and therapeutic potential</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">9841</span>– <span class="NLM_lpage">9878</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00435</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00435" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Snu73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=9841-9878&author=L.+Tanauthor=W.+Yanauthor=J.+D.+McCorvyauthor=J.+Cheng&title=Biased+ligands+of+G+protein-coupled+receptors+%28GPCRs%29%3A+structure-functional+selectivity+relationships+%28SFSRs%29+and+therapeutic+potential&doi=10.1021%2Facs.jmedchem.8b00435"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure-Functional Selectivity Relationships (SFSRs) and Therapeutic Potential</span></div><div class="casAuthors">Tan, Liang; Yan, Wenzhong; McCorvy, John D.; Cheng, Jianjun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9841-9878</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  G protein-coupled receptors (GPCRs) signal through both G-protein-dependent and G-protein-independent pathways, and β-arrestin recruitment is the most recognized one of the latter.  Biased ligands selective for either pathway are expected to regulate biol. functions of GPCRs in a more precise way, therefore providing new drug mols. with superior efficacy and/or reduced side effects.  During the past decade, biased ligands have been discovered and developed for many GPCRs, such as the μ opioid receptor, the angiotensin II receptor type 1, the dopamine D2 receptor, and many others.  In this Perspective, recent advances in this field are reviewed by discussing the structure-functional selectivity relationships (SFSRs) of GPCR biased ligands and the therapeutic potential of these mols.  Further understanding of the biol. functions assocd. with each signaling pathway and structural basis for biased signaling will facilitate future drug design in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNFjkAvar29LVg90H21EOLACvtfcHk0liw8xDDj_xHlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Snu73N&md5=a7bd605b82666357f5a0a209002225e5</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00435%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DW.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DCheng%26aufirst%3DJ.%26atitle%3DBiased%2520ligands%2520of%2520G%2520protein-coupled%2520receptors%2520%2528GPCRs%2529%253A%2520structure-functional%2520selectivity%2520relationships%2520%2528SFSRs%2529%2520and%2520therapeutic%2520potential%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D9841%26epage%3D9878%26doi%3D10.1021%2Facs.jmedchem.8b00435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gesty-Palmer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flannery, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corsino, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spurney, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefkowitz, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luttrell, L. M.</span></span> <span> </span><span class="NLM_article-title">A beta-arrestin-biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">1ra1</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.3000071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1126%2Fscitranslmed.3000071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=20368153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A280%3ADC%252BC3c3jvFSmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=1ra1&author=D.+Gesty-Palmerauthor=P.+Flanneryauthor=L.+Yuanauthor=L.+Corsinoauthor=R.+Spurneyauthor=R.+J.+Lefkowitzauthor=L.+M.+Luttrell&title=A+beta-arrestin-biased+agonist+of+the+parathyroid+hormone+receptor+%28PTH1R%29+promotes+bone+formation+independent+of+G+protein+activation&doi=10.1126%2Fscitranslmed.3000071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">A beta-arrestin-biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation</span></div><div class="casAuthors">Gesty-Palmer Diane; Flannery Pat; Yuan Ling; Corsino Leonor; Spurney Robert; Lefkowitz Robert J; Luttrell Louis M</div><div class="citationInfo"><span class="NLM_cas:title">Science translational medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1ra1</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">About 40% of the therapeutic agents in use today exert their effects through seven-transmembrane receptors (7TMRs).  When activated by ligands, these receptors trigger two pathways that independently transduce signals to the cell: one through heterotrimeric GTP-binding proteins (G proteins) and one through beta-arrestins; so-called biased agonists can selectively activate these distinct pathways.  Here, we investigate selective activation of these pathways through the use of a biased agonist for the type 1 parathyroid hormone (PTH)-PTH-related protein receptor (PTH1R), (D-Trp(12),Tyr(34))-PTH(7-34) (PTH-betaarr), which activates beta-arrestin but not classic G protein signaling.  In mice, PTH-betaarr induces anabolic bone formation, as does the nonselective agonist PTH(1-34), which activates both mechanisms.  In beta-arrestin2-null mice, the increase in bone mineral density evoked by PTH(1-34) is attenuated and that stimulated by PTH-betaarr is ablated.  The beta-arrestin2-dependent pathway contributes primarily to trabecular bone formation and does not stimulate bone resorption.  These results show that a biased agonist selective for the beta-arrestin pathway can elicit a response in vivo distinct from that elicited by nonselective agonists.  Ligands with these properties may form the basis for improved 7TMR-directed pharmacologic agents with enhanced therapeutic specificity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSmuM4aCIxthdXdcedVHT5tfW6udTcc2eb4cCLe3D5OK7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c3jvFSmug%253D%253D&md5=748e4367ded72b6b7e10fd759521ba62</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3000071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3000071%26sid%3Dliteratum%253Aachs%26aulast%3DGesty-Palmer%26aufirst%3DD.%26aulast%3DFlannery%26aufirst%3DP.%26aulast%3DYuan%26aufirst%3DL.%26aulast%3DCorsino%26aufirst%3DL.%26aulast%3DSpurney%26aufirst%3DR.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26aulast%3DLuttrell%26aufirst%3DL.%2BM.%26atitle%3DA%2520beta-arrestin-biased%2520agonist%2520of%2520the%2520parathyroid%2520hormone%2520receptor%2520%2528PTH1R%2529%2520promotes%2520bone%2520formation%2520independent%2520of%2520G%2520protein%2520activation%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2009%26volume%3D1%26spage%3D1ra1%26doi%3D10.1126%2Fscitranslmed.3000071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brame, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maguire, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torella, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheriyan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glen, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, I. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davenport, A. P.</span></span> <span> </span><span class="NLM_article-title">Design, characterization, and first-in-human study of the vascular actions of a novel biased apelin receptor agonist</span>. <i>Hypertension</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">834</span>– <span class="NLM_lpage">840</span>, <span class="refDoi"> DOI: 10.1161/hypertensionaha.114.05099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1161%2FHYPERTENSIONAHA.114.05099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=25712721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC2MXktVGrtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2015&pages=834-840&author=A.+L.+Brameauthor=J.+J.+Maguireauthor=P.+Yangauthor=A.+Dysonauthor=R.+Torellaauthor=J.+Cheriyanauthor=M.+Singerauthor=R.+C.+Glenauthor=I.+B.+Wilkinsonauthor=A.+P.+Davenport&title=Design%2C+characterization%2C+and+first-in-human+study+of+the+vascular+actions+of+a+novel+biased+apelin+receptor+agonist&doi=10.1161%2Fhypertensionaha.114.05099"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Characterization, and First-In-Human Study of the Vascular Actions of a Novel Biased Apelin Receptor Agonist</span></div><div class="casAuthors">Brame, Aimee L.; Maguire, Janet J.; Yang, Peiran; Dyson, Alex; Torella, Rubben; Cheriyan, Joseph; Singer, Mervyn; Glen, Robert C.; Wilkinson, Ian B.; Davenport, Anthony P.</div><div class="citationInfo"><span class="NLM_cas:title">Hypertension</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">834-840</span>CODEN:
                <span class="NLM_cas:coden">HPRTDN</span>;
        ISSN:<span class="NLM_cas:issn">0194-911X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">[Pyr]apelin-13 is an endogenous vasodilator and inotrope but is downregulated in pulmonary hypertension and heart failure, making the apelin receptor an attractive therapeutic target.  Agonists acting at the same G-protein-coupled receptor can be engineered to stabilize different conformational states and function as biased ligands, selectively stimulating either G-protein or β-arrestin pathways.  We used mol. dynamics simulations of apelin/receptor interactions to design cyclic analogs and identified MM07 as a biased agonist.  In β-arrestin and internalization assays (G-protein-independent), MM07 was 2 orders of magnitude less potent than [Pyr]apelin-13.  In a G-protein-dependent saphenous vein contraction assay, both peptides had comparable potency (pD2:[Pyr]apelin-13 9.93±0.24; MM07 9.54±0.42) and max. responses with a resulting bias for MM07 of ≈350- to 1300-fold for the G-protein pathway.  In rats, systemic infusions of MM07 (10-100 nmol) caused a dose-dependent increase in cardiac output that was significantly greater than the response to [Pyr]apelin-13.  Similarly, in human volunteers, MM07 produced a significant dose-dependent increase in forearm blood flow with a max. dilatation double that is seen with [Pyr]apelin-13.  Addnl., repeated doses of MM07 produced reproducible increases in forearm blood flow.  These responses are consistent with a more efficacious action of the biased agonist.  In human hand vein, both peptides reversed an established norepinephrine constrictor response and significantly increased venous flow.  Our results suggest that MM07 acting as a biased agonist at the apelin receptor can preferentially stimulate the G-protein pathway, which could translate to improved efficacy in the clinic by selectively stimulating vasodilatation and inotropic actions but avoiding activating detrimental β-arrestin-dependent pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVwBeW0p9RgbVg90H21EOLACvtfcHk0ljpMMiCTNa-9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXktVGrtr0%253D&md5=908911768ffa6edcd2ef9b1e80c8826a</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1161%2FHYPERTENSIONAHA.114.05099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FHYPERTENSIONAHA.114.05099%26sid%3Dliteratum%253Aachs%26aulast%3DBrame%26aufirst%3DA.%2BL.%26aulast%3DMaguire%26aufirst%3DJ.%2BJ.%26aulast%3DYang%26aufirst%3DP.%26aulast%3DDyson%26aufirst%3DA.%26aulast%3DTorella%26aufirst%3DR.%26aulast%3DCheriyan%26aufirst%3DJ.%26aulast%3DSinger%26aufirst%3DM.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26aulast%3DWilkinson%26aufirst%3DI.%2BB.%26aulast%3DDavenport%26aufirst%3DA.%2BP.%26atitle%3DDesign%252C%2520characterization%252C%2520and%2520first-in-human%2520study%2520of%2520the%2520vascular%2520actions%2520of%2520a%2520novel%2520biased%2520apelin%2520receptor%2520agonist%26jtitle%3DHypertension%26date%3D2015%26volume%3D65%26spage%3D834%26epage%3D840%26doi%3D10.1161%2Fhypertensionaha.114.05099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Godin, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, S. S. G.</span></span> <span> </span><span class="NLM_article-title">Biased agonism of the angiotensin II type 1 receptor</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">812</span>– <span class="NLM_lpage">816</span>, <span class="refDoi"> DOI: 10.2174/138955712800959134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.2174%2F138955712800959134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=22681254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVGmu7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=812-816&author=C.+M.+Godinauthor=S.+S.+G.+Ferguson&title=Biased+agonism+of+the+angiotensin+II+type+1+receptor&doi=10.2174%2F138955712800959134"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Biased agonism of the angiotensin II type 1 receptor</span></div><div class="casAuthors">Godin, C. M.; Ferguson, S. S. G.</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">812-816</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  G protein-coupled receptors (GPCRs) can be activated by multiple ligands and exhibit the capacity to couple to numerous intracellular signal transduction pathways.  This property allows GPCRs to be modulated by biased agonists that selectively activate specific subsets of GPCR-regulated cellular signaling proteins.  The angiotensin II type 1 receptor (AT1R) is a GPCR that endogenously binds to the peptide ligand angiotensin II.  More recently it has been demonstrated that a modified peptide, [Sar1I-le4-Ile8]-angiotensin II (SII) acts as a biased agonist towards the AT1R.  SII binds to the AT1R without promoting heterotrimeric G protein-coupling, but serves to link the receptor to the beta-arrestin-dependent activation of the mitogen activated protein kinase pathway.  The present mini-review summarize current knowledge regarding the role of biased agonists in stimulating biased AT1R signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqT-Zw0CW9XaLVg90H21EOLACvtfcHk0liikaAZdE66Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVGmu7nP&md5=774a49facf04056047bd3a7acb0e45b9</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.2174%2F138955712800959134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138955712800959134%26sid%3Dliteratum%253Aachs%26aulast%3DGodin%26aufirst%3DC.%2BM.%26aulast%3DFerguson%26aufirst%3DS.%2BS.%2BG.%26atitle%3DBiased%2520agonism%2520of%2520the%2520angiotensin%2520II%2520type%25201%2520receptor%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2012%26volume%3D12%26spage%3D812%26epage%3D816%26doi%3D10.2174%2F138955712800959134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spagnolo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wainford, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischetti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzola, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldisserotto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvadori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regoli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapusta, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calo, G.</span></span> <span> </span><span class="NLM_article-title">In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor</span>. <i>Peptides</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1240</span>– <span class="NLM_lpage">1251</span>, <span class="refDoi"> DOI: 10.1016/j.peptides.2007.04.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1016%2Fj.peptides.2007.04.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=17532097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtVaiu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=1240-1251&author=A.+Rizziauthor=B.+Spagnoloauthor=R.+D.+Wainfordauthor=C.+Fischettiauthor=R.+Guerriniauthor=G.+Marzolaauthor=A.+Baldisserottoauthor=S.+Salvadoriauthor=D.+Regoliauthor=D.+R.+Kapustaauthor=G.+Calo&title=In+vitro+and+in+vivo+studies+on+UFP-112%2C+a+novel+potent+and+long+lasting+agonist+selective+for+the+nociceptin%2Forphanin+FQ+receptor&doi=10.1016%2Fj.peptides.2007.04.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor</span></div><div class="casAuthors">Rizzi, Anna; Spagnolo, Barbara; Wainford, Richard D.; Fischetti, Carmela; Guerrini, Remo; Marzola, Giuliano; Baldisserotto, Anna; Salvadori, Severo; Regoli, Domenico; Kapusta, Daniel R.; Calo, Girolamo</div><div class="citationInfo"><span class="NLM_cas:title">Peptides (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1240-1251</span>CODEN:
                <span class="NLM_cas:coden">PPTDD5</span>;
        ISSN:<span class="NLM_cas:issn">0196-9781</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">[(PF)Phe4Aib7Arg14Lys15]N/OFQ-NH2 (UFP-112) has been designed as a novel ligand for the nociceptin/orphanin FQ (N/OFQ) peptide receptor (NOP) by combining into the same peptide different chem. modifications reported to increase N/OFQ potency.  In vitro data obtained in the elec. stimulated mouse vas deferens demonstrated that UFP-112 behaved as a high potency (pEC50 9.43) full agonist at the NOP receptor.  UFP-112 effects were sensitive to the NOP antagonist UFP-101 but not to naloxone and no longer evident in tissues taken from NOP-/- mice.  In vitro half life of UFP-112 in mouse plasma and brain homogenate was 2.6- and 3.5-fold higher than that of N/OFQ.  In vivo, in the mouse tail withdrawal assay, UFP-112 (1-100 pmol, i.c.v.) mimicked the actions of N/OFQ producing pronociceptive effects after i.c.v. administration and antinociceptive effects when given i.t.; in both cases, UFP-112 was approx. 100-fold more potent than the natural peptide and produced longer lasting effects.  UFP-112 also mimicked the hyperphagic effect of N/OFQ producing a bell shaped dose response curve with the max. reached at 10 pmol.  The hyperphagic effects of N/OFQ and UFP-112 were absent in NOP-/- mice.  Equi-effective high doses of UFP-112 (0.1 nmol) and N/OFQ (10 nmol) were injected i.c.v. in mice and spontaneous locomotor activity recorded for 16 h.  N/OFQ produced a clear inhibitory effect which lasted for 60 min while UFP-112 elicited longer lasting effects (>6 h).  In conscious rats, UFP-112 (0.1 and 10 nmol/kg, i.v.) produced a marked and sustained decrease in heart rate, blood pressure, and urinary sodium excretion and a profound increase in urine flow.  Collectively, these findings demonstrate that UFP-112 behaves in vitro and in vivo as a highly potent and selective ligand able to produce full and long lasting activation of NOP receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGombNnEOwl6-bVg90H21EOLACvtfcHk0liikaAZdE66Sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtVaiu7o%253D&md5=d1ef96ff0ba18bff8c08d79917dbadc2</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.peptides.2007.04.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.peptides.2007.04.020%26sid%3Dliteratum%253Aachs%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DSpagnolo%26aufirst%3DB.%26aulast%3DWainford%26aufirst%3DR.%2BD.%26aulast%3DFischetti%26aufirst%3DC.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DMarzola%26aufirst%3DG.%26aulast%3DBaldisserotto%26aufirst%3DA.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DKapusta%26aufirst%3DD.%2BR.%26aulast%3DCalo%26aufirst%3DG.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520studies%2520on%2520UFP-112%252C%2520a%2520novel%2520potent%2520and%2520long%2520lasting%2520agonist%2520selective%2520for%2520the%2520nociceptin%252Forphanin%2520FQ%2520receptor%26jtitle%3DPeptides%26date%3D2007%26volume%3D28%26spage%3D1240%26epage%3D1251%26doi%3D10.1016%2Fj.peptides.2007.04.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meunier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mouledous, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Topham, C. M.</span></span> <span> </span><span class="NLM_article-title">The nociceptin (ORL1) receptor: molecular cloning and functional architecture</span>. <i>Peptides</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">893</span>– <span class="NLM_lpage">900</span>, <span class="refDoi"> DOI: 10.1016/s0196-9781(00)00225-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1016%2FS0196-9781%2800%2900225-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10998522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BD3cXms1WrsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=893-900&author=J.+Meunierauthor=L.+Mouledousauthor=C.+M.+Topham&title=The+nociceptin+%28ORL1%29+receptor%3A+molecular+cloning+and+functional+architecture&doi=10.1016%2Fs0196-9781%2800%2900225-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The nociceptin (ORL1) receptor: molecular cloning and functional architecture</span></div><div class="casAuthors">Meunier, J.-C.; Mouledous, L.; Topham, C. M.</div><div class="citationInfo"><span class="NLM_cas:title">Peptides (New York)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">893-900</span>CODEN:
                <span class="NLM_cas:coden">PPTDD5</span>;
        ISSN:<span class="NLM_cas:issn">0196-9781</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review, with 68 refs.  Nociceptin and the ORL1 receptor share high sequence similarity with opioid peptides, particularly dynorphin A, and their receptors.  However, nociceptin and dynorphin A may use distinct mol. pathways to bind and activate their cognate receptors.  Activation of the κ-opioid receptor by dynorphin A is thought to require interactions of its N-terminal hydrophobic domain (Y1GGF) with the receptor opioid binding pocket, located within the transmembrane helix bundle, while activation of the ORL1 receptor appears to require interactions of the pos. charged core (R8KSARK) of nociceptin with the neg. charged second extracellular receptor loop.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgfiMfw8rCDLVg90H21EOLACvtfcHk0lippMQH7OrDkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXms1WrsLo%253D&md5=e82a23c14a0aaedaeef0e23470f36dc2</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2FS0196-9781%2800%2900225-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0196-9781%252800%252900225-4%26sid%3Dliteratum%253Aachs%26aulast%3DMeunier%26aufirst%3DJ.%26aulast%3DMouledous%26aufirst%3DL.%26aulast%3DTopham%26aufirst%3DC.%2BM.%26atitle%3DThe%2520nociceptin%2520%2528ORL1%2529%2520receptor%253A%2520molecular%2520cloning%2520and%2520functional%2520architecture%26jtitle%3DPeptides%26date%3D2000%26volume%3D21%26spage%3D893%26epage%3D900%26doi%3D10.1016%2Fs0196-9781%2800%2900225-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tancredi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrà, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arduin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calò, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regoli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvadori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temussi, P. A.</span></span> <span> </span><span class="NLM_article-title">The interaction of highly helical structural mutants with the NOP receptor discloses the role of the address domain of nociceptin/orphanin FQ</span>. <i>Chemistry</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2061</span>– <span class="NLM_lpage">2070</span>, <span class="refDoi"> DOI: 10.1002/chem.200401095</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1002%2Fchem.200401095" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=15712334" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BD2MXislOgtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=2061-2070&author=T.+Tancrediauthor=G.+Carr%C3%A0author=R.+Guerriniauthor=M.+Arduinauthor=G.+Cal%C3%B2author=D.+Regoliauthor=S.+Salvadoriauthor=P.+A.+Temussi&title=The+interaction+of+highly+helical+structural+mutants+with+the+NOP+receptor+discloses+the+role+of+the+address+domain+of+nociceptin%2Forphanin+FQ&doi=10.1002%2Fchem.200401095"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The interaction of highly helical structural mutants with the NOP receptor discloses the role of the address domain of nociceptin/orphanin FQ</span></div><div class="casAuthors">Tancredi, Teodorico; Carra, Giacomo; Guerrini, Remo; Arduin, Marika; Calo, Girolamo; Regoli, Domenico; Salvadori, Severo; Temussi, Piero Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2061-2070</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Nociceptin is a heptadecapeptide whose sequence is similar to that of Dynorphin A, sharing a message domain characterized by two glycines and two arom. residues, and a highly basic C-terminal address domain but, in spite of these similarities, displays no opioid activity.  Establishing the relative importance of the message and address domains of nociceptin has so far been hampered by its extreme conformational flexibility.  Mutants of this peptide, designed to increase the helical content in the address domain, can be employed to explain the mode of interaction with the NOP receptor.  Nociceptin analogs in which Ala residues are substituted with aminoisobutyric acid (Aib) show a substantial increment of activity in their interaction with the NOP receptor.  The increment of biol. activity was attributed to the well-documented ability of Aib to induce helicity.  Here the authors have verified this working hypothesis by a conformational investigation extended to new analogs in which the role of Aib is taken up by Leu.  The NMR conformational anal. confirms that all Ala/Aib peptides as well as [Leu7,11]-N/OFQ-amide and [Leu11,15]-N/OFQ-amide mutants (N/OFQ=nociceptin/orphanin FQ) have comparable helix content in helix-promoting media.  The authors show that the helical address domain of nociceptin can place key basic residues at an optimal distance from complementary acidic groups of the EL2 loop of the receptor.  The authors' structural data are used to rationalize pharmacol. data which show that although [Leu11,15]-N/OFQ-amide has an activity comparable to those of Ala/Aib peptides, [Leu7,11]-N/OFQ-amide is less active than N/OFQ-amide.  The authors hypothesize that bulky residues cannot be hosted in or near the hinge region (Thr5-Gly6-Ala7) without severe steric clash with the receptor.  This hypothesis is also consistent with previous data on this hinge region obtained by systematic substitution of Thr, Gly, and Ala with Pro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowPRo2dVGzsbVg90H21EOLACvtfcHk0lippMQH7OrDkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXislOgtb8%253D&md5=ef65ba54e0e12e43454a95a59e42cffc</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1002%2Fchem.200401095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.200401095%26sid%3Dliteratum%253Aachs%26aulast%3DTancredi%26aufirst%3DT.%26aulast%3DCarr%25C3%25A0%26aufirst%3DG.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DArduin%26aufirst%3DM.%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DTemussi%26aufirst%3DP.%2BA.%26atitle%3DThe%2520interaction%2520of%2520highly%2520helical%2520structural%2520mutants%2520with%2520the%2520NOP%2520receptor%2520discloses%2520the%2520role%2520of%2520the%2520address%2520domain%2520of%2520nociceptin%252Forphanin%2520FQ%26jtitle%3DChemistry%26date%3D2005%26volume%3D11%26spage%3D2061%26epage%3D2070%26doi%3D10.1002%2Fchem.200401095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daga, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaveri, N. T.</span></span> <span> </span><span class="NLM_article-title">Homology modeling and molecular dynamics simulations of the active state of the nociceptin receptor reveal new insights into agonist binding and activation</span>. <i>Proteins</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">1948</span>– <span class="NLM_lpage">1961</span>, <span class="refDoi"> DOI: 10.1002/prot.24077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1002%2Fprot.24077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=22489047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC38XntFSkur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2012&pages=1948-1961&author=P.+R.+Dagaauthor=N.+T.+Zaveri&title=Homology+modeling+and+molecular+dynamics+simulations+of+the+active+state+of+the+nociceptin+receptor+reveal+new+insights+into+agonist+binding+and+activation&doi=10.1002%2Fprot.24077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Homology modeling and molecular dynamics simulations of the active state of the nociceptin receptor reveal new insights into agonist binding and activation</span></div><div class="casAuthors">Daga, Pankaj R.; Zaveri, Nurulain T.</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Bioinformatics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1948-1961, S1948/1-S1948/8</span>CODEN:
                <span class="NLM_cas:coden">PSFBAF</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The opioid receptor-like receptor, also known as the nociceptin receptor (NOP), is a class A G protein-coupled receptor (GPCR) in the opioid receptor family.  Although NOP shares a significant homol. with the other opioid receptors, it does not bind known opioid ligands and has been shown to have a distinct mechanism of activation compared to the closely related opioid receptors mu, delta, and kappa.  Previously reported homol. models of the NOP receptor, based on the inactive-state GPCR crystal structures, give limited information on the activation and selectivity features of this fourth member of the opioid receptor family.  The authors report the first active-state homol. model of the NOP receptor based on the opsin GPCR crystal structure.  An inactive-state homol. model of NOP was also built using a multiple template approach.  Mol. dynamics simulation of the active-state NOP model and comparison to the inactive-state model suggest that NOP activation involves movements of transmembrane (TM)3 and TM6 and several activation microswitches, consistent with GPCR activation.  Docking of the selective nonpeptidic NOP agonist ligand Ro 64-6198 into the active-state model reveals active-site residues in NOP that play a role in the high selectivity of this ligand for NOP over the other opioid receptors.  Docking the shortest active fragment of endogenous agonist nociceptin/orphaninFQ (residues 1-13) shows that the NOP extracellular loop 2 (EL2) loop interacts with the pos. charged residues (8-13) of N/OFQ.  Both agonists show extensive polar interactions with residues at the extracellular end of the TM domain and EL2 loop, suggesting agonist-induced reorganization of polar networks, during receptor activation.  Proteins 2012; © 2012 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHyKNV6QUesbVg90H21EOLACvtfcHk0lippMQH7OrDkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntFSkur0%253D&md5=b239ff210a4b601c46401139c17f8fb5</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2Fprot.24077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.24077%26sid%3Dliteratum%253Aachs%26aulast%3DDaga%26aufirst%3DP.%2BR.%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26atitle%3DHomology%2520modeling%2520and%2520molecular%2520dynamics%2520simulations%2520of%2520the%2520active%2520state%2520of%2520the%2520nociceptin%2520receptor%2520reveal%2520new%2520insights%2520into%2520agonist%2520binding%2520and%2520activation%26jtitle%3DProteins%26date%3D2012%26volume%3D80%26spage%3D1948%26epage%3D1961%26doi%3D10.1002%2Fprot.24077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Della
Longa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arcovito, A.</span></span> <span> </span><span class="NLM_article-title">A dynamic picture of the early events in nociceptin binding to the NOP receptor by metadynamics</span>. <i>Biophys. J.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">1203</span>– <span class="NLM_lpage">1213</span>, <span class="refDoi"> DOI: 10.1016/j.bpj.2016.07.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1016%2Fj.bpj.2016.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=27653479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Sgs7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2016&pages=1203-1213&author=S.+Della%0ALongaauthor=A.+Arcovito&title=A+dynamic+picture+of+the+early+events+in+nociceptin+binding+to+the+NOP+receptor+by+metadynamics&doi=10.1016%2Fj.bpj.2016.07.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">A Dynamic Picture of the Early Events in Nociceptin Binding to the NOP Receptor by Metadynamics</span></div><div class="casAuthors">della Longa, Stefano; Arcovito, Alessandro</div><div class="citationInfo"><span class="NLM_cas:title">Biophysical Journal</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1203-1213</span>CODEN:
                <span class="NLM_cas:coden">BIOJAU</span>;
        ISSN:<span class="NLM_cas:issn">0006-3495</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Nociceptin (NCC, also known as FQ (N/OFQ)) is the 17-amino acid neuropeptide, endogenous ligand for the G-protein-coupled receptor (NOP, also known as ORL-1).  In this study, starting from the recently reported x-ray structure at pH 7 of NOP in complex with an antagonist, new insights, to our knowledge, on the binding geometry of NCC to NOP have been provided in silico.  After a rigid docking of NCC in an α-helix conformation, mol. dynamics (MD) and metadynamics (METAD), a method for the anal. of free-energy surfaces (FES), were performed on the protein-peptide complex.  Free-energy profiles were obtained as a function of the α-helix content of different segments of the 17-mer ligand, and a structural ensemble of conformations of NCC, corresponding to the min. of the FES, was extd., thus representing the NCC bound to the inactive form of NOP.  The structural features were compared with many known exptl. data.  The pose of the "message" domain (residues 1-4) of NCC differs from that of the known NOP antagonists, as being slightly slipped deeper inside the protein core.  A residual α-helix content in the central part of the peptide (residues 4-9) is maintained, whereas the C-terminal segment (residues 13-17) is unstructured and highly flexible.  An important stabilization due to interactions with residues D130 and D110 of the receptor has been found, in agreement with the large decrease in agonist potency reported for the D130A and D110A mutants.  The importance of the extracellular domain 2 (ECL2) in the selectivity toward the endogenous ligand has been confirmed.  A pivotal role for the conserved residue N133 is suggested and further supported by a study of the N133A in silico mutant.  Accordingly, N133 can work as a mol. microswitch driving the change between the inactive and active NOP conformations, in the framework of an extended H-bond and water network rearrangement in the deep binding site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT4-CBYIpqObVg90H21EOLACvtfcHk0lippMQH7OrDkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Sgs7vL&md5=04150fcde23e790592cbbe14ea4d8b2f</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.bpj.2016.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bpj.2016.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DDella%2BLonga%26aufirst%3DS.%26aulast%3DArcovito%26aufirst%3DA.%26atitle%3DA%2520dynamic%2520picture%2520of%2520the%2520early%2520events%2520in%2520nociceptin%2520binding%2520to%2520the%2520NOP%2520receptor%2520by%2520metadynamics%26jtitle%3DBiophys.%2520J.%26date%3D2016%26volume%3D111%26spage%3D1203%26epage%3D1213%26doi%3D10.1016%2Fj.bpj.2016.07.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janda, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, K. C.</span></span> <span> </span><span class="NLM_article-title">Wnt acylation and its functional implication in Wnt signalling regulation</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">211</span>– <span class="NLM_lpage">216</span>, <span class="refDoi"> DOI: 10.1042/bst20140249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1042%2FBST20140249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=25849919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlvFSjtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=211-216&author=C.+Y.+Jandaauthor=K.+C.+Garcia&title=Wnt+acylation+and+its+functional+implication+in+Wnt+signalling+regulation&doi=10.1042%2Fbst20140249"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt acylation and its functional implication in Wnt signalling regulation</span></div><div class="casAuthors">Janda, Claudia Y.; Garcia, K. Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">211-216</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Wnt proteins are conserved signalling mols. that have an essential role in regulating diverse processes during embryogenesis and adult tissue homoeostasis.  Wnts are post-translationally modified by palmitoylation, which is essential for Wnt secretion and function.  Intriguingly, the crystal structure of XWnt8 in complex with the extracellular domain of the Frizzled 8 cysteine-rich domain (Fzd8-CRD) revealed that Wnts use the fatty acid as a 'hotspot' residue to engage its receptor, which is a unique mode of receptor-ligand recognition.  In addn., there are several lines of evidence suggesting that Wnts engage several signalling modulators and alternative receptors by means of fatty acids as a crit. contact residue.  In the present article, we review our current understanding of Wnt acylation and its functional role in Wnt signalling regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolTAV6vOMoPrVg90H21EOLACvtfcHk0lhAkWt6Gnndyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlvFSjtrc%253D&md5=1ff3c73e18d01e779f82c039c8a062bb</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1042%2FBST20140249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20140249%26sid%3Dliteratum%253Aachs%26aulast%3DJanda%26aufirst%3DC.%2BY.%26aulast%3DGarcia%26aufirst%3DK.%2BC.%26atitle%3DWnt%2520acylation%2520and%2520its%2520functional%2520implication%2520in%2520Wnt%2520signalling%2520regulation%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2015%26volume%3D43%26spage%3D211%26epage%3D216%26doi%3D10.1042%2Fbst20140249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fredriksson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagerström, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundin, L.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiöth, H. B.</span></span> <span> </span><span class="NLM_article-title">The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">1256</span>– <span class="NLM_lpage">1272</span>, <span class="refDoi"> DOI: 10.1124/mol.63.6.1256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1124%2Fmol.63.6.1256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=12761335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkt1Shu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=1256-1272&author=R.+Fredrikssonauthor=M.+C.+Lagerstr%C3%B6mauthor=L.-G.+Lundinauthor=H.+B.+Schi%C3%B6th&title=The+G-protein-coupled+receptors+in+the+human+genome+form+five+main+families.+Phylogenetic+analysis%2C+paralogon+groups%2C+and+fingerprints&doi=10.1124%2Fmol.63.6.1256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints</span></div><div class="casAuthors">Fredriksson, Robert; Lagerstrom, Malin C.; Lundin, Lars-Gustav; Schioth, Helgi B.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1256-1272</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The superfamily of G-protein-coupled receptors (GPCRs) is very diverse in structure and function and its members are among the most pursued targets for drug development.  We identified more than 800 human GPCR sequences and simultaneously analyzed 342 unique functional nonolfactory human GPCR sequences with phylogenetic analyses.  Our results show, with high bootstrap support, five main families, named glutamate, rhodopsin, adhesion, frizzled/taste2, and secretin, forming the GRAFS classification system.  The rhodopsin family is the largest and forms four main groups with 13 subbranches.  Positions of the GPCRs in chromosomal paralogons regions indicate the importance of tetraploidizations or local gene duplication events for their creation.  We also searched for "fingerprint" motifs using Hidden Markov Models delineating the putative inter-relationship of the GRAFS families.  We show several common structural features indicating that the human GPCRs in the GRAFS families share a common ancestor.  This study represents the first overall map of the GPCRs in a single mammalian genome.  Our novel approach of analyzing such large and diverse sequence sets may be useful for studies on GPCRs in other genomes and divergent protein families.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdX4VhTsaDzrVg90H21EOLACvtfcHk0lhAkWt6Gnndyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkt1Shu7k%253D&md5=504ea873ee8469cd0b6016bc94943836</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1124%2Fmol.63.6.1256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.63.6.1256%26sid%3Dliteratum%253Aachs%26aulast%3DFredriksson%26aufirst%3DR.%26aulast%3DLagerstr%25C3%25B6m%26aufirst%3DM.%2BC.%26aulast%3DLundin%26aufirst%3DL.-G.%26aulast%3DSchi%25C3%25B6th%26aufirst%3DH.%2BB.%26atitle%3DThe%2520G-protein-coupled%2520receptors%2520in%2520the%2520human%2520genome%2520form%2520five%2520main%2520families.%2520Phylogenetic%2520analysis%252C%2520paralogon%2520groups%252C%2520and%2520fingerprints%26jtitle%3DMol.%2520Pharmacol.%26date%3D2003%26volume%3D63%26spage%3D1256%26epage%3D1272%26doi%3D10.1124%2Fmol.63.6.1256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carr, R.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benovic, J. L.</span></span> <span> </span><span class="NLM_article-title">From biased signalling to polypharmacology: unlocking unique intracellular signalling using pepducins</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">555</span>– <span class="NLM_lpage">561</span>, <span class="refDoi"> DOI: 10.1042/bst20150230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1042%2FBST20150230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=27068969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlslyqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2016&pages=555-561&author=R.+Carrauthor=J.+L.+Benovic&title=From+biased+signalling+to+polypharmacology%3A+unlocking+unique+intracellular+signalling+using+pepducins&doi=10.1042%2Fbst20150230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">From biased signalling to polypharmacology: unlocking unique intracellular signalling using pepducins</span></div><div class="casAuthors">Carr, Richard, III; Benovic, Jeffrey L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">555-561</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">For over a decade, pepducins have been utilized to develop unique pharmacol. profiles that have been particularly challenging for traditional drug discovery methods.  It is becoming increasingly clear that these cell-penetrating lipopeptides can access receptor conformations that are currently not accessible through orthosteric targeting.  This review addresses the emerging concepts in the development of pepducins including the elicitation of biased signalling, pepducin polypharmacol. and recent insight into their mechanism of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3aZFivLDit7Vg90H21EOLACvtfcHk0lhAkWt6Gnndyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlslyqt7g%253D&md5=dcaeb398ab7aee0e6f1712c24828e617</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1042%2FBST20150230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20150230%26sid%3Dliteratum%253Aachs%26aulast%3DCarr%26aufirst%3DR.%26aulast%3DBenovic%26aufirst%3DJ.%2BL.%26atitle%3DFrom%2520biased%2520signalling%2520to%2520polypharmacology%253A%2520unlocking%2520unique%2520intracellular%2520signalling%2520using%2520pepducins%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2016%26volume%3D44%26spage%3D555%26epage%3D561%26doi%3D10.1042%2Fbst20150230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsuji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirayama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isono, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagasawa, H.</span></span> <span> </span><span class="NLM_article-title">FRET-based imaging of transbilayer movement of pepducin in living cells by novel intracellular bioreductively activatable fluorescent probes</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">3030</span>– <span class="NLM_lpage">3037</span>, <span class="refDoi"> DOI: 10.1039/c3ob27445d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1039%2Fc3ob27445d" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=23532512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtVWks78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=3030-3037&author=M.+Tsujiauthor=S.+Uedaauthor=T.+Hirayamaauthor=K.+Okudaauthor=Y.+Sakaguchiauthor=A.+Isonoauthor=H.+Nagasawa&title=FRET-based+imaging+of+transbilayer+movement+of+pepducin+in+living+cells+by+novel+intracellular+bioreductively+activatable+fluorescent+probes&doi=10.1039%2Fc3ob27445d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">FRET-based imaging of transbilayer movement of pepducin in living cells by novel intracellular bioreductively activatable fluorescent probes</span></div><div class="casAuthors">Tsuji, Mieko; Ueda, Satoshi; Hirayama, Tasuku; Okuda, Kensuke; Sakaguchi, Yoshiaki; Isono, Aoi; Nagasawa, Hideko</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3030-3037</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">To elucidate the mechanisms of direct transmembrane penetration of pepducins, which are artificial lipopeptide G protein-coupled receptor (GPCR) modulators, the authors developed two types of FRET-based probes, Pep13-FL-SS-Dab (13) targeting the inner leaflet of the lipid bilayer and Pep13-Dab-SS-FL (14) targeting the cytosol, resp.  They are composed of a pepducin moiety and a fluorescent switch component consisting of 5(6)-carboxyfluorescein (FAM) as a fluorophore and dabcyl as a quencher connected through disulfide bond linkage.  When they are internalized into the cytosol, intracellular glutathione can cleave the disulfide bond to release the quencher, which results in a turn-on fluorescence signal.  Using these probes, the authors performed live cell imaging of transbilayer movements of pepducins on MCF-7 cells for the first time.  The results suggested that the lipid moiety of the probes facilitated pepducin flipping across and tethering to the membrane.  The present study raises the possibility of applying the probe architecture for direct intracellular drug delivery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosDiFgs14A-rVg90H21EOLACvtfcHk0lhgRHDGqISw9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtVWks78%253D&md5=6abf6bafd05b4eb055bdbae307eda210</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1039%2Fc3ob27445d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3ob27445d%26sid%3Dliteratum%253Aachs%26aulast%3DTsuji%26aufirst%3DM.%26aulast%3DUeda%26aufirst%3DS.%26aulast%3DHirayama%26aufirst%3DT.%26aulast%3DOkuda%26aufirst%3DK.%26aulast%3DSakaguchi%26aufirst%3DY.%26aulast%3DIsono%26aufirst%3DA.%26aulast%3DNagasawa%26aufirst%3DH.%26atitle%3DFRET-based%2520imaging%2520of%2520transbilayer%2520movement%2520of%2520pepducin%2520in%2520living%2520cells%2520by%2520novel%2520intracellular%2520bioreductively%2520activatable%2520fluorescent%2520probes%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2013%26volume%3D11%26spage%3D3030%26epage%3D3037%26doi%3D10.1039%2Fc3ob27445d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quoyer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janz, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armando, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukashova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benovic, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, S. W.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouvier, M.</span></span> <span> </span><span class="NLM_article-title">Pepducin targeting the C-X-C chemokine receptor type 4 acts as a biased agonist favoring activation of the inhibitory G protein</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">E5088</span>– <span class="NLM_lpage">E5097</span>, <span class="refDoi"> DOI: 10.1073/pnas.1312515110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1073%2Fpnas.1312515110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=24309376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC2cXns1SjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=E5088-E5097&author=J.+Quoyerauthor=J.+M.+Janzauthor=J.+Luoauthor=Y.+Renauthor=S.+Armandoauthor=V.+Lukashovaauthor=J.+L.+Benovicauthor=K.+E.+Carlsonauthor=S.+W.+Huntauthor=M.+Bouvier&title=Pepducin+targeting+the+C-X-C+chemokine+receptor+type+4+acts+as+a+biased+agonist+favoring+activation+of+the+inhibitory+G+protein&doi=10.1073%2Fpnas.1312515110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Pepducin targeting the C-X-C chemokine receptor type 4 acts as a biased agonist favoring activation of the inhibitory G protein</span></div><div class="casAuthors">Quoyer, Julie; Janz, Jay M.; Luo, Jiansong; Ren, Yong; Armando, Sylvain; Lukashova, Viktoria; Benovic, Jeffrey L.; Carlson, Kenneth E.; Hunt, Stephen W., III; Bouvier, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">E5088-E5097,SE5088/1-SE5088/6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Short lipidated peptide sequences derived from various intracellular loop regions of G protein-coupled receptors (GPCRs) are named pepducins and act as allosteric modulators of a no. of GPCRs.  Recently, a pepducin selectively targeting the C-X-C chemokine receptor type 4 (CXCR4) was found to be an allosteric agonist, active in both cell-based assays and in vivo.  However, the precise mechanism of action of this class of ligands remains poorly understood.  In particular, given the diversity of signaling effectors that can be engaged by a given receptor, it is not clear whether pepducins can show biased signaling leading to functional selectivity.  To explore the ligand-biased potential of pepducins, the authors assessed the effect of the CXCR4 selective pepducin, ATI-2341, on the ability of the receptor to engage the inhibitory G proteins (Gi1, Gi2 and Gi3), G13, and β-arrestins.  Using bioluminescence resonance energy transfer-based biosensors, the authors found that, in contrast to the natural CXCR4 ligand, stromal cell-derived factor-1α, which promotes the engagement of the three Gi subtypes, G13 and the two β-arrestins, ATI-2341 leads to the engagement of the Gi subtypes but not G13 or the β-arrestins.  Calcn. of the transduction ratio for each pathway revealed a strong neg. bias of ATI-2341 toward G13 and β-arrestins, revealing functional selectivity for the Gi pathways.  The neg. bias toward β-arrestins results from the reduced ability of the pepducin to promote GPCR kinase-mediated phosphorylation of the receptor.  In addn. to revealing ligand-biased signaling of pepducins, these findings shed some light on the mechanism of action of a unique class of allosteric regulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBOvGh6qLDbLVg90H21EOLACvtfcHk0lhgRHDGqISw9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXns1SjtQ%253D%253D&md5=748ab512167787aa3fe31642f7c244b1</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1312515110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1312515110%26sid%3Dliteratum%253Aachs%26aulast%3DQuoyer%26aufirst%3DJ.%26aulast%3DJanz%26aufirst%3DJ.%2BM.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DArmando%26aufirst%3DS.%26aulast%3DLukashova%26aufirst%3DV.%26aulast%3DBenovic%26aufirst%3DJ.%2BL.%26aulast%3DCarlson%26aufirst%3DK.%2BE.%26aulast%3DHunt%26aufirst%3DS.%2BW.%26aulast%3DBouvier%26aufirst%3DM.%26atitle%3DPepducin%2520targeting%2520the%2520C-X-C%2520chemokine%2520receptor%2520type%25204%2520acts%2520as%2520a%2520biased%2520agonist%2520favoring%2520activation%2520of%2520the%2520inhibitory%2520G%2520protein%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2013%26volume%3D110%26spage%3DE5088%26epage%3DE5097%26doi%3D10.1073%2Fpnas.1312515110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gabl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holdfeldt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundqvist, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lomei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlgren, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forsman, H.</span></span> <span> </span><span class="NLM_article-title">FPR2 signaling without beta-arrestin recruitment alters the functional repertoire of neutrophils</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>145</i></span>,  <span class="NLM_fpage">114</span>– <span class="NLM_lpage">122</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2017.08.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1016%2Fj.bcp.2017.08.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=28855087" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVWmsbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2017&pages=114-122&author=M.+Gablauthor=A.+Holdfeldtauthor=M.+Sundqvistauthor=J.+Lomeiauthor=C.+Dahlgrenauthor=H.+Forsman&title=FPR2+signaling+without+beta-arrestin+recruitment+alters+the+functional+repertoire+of+neutrophils&doi=10.1016%2Fj.bcp.2017.08.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">FPR2 signaling without β-arrestin recruitment alters the functional repertoire of neutrophils</span></div><div class="casAuthors">Gabl, Michael; Holdfeldt, Andre; Sundqvist, Martina; Lomei, Jalal; Dahlgren, Claes; Forsman, Huamei</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">114-122</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">G-protein coupled receptor (GPCR) biased agonism or functional selectivity has become an essential concept in GPCR research over the last years.  Receptor-specific biased agonists selectively trigger one signaling pathway over another and induce a restricted/directed functional response.  In this study, we aimed to characterize the concept of biased agonism for FPR2, a member of the formyl peptide receptor (FPR) subfamily of GPCRs.  We show that the earlier described FPR2-activating pepducin F2Pal10 is a biased FPR2 agonist.  The effects of F2Pal10 on neutrophil function differed in several aspects compared to those mediated by WKYMVM, a conventional FPR2-specific peptide agonist.  Upon interaction with FPR2 expressed by neutrophils both F2Pal10 and WKYMVM activated the PLC-PIP2-Ca2+ signaling pathway and the superoxide-generating NADPH-oxidase, but only WKYMVM activated the receptor to recruit β-arrestin.  The functional consequences linked to a lack of β-arrestin recruitment were further explored, and we demonstrate that FPR2 desensitization occurred independent of β-arrestin.  Despite this, reactivation of desensitized receptors achieved through a disruption of the cytoskeleton and through a novel FPR2 cross-talk mechanism with P2Y2R (the ATP receptor) and PAFR (the receptor for PAF) differed between F2Pal10-desensitized and WKYMVM-desensitized neutrophils.  Further, the inability to recruit β-arrestin was found to be assocd. with a reduced rate of receptor internalization and impaired chemotaxis in neutrophils.  In summary, we provide exptl. evidence of biased agonism for FPR2 and our data disclose crit. roles of β-arrestin in neutrophil chemotaxis and reactivation of desensitized receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqz-stXhQetSbVg90H21EOLACvtfcHk0lhgRHDGqISw9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVWmsbzP&md5=1031773a38e0c377d4bf6e251dcb5f7b</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2017.08.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2017.08.018%26sid%3Dliteratum%253Aachs%26aulast%3DGabl%26aufirst%3DM.%26aulast%3DHoldfeldt%26aufirst%3DA.%26aulast%3DSundqvist%26aufirst%3DM.%26aulast%3DLomei%26aufirst%3DJ.%26aulast%3DDahlgren%26aufirst%3DC.%26aulast%3DForsman%26aufirst%3DH.%26atitle%3DFPR2%2520signaling%2520without%2520beta-arrestin%2520recruitment%2520alters%2520the%2520functional%2520repertoire%2520of%2520neutrophils%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2017%26volume%3D145%26spage%3D114%26epage%3D122%26doi%3D10.1016%2Fj.bcp.2017.08.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carr, R.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quoyer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panettieri, R. A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janz, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouvier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benovic, J. L.</span></span> <span> </span><span class="NLM_article-title">Development and characterization of pepducins as Gs-biased allosteric agonists</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">35668</span>– <span class="NLM_lpage">35684</span>, <span class="refDoi"> DOI: 10.1074/jbc.m114.618819</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1074%2Fjbc.M114.618819" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=25395624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitFOhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=35668-35684&author=R.+Carrauthor=Y.+Duauthor=J.+Quoyerauthor=R.+A.+Panettieriauthor=J.+M.+Janzauthor=M.+Bouvierauthor=B.+K.+Kobilkaauthor=J.+L.+Benovic&title=Development+and+characterization+of+pepducins+as+Gs-biased+allosteric+agonists&doi=10.1074%2Fjbc.m114.618819"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Development and Characterization of Pepducins as Gs-biased Allosteric Agonists</span></div><div class="casAuthors">Carr, Richard, III; Du, Yang; Quoyer, Julie; Panettieri, Reynold A., Jr.; Janz, Jay M.; Bouvier, Michel; Kobilka, Brian K.; Benovic, Jeffrey L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">35668-35684</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The β2-adrenergic receptor (β2AR) is a prototypical G protein-coupled receptor that mediates many hormonal responses, including cardiovascular and pulmonary function. β-Agonists used to combat hypercontractility in airway smooth muscle stimulate β2AR-dependent cAMP prodn. that ultimately promotes airway relaxation.  Chronic stimulation of the β2AR by long acting β-agonists used in the treatment of asthma can promote attenuated responsiveness to agonists and an increased frequency of fatal asthmatic attacks. β2AR desensitization to β-agonists is primarily mediated by G protein-coupled receptor kinases and β-arrestins that attenuate receptor-Gs coupling and promote β2AR internalization and degrdn.  A biased agonist that can selectively stimulate Gs signaling without promoting receptor interaction with G protein-coupled receptor kinases and β-arrestins should serve as an advantageous asthma therapeutic.  To identify such mols., we screened ∼50 lipidated peptides derived from the intracellular loops of the β2AR, known as pepducins.  This screen revealed two classes of Gs-biased pepducins, receptor-independent and receptor-dependent, as well as several β-arrestin-biased pepducins.  The receptor-independent Gs-biased pepducins operate by directly stimulating G protein activation.  In contrast, receptor-dependent Gs-biased pepducins appear to stabilize a Gs-biased conformation of the β2AR that couples to Gs but does not undergo G protein-coupled receptor kinase-mediated phosphorylation or β-arrestin-mediated internalization.  Functional studies in primary human airway smooth muscle cells demonstrate that Gs-biased pepducins are not subject to conventional desensitization and thus may be good candidates for the development of next generation asthma therapeutics.  Our study reports the first Gs-biased activator of the β2AR and provides valuable tools for the study of β2AR function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-lWPD7GDCHLVg90H21EOLACvtfcHk0ljLjPiwqXEwbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitFOhtQ%253D%253D&md5=d50350aa74734b00958e1a09b42e5161</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.618819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.618819%26sid%3Dliteratum%253Aachs%26aulast%3DCarr%26aufirst%3DR.%26aulast%3DDu%26aufirst%3DY.%26aulast%3DQuoyer%26aufirst%3DJ.%26aulast%3DPanettieri%26aufirst%3DR.%2BA.%26aulast%3DJanz%26aufirst%3DJ.%2BM.%26aulast%3DBouvier%26aufirst%3DM.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26aulast%3DBenovic%26aufirst%3DJ.%2BL.%26atitle%3DDevelopment%2520and%2520characterization%2520of%2520pepducins%2520as%2520Gs-biased%2520allosteric%2520agonists%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D35668%26epage%3D35684%26doi%3D10.1074%2Fjbc.m114.618819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carr, R.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynham, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tilley, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benovic, J. L.</span></span> <span> </span><span class="NLM_article-title">Beta-arrestin-biased signaling through the beta2-adrenergic receptor promotes cardiomyocyte contraction</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">E4107</span>– <span class="NLM_lpage">E4116</span>, <span class="refDoi"> DOI: 10.1073/pnas.1606267113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1073%2Fpnas.1606267113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=27354517" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=E4107-E4116&author=R.+Carrauthor=J.+Schillingauthor=J.+Songauthor=R.+L.+Carterauthor=Y.+Duauthor=S.+M.+Yooauthor=C.+J.+Traynhamauthor=W.+J.+Kochauthor=J.+Y.+Cheungauthor=D.+G.+Tilleyauthor=J.+L.+Benovic&title=Beta-arrestin-biased+signaling+through+the+beta2-adrenergic+receptor+promotes+cardiomyocyte+contraction&doi=10.1073%2Fpnas.1606267113"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1606267113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1606267113%26sid%3Dliteratum%253Aachs%26aulast%3DCarr%26aufirst%3DR.%26aulast%3DSchilling%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DCarter%26aufirst%3DR.%2BL.%26aulast%3DDu%26aufirst%3DY.%26aulast%3DYoo%26aufirst%3DS.%2BM.%26aulast%3DTraynham%26aufirst%3DC.%2BJ.%26aulast%3DKoch%26aufirst%3DW.%2BJ.%26aulast%3DCheung%26aufirst%3DJ.%2BY.%26aulast%3DTilley%26aufirst%3DD.%2BG.%26aulast%3DBenovic%26aufirst%3DJ.%2BL.%26atitle%3DBeta-arrestin-biased%2520signaling%2520through%2520the%2520beta2-adrenergic%2520receptor%2520promotes%2520cardiomyocyte%2520contraction%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2016%26volume%3D113%26spage%3DE4107%26epage%3DE4116%26doi%3D10.1073%2Fpnas.1606267113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mollereau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmentier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mailleux, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butour, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moisand, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chalon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caput, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vassart, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meunier, J.-C.</span></span> <span> </span><span class="NLM_article-title">ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>341</i></span>,  <span class="NLM_fpage">33</span>– <span class="NLM_lpage">38</span>, <span class="refDoi"> DOI: 10.1016/0014-5793(94)80235-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1016%2F0014-5793%2894%2980235-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=8137918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADyaK2cXksFamurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=1994&pages=33-38&author=C.+Mollereauauthor=M.+Parmentierauthor=P.+Mailleuxauthor=J.-L.+Butourauthor=C.+Moisandauthor=P.+Chalonauthor=D.+Caputauthor=G.+Vassartauthor=J.-C.+Meunier&title=ORL1%2C+a+novel+member+of+the+opioid+receptor+family.+Cloning%2C+functional+expression+and+localization&doi=10.1016%2F0014-5793%2894%2980235-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization</span></div><div class="casAuthors">Mollereau, Catherine; Parmentier, Marc; Mailleux, Pierre; Butour, Jean Luc; Moisand, Christiane; Chalon, Pascale; Caput, Daniel; Vassart, Gilbert; Meunier, Jean Claude</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-8</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    </div><div class="casAbstract">Selective PCR amplification of human and mouse genomic DNAs with oligonucleotides encoding highly conserved regions of the β-opioid and somatostatin receptors generated a human DNA probe (hOP01, 761 bp) and its murine counterpart (mOP86, 447 bp).  Probe hOP01 was used to screen a cDNA library from human brainstem.  A clone (named hORL1) was isolated, sequenced and found to encode a protein of 370 amino acids whose primary structure displays the seven putative membrane-spanning domains of a G protein-coupled membrane receptor.  The hORL1 receptor is most closely related to opioid receptors not only on structural (sequence) but also on functional grounds: hORL1 is 49-50% identical to the murine μ-, δ- and κ-opioid receptors and, in CHO-K1 cells stably transfected with a pRc/CMV:hORL1 construct, ORL1 mediates inhibition of adenylyl cyclase by etorphine, a universal (nonselective) opiate agonist.  Yet, hORL1 appears not to be a typical opioid receptor.  Neither is it a somatostatin or σ (N-allylnormetazocine) receptor.  The mRNAs hybridizing with synthetic oligonucleotides complementary to mOP86 are present in many regions of the mouse brain and spinal cord, particularly in limbic (amygdala, hippocampus, septum, habenula, ...) and hypothalamic structures.  The authors conclude that the hORL1 receptor is a new member of the opioid receptor family with a potential role in modulating a no. of brain functions, including instinctive behaviors and emotions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWFR7ExrwbJrVg90H21EOLACvtfcHk0ljLjPiwqXEwbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXksFamurs%253D&md5=7a7190c4703811558b3ce3e60e9df7e8</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2F0014-5793%2894%2980235-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-5793%252894%252980235-1%26sid%3Dliteratum%253Aachs%26aulast%3DMollereau%26aufirst%3DC.%26aulast%3DParmentier%26aufirst%3DM.%26aulast%3DMailleux%26aufirst%3DP.%26aulast%3DButour%26aufirst%3DJ.-L.%26aulast%3DMoisand%26aufirst%3DC.%26aulast%3DChalon%26aufirst%3DP.%26aulast%3DCaput%26aufirst%3DD.%26aulast%3DVassart%26aufirst%3DG.%26aulast%3DMeunier%26aufirst%3DJ.-C.%26atitle%3DORL1%252C%2520a%2520novel%2520member%2520of%2520the%2520opioid%2520receptor%2520family.%2520Cloning%252C%2520functional%2520expression%2520and%2520localization%26jtitle%3DFEBS%2520Lett.%26date%3D1994%26volume%3D341%26spage%3D33%26epage%3D38%26doi%3D10.1016%2F0014-5793%2894%2980235-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zaratin, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrone, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sbacchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garnier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fossati, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrillo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronzoni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giardina, G. A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheideler, M. A.</span></span> <span> </span><span class="NLM_article-title">Modification of nociception and morphine tolerance by the selective opiate receptor-like orphan receptor antagonist (-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5<i>H</i>-benzocyclohepten-5-ol (SB-612111)</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>308</i></span>,  <span class="NLM_fpage">454</span>– <span class="NLM_lpage">461</span>, <span class="refDoi"> DOI: 10.1124/jpet.103.055848</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1124%2Fjpet.103.055848" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=14593080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtlSqtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=308&publication_year=2004&pages=454-461&author=P.+F.+Zaratinauthor=G.+Petroneauthor=M.+Sbacchiauthor=M.+Garnierauthor=C.+Fossatiauthor=P.+Petrilloauthor=S.+Ronzoniauthor=G.+A.+M.+Giardinaauthor=M.+A.+Scheideler&title=Modification+of+nociception+and+morphine+tolerance+by+the+selective+opiate+receptor-like+orphan+receptor+antagonist+%28-%29-cis-1-methyl-7-%5B%5B4-%282%2C6-dichlorophenyl%29piperidin-1-yl%5Dmethyl%5D-6%2C7%2C8%2C9-tetrahydro-5H-benzocyclohepten-5-ol+%28SB-612111%29&doi=10.1124%2Fjpet.103.055848"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Modification of nociception and morphine tolerance by the selective opiate receptor-like orphan receptor antagonist (-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol (SB-612111)</span></div><div class="casAuthors">Zaratin, Paola F.; Petrone, Giuseppe; Sbacchi, Massimo; Garnier, Martine; Fossati, Claudia; Petrillo, Paola; Ronzoni, Silvio; Giardina, Giuseppe A. M.; Scheideler, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">308</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">454-461</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">SB-612111 is a novel human opiate receptor-like orphan receptor (ORL-1) antagonist that has high affinity for the clonal human ORL-1 receptor (hORL-1 Ki = 0.33 nM), selectivity vs. μ- (174-fold), δ- (6391-fold), and κ (486-fold)-opioid receptors and is able to inhibit nociceptin signaling via hORL-1 in a whole cell gene reporter assay.  SB-612111 has no measurable antinociceptive effects in vivo in the mouse hot-plate test after i.v. administration but is able to antagonize the antimorphine action of nociceptin [ED50 = 0.69 mg/kg, 95% confidence limit (CL) = 0.34-1.21].  SB-62111 administration can also reverse tolerance to morphine in this model, established via repeated morphine administration.  In addn., i.v. SB-612111 can antagonize nociceptin-induced thermal hyperalgesia in a dose-dependent manner (ED50 = 0.62 mg/kg i.v., 95% CL = 0.22-1.89) and is effective per se at reversing thermal hyperalgesia in the rat carrageenan inflammatory pain model.  These data show that an ORL-1 receptor antagonist may be a useful adjunct to chronic pain therapy with opioids and can be used to treat conditions in which thermal hyperalgesia is a significant component of the pain response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZbUKJ64ZkmbVg90H21EOLACvtfcHk0ljLjPiwqXEwbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtlSqtLo%253D&md5=c56ae72c9113af5aeb7168b9a1646b7b</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.055848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.055848%26sid%3Dliteratum%253Aachs%26aulast%3DZaratin%26aufirst%3DP.%2BF.%26aulast%3DPetrone%26aufirst%3DG.%26aulast%3DSbacchi%26aufirst%3DM.%26aulast%3DGarnier%26aufirst%3DM.%26aulast%3DFossati%26aufirst%3DC.%26aulast%3DPetrillo%26aufirst%3DP.%26aulast%3DRonzoni%26aufirst%3DS.%26aulast%3DGiardina%26aufirst%3DG.%2BA.%2BM.%26aulast%3DScheideler%26aufirst%3DM.%2BA.%26atitle%3DModification%2520of%2520nociception%2520and%2520morphine%2520tolerance%2520by%2520the%2520selective%2520opiate%2520receptor-like%2520orphan%2520receptor%2520antagonist%2520%2528-%2529-cis-1-methyl-7-%255B%255B4-%25282%252C6-dichlorophenyl%2529piperidin-1-yl%255Dmethyl%255D-6%252C7%252C8%252C9-tetrahydro-5H-benzocyclohepten-5-ol%2520%2528SB-612111%2529%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D308%26spage%3D454%26epage%3D461%26doi%3D10.1124%2Fjpet.103.055848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spagnolo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrà, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fantin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischetti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hebbes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapella, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanton, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morari, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regoli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calò, G.</span></span> <span> </span><span class="NLM_article-title">Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5<i>H</i>-benzocyclohepten-5-ol]: in vitro studies</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>321</i></span>,  <span class="NLM_fpage">961</span>– <span class="NLM_lpage">967</span>, <span class="refDoi"> DOI: 10.1124/jpet.106.116764</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1124%2Fjpet.106.116764" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=17329552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFeqsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=321&publication_year=2007&pages=961-967&author=B.+Spagnoloauthor=G.+Carr%C3%A0author=M.+Fantinauthor=C.+Fischettiauthor=C.+Hebbesauthor=J.+McDonaldauthor=T.+A.+Barnesauthor=A.+Rizziauthor=C.+Trapellaauthor=G.+Fantonauthor=M.+Morariauthor=D.+G.+Lambertauthor=D.+Regoliauthor=G.+Cal%C3%B2&title=Pharmacological+characterization+of+the+nociceptin%2Forphanin+FQ+receptor+antagonist+SB-612111+%5B%28-%29-cis-1-methyl-7-%5B%5B4-%282%2C6-dichlorophenyl%29piperidin-1-yl%5Dmethyl%5D-6%2C7%2C8%2C9-tetrahydro-5H-benzocyclohepten-5-ol%5D%3A+in+vitro+studies&doi=10.1124%2Fjpet.106.116764"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vitro studies</span></div><div class="casAuthors">Spagnolo, Barbara; Carra, Giacomo; Fantin, Martina; Fischetti, Carmela; Hebbes, Chris; McDonald, John; Barnes, Timothy A.; Rizzi, Anna; Trapella, Claudio; Fanton, Giulia; Morari, Michele; Lambert, Dave G.; Regoli, Domenico; Calo, Girolamo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">321</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">961-967</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The compd. SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol] was recently identified as a selective antagonist for the nociceptin/orphanin FQ (N/OFQ) peptide receptor (NOP).  In the present study, the in vitro pharmacol. profile of SB-612111 at human recombinant NOP receptors expressed in Chinese hamster ovary (CHO) cells [receptor binding, guanosine 5'-O-(3-[35S]thio)triphosphate (GTPγ[35S]) binding, and cAMP level expts.] as well as at native NOP receptors expressed in peripheral (mouse and rat vas deferens, guinea pig ileum) and central (mouse cerebral cortex synaptosomes releasing [3H]5-HT) prepns. was evaluated and compared with that of the std. nonpeptide antagonist (±)J-113397 [(±)-trans-1-[1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one].  SB-612111 produced a concn.-dependent displacement of [3H]N/OFQ binding to CHOhNOP cell membranes, showing higher affinity and NOP selectivity over classical opioid receptors than (±)J-113397.  SB-612111 and (±)J-113397 competitively antagonized the effects of N/OFQ on GTPγ[35S] binding in CHOhNOP cell membranes (pKB, 9.70 and 8.71, resp.) and on cAMP accumulation in CHOhNOP cells (pKB, 8.63 and 7.95, resp.), being per se inactive.  In isolated peripheral tissues of mice, rats, and guinea pigs and in mouse cerebral cortex synaptosomes preloaded with [3H]5-HT, SB-612111 competitively antagonized the inhibitory effects of N/OFQ, with pA2 values in the range of 8.20 to 8.50.  In parallel expts., (±)J-113397 was found to be 2- to 9-fold less potent than SB-612111.  In the elec. stimulated tissues, 1 μM SB-612111 did not modify the effects of classical opioid receptor agonists.  In conclusion, the results of the present study demonstrated that SB-612111 is among the most potent and NOP-selective nonpeptide antagonists identified to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozelFgTfoi5rVg90H21EOLACvtfcHk0lhKNzjgEifPGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFeqsrw%253D&md5=49c903afa586c64284535b50692bb877</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.116764&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.116764%26sid%3Dliteratum%253Aachs%26aulast%3DSpagnolo%26aufirst%3DB.%26aulast%3DCarr%25C3%25A0%26aufirst%3DG.%26aulast%3DFantin%26aufirst%3DM.%26aulast%3DFischetti%26aufirst%3DC.%26aulast%3DHebbes%26aufirst%3DC.%26aulast%3DMcDonald%26aufirst%3DJ.%26aulast%3DBarnes%26aufirst%3DT.%2BA.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DFanton%26aufirst%3DG.%26aulast%3DMorari%26aufirst%3DM.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26atitle%3DPharmacological%2520characterization%2520of%2520the%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520antagonist%2520SB-612111%2520%255B%2528-%2529-cis-1-methyl-7-%255B%255B4-%25282%252C6-dichlorophenyl%2529piperidin-1-yl%255Dmethyl%255D-6%252C7%252C8%252C9-tetrahydro-5H-benzocyclohepten-5-ol%255D%253A%2520in%2520vitro%2520studies%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D321%26spage%3D961%26epage%3D967%26doi%3D10.1124%2Fjpet.106.116764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzza, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calo, G.</span></span> <span> </span><span class="NLM_article-title">Detailed in vitro pharmacological characterization of the clinically viable nociceptin/orphanin FQ peptide receptor antagonist BTRX-246040</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>373</i></span>,  <span class="NLM_fpage">34</span>– <span class="NLM_lpage">43</span>, <span class="refDoi"> DOI: 10.1124/jpet.119.262865</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1124%2Fjpet.119.262865" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=31937563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BB3cXovV2rs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2020&pages=34-43&author=F.+Ferrariauthor=S.+Rizzoauthor=C.+Ruzzaauthor=G.+Calo&title=Detailed+in+vitro+pharmacological+characterization+of+the+clinically+viable+nociceptin%2Forphanin+FQ+peptide+receptor+antagonist+BTRX-246040&doi=10.1124%2Fjpet.119.262865"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Detailed in vitro pharmacological characterization of the clinically viable nociceptin/orphanin FQ peptide receptor antagonist BTRX-246040</span></div><div class="casAuthors">Ferrari, Federica; Rizzo, Sabrina; Ruzza, Chiara; Calo, Girolamo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">373</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">34-43</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The peptide nociceptin/orphanin FQ (N/OFQ) is the natural ligand of the N/OFQ receptor (NOP), which is widely expressed in the central and peripheral nervous system.  Selective NOP antagonists are worthy of testing as innovative drugs to treat depression, Parkinson disease, and drug abuse.  The aim of this study was to perform a detailed in vitro characterization of BTRX-246040 (also known as LY2940094, [2-[4-[(2-chloro-4,4-difluoro-spiro[5H-thieno [2,3-c]pyran-7,4'-piperidine]-1'-yl)methyl]-3-methyl-pyrazol-1-yl]-3-pyridyl]methanol), a novel NOP antagonist that has been already studied in humans.  BTRX-246040 has been tested in vitro in the following assays: calcium mobilization in cells expressing NOP and classic opioid receptors and chimeric G proteins, bioluminescence resonance energy transfer assay measuring NOP interaction with G proteins and β-arrestins, the label-free dynamic mass redistribution assay, and the elec. stimulated mouse vas deferens.  BTRX-246040 was systematically compared with the std. NOP antagonist SB-612111.  In all assays, BTRX-246040 behaves as a pure and selective antagonist at human recombinant and murine nativeNOP receptors displaying 3-10-fold higher potency than the std. antagonist SB-612111.  BTRX-246040 is an essential pharmacol. tool to further investigate the therapeutic potential of NOP antagonists in preclin. and clin. studies.  SIGNIFICANCE STATEMENT NOP antagonists may be innovative antidepressant drugs.  In this research, the novel clin. viable NOP antagonist BTRX-246040 has been deeply characterized in vitro in a panel of assays.  BTRX-246040 resulted a pure, potent, and selective NOP antagonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF6Ni0I1ikg7Vg90H21EOLACvtfcHk0lhKNzjgEifPGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXovV2rs70%253D&md5=6db0fa782a8f9cede1d4eef10b0a9ddd</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1124%2Fjpet.119.262865&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.119.262865%26sid%3Dliteratum%253Aachs%26aulast%3DFerrari%26aufirst%3DF.%26aulast%3DRizzo%26aufirst%3DS.%26aulast%3DRuzza%26aufirst%3DC.%26aulast%3DCalo%26aufirst%3DG.%26atitle%3DDetailed%2520in%2520vitro%2520pharmacological%2520characterization%2520of%2520the%2520clinically%2520viable%2520nociceptin%252Forphanin%2520FQ%2520peptide%2520receptor%2520antagonist%2520BTRX-246040%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2020%26volume%3D373%26spage%3D34%26epage%3D43%26doi%3D10.1124%2Fjpet.119.262865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Negri, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melchiorri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lattanzi, R.</span></span> <span> </span><span class="NLM_article-title">Pharmacology of amphibian opiate peptides</span>. <i>Peptides</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1639</span>– <span class="NLM_lpage">1647</span>, <span class="refDoi"> DOI: 10.1016/s0196-9781(00)00295-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1016%2FS0196-9781%2800%2900295-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=11090917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BD3cXot1ygs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=1639-1647&author=L.+Negriauthor=P.+Melchiorriauthor=R.+Lattanzi&title=Pharmacology+of+amphibian+opiate+peptides&doi=10.1016%2Fs0196-9781%2800%2900295-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology of Amphibian Opiate Peptides</span></div><div class="casAuthors">Negri, L.; Melchiorri, P.; Lattanzi, R.</div><div class="citationInfo"><span class="NLM_cas:title">Peptides (New York)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1639-1647</span>CODEN:
                <span class="NLM_cas:coden">PPTDD5</span>;
        ISSN:<span class="NLM_cas:issn">0196-9781</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review, with 116 refs., on dermorphin and deltorphin, opiate peptides found only in the skin of South American frogs belonging to the subfamily Phyllomedusinae.  The authors presented a brief history of the discovery of these opiate peptides; their distinctive feature of the presence of a naturally occurring D-enantiomer at the 2nd position of their common N-terminal sequence; their structure-activity relationship; brain opiate receptors binding these peptides; pharmacokinetics; and pharmacol. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoa8bAEZow_ObVg90H21EOLACvtfcHk0lhKNzjgEifPGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXot1ygs70%253D&md5=ca0ac8c7493512e26185c20f7fcba6de</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2FS0196-9781%2800%2900295-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0196-9781%252800%252900295-3%26sid%3Dliteratum%253Aachs%26aulast%3DNegri%26aufirst%3DL.%26aulast%3DMelchiorri%26aufirst%3DP.%26aulast%3DLattanzi%26aufirst%3DR.%26atitle%3DPharmacology%2520of%2520amphibian%2520opiate%2520peptides%26jtitle%3DPeptides%26date%3D2000%26volume%3D21%26spage%3D1639%26epage%3D1647%26doi%3D10.1016%2Fs0196-9781%2800%2900295-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosterlitz, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fothergill, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, H. R.</span></span> <span> </span><span class="NLM_article-title">Identification of two related pentapeptides from the brain with potent opiate agonist activity</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>258</i></span>,  <span class="NLM_fpage">577</span>– <span class="NLM_lpage">580</span>, <span class="refDoi"> DOI: 10.1038/258577a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1038%2F258577a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1207728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADyaE28XhtVWjurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=258&publication_year=1975&pages=577-580&author=J.+Hughesauthor=T.+W.+Smithauthor=H.+W.+Kosterlitzauthor=L.+A.+Fothergillauthor=B.+A.+Morganauthor=H.+R.+Morris&title=Identification+of+two+related+pentapeptides+from+the+brain+with+potent+opiate+agonist+activity&doi=10.1038%2F258577a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of two related pentapeptides from the brain with potent opiate agonist activity</span></div><div class="casAuthors">Hughes, J.; Smith, T. W.; Kosterlitz, H. W.; Fothergill, Linda A.; Morgan, B. A.; Morris, H. R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">258</span>
        (<span class="NLM_cas:issue">5536</span>),
    <span class="NLM_cas:pages">577-9</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Dansyl-Edman sequencing and mass spectrometry showed that enkephalin, a natural ligand for opiate receptors, is composed of Tyr-Gly-Gly-Phe-Met and Tyr-Gly-Gly-Phe-Leu.  The biol. potencies of the sep. synthetic pentapeptides compared well with natural enkephalin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ8eTondwYrLVg90H21EOLACvtfcHk0ljDsJmQ6HlBkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XhtVWjurw%253D&md5=4db35634178f0a60d35bf3cf0b92a3fc</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2F258577a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F258577a0%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DT.%2BW.%26aulast%3DKosterlitz%26aufirst%3DH.%2BW.%26aulast%3DFothergill%26aufirst%3DL.%2BA.%26aulast%3DMorgan%26aufirst%3DB.%2BA.%26aulast%3DMorris%26aufirst%3DH.%2BR.%26atitle%3DIdentification%2520of%2520two%2520related%2520pentapeptides%2520from%2520the%2520brain%2520with%2520potent%2520opiate%2520agonist%2520activity%26jtitle%3DNature%26date%3D1975%26volume%3D258%26spage%3D577%26epage%3D580%26doi%3D10.1038%2F258577a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Michel, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlton, S. J.</span></span> <span> </span><span class="NLM_article-title">Biased agonism in drug discovery-is it too soon to choose a path?</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">259</span>– <span class="NLM_lpage">265</span>, <span class="refDoi"> DOI: 10.1124/mol.117.110890</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1124%2Fmol.117.110890" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=29326242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs12qsr3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2018&pages=259-265&author=M.+C.+Michelauthor=S.+J.+Charlton&title=Biased+agonism+in+drug+discovery-is+it+too+soon+to+choose+a+path%3F&doi=10.1124%2Fmol.117.110890"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Biased agonism in drug discovery-is it too soon to choose a path?</span></div><div class="casAuthors">Michel, Martin C.; Charlton, Steven J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">259-265</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A single receptor can activate multiple signaling pathways that have distinct or even opposite effects on cell function.  Biased agonists stabilize receptor conformations preferentially stimulating one of these pathways, and therefore allow a more targeted modulation of cell function and treatment of disease.  Dedicated development of biased agonists has led to promising drug candidates in clin. development, such as the G proteinbiased μ opioid receptor agonist oliceridine.  However, leveraging the theor. potential of biased agonism for drug discovery faces several challenges.  Some of these challenges are tech., such as techniques for quant. anal. of bias and development of suitable screening assays; others are more fundamental, such as the need to robustly identify in a very early phase which cell type harbors the cellular target of the drug candidate, which signaling pathway leads to the desired therapeutic effect, and how these pathways may be modulated in the disease to be treated.  We conclude that biased agonism has potential mainly in the treatment of conditions with a wellunderstood pathophysiol.; in contrast, it may increase effort and com. risk under circumstances where the pathophysiol. has been less well defined, as is the case with many highly innovative treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC0JJ5dRicyLVg90H21EOLACvtfcHk0ljDsJmQ6HlBkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs12qsr3K&md5=a975e0fedbb29ba2059fe14c5be5d434</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1124%2Fmol.117.110890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.117.110890%26sid%3Dliteratum%253Aachs%26aulast%3DMichel%26aufirst%3DM.%2BC.%26aulast%3DCharlton%26aufirst%3DS.%2BJ.%26atitle%3DBiased%2520agonism%2520in%2520drug%2520discovery-is%2520it%2520too%2520soon%2520to%2520choose%2520a%2520path%253F%26jtitle%3DMol.%2520Pharmacol.%26date%3D2018%26volume%3D93%26spage%3D259%26epage%3D265%26doi%3D10.1124%2Fmol.117.110890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benoiton, N. L.</span></span> <i>Chemistry of Peptide Synthesis</i>; <span class="NLM_publisher-name">Taylor & Francis Group</span>: <span class="NLM_publisher-loc">6000 Broken Sound Parkway NW, Suite 300, Boca Raton, FL, 33487-2742, USA</span>, <span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=N.+L.+Benoiton&title=Chemistry+of+Peptide+Synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBenoiton%26aufirst%3DN.%2BL.%26btitle%3DChemistry%2520of%2520Peptide%2520Synthesis%26pub%3DTaylor%2520%2526%2520Francis%2520Group%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rich, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gesellchen, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckner, C. K.</span></span> <span> </span><span class="NLM_article-title">Alkylating derivatives of amino acids and peptides. Synthesis of N-maleoylamino acids, [1-(N-maleoylglycyl)cysteinyl]oxytocin. Effects on vasopressin-stimulated water loss from isolated toad bladder</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1004</span>– <span class="NLM_lpage">1010</span>, <span class="refDoi"> DOI: 10.1021/jm00244a011</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00244a011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADyaE2MXmtVajur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1975&pages=1004-1010&author=D.+H.+Richauthor=P.+D.+Gesellchenauthor=A.+Tongauthor=A.+Cheungauthor=C.+K.+Buckner&title=Alkylating+derivatives+of+amino+acids+and+peptides.+Synthesis+of+N-maleoylamino+acids%2C+%5B1-%28N-maleoylglycyl%29cysteinyl%5Doxytocin.+Effects+on+vasopressin-stimulated+water+loss+from+isolated+toad+bladder&doi=10.1021%2Fjm00244a011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Alkylating derivatives of amino acids and peptides.  Synthesis of N-maleoylamino acids, [1-(N-maleoylglycyl)cysteinyl]oxytocin, and [1-(N-maleoyl-11-aminoundecanoyl)cysteinyl]oxytocin.  Effects on vasopressin-stimulated water loss from isolated toad bladder</span></div><div class="casAuthors">Rich, Daniel H.; Gesellchen, Paul D.; Tong, Alex; Cheung, Al; Buckner, Carl K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1004-10</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Eight N-maleoylamino acids were prepd. by cyclization of the corresponding maleamic acids, while 5 N-maleoylamino acid esters were prepd. by the reaction of the ester with maleic anhydride [108-31-6].  These compds. inhibited both the oxytocin-induced contraction in the isolated rat uterus and vasopressin-induced water loss from the isolated toad bladder.  Acylation of oxytocin acetate [6233-83-6] with the appropriate maleoylamino acid gave N-maleoylglycyloxytocin (I) [57078-96-3] and N-maleoyl-11-aminoundecanoyloxytocin (II) [57078-97-4].  I and II were inactive in the rat uterus assay ≤3 × 10-5M, and had inhibitory activity only on the mucosal surface in the toad bladder assay.  Structure-activity relations, the relation of activity to partition coeff., and the role of sulfhydryl group binding at neurohypophyseal receptors are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYXqdsVEXQrbVg90H21EOLACvtfcHk0ljDsJmQ6HlBkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXmtVajur4%253D&md5=51a9d1485560c7a67f5df39eb2d634d5</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjm00244a011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00244a011%26sid%3Dliteratum%253Aachs%26aulast%3DRich%26aufirst%3DD.%2BH.%26aulast%3DGesellchen%26aufirst%3DP.%2BD.%26aulast%3DTong%26aufirst%3DA.%26aulast%3DCheung%26aufirst%3DA.%26aulast%3DBuckner%26aufirst%3DC.%2BK.%26atitle%3DAlkylating%2520derivatives%2520of%2520amino%2520acids%2520and%2520peptides.%2520Synthesis%2520of%2520N-maleoylamino%2520acids%252C%2520%255B1-%2528N-maleoylglycyl%2529cysteinyl%255Doxytocin.%2520Effects%2520on%2520vasopressin-stimulated%2520water%2520loss%2520from%2520isolated%2520toad%2520bladder%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1975%26volume%3D18%26spage%3D1004%26epage%3D1010%26doi%3D10.1021%2Fjm00244a011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngai, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacAry, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lear, M. J.</span></span> <span> </span><span class="NLM_article-title">Practical synthesis of maleimides and coumarin-linked probes for protein and antibody labelling via reduction of native disulfides</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">3400</span>– <span class="NLM_lpage">3406</span>, <span class="refDoi"> DOI: 10.1039/b904060a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1039%2Fb904060a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=19675893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsl2itrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=3400-3406&author=H.+Y.+Songauthor=M.+H.+Ngaiauthor=Z.+Y.+Songauthor=P.+A.+MacAryauthor=J.+Hobleyauthor=M.+J.+Lear&title=Practical+synthesis+of+maleimides+and+coumarin-linked+probes+for+protein+and+antibody+labelling+via+reduction+of+native+disulfides&doi=10.1039%2Fb904060a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Practical synthesis of maleimides and coumarin-linked probes for protein and antibody labelling via reduction of native disulfides</span></div><div class="casAuthors">Song, Hong Y.; Ngai, Mun H.; Song, Zhen Y.; MacAry, Paul A.; Hobley, Jonathan; Lear, Martin J.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3400-3406</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The cellular tracking, detection and sensing of protein or antibody movement are important aspects to advance the understanding of biomol. interactions and activity.  Antibodies modified with fluorescent dyes are also valuable tools, esp. in immunol. research.  The authors describe here a proof-of-principle study of a new water-sol. coumarin probe with a maleimide thiol-reacting unit to fluorescently tag biomols.  Highlights include: (1) a convenient water-based prepn. of N-substituted maleimides, (2) a one-pot prepn. of activated maleimido-esters, and (3) a bio-conjugation protocol for the selenol-promoted redn. of native disulfide bonds and the 'site-specific' labeling of antibodies with no significant loss of activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqejqbTih3MJrVg90H21EOLACvtfcHk0lj4WwqeaoM72Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsl2itrw%253D&md5=8dabf1f4827e7b1bafbf7de2c9345fbf</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1039%2Fb904060a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb904060a%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DH.%2BY.%26aulast%3DNgai%26aufirst%3DM.%2BH.%26aulast%3DSong%26aufirst%3DZ.%2BY.%26aulast%3DMacAry%26aufirst%3DP.%2BA.%26aulast%3DHobley%26aufirst%3DJ.%26aulast%3DLear%26aufirst%3DM.%2BJ.%26atitle%3DPractical%2520synthesis%2520of%2520maleimides%2520and%2520coumarin-linked%2520probes%2520for%2520protein%2520and%2520antibody%2520labelling%2520via%2520reduction%2520of%2520native%2520disulfides%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2009%26volume%3D7%26spage%3D3400%26epage%3D3406%26doi%3D10.1039%2Fb904060a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vachon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herz, A.</span></span> <span> </span><span class="NLM_article-title">Opioid receptor desensitization in NG 108-15 cells. Differential effects of a full and a partial agonist on the opioid-dependent GTPase</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">2889</span>– <span class="NLM_lpage">2897</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(87)90199-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1016%2F0006-2952%2887%2990199-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=2820424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADyaL2sXlvFWgsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1987&pages=2889-2897&author=L.+Vachonauthor=T.+Costaauthor=A.+Herz&title=Opioid+receptor+desensitization+in+NG+108-15+cells.+Differential+effects+of+a+full+and+a+partial+agonist+on+the+opioid-dependent+GTPase&doi=10.1016%2F0006-2952%2887%2990199-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Opioid receptor desensitization in NG 108-15 cells.  Differential effects of a full and a partial agonist on the opioid-dependent GTPase</span></div><div class="casAuthors">Vachon, Luc; Costa, Tommaso; Herz, Albert</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2889-97</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">Opioid receptor binding and the opioid-mediated stimulation of low Km GTPase and inhibition of adenylate cyclase were studied in membranes derived from NG 108-15 cells pretreated with either the opioid peptide [L-Ala2,L-Leu5]enkephalin (DADLE) or morphine.  Pretreatment with DADLE resulted in a concn.-dependent loss of responsiveness of GTPase to the peptide; this effect was entirely accounted for by a redn. in the maximal stimulation produced acutely by DADLE, without changes in the 50% effective concn. of the peptide, indicating a non-competitive type of desensitization.  The degree of desensitization of GTPase was similar after 1 and 24 h of pretreatment with DADLE, indicating that the process occurs rapidly.  In contrast, morphine, which was 70-80% as potent as DADLE in stimulating GTPase and inhibiting adenylate cyclase in acute conditions, induced only a minimal desensitization of the opioid-GTPase system and, in contrast to DADLE, did not desensitize adenylate cyclase.  Pretreatment with DADLE for 1 h decreased opioid receptor d. which was quant. similar to the degree of desensitization of GTPase: both these effects of DADLE were antagonized to a similar extent when morphine was also present in the pretreatment.  Thus, desensitization of the opioid-stimulated GTPase appears to be correlated with down-regulation of the opioid receptor.  Moreover, these findings suggest that partial agonists cannot induce this process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs0YtHkrztmbVg90H21EOLACvtfcHk0lj4WwqeaoM72Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXlvFWgsr4%253D&md5=be4ca5176c9c32d4aae6c573608b2dc2</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2887%2990199-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252887%252990199-7%26sid%3Dliteratum%253Aachs%26aulast%3DVachon%26aufirst%3DL.%26aulast%3DCosta%26aufirst%3DT.%26aulast%3DHerz%26aufirst%3DA.%26atitle%3DOpioid%2520receptor%2520desensitization%2520in%2520NG%2520108-15%2520cells.%2520Differential%2520effects%2520of%2520a%2520full%2520and%2520a%2520partial%2520agonist%2520on%2520the%2520opioid-dependent%2520GTPase%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1987%26volume%3D36%26spage%3D2889%26epage%3D2897%26doi%3D10.1016%2F0006-2952%2887%2990199-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neubig, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spedding, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenakin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span> <span> </span><span class="NLM_article-title">International union of pharmacology committee on receptor nomenclature and drug classification. XXXVIII. Update on terms and symbols in quantitative pharmacology</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">597</span>– <span class="NLM_lpage">606</span>, <span class="refDoi"> DOI: 10.1124/pr.55.4.4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1124%2Fpr.55.4.4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=14657418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtlWkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2003&pages=597-606&author=R.+R.+Neubigauthor=M.+Speddingauthor=T.+Kenakinauthor=A.+Christopoulos&title=International+union+of+pharmacology+committee+on+receptor+nomenclature+and+drug+classification.+XXXVIII.+Update+on+terms+and+symbols+in+quantitative+pharmacology&doi=10.1124%2Fpr.55.4.4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology</span></div><div class="casAuthors">Neubig, Richard R.; Spedding, Michael; Kenakin, Terry; Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">597-606</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The recommendations that follow have been updated from the proposals of a Tech. Subcommittee set up by the International Union of Pharmacol. Committee on Receptor Nomenclature and Drug Classification.  International Union of Pharmacol. Committee on Receptor Nomenclature and Drug Classification. IX.  Recommendations on terms and symbols in quant. pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobvkWoNCTvu7Vg90H21EOLACvtfcHk0lj4WwqeaoM72Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtlWkuw%253D%253D&md5=8a467ff5e3812d34d42179491555793d</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1124%2Fpr.55.4.4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.55.4.4%26sid%3Dliteratum%253Aachs%26aulast%3DNeubig%26aufirst%3DR.%2BR.%26aulast%3DSpedding%26aufirst%3DM.%26aulast%3DKenakin%26aufirst%3DT.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DInternational%2520union%2520of%2520pharmacology%2520committee%2520on%2520receptor%2520nomenclature%2520and%2520drug%2520classification.%2520XXXVIII.%2520Update%2520on%2520terms%2520and%2520symbols%2520in%2520quantitative%2520pharmacology%26jtitle%3DPharmacol.%2520Rev.%26date%3D2003%26volume%3D55%26spage%3D597%26epage%3D606%26doi%3D10.1124%2Fpr.55.4.4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kenakin, T. A.</span></span> <i>Pharmacology Primer. Techniques for More Effective and Strategic Drug Discovery</i>, <span class="NLM_edition">4</span>th ed.; <span class="NLM_publisher-name">Elsevier Science Publishing Co Inc.</span>: <span class="NLM_publisher-loc">525 B Street, Suite 1800, San Diego, CA, 92101-4495, USA</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=T.+A.+Kenakin&title=Pharmacology+Primer.+Techniques+for+More+Effective+and+Strategic+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DKenakin%26aufirst%3DT.%2BA.%26btitle%3DPharmacology%2520Primer.%2520Techniques%2520for%2520More%2520Effective%2520and%2520Strategic%2520Drug%2520Discovery%26pub%3DElsevier%2520Science%2520Publishing%2520Co%2520Inc%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pineyro, G.</span></span> <span> </span><span class="NLM_article-title">Practical guide for calculating and representing biased signaling by GPCR ligands: A stepwise approach</span>. <i>Methods</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">78</span>– <span class="NLM_lpage">86</span>, <span class="refDoi"> DOI: 10.1016/j.ymeth.2015.09.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1016%2Fj.ymeth.2015.09.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=26364590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFShsrjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2016&pages=78-86&author=K.+Nagiauthor=G.+Pineyro&title=Practical+guide+for+calculating+and+representing+biased+signaling+by+GPCR+ligands%3A+A+stepwise+approach&doi=10.1016%2Fj.ymeth.2015.09.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Practical guide for calculating and representing biased signaling by GPCR ligands: A stepwise approach</span></div><div class="casAuthors">Nagi, Karim; Pineyro, Graciela</div><div class="citationInfo"><span class="NLM_cas:title">Methods (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">78-86</span>CODEN:
                <span class="NLM_cas:coden">MTHDE9</span>;
        ISSN:<span class="NLM_cas:issn">1046-2023</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Signaling bias makes ref. to the capacity of G-protein coupled receptor (GPCR) ligands to direct pharmacol. stimuli to a subset of effectors among all of those controlled by the receptor.  This new signaling modality has added texture to the classical notion of efficacy.  In doing so, it has opened new avenues for the development of therapeutic GPCR ligands that specifically modulate signals underlying desired effects while sparing those that support undesired drug actions.  Essential to taking advantage of this texture is the ability to identify, quantify and represent bias in a reliable and intuitive manner that ensures comparison among ligands.  Here, we present a practical guide on how the operational model may be used to evaluate ligand efficiency to induce different responses, how differences in response may be used to est. bias and how quant. information derived from this anal. may be graphically represented to recreate a drug's unique signaling footprint.  The approach used is discussed in terms of data interpretation and limitations that may influence the conclusions drawn from the anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs73ewRZinOLVg90H21EOLACvtfcHk0lj6fwh0we_GzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFShsrjI&md5=8f8cf53cb073bdc0815452dc5b231eb0</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.ymeth.2015.09.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ymeth.2015.09.010%26sid%3Dliteratum%253Aachs%26aulast%3DNagi%26aufirst%3DK.%26aulast%3DPineyro%26aufirst%3DG.%26atitle%3DPractical%2520guide%2520for%2520calculating%2520and%2520representing%2520biased%2520signaling%2520by%2520GPCR%2520ligands%253A%2520A%2520stepwise%2520approach%26jtitle%3DMethods%26date%3D2016%26volume%3D92%26spage%3D78%26epage%3D86%26doi%3D10.1016%2Fj.ymeth.2015.09.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 3 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ellen  Gulezian</span>, <span class="hlFld-ContribAuthor ">Christina  Crivello</span>, <span class="hlFld-ContribAuthor ">Janna  Bednenko</span>, <span class="hlFld-ContribAuthor ">Claudia  Zafra</span>, <span class="hlFld-ContribAuthor ">Yihui  Zhang</span>, <span class="hlFld-ContribAuthor ">Paul  Colussi</span>, <span class="hlFld-ContribAuthor ">Sunyia  Hussain</span>. </span><span class="cited-content_cbyCitation_article-title">Membrane protein production and formulation for drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Trends in Pharmacological Sciences</span><span> <strong>2021,</strong> <em>42 </em>
                                    (8)
                                     , 657-674. <a href="https://doi.org/10.1016/j.tips.2021.05.006" title="DOI URL">https://doi.org/10.1016/j.tips.2021.05.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tips.2021.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tips.2021.05.006%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Pharmacological%2520Sciences%26atitle%3DMembrane%252Bprotein%252Bproduction%252Band%252Bformulation%252Bfor%252Bdrug%252Bdiscovery%26aulast%3DGulezian%26aufirst%3DEllen%26date%3D2021%26volume%3D42%26issue%3D8%26spage%3D657%26epage%3D674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joaquim  Azevedo Neto</span>, <span class="hlFld-ContribAuthor ">Chiara  Ruzza</span>, <span class="hlFld-ContribAuthor ">Chiara  Sturaro</span>, <span class="hlFld-ContribAuthor ">Davide  Malfacini</span>, <span class="hlFld-ContribAuthor ">Salvatore  Pacifico</span>, <span class="hlFld-ContribAuthor ">Nurulain T.  Zaveri</span>, <span class="hlFld-ContribAuthor ">Girolamo  Calò</span>. </span><span class="cited-content_cbyCitation_article-title">Functional Selectivity Does Not Predict Antinociceptive/Locomotor Impairing Potencies of NOP Receptor Agonists. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Neuroscience</span><span> <strong>2021,</strong> <em>15 </em><a href="https://doi.org/10.3389/fnins.2021.657153" title="DOI URL">https://doi.org/10.3389/fnins.2021.657153</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnins.2021.657153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnins.2021.657153%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Neuroscience%26atitle%3DFunctional%252BSelectivity%252BDoes%252BNot%252BPredict%252BAntinociceptive%25252FLocomotor%252BImpairing%252BPotencies%252Bof%252BNOP%252BReceptor%252BAgonists%26aulast%3DAzevedo%2BNeto%26aufirst%3DJoaquim%26date%3D2021%26date%3D2021%26volume%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karol  Wtorek</span>, <span class="hlFld-ContribAuthor ">Anna  Janecka</span>. </span><span class="cited-content_cbyCitation_article-title">Potential of Nociceptin/Orphanin FQ Peptide Analogs for Drug Development. </span><span class="cited-content_cbyCitation_journal-name">Chemistry & Biodiversity</span><span> <strong>2021,</strong> <em>18 </em>
                                    (1)
                                     <a href="https://doi.org/10.1002/cbdv.202000871" title="DOI URL">https://doi.org/10.1002/cbdv.202000871</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbdv.202000871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbdv.202000871%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%2526%2520Biodiversity%26atitle%3DPotential%252Bof%252BNociceptin%25252FOrphanin%252BFQ%252BPeptide%252BAnalogs%252Bfor%252BDrug%252BDevelopment%26aulast%3DWtorek%26aufirst%3DKarol%26date%3D2021%26date%3D2020%26volume%3D18%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.9b02057/20210219/images/medium/jm9b02057_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.9b02057/20210219/images/large/jm9b02057_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02057&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.9b02057/20210219/images/medium/jm9b02057_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.9b02057/20210219/images/large/jm9b02057_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-19/acs.jmedchem.9b02057/20210219/images/large/jm9b02057_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b02057&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) NaHCO<sub>3</sub>, CH<sub>3</sub>CN/H<sub>2</sub>O, 5 min; (ii) HATU, DIPEA, DMF, 0 °C to rt, 12 h; (iii) WSC, HOBt, DMF, rt, 3 h; (iv) TFA/H<sub>2</sub>O/triethylsilane, rt, 3 h; and (v) Et<sub>3</sub>N, CH<sub>3</sub>CN, rt, 0.5 h.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i37">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24054" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24054" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 70 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. G.</span></span> <span> </span><span class="NLM_article-title">The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">694</span>– <span class="NLM_lpage">710</span>, <span class="refDoi"> DOI: 10.1038/nrd2572</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1038%2Fnrd2572" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=18670432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptFOqsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=694-710&author=D.+G.+Lambert&title=The+nociceptin%2Forphanin+FQ+receptor%3A+a+target+with+broad+therapeutic+potential&doi=10.1038%2Fnrd2572"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential</span></div><div class="casAuthors">Lambert, David G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">694-710</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In this Review, Lambert describes the physiol. and potential clin. applications of nociceptin/orphanin FQ and its receptor.  This peptide-receptor system has been implicated in a wide range of biol. functions such as pain, drug abuse, cardiovascular control and immunity.  Identification of the enigmatic nociceptin/orphanin FQ peptide (N/OFQ) in 1995 represented the first successful use of reverse pharmacol. and led to deorphanization of the N/OFQ receptor (NOP).  Subsequently, the N/OFQ-NOP system has been implicated in a wide range of biol. functions, including pain, drug abuse, cardiovascular control and immunity.  Although this could be considered a hurdle for the development of pharmaceuticals selective for a specific disease indication, NOP represents a viable drug target.  This article describes potential clin. indications and highlights the current status of the very limited no. of clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuID92HZwUB7Vg90H21EOLACvtfcHk0ljBlefltcVU_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptFOqsL0%253D&md5=46c1952ed4a0ac1aa7779276bda5bba6</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrd2572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2572%26sid%3Dliteratum%253Aachs%26aulast%3DLambert%26aufirst%3DD.%2BG.%26atitle%3DThe%2520nociceptin%252Forphanin%2520FQ%2520receptor%253A%2520a%2520target%2520with%2520broad%2520therapeutic%2520potential%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D694%26epage%3D710%26doi%3D10.1038%2Fnrd2572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Toll, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruchas, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calo’, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaveri, N. T.</span></span> <span> </span><span class="NLM_article-title">Nociceptin/orphanin FQ receptor structure, signaling, ligands, functions, and interactions with opioid systems</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">419</span>– <span class="NLM_lpage">457</span>, <span class="refDoi"> DOI: 10.1124/pr.114.009209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1124%2Fpr.114.009209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=26956246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A280%3ADC%252BC28josFaltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2016&pages=419-457&author=L.+Tollauthor=M.+R.+Bruchasauthor=G.+Calo%E2%80%99author=B.+M.+Coxauthor=N.+T.+Zaveri&title=Nociceptin%2Forphanin+FQ+receptor+structure%2C+signaling%2C+ligands%2C+functions%2C+and+interactions+with+opioid+systems&doi=10.1124%2Fpr.114.009209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems</span></div><div class="casAuthors">Toll Lawrence; Bruchas Michael R; Calo' Girolamo; Cox Brian M; Zaveri Nurulain T</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">419-57</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The NOP receptor (nociceptin/orphanin FQ opioid peptide receptor) is the most recently discovered member of the opioid receptor family and, together with its endogenous ligand, N/OFQ, make up the fourth members of the opioid receptor and opioid peptide family.  Because of its more recent discovery, an understanding of the cellular and behavioral actions induced by NOP receptor activation are less well developed than for the other members of the opioid receptor family.  All of these factors are important because NOP receptor activation has a clear modulatory role on mu opioid receptor-mediated actions and thereby affects opioid analgesia, tolerance development, and reward.  In addition to opioid modulatory actions, NOP receptor activation has important effects on motor function and other physiologic processes.  This review discusses how NOP pharmacology intersects, contrasts, and interacts with the mu opioid receptor in terms of tertiary structure and mechanism of receptor activation; location of receptors in the central nervous system; mechanisms of desensitization and downregulation; cellular actions; intracellular signal transduction pathways; and behavioral actions with respect to analgesia, tolerance, dependence, and reward.  This is followed by a discussion of the agonists and antagonists that have most contributed to our current knowledge.  Because NOP receptors are highly expressed in brain and spinal cord and NOP receptor activation sometimes synergizes with mu receptor-mediated actions and sometimes opposes them, an understanding of NOP receptor pharmacology in the context of these interactions with the opioid receptors will be crucial to the development of novel therapeutics that engage the NOP receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4KujB2a63gCEJCPKhJPuqfW6udTcc2eZ1-oVNsj67Lrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28josFaltw%253D%253D&md5=2a2c601fcd493fa3f67b0adee9259e02</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1124%2Fpr.114.009209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.114.009209%26sid%3Dliteratum%253Aachs%26aulast%3DToll%26aufirst%3DL.%26aulast%3DBruchas%26aufirst%3DM.%2BR.%26aulast%3DCalo%25E2%2580%2599%26aufirst%3DG.%26aulast%3DCox%26aufirst%3DB.%2BM.%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26atitle%3DNociceptin%252Forphanin%2520FQ%2520receptor%2520structure%252C%2520signaling%252C%2520ligands%252C%2520functions%252C%2520and%2520interactions%2520with%2520opioid%2520systems%26jtitle%3DPharmacol.%2520Rev.%26date%3D2016%26volume%3D68%26spage%3D419%26epage%3D457%26doi%3D10.1124%2Fpr.114.009209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Preti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caló, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span> <span> </span><span class="NLM_article-title">NOP-targeted peptide ligands</span>. <i>Handb. Exp. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>254</i></span>,  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">36</span>, <span class="refDoi"> DOI: 10.1007/164_2018_198</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1007%2F164_2018_198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=30689091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmtlGltbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=254&publication_year=2019&pages=17-36&author=D.+Pretiauthor=G.+Cal%C3%B3author=R.+Guerrini&title=NOP-targeted+peptide+ligands&doi=10.1007%2F164_2018_198"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">NOP-Targeted Peptide Ligands</span></div><div class="casAuthors">Preti, Delia; Calo, Girolamo; Guerrini, Remo</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">254</span>
        (<span class="NLM_cas:issue">Nociceptin/Orphanin FQ Peptide Receptor</span>),
    <span class="NLM_cas:pages">17-36</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">1865-0325</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  The nociceptin/orphanin FQ (N/OFQ)-N/OFQ peptide (NOP) receptor system is widely distributed at both the peripheral and central level where it modulates important biol. functions with increasing therapeutic implications.  This chapter wants to provide a comprehensive and updated overview focused on the available structure-activity relationship studies on NOP receptor peptide ligands developed through different rational approaches.  Punctual modifications and cyclizations of the N/OFQ sequence have been properly combined furnishing potent NOP selective ligands with different pharmacol. activities (full and partial agonists, pure antagonists) and enhanced metabolic stability in vivo.  The screening of peptide libraries provided a second family of NOP ligands that have been successfully optimized.  Moreover, recent findings suggest the possibility to apply different multimerization strategies for the realization of multi-target NOP/opioid receptor ligands or tetrabranched N/OFQ derivs. with extraordinarily prolonged duration of action in vivo.  The diverse approaches led to the identification of important pharmacol. tools along with drug candidates currently in clin. development such as Rec 0438 (aka UFP-112) for the treatment of overactive bladder and SER 100 (aka ZP120) for the clin. management of systolic hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0uwIBk5Xr5LVg90H21EOLACvtfcHk0lh5l3XcqxGa5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmtlGltbg%253D&md5=c89a7a0d238db175ec330a0ec2975150</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2F164_2018_198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F164_2018_198%26sid%3Dliteratum%253Aachs%26aulast%3DPreti%26aufirst%3DD.%26aulast%3DCal%25C3%25B3%26aufirst%3DG.%26aulast%3DGuerrini%26aufirst%3DR.%26atitle%3DNOP-targeted%2520peptide%2520ligands%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2019%26volume%3D254%26spage%3D17%26epage%3D36%26doi%3D10.1007%2F164_2018_198" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vardy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapella, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>485</i></span>,  <span class="NLM_fpage">395</span>– <span class="NLM_lpage">399</span>, <span class="refDoi"> DOI: 10.1038/nature11085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1038%2Fnature11085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=22596163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC38XntF2jtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=485&publication_year=2012&pages=395-399&author=A.+A.+Thompsonauthor=W.+Liuauthor=E.+Chunauthor=V.+Katritchauthor=H.+Wuauthor=E.+Vardyauthor=X.-P.+Huangauthor=C.+Trapellaauthor=R.+Guerriniauthor=G.+Caloauthor=B.+L.+Rothauthor=V.+Cherezovauthor=R.+C.+Stevens&title=Structure+of+the+nociceptin%2Forphanin+FQ+receptor+in+complex+with+a+peptide+mimetic&doi=10.1038%2Fnature11085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic</span></div><div class="casAuthors">Thompson, Aaron A.; Liu, Wei; Chun, Eugene; Katritch, Vsevolod; Wu, Huixian; Vardy, Eyal; Huang, Xi-Ping; Trapella, Claudio; Guerrini, Remo; Calo, Girolamo; Roth, Bryan L.; Cherezov, Vadim; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">485</span>
        (<span class="NLM_cas:issue">7398</span>),
    <span class="NLM_cas:pages">395-399</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Members of the opioid receptor family of G-protein-coupled receptors (GPCRs) are found throughout the peripheral and central nervous system, where they have key roles in nociception and analgesia.  Unlike the classical' opioid receptors, δ, κ and μ (δ-OR, κ-OR and μ-OR), which were delineated by pharmacol. criteria in the 1970s and 1980s, the nociceptin/orphanin FQ (N/OFQ) peptide receptor (NOP, also known as ORL-1) was discovered relatively recently by mol. cloning and characterization of an orphan GPCR.  Although it shares high sequence similarity with classical opioid GPCR subtypes (∼60%), NOP has a markedly distinct pharmacol., featuring activation by the endogenous peptide N/OFQ, and unique selectivity for exogenous ligands.  Here we report the crystal structure of human NOP, solved in complex with the peptide mimetic antagonist compd.-24 (C-24), revealing at. details of ligand-receptor recognition and selectivity.  Compd.-24 mimics the first four amino-terminal residues of the NOP-selective peptide antagonist UFP-101, a close deriv. of N/OFQ, and provides important clues to the binding of these peptides.  The x-ray structure also shows substantial conformational differences in the pocket regions between NOP and the classical opioid receptors κ and μ, and these are probably due to a small no. of residues that vary between these receptors.  The NOP-compd.-24 structure explains the divergent selectivity profile of NOP and provides a new structural template for the design of NOP ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq0_U24fZ4r7Vg90H21EOLACvtfcHk0ljhE0w3z9Gfww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntF2jtbk%253D&md5=56819d10685f8a389710e9005d595d5b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnature11085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11085%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DA.%2BA.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DChun%26aufirst%3DE.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DVardy%26aufirst%3DE.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DCalo%26aufirst%3DG.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructure%2520of%2520the%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520in%2520complex%2520with%2520a%2520peptide%2520mimetic%26jtitle%3DNature%26date%3D2012%26volume%3D485%26spage%3D395%26epage%3D399%26doi%3D10.1038%2Fnature11085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapella, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malfacini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caló, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">The importance of ligand-receptor conformational pairs in stabilization: spotlight on the N/OFQ G protein-coupled receptor</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">2291</span>– <span class="NLM_lpage">2299</span>, <span class="refDoi"> DOI: 10.1016/j.str.2015.07.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1016%2Fj.str.2015.07.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=26526853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslGltbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=2291-2299&author=R.+L.+Millerauthor=A.+A.+Thompsonauthor=C.+Trapellaauthor=R.+Guerriniauthor=D.+Malfaciniauthor=N.+Patelauthor=G.+W.+Hanauthor=V.+Cherezovauthor=G.+Cal%C3%B3author=V.+Katritchauthor=R.+C.+Stevens&title=The+importance+of+ligand-receptor+conformational+pairs+in+stabilization%3A+spotlight+on+the+N%2FOFQ+G+protein-coupled+receptor&doi=10.1016%2Fj.str.2015.07.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The Importance of Ligand-Receptor Conformational Pairs in Stabilization: Spotlight on the N/OFQ G Protein-Coupled Receptor</span></div><div class="casAuthors">Miller, Rebecca L.; Thompson, Aaron A.; Trapella, Claudio; Guerrini, Remo; Malfacini, Davide; Patel, Nilkanth; Han, Gye Won; Cherezov, Vadim; Calo, Girolamo; Katritch, Vsevolod; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2291-2299</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Understanding the mechanism by which ligands affect receptor conformational equil. is key in accelerating membrane protein structural biol.  In the case of G protein-coupled receptors (GPCRs), we currently pursue a brute-force approach for identifying ligands that stabilize receptors and facilitate crystallogenesis.  The nociceptin/orphanin FQ peptide receptor (NOP) is a member of the opioid receptor subfamily of GPCRs for which many structurally diverse ligands are available for screening.  We obsd. that antagonist potency is correlated with a ligand's ability to induce receptor stability (Tm) and crystallogenesis.  Using this screening strategy, we solved two structures of NOP in complex with top candidate ligands SB-612111 and C-35.  Docking studies indicate that while potent, stabilizing antagonists strongly favor a single binding orientation, less potent ligands can adopt multiple binding modes, contributing to their low Tm values.  These results suggest a mechanism for ligand-aided crystallogenesis whereby potent antagonists stabilize a single ligand-receptor conformational pair.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZK63i7P2bfLVg90H21EOLACvtfcHk0ljhE0w3z9Gfww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslGltbbL&md5=ba984e9560d38b6a19a48d7fc4b7b231</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2015.07.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2015.07.024%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DR.%2BL.%26aulast%3DThompson%26aufirst%3DA.%2BA.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DMalfacini%26aufirst%3DD.%26aulast%3DPatel%26aufirst%3DN.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DCal%25C3%25B3%26aufirst%3DG.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DThe%2520importance%2520of%2520ligand-receptor%2520conformational%2520pairs%2520in%2520stabilization%253A%2520spotlight%2520on%2520the%2520N%252FOFQ%2520G%2520protein-coupled%2520receptor%26jtitle%3DStructure%26date%3D2015%26volume%3D23%26spage%3D2291%26epage%3D2299%26doi%3D10.1016%2Fj.str.2015.07.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kantola, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheinin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulbrandsen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meland, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smerud, K. T.</span></span> <span> </span><span class="NLM_article-title">Safety, tolerability, and antihypertensive effect of SER100, an opiate receptor-like 1 (ORL-1) partial agonist, in patients with isolated systolic hypertension</span>. <i>Clin. Pharmacol. Drug Dev.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">584</span>– <span class="NLM_lpage">591</span>, <span class="refDoi"> DOI: 10.1002/cpdd.330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1002%2Fcpdd.330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=28032481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslymsLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2017&pages=584-591&author=I.+Kantolaauthor=M.+Scheininauthor=T.+Gulbrandsenauthor=N.+Melandauthor=K.+T.+Smerud&title=Safety%2C+tolerability%2C+and+antihypertensive+effect+of+SER100%2C+an+opiate+receptor-like+1+%28ORL-1%29+partial+agonist%2C+in+patients+with+isolated+systolic+hypertension&doi=10.1002%2Fcpdd.330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, Tolerability, and Antihypertensive Effect of SER100, an Opiate Receptor-Like 1 (ORL-1) Partial Agonist, in Patients With Isolated Systolic Hypertension</span></div><div class="casAuthors">Kantola, Ilkka; Scheinin, Mika; Gulbrandsen, Trygve; Meland, Nils; Smerud, Knut T.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology in Drug Development</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">584-591</span>CODEN:
                <span class="NLM_cas:coden">CPDDAH</span>;
        ISSN:<span class="NLM_cas:issn">2160-7648</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The purpose of the present trial was to evaluate safety, tolerability, and effect on systolic blood pressure (SBP) of SER100 in a small group of patients with isolated systolic hypertension (ISH) in treatment with at least 1 antihypertensive drug.  Eligible patients were randomized to either SER100 (10 mg) or placebo in a crossover design, and 2 doses were given s.c. (SC), 8 h apart, on 2 consecutive days.  On all treatment days patients were monitored with an ambulatory blood pressure measurement device for 12 daytime hours.  Seventeen patients completed treatment.  There were no serious or severe adverse events.  Relative to placebo SER100 induced an av. redn. of SBP during the 2 treatment days of 7.0 mm Hg (P = 0.0032), whereas the av. redn. of diastolic blood pressure (DBP) over the same period was 3.8 mm Hg (P = 0.0011).  For patients with ISH, this short-term cross-over study of SC SER100 demonstrated an acceptable safety profile and consistent, significant lowering of SBP and DBP.  As initial clin. proof of concept for a new class of drugs, a nociceptin agonist peptide, the results were encouraging and warrant further research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ_slehbrn6bVg90H21EOLACvtfcHk0ljhE0w3z9Gfww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslymsLvN&md5=d913f92852f1eb924f0d2cf8e49811df</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fcpdd.330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcpdd.330%26sid%3Dliteratum%253Aachs%26aulast%3DKantola%26aufirst%3DI.%26aulast%3DScheinin%26aufirst%3DM.%26aulast%3DGulbrandsen%26aufirst%3DT.%26aulast%3DMeland%26aufirst%3DN.%26aulast%3DSmerud%26aufirst%3DK.%2BT.%26atitle%3DSafety%252C%2520tolerability%252C%2520and%2520antihypertensive%2520effect%2520of%2520SER100%252C%2520an%2520opiate%2520receptor-like%25201%2520%2528ORL-1%2529%2520partial%2520agonist%252C%2520in%2520patients%2520with%2520isolated%2520systolic%2520hypertension%26jtitle%3DClin.%2520Pharmacol.%2520Drug%2520Dev.%26date%3D2017%26volume%3D6%26spage%3D584%26epage%3D591%26doi%3D10.1002%2Fcpdd.330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Angelico, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barchielli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzeri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calo, G.</span></span> <span> </span><span class="NLM_article-title">Nociceptin/orphanin FQ and urinary bladder</span>. <i>Handb. Exp. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>254</i></span>,  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">365</span>, <span class="refDoi"> DOI: 10.1007/164_2018_182</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1007%2F164_2018_182" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=30430260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmtlGltbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=254&publication_year=2019&pages=347-365&author=P.+Angelicoauthor=M.+Barchielliauthor=M.+Lazzeriauthor=R.+Guerriniauthor=G.+Calo&title=Nociceptin%2Forphanin+FQ+and+urinary+bladder&doi=10.1007%2F164_2018_182"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Nociceptin/Orphanin FQ and Urinary Bladder</span></div><div class="casAuthors">Angelico, Patrizia; Barchielli, Marco; Lazzeri, Massimo; Guerrini, Remo; Calo, Girolamo</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">254</span>
        (<span class="NLM_cas:issue">Nociceptin/Orphanin FQ Peptide Receptor</span>),
    <span class="NLM_cas:pages">347-365</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">1865-0325</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Following identification as the endogenous ligand for the NOP receptor, nociceptin/orphanin FQ (N/OFQ) has been shown to control several biol. functions including the micturition reflex.  N/OFQ elicits a robust inhibitory effect on rat micturition by reducing the excitability of the afferent fibers.  After intravesical administration N/OFQ increases urodynamic bladder capacity and vol. threshold in overactive bladder patients but not in normal subjects.  Moreover daily treatment with intravesical N/OFQ for 10 days significantly reduced urine leakage episodes.  Different chem. modifications were combined into the N/OFQ sequence to generate Rec 0438 (aka UFP-112), a peptide NOP full agonist with high potency and selectivity and long-lasting duration of action.  Rec 0438 mimicked the robust inhibitory effects of N/OFQ on rat micturition reflex; its action is solely due to NOP receptor stimulation, does not show tolerance liability after 2 wk of treatment, and can be elicited by intravesical administration.  Collectively the evidence summarized and discussed in this chapter strongly suggests that NOP agonists are promising innovative drugs to treat overactive bladder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrLANrPTYpKbVg90H21EOLACvtfcHk0lgY3ePDtUokyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmtlGltbY%253D&md5=20a4cc9f7056c78a0bad4e8743cf53f7</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2F164_2018_182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F164_2018_182%26sid%3Dliteratum%253Aachs%26aulast%3DAngelico%26aufirst%3DP.%26aulast%3DBarchielli%26aufirst%3DM.%26aulast%3DLazzeri%26aufirst%3DM.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DCalo%26aufirst%3DG.%26atitle%3DNociceptin%252Forphanin%2520FQ%2520and%2520urinary%2520bladder%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2019%26volume%3D254%26spage%3D347%26epage%3D365%26doi%3D10.1007%2F164_2018_182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. G.</span></span> <span> </span><span class="NLM_article-title">Nociceptin/orphanin FQ receptor ligands and translational challenges: focus on cebranopadol as an innovative analgesic</span>. <i>Br. J. Anaesth.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">1105</span>– <span class="NLM_lpage">1114</span>, <span class="refDoi"> DOI: 10.1016/j.bja.2018.06.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1016%2Fj.bja.2018.06.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=30336855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkvVGjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2018&pages=1105-1114&author=G.+Caloauthor=D.+G.+Lambert&title=Nociceptin%2Forphanin+FQ+receptor+ligands+and+translational+challenges%3A+focus+on+cebranopadol+as+an+innovative+analgesic&doi=10.1016%2Fj.bja.2018.06.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Nociceptin/orphanin FQ receptor ligands and translational challenges: focus on cebranopadol as an innovative analgesic</span></div><div class="casAuthors">Calo, G.; Lambert, D. G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Anaesthesia</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1105-1114</span>CODEN:
                <span class="NLM_cas:coden">BJANAD</span>;
        ISSN:<span class="NLM_cas:issn">1471-6771</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Opioids are characterised as classical (mu, delta, and kappa) along with the non-classical nociceptin/orphanin FQ (N/OFQ) receptor or NOP.  Targeting NOP has therapeutic indications in control of the cardiovascular and respiratory systems and micturition, and a profile as an antidepressant.  For all of these indications, there are translational human data.  Opioids such as morphine and fentanyl (activating the mu receptor) are the mainstay of pain treatment in the perioperative period, despite a challenging side-effect profile.  Opioids in general have poor efficacy in neuropathic pain.  Moreover, longer term use is assocd. with tolerance.  There is good evidence interactions between opioid receptors, and receptor co-activation can reduce side-effects without compromising analgesia; this is particularly true for mu and NOP co-activation.  Recent pharmaceutical development has produced a mixed opioid/NOP agonist, cebranopadol.  This new chem. entity is effective in animal models of nociceptive and neuropathic pain with greater efficacy in the latter.  In animal models, there is little evidence for respiratory depression, and tolerance (compared with morphine) only develops after long treatment periods.  There is now early phase clin. development in diabetic neuropathy, cancer pain, and low back pain where cebranopadol displays significant efficacy.  In 1996, N/OFQ was formally identified with an innovative analgesic profile.  Approx. 20 yr later, cebranopadol as a clin. ligand is advancing through the human trials process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYrn8LanDB8bVg90H21EOLACvtfcHk0lgY3ePDtUokyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkvVGjtg%253D%253D&md5=bcc4df676d94a0250830edd3ea13c74e</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.bja.2018.06.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bja.2018.06.024%26sid%3Dliteratum%253Aachs%26aulast%3DCalo%26aufirst%3DG.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26atitle%3DNociceptin%252Forphanin%2520FQ%2520receptor%2520ligands%2520and%2520translational%2520challenges%253A%2520focus%2520on%2520cebranopadol%2520as%2520an%2520innovative%2520analgesic%26jtitle%3DBr.%2520J.%2520Anaesth.%26date%3D2018%26volume%3D121%26spage%3D1105%26epage%3D1114%26doi%3D10.1016%2Fj.bja.2018.06.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Witkin, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, W. J.</span></span> <span> </span><span class="NLM_article-title">Therapeutic approaches for NOP receptor antagonists in neurobehavioral disorders: clinical studies in major depressive disorder and alcohol use disorder with BTRX-246040 (LY2940094)</span>. <i>Handb. Exp. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>254</i></span>,  <span class="NLM_fpage">399</span>– <span class="NLM_lpage">415</span>, <span class="refDoi"> DOI: 10.1007/164_2018_186</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1007%2F164_2018_186" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=30701317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmtlGltbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=254&publication_year=2019&pages=399-415&author=J.+M.+Witkinauthor=T.+L.+Wallaceauthor=W.+J.+Martin&title=Therapeutic+approaches+for+NOP+receptor+antagonists+in+neurobehavioral+disorders%3A+clinical+studies+in+major+depressive+disorder+and+alcohol+use+disorder+with+BTRX-246040+%28LY2940094%29&doi=10.1007%2F164_2018_186"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic Approaches for NOP Receptor Antagonists in Neurobehavioral Disorders: Clinical Studies in Major Depressive Disorder and Alcohol Use Disorder with BTRX-246040 (LY2940094)</span></div><div class="casAuthors">Witkin, Jeffrey M.; Wallace, Tanya L.; Martin, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">254</span>
        (<span class="NLM_cas:issue">Nociceptin/Orphanin FQ Peptide Receptor</span>),
    <span class="NLM_cas:pages">399-415</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">1865-0325</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  BTRX-246040 (formerly LY2940094) was designed to test this hypothesis in the clinic.  A small clin. proof of concept study demonstrated efficacy of BTRX-246040 in MDD patients.  In this study, BTRX-246040 (40 mg, p.o.) significantly reduced neg. bias as assessed by the facial recognition test within 1 wk of treatment and decreased depression symptoms after 8 wk.  BTRX-246040 also reduced depression symptoms in a second trial with heavy alc. drinkers.  Given the comorbidity of MDD and alc. use disorder, a compd. with such effects in patients could be a valuable addn. to the medications available.  A proof of concept study showed efficacy of BTRX-246040 in reducing heavy drinking and increasing the probability of abstinence in individuals diagnosed with alc. dependence.  In addn., plasma levels of gamma-glutamyl transferase were decreased by BTRX-246040 compared to placebo control implying improvement in liver function.  Collectively, the clin. data reviewed within this chapter suggest that BTRX-264040 functions to normalize dysfunction in reward circuits.  The overall efficacy and safety of this compd. with a novel mechanism of action are encouraging of further clin. development.  BTRX-246040 is currently under development for MDD by BlackThorn Therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeAMk0S5iW1LVg90H21EOLACvtfcHk0lgY3ePDtUokyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmtlGltbo%253D&md5=90e8b039b4d9a375f4d2c8a92f96353e</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2F164_2018_186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F164_2018_186%26sid%3Dliteratum%253Aachs%26aulast%3DWitkin%26aufirst%3DJ.%2BM.%26aulast%3DWallace%26aufirst%3DT.%2BL.%26aulast%3DMartin%26aufirst%3DW.%2BJ.%26atitle%3DTherapeutic%2520approaches%2520for%2520NOP%2520receptor%2520antagonists%2520in%2520neurobehavioral%2520disorders%253A%2520clinical%2520studies%2520in%2520major%2520depressive%2520disorder%2520and%2520alcohol%2520use%2520disorder%2520with%2520BTRX-246040%2520%2528LY2940094%2529%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2019%26volume%3D254%26spage%3D399%26epage%3D415%26doi%3D10.1007%2F164_2018_186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luttrell, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maudsley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohn, L. M.</span></span> <span> </span><span class="NLM_article-title">Fulfilling the promise of “biased” G protein-coupled receptor agonism</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">579</span>– <span class="NLM_lpage">588</span>, <span class="refDoi"> DOI: 10.1124/mol.115.099630</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1124%2Fmol.115.099630" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=26134495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVCgs77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2015&pages=579-588&author=L.+M.+Luttrellauthor=S.+Maudsleyauthor=L.+M.+Bohn&title=Fulfilling+the+promise+of+%E2%80%9Cbiased%E2%80%9D+G+protein-coupled+receptor+agonism&doi=10.1124%2Fmol.115.099630"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Fulfilling the promise of "biased" G protein-coupled receptor agonism</span></div><div class="casAuthors">Luttrell, Louis M.; Maudsley, Stuart; Bohn, Laura M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">579-588</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The fact that over 30% of current pharmaceuticals target hepta-helical G protein-coupled receptors (GPCRs) attests to their tractability as drug targets.  Although GPCR drug development has traditionally focused on conventional agonists and antagonists, the growing appreciation that GPCRs mediate physiol. relevant effects via both G protein and non-G protein effectors has prompted the search for ligands that can "bias" downstream signaling in favor of one or the other process.  Biased ligands are novel entities with distinct signaling profiles dictated by ligand structure, and the potential prospect of biased ligands as better drugs has been pleonastically proclaimed.  Indeed, preclin. proof-of-concept studies have demonstrated that both G protein and arrestin pathway-selective ligands can promote beneficial effects in vivo while simultaneously antagonizing deleterious ones.  But along with opportunity comes added complexity and new challenges for drug discovery.  If ligands can be biased, then ligand classification becomes assay dependent, and more nuanced screening approaches are needed to capture ligand efficacy across several dimensions of signaling.  Moreover, because the signaling repertoire of biased ligands differs from that of the native agonist, unpredicted responses may arise in vivo as these unbalanced signals propagate.  For any given GPCR target, establishing a framework relating in vitro efficacy to in vivo biol. response is crucial to biased drug discovery.  This review discusses approaches to describing ligand efficacy in vitro, translating ligand bias into biol. response, and developing a systems-level understanding of biased agonism in vivo, with the overall goal of overcoming current barriers to developing biased GPCR therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp03ReQ3oHsSbVg90H21EOLACvtfcHk0ljX_Cx0opH9jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVCgs77N&md5=515e0ebeb7147efb48b9eca015905306</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1124%2Fmol.115.099630&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.115.099630%26sid%3Dliteratum%253Aachs%26aulast%3DLuttrell%26aufirst%3DL.%2BM.%26aulast%3DMaudsley%26aufirst%3DS.%26aulast%3DBohn%26aufirst%3DL.%2BM.%26atitle%3DFulfilling%2520the%2520promise%2520of%2520%25E2%2580%259Cbiased%25E2%2580%259D%2520G%2520protein-coupled%2520receptor%2520agonism%26jtitle%3DMol.%2520Pharmacol.%26date%3D2015%26volume%3D88%26spage%3D579%26epage%3D588%26doi%3D10.1124%2Fmol.115.099630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kenakin, T.</span></span> <span> </span><span class="NLM_article-title">New concepts in pharmacological efficacy at 7TM receptors: IUPHAR review 2</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>168</i></span>,  <span class="NLM_fpage">554</span>– <span class="NLM_lpage">575</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2012.02223.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1111%2Fj.1476-5381.2012.02223.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=22994528" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFKhsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2013&pages=554-575&author=T.+Kenakin&title=New+concepts+in+pharmacological+efficacy+at+7TM+receptors%3A+IUPHAR+review+2&doi=10.1111%2Fj.1476-5381.2012.02223.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">New concepts in pharmacological efficacy at 7TM receptors: IUPHAR Review 2</span></div><div class="casAuthors">Kenakin, Terry</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">554-575</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The present-day concept of drug efficacy has changed completely from its original description as the property of agonists that causes tissue activation.  The ability to visualize the multiple behaviors of seven transmembrane receptors has shown that drugs can have many efficacies and also that the transduction of drug stimulus to various cellular stimulus-response cascades can be biased towards some but not all pathways.  This latter effect leads to agonist "functional selectivity", which can be favorable for the improvement of agonist therapeutics.  However, in addn., biased agonist potency becomes cell type dependent with the loss of the monotonic behavior of stimulus-response mechanisms, leading to potential problems in agonist quantification.  This has an extremely important effect on the discovery process for new agonists since it now cannot be assumed that a given screening or lead optimization assay will correctly predict therapeutic behavior.  This review discusses these ideas and how new approaches to quantifying agonist effect may be used to circumvent the cell type dependence of agonism.  This article, written by a corresponding member of the International Union of Basic and Clin. Pharmacol. Committee on Receptor Nomenclature and Drug Classification (NC-IUPHAR), reviews our current understanding of the interaction of ligands with seven transmembrane receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN8xYts-AwKbVg90H21EOLACvtfcHk0ljX_Cx0opH9jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFKhsrc%253D&md5=0cf56bcf1a1ec26d67445795eca9d90b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2012.02223.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2012.02223.x%26sid%3Dliteratum%253Aachs%26aulast%3DKenakin%26aufirst%3DT.%26atitle%3DNew%2520concepts%2520in%2520pharmacological%2520efficacy%2520at%25207TM%2520receptors%253A%2520IUPHAR%2520review%25202%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D168%26spage%3D554%26epage%3D575%26doi%3D10.1111%2Fj.1476-5381.2012.02223.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raehal, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohn, L. M.</span></span> <span> </span><span class="NLM_article-title">Morphine side effects in beta-arrestin 2 knockout mice</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>314</i></span>,  <span class="NLM_fpage">1195</span>– <span class="NLM_lpage">1201</span>, <span class="refDoi"> DOI: 10.1124/jpet.105.087254</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1124%2Fjpet.105.087254" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=15917400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpvFSqsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2005&pages=1195-1201&author=K.+M.+Raehalauthor=J.+K.+L.+Walkerauthor=L.+M.+Bohn&title=Morphine+side+effects+in+beta-arrestin+2+knockout+mice&doi=10.1124%2Fjpet.105.087254"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Morphine side effects in β-arrestin 2 knockout mice</span></div><div class="casAuthors">Raehal, Kirsten M.; Walker, Julia K. L.; Bohn, Laura M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">314</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1195-1201</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Morphine is a potent analgesic, yet, like most opioid narcotics, it exerts unwanted side effects such as constipation and respiratory suppression, thereby limiting its clin. utility.  Pharmacol. approaches taken to preserve the analgesic properties, while eliminating the unwanted side effects, have met with very limited success.  Here, we provide evidence that altering μ opioid receptor regulation may provide a novel approach to discriminate morphine's beneficial and deleterious effects in vivo.  We have previously reported that mice lacking the G protein-coupled receptor regulatory protein, β-arrestin 2, display profoundly altered morphine responses.  β-Arrestin 2 knockout mice have enhanced and prolonged morphine analgesia with very little morphine tolerance.  In this report, we examine whether the side effects of morphine treatment are also augmented in this animal model.  Surprisingly, the genetic disruption of opioid receptor regulation, while enhancing and prolonging analgesia, dramatically attenuates the respiratory suppression and acute constipation caused by morphine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGg-s6s4R0F7Vg90H21EOLACvtfcHk0ljX_Cx0opH9jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpvFSqsLw%253D&md5=0d3696e563ae3a6f6ce2cb2570cbb890</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.087254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.087254%26sid%3Dliteratum%253Aachs%26aulast%3DRaehal%26aufirst%3DK.%2BM.%26aulast%3DWalker%26aufirst%3DJ.%2BK.%2BL.%26aulast%3DBohn%26aufirst%3DL.%2BM.%26atitle%3DMorphine%2520side%2520effects%2520in%2520beta-arrestin%25202%2520knockout%2520mice%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D314%26spage%3D1195%26epage%3D1201%26doi%3D10.1124%2Fjpet.105.087254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bohn, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefkowitz, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gainetdinov, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peppel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, F. T.</span></span> <span> </span><span class="NLM_article-title">Enhanced morphine analgesia in mice lacking beta-arrestin 2</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">2495</span>– <span class="NLM_lpage">2498</span>, <span class="refDoi"> DOI: 10.1126/science.286.5449.2495</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1126%2Fscience.286.5449.2495" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10617462" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmvVKg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=2495-2498&author=L.+M.+Bohnauthor=R.+J.+Lefkowitzauthor=R.+R.+Gainetdinovauthor=K.+Peppelauthor=M.+G.+Caronauthor=F.+T.+Lin&title=Enhanced+morphine+analgesia+in+mice+lacking+beta-arrestin+2&doi=10.1126%2Fscience.286.5449.2495"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced morphine analgesia in mice lacking β-arrestin 2</span></div><div class="casAuthors">Bohn, Laura M.; Lefkowitz, Robert J.; Gainetdinov, Raul R.; Peppel, Karsten; Caron, Marc G.; Lin, Fang-Tsyr</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">5449</span>),
    <span class="NLM_cas:pages">2495-2498</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The ability of morphine to alleviate pain is mediated through a heterotrimeric guanine nucleotide binding protein (G protein)-coupled heptahelical receptor (GPCR), the μ opioid receptor (μOR).  The efficiency of GPCR signaling is tightly regulated and ultimately limited by the coordinated phosphorylation of the receptors by specific GPCR kinases and the subsequent interaction of the phosphorylated receptors with β-arrestin 1 and β-arrestin 2.  Functional deletion of the β-arrestin 2 gene in mice resulted in remarkable potentiation and prolongation of the analgesic effect of morphine, suggesting that μOR desensitization was impaired.  These results provide evidence in vivo for the physiol. importance of β-arrestin 2 in regulating the function of a specific GPCR, the μOR.  Moreover, they suggest that inhibition of β-arrestin 2 function might lead to enhanced analgesic effectiveness of morphine and provide potential new avenues for the study and treatment of pain, narcotic tolerance, and dependence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSeiDXvYdnz7Vg90H21EOLACvtfcHk0lhyQ3vNkWHr4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmvVKg&md5=95f67b133e86422f385d1a7f8165d772</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1126%2Fscience.286.5449.2495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.286.5449.2495%26sid%3Dliteratum%253Aachs%26aulast%3DBohn%26aufirst%3DL.%2BM.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26aulast%3DGainetdinov%26aufirst%3DR.%2BR.%26aulast%3DPeppel%26aufirst%3DK.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26aulast%3DLin%26aufirst%3DF.%2BT.%26atitle%3DEnhanced%2520morphine%2520analgesia%2520in%2520mice%2520lacking%2520beta-arrestin%25202%26jtitle%3DScience%26date%3D1999%26volume%3D286%26spage%3D2495%26epage%3D2498%26doi%3D10.1126%2Fscience.286.5449.2495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siuda, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, R.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rominger, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Violin, J. D.</span></span> <span> </span><span class="NLM_article-title">Biased mu-opioid receptor ligands: a promising new generation of pain therapeutics</span>. <i>Curr. Opin. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">84</span>, <span class="refDoi"> DOI: 10.1016/j.coph.2016.11.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1016%2Fj.coph.2016.11.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=27936408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFKjs73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2017&pages=77-84&author=E.+R.+Siudaauthor=R.+Carrauthor=D.+H.+Romingerauthor=J.+D.+Violin&title=Biased+mu-opioid+receptor+ligands%3A+a+promising+new+generation+of+pain+therapeutics&doi=10.1016%2Fj.coph.2016.11.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Biased mu-opioid receptor ligands: a promising new generation of pain therapeutics</span></div><div class="casAuthors">Siuda, Edward R.; Carr, Richard, III; Rominger, David H.; Violin, Jonathan D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">77-84</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Opioid chem. and biol. occupy a pivotal place in the history of pharmacol. and medicine.  Morphine offers unmatched efficacy in alleviating acute pain, but is also assocd. with a host of adverse side effects.  The advent of biased agonism at G protein-coupled receptors has expanded our understanding of intracellular signaling and highlighted the concept that certain ligands are able to differentially modulate downstream pathways.  The ability to target one pathway over another has allowed for the development of biased ligands with robust clin. efficacy and fewer adverse events.  In this review we summarize these concepts with an emphasis on biased mu opioid receptor pharmacol. and highlight how far opioid pharmacol. has evolved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnIOVY351osLVg90H21EOLACvtfcHk0lhyQ3vNkWHr4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFKjs73K&md5=f261dab2f2940cb828ec2db9f4d67f1c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2016.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2016.11.007%26sid%3Dliteratum%253Aachs%26aulast%3DSiuda%26aufirst%3DE.%2BR.%26aulast%3DCarr%26aufirst%3DR.%26aulast%3DRominger%26aufirst%3DD.%2BH.%26aulast%3DViolin%26aufirst%3DJ.%2BD.%26atitle%3DBiased%2520mu-opioid%2520receptor%2520ligands%253A%2520a%2520promising%2520new%2520generation%2520of%2520pain%2520therapeutics%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2017%26volume%3D32%26spage%3D77%26epage%3D84%26doi%3D10.1016%2Fj.coph.2016.11.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kliewer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmiedel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christie, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, S.</span></span> <span> </span><span class="NLM_article-title">Morphine-induced respiratory depression is independent of beta-arrestin 2 signalling</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>177</i></span>,  <span class="NLM_fpage">2923</span>– <span class="NLM_lpage">2931</span>, <span class="refDoi"> DOI: 10.1111/bph.15004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1111%2Fbph.15004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=32052419" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjtFersLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2020&pages=2923-2931&author=A.+Kliewerauthor=A.+Gillisauthor=R.+Hillauthor=F.+Schmiedelauthor=C.+Baileyauthor=E.+Kellyauthor=G.+Hendersonauthor=M.+J.+Christieauthor=S.+Schulz&title=Morphine-induced+respiratory+depression+is+independent+of+beta-arrestin+2+signalling&doi=10.1111%2Fbph.15004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Morphine-induced respiratory depression is independent of β-arrestin2 signalling</span></div><div class="casAuthors">Kliewer, Andrea; Gillis, Alexander; Hill, Rob; Schmidel, Frank; Bailey, Chris; Kelly, Eamonn; Henderson, Graeme; Christie, MacDonald J.; Schulz, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">177</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2923-2931</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">GPCRs can signal through both G proteins and β-arrestin2.  For the μ-opioid receptor, early exptl. evidence from a single study suggested that G protein signalling mediates analgesia, whereas β-arrestin2 signalling mediates respiratory depression and constipation.  Consequently, for more than a decade, much research effort has been focused on developing biased μ-opioid agonists that preferentially target G protein signalling over β-arrestin signalling, as it was believed that such drugs would be analgesics devoid of respiratory depressant activity.  The present study was set up to re-examine opioid-induced respiratory depression in β-arrestin2 knockout mice.  To this end, a consortium was formed consisting of three different labs. located in different countries to evaluate independently opioid-induced respiratory depression.  Our consensus results unequivocally demonstrate that the prototypical μ-opioid agonist morphine as well as the potent opioid fentanyl do indeed induce respiratory depression and constipation in β-arrestin2 knockout mice in a dose-dependent manner indistinguishable from that obsd. in wild-type mice.  Our findings do not support the original suggestion that β-arrestin2 signalling plays a key role in opioid-induced respiratory depression and call into question the concept of developing G protein-biased μ-opioid receptor agonists as a strategy for the development of safer opioid analgesic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtInyxD8GRBbVg90H21EOLACvtfcHk0lhyQ3vNkWHr4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjtFersLw%253D&md5=7913eb638bb57db9a7ed8d43aab61d48</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1111%2Fbph.15004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.15004%26sid%3Dliteratum%253Aachs%26aulast%3DKliewer%26aufirst%3DA.%26aulast%3DGillis%26aufirst%3DA.%26aulast%3DHill%26aufirst%3DR.%26aulast%3DSchmiedel%26aufirst%3DF.%26aulast%3DBailey%26aufirst%3DC.%26aulast%3DKelly%26aufirst%3DE.%26aulast%3DHenderson%26aufirst%3DG.%26aulast%3DChristie%26aufirst%3DM.%2BJ.%26aulast%3DSchulz%26aufirst%3DS.%26atitle%3DMorphine-induced%2520respiratory%2520depression%2520is%2520independent%2520of%2520beta-arrestin%25202%2520signalling%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2020%26volume%3D177%26spage%3D2923%26epage%3D2931%26doi%3D10.1111%2Fbph.15004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kliewer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmiedel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sianati, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bateman, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levitt, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christie, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, S.</span></span> <span> </span><span class="NLM_article-title">Phosphorylation-deficient G-protein-biased mu-opioid receptors improve analgesia and diminish tolerance but worsen opioid side effects</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">367</span>, <span class="refDoi"> DOI: 10.1038/s41467-018-08162-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1038%2Fs41467-018-08162-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=30664663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC1MXntFeks7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=367&author=A.+Kliewerauthor=F.+Schmiedelauthor=S.+Sianatiauthor=A.+Baileyauthor=J.+T.+Batemanauthor=E.+S.+Levittauthor=J.+T.+Williamsauthor=M.+J.+Christieauthor=S.+Schulz&title=Phosphorylation-deficient+G-protein-biased+mu-opioid+receptors+improve+analgesia+and+diminish+tolerance+but+worsen+opioid+side+effects&doi=10.1038%2Fs41467-018-08162-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation-deficient G-protein-biased mu-opioid receptors improve analgesia and diminish tolerance but worsen opioid side effects</span></div><div class="casAuthors">Kliewer, A.; Schmiedel, F.; Sianati, S.; Bailey, A.; Bateman, J. T.; Levitt, E. S.; Williams, J. T.; Christie, M. J.; Schulz, S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">367</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Opioid analgesics are powerful pain relievers; however, over time, pain control diminishes as analgesic tolerance develops.  The mol. mechanisms initiating tolerance have remained unresolved to date.  We have previously shown that desensitization of the mu-opioid receptor and interaction with beta-arrestins is controlled by carboxyl-terminal phosphorylation.  Here we created knockin mice with a series of serine- and threonine-to-alanine mutations that render the receptor increasingly unable to recruit beta-arrestins.  Desensitization is inhibited in locus coeruleus neurons of mutant mice.  Opioid-induced analgesia is strongly enhanced and analgesic tolerance is greatly diminished.  Surprisingly, respiratory depression, constipation, and opioid withdrawal signs are unchanged or exacerbated, indicating that beta-arrestin recruitment does not contribute to the severity of opioid side effects and, hence, predicting that G-protein-biased mu-agonists are still likely to elicit severe adverse effects.  In conclusion, our findings identify carboxyl-terminal multisite phosphorylation as key step that drives acute mu-opioid receptor desensitization and long-term tolerance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaEj4ARbzSS7Vg90H21EOLACvtfcHk0lg0JSq1gkUv4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXntFeks7k%253D&md5=19fa2354d75d29b28503d21f63754d45</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fs41467-018-08162-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-018-08162-1%26sid%3Dliteratum%253Aachs%26aulast%3DKliewer%26aufirst%3DA.%26aulast%3DSchmiedel%26aufirst%3DF.%26aulast%3DSianati%26aufirst%3DS.%26aulast%3DBailey%26aufirst%3DA.%26aulast%3DBateman%26aufirst%3DJ.%2BT.%26aulast%3DLevitt%26aufirst%3DE.%2BS.%26aulast%3DWilliams%26aufirst%3DJ.%2BT.%26aulast%3DChristie%26aufirst%3DM.%2BJ.%26aulast%3DSchulz%26aufirst%3DS.%26atitle%3DPhosphorylation-deficient%2520G-protein-biased%2520mu-opioid%2520receptors%2520improve%2520analgesia%2520and%2520diminish%2520tolerance%2520but%2520worsen%2520opioid%2520side%2520effects%26jtitle%3DNat.%2520Commun.%26date%3D2019%26volume%3D10%26spage%3D367%26doi%3D10.1038%2Fs41467-018-08162-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gillis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gondin, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kliewer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alamein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manandhar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santiago, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritzwanker, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmiedel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katte, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reekie, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimsey, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassiou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krasel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halls, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christie, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canals, M.</span></span> <span> </span><span class="NLM_article-title">Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists</span>. <i>Sci. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">eaaz3140</span>, <span class="refDoi"> DOI: 10.1126/scisignal.aaz3140</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1126%2Fscisignal.aaz3140" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=32234959" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2020&pages=eaaz3140&author=A.+Gillisauthor=A.+B.+Gondinauthor=A.+Kliewerauthor=J.+Sanchezauthor=H.+D.+Limauthor=C.+Alameinauthor=P.+Manandharauthor=M.+Santiagoauthor=S.+Fritzwankerauthor=F.+Schmiedelauthor=T.+A.+Katteauthor=T.+Reekieauthor=N.+L.+Grimseyauthor=M.+Kassiouauthor=B.+Kellamauthor=C.+Kraselauthor=M.+L.+Hallsauthor=M.+Connorauthor=J.+R.+Laneauthor=S.+Schulzauthor=M.+J.+Christieauthor=M.+Canals&title=Low+intrinsic+efficacy+for+G+protein+activation+can+explain+the+improved+side+effect+profiles+of+new+opioid+agonists&doi=10.1126%2Fscisignal.aaz3140"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.aaz3140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.aaz3140%26sid%3Dliteratum%253Aachs%26aulast%3DGillis%26aufirst%3DA.%26aulast%3DGondin%26aufirst%3DA.%2BB.%26aulast%3DKliewer%26aufirst%3DA.%26aulast%3DSanchez%26aufirst%3DJ.%26aulast%3DLim%26aufirst%3DH.%2BD.%26aulast%3DAlamein%26aufirst%3DC.%26aulast%3DManandhar%26aufirst%3DP.%26aulast%3DSantiago%26aufirst%3DM.%26aulast%3DFritzwanker%26aufirst%3DS.%26aulast%3DSchmiedel%26aufirst%3DF.%26aulast%3DKatte%26aufirst%3DT.%2BA.%26aulast%3DReekie%26aufirst%3DT.%26aulast%3DGrimsey%26aufirst%3DN.%2BL.%26aulast%3DKassiou%26aufirst%3DM.%26aulast%3DKellam%26aufirst%3DB.%26aulast%3DKrasel%26aufirst%3DC.%26aulast%3DHalls%26aufirst%3DM.%2BL.%26aulast%3DConnor%26aufirst%3DM.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DSchulz%26aufirst%3DS.%26aulast%3DChristie%26aufirst%3DM.%2BJ.%26aulast%3DCanals%26aufirst%3DM.%26atitle%3DLow%2520intrinsic%2520efficacy%2520for%2520G%2520protein%2520activation%2520can%2520explain%2520the%2520improved%2520side%2520effect%2520profiles%2520of%2520new%2520opioid%2520agonists%26jtitle%3DSci.%2520Signaling%26date%3D2020%26volume%3D13%26spage%3Deaaz3140%26doi%3D10.1126%2Fscisignal.aaz3140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mascarella, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spangler, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurevich, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarro, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, F. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruchas, M. R.</span></span> <span> </span><span class="NLM_article-title">Quantitative signaling and structure-activity analyses demonstrate functional selectivity at the nociceptin/orphanin FQ opioid receptor</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>88</i></span>,  <span class="NLM_fpage">502</span>– <span class="NLM_lpage">511</span>, <span class="refDoi"> DOI: 10.1124/mol.115.099150</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1124%2Fmol.115.099150" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=26134494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlyktLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2015&pages=502-511&author=S.+D.+Changauthor=S.+W.+Mascarellaauthor=S.+M.+Spanglerauthor=V.+V.+Gurevichauthor=H.+A.+Navarroauthor=F.+I.+Carrollauthor=M.+R.+Bruchas&title=Quantitative+signaling+and+structure-activity+analyses+demonstrate+functional+selectivity+at+the+nociceptin%2Forphanin+FQ+opioid+receptor&doi=10.1124%2Fmol.115.099150"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative signaling and structure-activity analyses demonstrate functional selectivity at the nociceptin/orphanin FQ opioid receptor</span></div><div class="casAuthors">Chang, Steven D.; Mascarella, S. Wayne; Spangler, Skylar M.; Gurevich, Vsevolod V.; Navarro, Hernan A.; Carroll, F. Ivy; Bruchas, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">502-511</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Pancreatic cancer has the lowest 5-yr survival rate of all major cancers despite decades of effort to design and implement novel, more effective treatment options.  In this study, we tested whether the dual phosphoinositide 3-kinase/mechanistic target of rapamycin inhibitor BEZ235 (BEZ) potentiates the antitumor effects of doxorubicin (DOX) against pancreatic cancer.  Cotreatment of BEZ235 with DOX resulted in dose-dependent inhibition of the phosphoinositide 3-kinase/mechanistic target of rapamycin survival pathway, which corresponded with an increase in poly ADP ribose polymerase cleavage.  Moreover, BEZ cotreatment significantly improved the effects of DOX toward both cell viability and cell death in part through reduced Bcl-2 expression and increased expression of the shorter, more cytotoxic forms of BIM.  BEZ also facilitated intracellular accumulation of DOX, which led to enhanced DNA damage and reactive oxygen species generation.  Furthermore, BEZ in combination with gemcitabine reduced MiaPaca2 cell proliferation but failed to increase reactive oxygen species generation or BIM expression, resulting in reduced necrosis and apoptosis.  Treatment with BEZ and DOX in mice bearing tumor xenographs significantly repressed tumor growth as compared with BEZ, DOX, or gemcitabine.  Addnl., in contrast to the enhanced expression seen in MiaPaca2 cells, BEZ and DOX cotreatment reduced BIM expression in H9C2 cardiomyocytes.  Also, the Bcl-2/Bax ratio was increased, which was assocd. with a redn. in cell death.  In vivo echocardiog. showed decreased cardiac function with DOX treatment, which was not improved by combination treatment with BEZ.  Thus, we propose that combining BEZ with DOX would be a better option for patients than current std. of care by providing a more effective tumor response without the assocd. increase in toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowdAZqtUuLx7Vg90H21EOLACvtfcHk0lg0JSq1gkUv4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlyktLrI&md5=2bbd01f7e2c6b21e01a2406b69971eef</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1124%2Fmol.115.099150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.115.099150%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DS.%2BD.%26aulast%3DMascarella%26aufirst%3DS.%2BW.%26aulast%3DSpangler%26aufirst%3DS.%2BM.%26aulast%3DGurevich%26aufirst%3DV.%2BV.%26aulast%3DNavarro%26aufirst%3DH.%2BA.%26aulast%3DCarroll%26aufirst%3DF.%2BI.%26aulast%3DBruchas%26aufirst%3DM.%2BR.%26atitle%3DQuantitative%2520signaling%2520and%2520structure-activity%2520analyses%2520demonstrate%2520functional%2520selectivity%2520at%2520the%2520nociceptin%252Forphanin%2520FQ%2520opioid%2520receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2015%26volume%3D88%26spage%3D502%26epage%3D511%26doi%3D10.1124%2Fmol.115.099150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malfacini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambrosio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gro’, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sbraccia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapella, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonora, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinton, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calo’, G.</span></span> <span> </span><span class="NLM_article-title">Pharmacological profile of nociceptin/orphanin FQ receptors interacting with G-proteins and beta-arrestins 2</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">e0132865</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0132865</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1371%2Fjournal.pone.0132865" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=26248189" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFOisrzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=e0132865&author=D.+Malfaciniauthor=C.+Ambrosioauthor=M.+C.+Gro%E2%80%99author=M.+Sbracciaauthor=C.+Trapellaauthor=R.+Guerriniauthor=M.+Bonoraauthor=P.+Pintonauthor=T.+Costaauthor=G.+Calo%E2%80%99&title=Pharmacological+profile+of+nociceptin%2Forphanin+FQ+receptors+interacting+with+G-proteins+and+beta-arrestins+2&doi=10.1371%2Fjournal.pone.0132865"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological profile of nociceptin/orphanin FQ receptors interacting with G-proteins and β-arrestins 2</span></div><div class="casAuthors">Malfacini, D.; Ambrosio, C.; Gro, M. C.; Sbraccia, M.; Trapella, C.; Guerrini, R.; Bonora, M.; Pinton, P.; Costa, T.; Calo, G.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e0132865/1-e0132865/22</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Nociceptin/orphanin FQ (N/OFQ) controls several biol. functions by selectively activating an opioid like receptor named N/OFQ peptide receptor (NOP).  Biased agonism is emerging as an important and therapeutically relevant pharmacol. concept in the field of G protein coupled receptors including opioids.  To evaluate the relevance of this phenomenon in the NOP receptor, we used a bioluminescence resonance energy transfer technol. to measure the interactions of the NOP receptor with either G proteins or β-arrestin 2 in the absence and in presence of increasing concn. of ligands.  A large panel of receptor ligands was investigated by comparing their ability to promote or block NOP/G protein and NOP/arrestin interactions.  In this study we report a systematic anal. of the functional selectivity of NOP receptor ligands.  NOP/G protein interactions (investigated in cell membranes) allowed a precise estn. of both ligand potency and efficacy yielding data highly consistent with the known pharmacol. profile of this receptor.  The same panel of ligands displayed marked differences in the ability to promote NOP/β-arrestin 2 interactions (evaluated in whole cells).  In particular, full agonists displayed a general lower potency and for some ligands an inverted rank order of potency was noted.  Most partial agonists behaved as pure competitive antagonists of receptor/arrestin interaction.  Antagonists displayed similar values of potency for NOP/Gβ1 or NOP/β-arrestin 2 interaction.  Using N/OFQ as ref. ligand we computed the bias factors of NOP ligands and a no. of agonists with greater efficacy at G protein coupling were identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfT4SDzCFVILVg90H21EOLACvtfcHk0lgkZUdbrQifqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFOisrzP&md5=59067ccbe7155469015db1132c0e12cb</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0132865&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0132865%26sid%3Dliteratum%253Aachs%26aulast%3DMalfacini%26aufirst%3DD.%26aulast%3DAmbrosio%26aufirst%3DC.%26aulast%3DGro%25E2%2580%2599%26aufirst%3DM.%2BC.%26aulast%3DSbraccia%26aufirst%3DM.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DBonora%26aufirst%3DM.%26aulast%3DPinton%26aufirst%3DP.%26aulast%3DCosta%26aufirst%3DT.%26aulast%3DCalo%25E2%2580%2599%26aufirst%3DG.%26atitle%3DPharmacological%2520profile%2520of%2520nociceptin%252Forphanin%2520FQ%2520receptors%2520interacting%2520with%2520G-proteins%2520and%2520beta-arrestins%25202%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26spage%3De0132865%26doi%3D10.1371%2Fjournal.pone.0132865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moulédous, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Froment, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dasgupta, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Günther, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunori, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieffer, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toll, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruchas, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaveri, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, S.</span></span> <span> </span><span class="NLM_article-title">Agonist-selective NOP receptor phosphorylation correlates in vitro and in vivo and reveals differential post-activation signaling by chemically diverse agonists</span>. <i>Sci. Signaling</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">eaau8072</span>, <span class="refDoi"> DOI: 10.1126/scisignal.aau8072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1126%2Fscisignal.aau8072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=30914485" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2019&pages=eaau8072&author=A.+Mannauthor=L.+Moul%C3%A9dousauthor=C.+Fromentauthor=P.+R.+O%E2%80%99Neillauthor=P.+Dasguptaauthor=T.+G%C3%BCntherauthor=G.+Brunoriauthor=B.+L.+Kiefferauthor=L.+Tollauthor=M.+R.+Bruchasauthor=N.+T.+Zaveriauthor=S.+Schulz&title=Agonist-selective+NOP+receptor+phosphorylation+correlates+in+vitro+and+in+vivo+and+reveals+differential+post-activation+signaling+by+chemically+diverse+agonists&doi=10.1126%2Fscisignal.aau8072"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.aau8072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.aau8072%26sid%3Dliteratum%253Aachs%26aulast%3DMann%26aufirst%3DA.%26aulast%3DMoul%25C3%25A9dous%26aufirst%3DL.%26aulast%3DFroment%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DP.%2BR.%26aulast%3DDasgupta%26aufirst%3DP.%26aulast%3DG%25C3%25BCnther%26aufirst%3DT.%26aulast%3DBrunori%26aufirst%3DG.%26aulast%3DKieffer%26aufirst%3DB.%2BL.%26aulast%3DToll%26aufirst%3DL.%26aulast%3DBruchas%26aufirst%3DM.%2BR.%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26aulast%3DSchulz%26aufirst%3DS.%26atitle%3DAgonist-selective%2520NOP%2520receptor%2520phosphorylation%2520correlates%2520in%2520vitro%2520and%2520in%2520vivo%2520and%2520reveals%2520differential%2520post-activation%2520signaling%2520by%2520chemically%2520diverse%2520agonists%26jtitle%3DSci.%2520Signaling%26date%3D2019%26volume%3D12%26spage%3Deaau8072%26doi%3D10.1126%2Fscisignal.aau8072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Asth, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzza, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malfacini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medeiros, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaveri, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavioli, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calo’, G.</span></span> <span> </span><span class="NLM_article-title">Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic-versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">434</span>– <span class="NLM_lpage">442</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2016.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1016%2Fj.neuropharm.2016.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=26867504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC28XivFKiur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2016&pages=434-442&author=L.+Asthauthor=C.+Ruzzaauthor=D.+Malfaciniauthor=I.+Medeirosauthor=R.+Guerriniauthor=N.+T.+Zaveriauthor=E.+C.+Gavioliauthor=G.+Calo%E2%80%99&title=Beta-arrestin+2+rather+than+G+protein+efficacy+determines+the+anxiolytic-versus+antidepressant-like+effects+of+nociceptin%2Forphanin+FQ+receptor+ligands&doi=10.1016%2Fj.neuropharm.2016.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic-versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands</span></div><div class="casAuthors">Asth, L.; Ruzza, C.; Malfacini, D.; Medeiros, I.; Guerrini, R.; Zaveri, N. T.; Gavioli, E. C.; Calo, G.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">434-442</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nociceptin/orphanin FQ (N/OFQ) receptor (NOP) agonists produce anxiolytic-like effects in rodents while antagonists promote antidepressant-like effects.  The aim of this study was to investigate the effect on anxiety and depression of NOP receptor partial agonists such as the peptides [F/G]N/OFQ(1-13)NH2 and UFP-113 and the non-peptide AT-090.  In vitro AT-090, UFP-113, and [F/G]N/OFQ(1-13)NH2 were tested for their ability to promote NOP/G-protein and NOP/β-arrestin 2 interaction, using a bioluminescence resonance energy transfer assay.  In vivo, they were tested in mice in the elevated plus maze (EPM) and in the forced swim (FST) tests.  NOP partial agonists effects were systematically compared to those of full agonists (N/OFQ and Ro 65-6570) and antagonists (UFP-101 and SB-612111).  In vitro, AT-090, UFP-113, and [F/G]N/OFQ(1-13)NH2 promoted NOP/G protein interaction, with maximal effects lower than those evoked by N/OFQ and Ro 65-6570.  AT-090 behaved as a NOP partial agonist also in inducing β-arrestin 2 recruitment, while UFP-113 and [F/G]N/OFQ(1-13)NH2 were inactive in this assay.  In vivo, AT-090 induced anxiolytic-like effects in the EPM but was inactive in the FST.  Opposite results were obtained with UFP-113 and [F/G]N/OFQ(1-13)NH2.  NOP ligands producing similar effects on NOP/G protein interaction (partial agonism) but showing different effects on β-arrestin 2 recruitment (partial agonism vs antagonism) elicited different actions on anxiety and mood.  These results suggest that the action of a NOP ligand on emotional states is better predicted based on its β-arrestin 2 rather than G-protein efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBoIUIFuXBjbVg90H21EOLACvtfcHk0lgkZUdbrQifqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XivFKiur8%253D&md5=07a5cd55a63a1822dc51970fe99e52f1</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2016.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2016.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DAsth%26aufirst%3DL.%26aulast%3DRuzza%26aufirst%3DC.%26aulast%3DMalfacini%26aufirst%3DD.%26aulast%3DMedeiros%26aufirst%3DI.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26aulast%3DGavioli%26aufirst%3DE.%2BC.%26aulast%3DCalo%25E2%2580%2599%26aufirst%3DG.%26atitle%3DBeta-arrestin%25202%2520rather%2520than%2520G%2520protein%2520efficacy%2520determines%2520the%2520anxiolytic-versus%2520antidepressant-like%2520effects%2520of%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520ligands%26jtitle%3DNeuropharmacology%26date%3D2016%26volume%3D105%26spage%3D434%26epage%3D442%26doi%3D10.1016%2Fj.neuropharm.2016.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calò, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neugebauer, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvadori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regoli, D.</span></span> <span> </span><span class="NLM_article-title">The mouse vas deferens: a pharmacological preparation sensitive to nociceptin</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>311</i></span>,  <span class="NLM_fpage">R3</span>– <span class="NLM_lpage">R5</span>, <span class="refDoi"> DOI: 10.1016/0014-2999(96)00563-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1016%2F0014-2999%2896%2900563-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=8884244" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADyaK28XlsFWks78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=1996&pages=R3-R5&author=G.+Cal%C3%B2author=A.+Rizziauthor=G.+Bogoniauthor=V.+Neugebauerauthor=S.+Salvadoriauthor=R.+Guerriniauthor=C.+Bianchiauthor=D.+Regoli&title=The+mouse+vas+deferens%3A+a+pharmacological+preparation+sensitive+to+nociceptin&doi=10.1016%2F0014-2999%2896%2900563-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The mouse vas deferens: a pharmacological preparation sensitive to nociceptin</span></div><div class="casAuthors">Calo, Girolamo; Rizzi, Anna; Bogoni, Giovanni; Neugebauer, Vitold; Salvadori, Severo; Guerrini, Remo; Bianchi, Clementina; Regoli, Domenico</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">311</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">R3-R5</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The newly discovered neuropeptide, nociceptin (alias orphanin FQ), was tested for its potential direct effects, as well as for its ability to modify the elec. evoked contractions in several isolated organs suspended in vitro.  The elec. stimulated mouse vas deferens is a sensitive prepn. on which nociceptin exerts an inhibitory effect which is not affected by naloxone.  The mouse vas deferens is therefore proposed as a bioassay for nociceptin and related compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWqLkwn2Toz7Vg90H21EOLACvtfcHk0lgkZUdbrQifqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlsFWks78%253D&md5=3da5c3c35fc524d2b26dd1c1d359e594</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2896%2900563-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252896%252900563-8%26sid%3Dliteratum%253Aachs%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DBogoni%26aufirst%3DG.%26aulast%3DNeugebauer%26aufirst%3DV.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DBianchi%26aufirst%3DC.%26aulast%3DRegoli%26aufirst%3DD.%26atitle%3DThe%2520mouse%2520vas%2520deferens%253A%2520a%2520pharmacological%2520preparation%2520sensitive%2520to%2520nociceptin%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1996%26volume%3D311%26spage%3DR3%26epage%3DR5%26doi%3D10.1016%2F0014-2999%2896%2900563-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Molinari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vezzi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sbraccia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grò, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riitano, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambrosio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casella, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, T.</span></span> <span> </span><span class="NLM_article-title">Morphine-like opiates selectively antagonize receptor-arrestin interactions</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">12522</span>– <span class="NLM_lpage">12535</span>, <span class="refDoi"> DOI: 10.1074/jbc.m109.059410</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1074%2Fjbc.M109.059410" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=20189994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvVGjtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=12522-12535&author=P.+Molinariauthor=V.+Vezziauthor=M.+Sbracciaauthor=C.+Gr%C3%B2author=D.+Riitanoauthor=C.+Ambrosioauthor=I.+Casellaauthor=T.+Costa&title=Morphine-like+opiates+selectively+antagonize+receptor-arrestin+interactions&doi=10.1074%2Fjbc.m109.059410"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Morphine-like Opiates Selectively Antagonize Receptor-Arrestin Interactions</span></div><div class="casAuthors">Molinari, Paola; Vezzi, Vanessa; Sbraccia, Maria; Gro, Cristina; Riitano, Daniela; Ambrosio, Caterina; Casella, Ida; Costa, Tommaso</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">12522-12535</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The addictive potential of opioids may be related to their differential ability to induce G protein signaling and endocytosis.  We compared the ability of 20 ligands (sampled from the main chem. classes of opioids) to promote the assocn. of μ and δ receptors with G protein or β-arrestin 2.  Receptor-arrestin binding was monitored by bioluminescence resonance energy transfer (BRET) in intact cells, where pertussis toxin expts. indicated that the interaction was minimally affected by receptor signaling.  To assess receptor-G protein coupling without competition from arrestins, we employed a cell-free BRET assay using membranes isolated from cells expressing luminescent receptors and fluorescent Gβ1.  In this system, the agonist-induced enhancement of BRET (indicating shortening of distance between the two proteins) was Gα-mediated (as shown by sensitivity to pertussis toxin and guanine nucleotides) and yielded data consistent with the known pharmacol. of the ligands.  We found marked differences of efficacy for G protein and arrestin, with a pattern suggesting more restrictive structural requirements for arrestin efficacy.  The anal. of such differences identified a subset of structures showing a marked discrepancy between efficacies for G protein and arrestin.  Addictive opiates like morphine and oxymorphone exhibited large differences both at δ and μ receptors.  Thus, they were effective agonists for G protein coupling but acted as competitive enkephalins antagonists (δ) or partial agonists (μ) for arrestin.  This arrestin-selective antagonism resulted in inhibition of short and long term events mediated by arrestin, such as rapid receptor internalization and down-regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgITOiZm3ElrVg90H21EOLACvtfcHk0ljT2KgT6aFlhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvVGjtL0%253D&md5=9e7042df0124343705535806173d7247</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.059410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.059410%26sid%3Dliteratum%253Aachs%26aulast%3DMolinari%26aufirst%3DP.%26aulast%3DVezzi%26aufirst%3DV.%26aulast%3DSbraccia%26aufirst%3DM.%26aulast%3DGr%25C3%25B2%26aufirst%3DC.%26aulast%3DRiitano%26aufirst%3DD.%26aulast%3DAmbrosio%26aufirst%3DC.%26aulast%3DCasella%26aufirst%3DI.%26aulast%3DCosta%26aufirst%3DT.%26atitle%3DMorphine-like%2520opiates%2520selectively%2520antagonize%2520receptor-arrestin%2520interactions%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D12522%26epage%3D12535%26doi%3D10.1074%2Fjbc.m109.059410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerlesi, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzza, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malfacini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianco, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapella, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calo’, G.</span></span> <span> </span><span class="NLM_article-title">Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonist</span>. <i>Pharmacol. Res. Perspect.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">e00247</span>, <span class="refDoi"> DOI: 10.1002/prp2.247</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1002%2Fprp2.247" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=28116100" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2016&pages=e00247&author=A.+Rizziauthor=M.+C.+Cerlesiauthor=C.+Ruzzaauthor=D.+Malfaciniauthor=F.+Ferrariauthor=S.+Biancoauthor=T.+Costaauthor=R.+Guerriniauthor=C.+Trapellaauthor=G.+Calo%E2%80%99&title=Pharmacological+characterization+of+cebranopadol+a+novel+analgesic+acting+as+mixed+nociceptin%2Forphanin+FQ+and+opioid+receptor+agonist&doi=10.1002%2Fprp2.247"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fprp2.247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprp2.247%26sid%3Dliteratum%253Aachs%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DCerlesi%26aufirst%3DM.%2BC.%26aulast%3DRuzza%26aufirst%3DC.%26aulast%3DMalfacini%26aufirst%3DD.%26aulast%3DFerrari%26aufirst%3DF.%26aulast%3DBianco%26aufirst%3DS.%26aulast%3DCosta%26aufirst%3DT.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DCalo%25E2%2580%2599%26aufirst%3DG.%26atitle%3DPharmacological%2520characterization%2520of%2520cebranopadol%2520a%2520novel%2520analgesic%2520acting%2520as%2520mixed%2520nociceptin%252Forphanin%2520FQ%2520and%2520opioid%2520receptor%2520agonist%26jtitle%3DPharmacol.%2520Res.%2520Perspect.%26date%3D2016%26volume%3D4%26spage%3De00247%26doi%3D10.1002%2Fprp2.247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bird, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cerlesi, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malfacini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vezzi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molinari, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micheli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mannelli, L. D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghelardini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calò, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. G.</span></span> <span> </span><span class="NLM_article-title">Characterisation of the novel mixed mu-NOP peptide ligand dermorphin-N/OFQ (DeNo)</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">e0156897</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0156897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1371%2Fjournal.pone.0156897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=27272042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslCqu7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=e0156897&author=M.+F.+Birdauthor=M.+C.+Cerlesiauthor=M.+Brownauthor=D.+Malfaciniauthor=V.+Vezziauthor=P.+Molinariauthor=L.+Micheliauthor=L.+D.+C.+Mannelliauthor=C.+Ghelardiniauthor=R.+Guerriniauthor=G.+Cal%C3%B2author=D.+G.+Lambert&title=Characterisation+of+the+novel+mixed+mu-NOP+peptide+ligand+dermorphin-N%2FOFQ+%28DeNo%29&doi=10.1371%2Fjournal.pone.0156897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Characterisation of the novel mixed mu-NOP peptide ligand dermorphin-N/OFQ (DeNo)</span></div><div class="casAuthors">Bird, Mark F.; Cerlesi, Maria Camilla; Brown, Mark; Malfacini, Davide; Vezzi, Vanessa; Molinari, Paola; Micheli, Laura; Mannelli, Lorenzo Di Cesare; Ghelardini, Carla; Guerrini, Remo; Calo, Girolamo; Lambert, David G.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e0156897/1-e0156897/22</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Introduction Opioid receptors are currently classified as Mu (μ), Delta (δ), Kappa (κ) plus the opioid related nociceptin/orphanin FQ (N/OFQ) peptide receptor (NOP).  Despite compelling evidence for interactions and benefits of targeting more than one receptor type in producing analgesia, clin. ligands are Mu agonists.  In this study we have designed a Mu-NOP agonist named DeNo.  The Mu agonist component is provided by dermorphin, a peptide isolated from the skin of Phyllomedusa frogs and the NOP component by the endogenous agonist N/OFQ.  Methods We have assessed receptor binding profile of DeNo and compared with dermorphin and N/ OFQ.  In a series of functional screens we have assessed the ability to (i) increase Ca2+ in cells coexpressing recombinant receptors and a the chimeric protein Gαqi5, (ii) stimulate the binding of GTPγ[35S], (iii) inhibit cAMP formation, (iv) activate MAPKinase, (v) stimulate receptor-G protein and arrestin interaction using BRET, (vi) elec. stimulated guinea pig ileum (gpI) assay and (vii) ability to produce analgesia via the intrathecal route in rats.  Results DeNo bound to Mu (pKi; 9.55) and NOP (pKi; 10.22) and with reasonable selectivity.  This translated to increased Ca2+ in Gαqi5 expressing cells (pEC50 Mu 7.17; NOP 9.69), increased binding of GTPγ[35S] (pEC50 Mu 7.70; NOP 9.50) and receptor-G protein interaction in BRET (pEC50 Mu 8.01; NOP 9.02). cAMP formation was inhibited and arrestin was activated (pEC50 Mu 6.36; NOP 8.19).  For MAPK DeNo activated p38 and ERK1/2 at Mu but only ERK1/2 at NOP.  In the gpI DeNO inhibited elec.-evoked contractions (pEC50 8.63) that was sensitive to both Mu and NOP antagonists.  DeNo was antinociceptive in rats.  Conclusion Collectively these data validate the strategy used to create a novel bivalent Mu-NOP peptide agonist by combining dermorphin (Mu) and N/OFQ (NOP).  This mol. behaves essentially as the parent compds. in vitro.  In the antonocicoeptive assays employed in this study DeNo displays only weak antinociceptive properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGf0rqpcJ8OrVg90H21EOLACvtfcHk0ljT2KgT6aFlhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslCqu7nI&md5=5e929f3870f21dc463ccc60417dc59bd</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0156897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0156897%26sid%3Dliteratum%253Aachs%26aulast%3DBird%26aufirst%3DM.%2BF.%26aulast%3DCerlesi%26aufirst%3DM.%2BC.%26aulast%3DBrown%26aufirst%3DM.%26aulast%3DMalfacini%26aufirst%3DD.%26aulast%3DVezzi%26aufirst%3DV.%26aulast%3DMolinari%26aufirst%3DP.%26aulast%3DMicheli%26aufirst%3DL.%26aulast%3DMannelli%26aufirst%3DL.%2BD.%2BC.%26aulast%3DGhelardini%26aufirst%3DC.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26atitle%3DCharacterisation%2520of%2520the%2520novel%2520mixed%2520mu-NOP%2520peptide%2520ligand%2520dermorphin-N%252FOFQ%2520%2528DeNo%2529%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26spage%3De0156897%26doi%3D10.1371%2Fjournal.pone.0156897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cerlesi, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bird, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiguchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malfacini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzza, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span> <span> </span><span class="NLM_article-title">Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt<sup>1</sup>]N/OFQ(1-13)</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>794</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">126</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2016.11.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1016%2Fj.ejphar.2016.11.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=27871910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFGgtLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=794&publication_year=2017&pages=115-126&author=M.+C.+Cerlesiauthor=H.+Dingauthor=M.+F.+Birdauthor=N.+Kiguchiauthor=F.+Ferrariauthor=D.+Malfaciniauthor=A.+Rizziauthor=C.+Ruzzaauthor=D.+G.+Lambertauthor=M.-C.+Koauthor=G.+Caloauthor=R.+Guerrini&title=Pharmacological+studies+on+the+NOP+and+opioid+receptor+agonist+PWT2-%5BDmt1%5DN%2FOFQ%281-13%29&doi=10.1016%2Fj.ejphar.2016.11.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt1]N/OFQ(1-13)</span></div><div class="casAuthors">Cerlesi, Maria Camilla; Ding, Huiping; Bird, Mark F.; Kiguchi, Norikazu; Ferrari, Federica; Malfacini, Davide; Rizzi, Anna; Ruzza, Chiara; Lambert, David G.; Ko, Mei-Chuan; Calo, Girolamo; Guerrini, Remo</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">794</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">115-126</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">An innovative chem. strategy named peptide welding technol. (PWT) has been developed for the facile synthesis of tetrabranched peptides. [Dmt1]N/OFQ(1-13)-NH2 acts as a universal agonist for nociceptin/orphanin FQ (N/OFQ) and classical opioid receptors.  The present study investigated the pharmacol. profile of the PWT deriv. of [Dmt1]N/OFQ(1-13)NH2 (PWT2-[Dmt1]) in several assays in vitro and in vivo after spinal administration in monkeys subjected to the tail withdrawal assay.  PWT2-[Dmt1] mimicked the effects of [Dmt1]N/OFQ(1-13)-NH2 displaying full agonist activity, similar affinity/potency and selectivity at human recombinant N/OFQ (NOP) and opioid receptors in receptor binding, stimulation of [35S]GTPγS binding, calcium mobilization in cells expressing chimeric G proteins, and BRET studies for measuring receptor/G-protein and receptor/β-arrestin 2 interaction.  In vivo in monkeys PWT2-[Dmt1] elicited dose-dependent and robust antinociceptive effects being more potent and longer lasting than [Dmt1]N/OFQ(1-13)-NH2.  The analgesic action of PWT2-[Dmt1] was sensitive to the NOP receptor antagonist J-113397, but not naltrexone.  Thus, the present study demonstrated that the tetrabranched deriv. of [Dmt1]N/OFQ(1-13)-NH2 obtained with the PWT technol. maintains the in vitro pharmacol. profile of the parent peptide but displays higher potency and longer lasting action in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaU2tLfW3W0LVg90H21EOLACvtfcHk0liVjr2YVNGqEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFGgtLfI&md5=972be07440d904aa7463e15506271d23</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2016.11.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2016.11.026%26sid%3Dliteratum%253Aachs%26aulast%3DCerlesi%26aufirst%3DM.%2BC.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DBird%26aufirst%3DM.%2BF.%26aulast%3DKiguchi%26aufirst%3DN.%26aulast%3DFerrari%26aufirst%3DF.%26aulast%3DMalfacini%26aufirst%3DD.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DRuzza%26aufirst%3DC.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26aulast%3DKo%26aufirst%3DM.-C.%26aulast%3DCalo%26aufirst%3DG.%26aulast%3DGuerrini%26aufirst%3DR.%26atitle%3DPharmacological%2520studies%2520on%2520the%2520NOP%2520and%2520opioid%2520receptor%2520agonist%2520PWT2-%255BDmt1%255DN%252FOFQ%25281-13%2529%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2017%26volume%3D794%26spage%3D115%26epage%3D126%26doi%3D10.1016%2Fj.ejphar.2016.11.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malfacini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Journigan, B. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bird, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapella, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calo’, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaveri, N. T.</span></span> <span> </span><span class="NLM_article-title">In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403</span>. <i>Pharmacol. Res. Perspect.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">e00333</span>, <span class="refDoi"> DOI: 10.1002/prp2.333</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1002%2Fprp2.333" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2017&pages=e00333&author=F.+Ferrariauthor=D.+Malfaciniauthor=B.+V.+Journiganauthor=M.+F.+Birdauthor=C.+Trapellaauthor=R.+Guerriniauthor=D.+G.+Lambertauthor=G.+Calo%E2%80%99author=N.+T.+Zaveri&title=In+vitro+pharmacological+characterization+of+a+novel+unbiased+NOP+receptor-selective+nonpeptide+agonist+AT-403&doi=10.1002%2Fprp2.333"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fprp2.333&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprp2.333%26sid%3Dliteratum%253Aachs%26aulast%3DFerrari%26aufirst%3DF.%26aulast%3DMalfacini%26aufirst%3DD.%26aulast%3DJournigan%26aufirst%3DB.%2BV.%26aulast%3DBird%26aufirst%3DM.%2BF.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26aulast%3DCalo%25E2%2580%2599%26aufirst%3DG.%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26atitle%3DIn%2520vitro%2520pharmacological%2520characterization%2520of%2520a%2520novel%2520unbiased%2520NOP%2520receptor-selective%2520nonpeptide%2520agonist%2520AT-403%26jtitle%3DPharmacol.%2520Res.%2520Perspect.%26date%3D2017%26volume%3D5%26spage%3De00333%26doi%3D10.1002%2Fprp2.333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kenakin, T.</span></span> <span> </span><span class="NLM_article-title">Biased receptor signaling in drug discovery</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">267</span>– <span class="NLM_lpage">315</span>, <span class="refDoi"> DOI: 10.1124/pr.118.016790</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1124%2Fpr.118.016790" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=30914442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvV2gtL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2019&pages=267-315&author=T.+Kenakin&title=Biased+receptor+signaling+in+drug+discovery&doi=10.1124%2Fpr.118.016790"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Biased receptor signaling in drug discovery</span></div><div class="casAuthors">Kenakin, Terry</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">267-315</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  A great deal of exptl. evidence suggests that ligands can stabilize different receptor active states that go on to interact with cellular signaling proteins to form a range of different complexes in varying quantities.  In pleiotropically linked receptor systems, this leads to selective activation of some signaling pathways at the expense of others (biased signaling).  This article summarizes the current knowledge about the complex components of receptor systems, the evidence that biased signaling is used in natural physiol. to fine-tune signaling, and the current thoughts on how this mechanism may be applied to the design of better drugs.  Although this is a fairly newly discovered phenomenon, theor. and exptl. data suggest that it is a ubiquitous behavior of ligands and receptors and to be expected.  Biased signaling is simple to detect in vitro and there are numerous methods to quantify the effect with scales that can be used to optimize this activity in structure-activity medicinal chem. studies.  At present, the major hurdle in the application of this mechanism to therapeutics is the translation of in vitro bias to in vivo effect; this is because of the numerous factors that can modify measures of bias in natural physiol. systems.  In spite of this, biased signaling still has the potential to justify revisiting of receptor targets previously thought to be intractable and also furnishes the means to pursue targets previously thought to be forbidden due to deleterious physiol. (as these may be eliminated through biased signaling).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomawYtBX53pbVg90H21EOLACvtfcHk0liVjr2YVNGqEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvV2gtL3E&md5=ddf8cb5adb1dc14783bfc82a308fc70d</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1124%2Fpr.118.016790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.118.016790%26sid%3Dliteratum%253Aachs%26aulast%3DKenakin%26aufirst%3DT.%26atitle%3DBiased%2520receptor%2520signaling%2520in%2520drug%2520discovery%26jtitle%3DPharmacol.%2520Rev.%26date%3D2019%26volume%3D71%26spage%3D267%26epage%3D315%26doi%3D10.1124%2Fpr.118.016790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dooley, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houghten, R. A.</span></span> <span> </span><span class="NLM_article-title">Orphanin FQ: receptor binding and analog structure activity relationships in rat brain</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">PL23</span>– <span class="NLM_lpage">PL29</span>, <span class="refDoi"> DOI: 10.1016/0024-3205(96)00261-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1016%2F0024-3205%2896%2900261-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=8684262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADyaK28XjsFGhsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1996&pages=PL23-PL29&author=C.+T.+Dooleyauthor=R.+A.+Houghten&title=Orphanin+FQ%3A+receptor+binding+and+analog+structure+activity+relationships+in+rat+brain&doi=10.1016%2F0024-3205%2896%2900261-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Orphanin FQ: receptor binding and analog structure activity relationships in rat brain</span></div><div class="casAuthors">Dooley, Colette T.; Houghten, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">PL23-PL29</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A tritiated form of orphanin FQ (a heptadecapeptide also known as Nociceptin) has been prepd.  This radioligand (33 Ci/mmole) was used to develop a radioreceptor assay using rat brain homogenates.  Binding was obsd. to be saturable, and analyses of the binding data indicate the presence of a single binding site with a dissocn. const. of 5 nM and Bmax of 535 fmoles/mg protein.  Thirty-four analogs of orphanin FQ, including a complete alanine "scan" of orphanin FQ, and truncation analogs from both the N- and C-terminals were synthesized and tested.  The data obtained indicate that the N-terminus plays a more crit. role in binding than the C-terminus and that residues 1, 2, 4, and 8 are essential for binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsICd529z6WbVg90H21EOLACvtfcHk0lg9CZkvKJHGdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjsFGhsL8%253D&md5=ff4ab4643920535ad6649137593f1b63</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2F0024-3205%2896%2900261-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0024-3205%252896%252900261-5%26sid%3Dliteratum%253Aachs%26aulast%3DDooley%26aufirst%3DC.%2BT.%26aulast%3DHoughten%26aufirst%3DR.%2BA.%26atitle%3DOrphanin%2520FQ%253A%2520receptor%2520binding%2520and%2520analog%2520structure%2520activity%2520relationships%2520in%2520rat%2520brain%26jtitle%3DLife%2520Sci.%26date%3D1996%26volume%3D59%26spage%3DPL23%26epage%3DPL29%26doi%3D10.1016%2F0024-3205%2896%2900261-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reinscheid, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ardati, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monsma, F. J.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Civelli, O.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship studies on the novel neuropeptide orphanin FQ</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>271</i></span>,  <span class="NLM_fpage">14163</span>– <span class="NLM_lpage">14168</span>, <span class="refDoi"> DOI: 10.1074/jbc.271.24.14163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1074%2Fjbc.271.24.14163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=8662940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADyaK28Xjs1Oit70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=14163-14168&author=R.+K.+Reinscheidauthor=A.+Ardatiauthor=F.+J.+Monsmaauthor=O.+Civelli&title=Structure-activity+relationship+studies+on+the+novel+neuropeptide+orphanin+FQ&doi=10.1074%2Fjbc.271.24.14163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship studies on the novel neuropeptide orphanin FQ</span></div><div class="casAuthors">Reinscheid, Rainer K.; Ardati, Ali; Monsma, Frederick J., Jr.; Civelli, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">14163-14168</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The heptadecapeptide orphanin FQ (OFQ) is an endogenous ligand to an opioid-like G protein-coupled receptor.  Although the primary structure of OFQ exhibits some similarity to the opioid peptides, OFQ is not recognized by opioid receptors nor does the OFQ receptor bind opioid ligands.  To investigate the structural determinants of this ligand/receptor selectivity, we conducted a systematic structure-activity study on OFQ to characterize which sites of the mol. are important for receptor activation.  Alanine- and D-amino acid-scanning mutagenesis revealed several residues in the amino-terminal half of OFQ which participate in both receptor binding and activation.  Most strikingly, the Phe1 position could be changed to a tyrosine without loss of biol. activity.  In addn., the OFQ receptor seemed to require recognition of the complete peptide mol. for activation.  These results indicate that the mode of interaction of OFQ with its receptor may be different from that of the opioid peptides with their resp. receptors and might therefore account for the obsd. selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkGdhen8JcfbVg90H21EOLACvtfcHk0lg9CZkvKJHGdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xjs1Oit70%253D&md5=e2b061b269da3ffe335aa8261ba431a4</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.24.14163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.24.14163%26sid%3Dliteratum%253Aachs%26aulast%3DReinscheid%26aufirst%3DR.%2BK.%26aulast%3DArdati%26aufirst%3DA.%26aulast%3DMonsma%26aufirst%3DF.%2BJ.%26aulast%3DCivelli%26aufirst%3DO.%26atitle%3DStructure-activity%2520relationship%2520studies%2520on%2520the%2520novel%2520neuropeptide%2520orphanin%2520FQ%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D14163%26epage%3D14168%26doi%3D10.1074%2Fjbc.271.24.14163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calo’, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazarus, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvadori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temussi, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regoli, D.</span></span> <span> </span><span class="NLM_article-title">Address and message sequences for the nociceptin receptor: a structure-activity study of nociceptin-(1-13)-peptide amide</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1789</span>– <span class="NLM_lpage">1793</span>, <span class="refDoi"> DOI: 10.1021/jm970011b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970011b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADyaK2sXjt1SqsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=1789-1793&author=R.+Guerriniauthor=G.+Calo%E2%80%99author=A.+Rizziauthor=C.+Bianchiauthor=L.+H.+Lazarusauthor=S.+Salvadoriauthor=P.+A.+Temussiauthor=D.+Regoli&title=Address+and+message+sequences+for+the+nociceptin+receptor%3A+a+structure-activity+study+of+nociceptin-%281-13%29-peptide+amide&doi=10.1021%2Fjm970011b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Address and Message Sequences for the Nociceptin Receptor: A Structure-Activity Study of Nociceptin-(1-13)-peptide amide</span></div><div class="casAuthors">Guerrini, Remo; Calo', Girolamo; Rizzi, Anna; Bianchi, Clementina; Lazarus, Lawrence H.; Salvadori, Severo; Temussi, Piero A.; Regoli, Domenico</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1789-1793</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Nociceptin (NC) and some of its fragments as well as nociceptin-(1-13)-peptide amide NC(1-13)-NH2 and a series of its analogs were prepd. and tested in the mouse vas deferens to identify the sequences involved in the activation (message) and in the binding (address) of nociceptin to its receptor.  The NC receptor that inhibits the elec. evoked twitches of the mouse vas deferens was demonstrated to be distinct from the δ opioid receptor, since naloxone and Dmt-Tic-OH (a selective δ opioid receptor antagonist) block the δ opioid receptor but have no effect on the nociceptin receptor.  From structure-activity expts. suggest that (a) the entire sequence of NC may not be required for full biol. activities, since NC(1-13)-NH2 is as active as NC; (b) fragments of NC have however to be amidated as in NC(1-13)-NH2 to be protected from degrdn. by proteases; (c) cationic residues (as Arg8,12, Lys9,13) appear to play a functional role, since their replacement with Ala in the sequence of NC(1-13)-NH2 leads to inactivity; (d) the N-terminal tetrapeptide Phe-Gly-Gly-Phe is essential for activity: its full length and flexibility appear to be required for NC receptor activation and/or occupation; (e) Phe4 and not Phe1 appears to be the residue involved in receptor activation, since the replacement of Phe1 with Leu has no effect, while that of Phe4 leads to inactivity.  The data summarized in this paper indicate that the structural requirements of NC for occupation and activation of its receptor are different from that of opioids, particularly δ agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphC5NH2WPOFLVg90H21EOLACvtfcHk0lg9CZkvKJHGdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjt1SqsL0%253D&md5=c3ca11cbac28740db5babed384a5ddde</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm970011b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970011b%26sid%3Dliteratum%253Aachs%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DCalo%25E2%2580%2599%26aufirst%3DG.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DBianchi%26aufirst%3DC.%26aulast%3DLazarus%26aufirst%3DL.%2BH.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DTemussi%26aufirst%3DP.%2BA.%26aulast%3DRegoli%26aufirst%3DD.%26atitle%3DAddress%2520and%2520message%2520sequences%2520for%2520the%2520nociceptin%2520receptor%253A%2520a%2520structure-activity%2520study%2520of%2520nociceptin-%25281-13%2529-peptide%2520amide%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D1789%26epage%3D1793%26doi%3D10.1021%2Fjm970011b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calo’, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigoni, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regoli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvadori, S.</span></span> <span> </span><span class="NLM_article-title">Structure-activity study of the nociceptin(1-13)-NH<sub>2</sub> N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">3360</span>– <span class="NLM_lpage">3366</span>, <span class="refDoi"> DOI: 10.1021/jm970805q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970805q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADyaK1cXkvF2nt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=3360-3366&author=G.+Calo%E2%80%99author=R.+Guerriniauthor=R.+Bigoniauthor=A.+Rizziauthor=C.+Bianchiauthor=D.+Regoliauthor=S.+Salvadori&title=Structure-activity+study+of+the+nociceptin%281-13%29-NH2+N-terminal+tetrapeptide+and+discovery+of+a+nociceptin+receptor+antagonist&doi=10.1021%2Fjm970805q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Study of the Nociceptin(1-13)-NH2 N-Terminal Tetrapeptide and Discovery of a Nociceptin Receptor Antagonist</span></div><div class="casAuthors">Calo, Girolamo; Guerrini, Remo; Bigoni, Raffaella; Rizzi, Anna; Bianchi, Clementina; Regoli, Domenico; Salvadori, Severo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3360-3366</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the present study, the minimal fragment sequence required to fully activate the nociceptin (NC) receptor, namely H-Phe-Gly-Gly-Phe-Thr-Gly-Ala-Arg-Lys-Ser-Ala-Arg-Lys-NH2 [NC(1-13)-NH2], was used as template for the design of a series of new compds.  Changes were made in the N-terminal tetrapeptide Phe-Gly-Gly-Phe, which has been shown to be essential for receptor occupation and activation.  The new compds. were tested for their ability to inhibit the elec. evoked contraction of the mouse vas deferens, a pharmacol. prepn. sensitive to NC.  Results obtained indicate that (a) the replacement of Gly2 or Gly3 with an arom. residue (Phe) of L or D chirality eliminates the ability of the peptide to occupy the NC receptor; (b) the distance between Phe1 and Phe4 of NC appears to be crit., since any alteration of it leads to a marked decrease or a total elimination of biol. activity; and (c) the insertion of a pseudopeptide bond between Phe1 and Gly2 maintains affinity but eliminates the ability of the peptide to activate the NC receptor and leads to antagonism.  The peptide [Phe1ψ(CH2-NH)Gly2]-NC(1-13)-NH2 acts as a selective NC receptor antagonist and is inactive on opioid receptors.  The results summarized in this paper confirm and extend our previous findings by showing that the structural requirements for NC binding to its receptor are clearly different from those of opioids; in addn., this structure-activity study has led to the identification of the first NC receptor selective antagonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogyRDk3ShRFLVg90H21EOLACvtfcHk0lhC_29wXy_J8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkvF2nt78%253D&md5=8b82c1e8f4e45c106afa365c3356787c</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm970805q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970805q%26sid%3Dliteratum%253Aachs%26aulast%3DCalo%25E2%2580%2599%26aufirst%3DG.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DBigoni%26aufirst%3DR.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DBianchi%26aufirst%3DC.%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DSalvadori%26aufirst%3DS.%26atitle%3DStructure-activity%2520study%2520of%2520the%2520nociceptin%25281-13%2529-NH2%2520N-terminal%2520tetrapeptide%2520and%2520discovery%2520of%2520a%2520nociceptin%2520receptor%2520antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D3360%26epage%3D3366%26doi%3D10.1021%2Fjm970805q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calo’, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigoni, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toth, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gessi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashiba, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borea, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomatis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvadori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regoli, D.</span></span> <span> </span><span class="NLM_article-title">Further studies on nociceptin-related peptides: discovery of a new chemical template with antagonist activity on the nociceptin receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">2805</span>– <span class="NLM_lpage">2813</span>, <span class="refDoi"> DOI: 10.1021/jm990075h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990075h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BD3cXksFOqsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2805-2813&author=R.+Guerriniauthor=G.+Calo%E2%80%99author=R.+Bigoniauthor=A.+Rizziauthor=K.+Varaniauthor=G.+Tothauthor=S.+Gessiauthor=E.+Hashibaauthor=Y.+Hashimotoauthor=D.+G.+Lambertauthor=P.+A.+Boreaauthor=R.+Tomatisauthor=S.+Salvadoriauthor=D.+Regoli&title=Further+studies+on+nociceptin-related+peptides%3A+discovery+of+a+new+chemical+template+with+antagonist+activity+on+the+nociceptin+receptor&doi=10.1021%2Fjm990075h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Further Studies on Nociceptin-Related Peptides: Discovery of a New Chemical Template with Antagonist Activity on the Nociceptin Receptor</span></div><div class="casAuthors">Guerrini, Remo; Calo, Girolamo; Bigoni, Raffaella; Rizzi, Anna; Varani, Katia; Toth, Geza; Gessi, Stefania; Hashiba, Eiji; Hashimoto, Yoshio; Lambert, David G.; Borea, Pier Andrea; Tomatis, Roberto; Salvadori, Severo; Regoli, Domenico</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2805-2813</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Three series of nociceptin (NC)-related peptides were synthesized and their abilities (i) to bind to the NC sites expressed in mouse forebrain membranes, (ii) to inhibit the elec. evoked contraction of the mouse vas deferens, and (iii) to inhibit forskolin-stimulated cAMP accumulation in Chinese hamster ovary cells expressing the human recombinant NC receptor (CHONCR) were investigated.  The compds. of the first series (a series) have an ordinary Xaa1-Gly2 bond, those of the second series (b series) have a Xaa1Ψ(CH2-NH)Gly2 pseudopeptide bond, and those of the third series (c series) have a peptoid (Nxaa1-Gly2) structure.  The affinity values measured in the binding assay and in the two functional assays with the compds. of the three series showed high levels of correlation.  Thus, (I) the compds. of the a series in which Phe1 was substituted with Tyr, Cha, or Leu acted as potent NC receptor agonists; (II) the b series compds. behaved as NC receptor antagonists in the mouse vas deferens and as full agonists in CHONCR cells with different potencies depending on the first amino acid residue, [Phe1Ψ(CH2-NH)Gly2]NC(1-17)NH2 and [Phe1Ψ(CH2-NH)Gly2]NC(1-13)NH2 being the most potent compds.; (III) the compds. of the third series were all inactive both as agonists and as antagonists with the exception of [Nphe1]NC(1-17)NH2 and [Nphe1]NC(1-13)NH2, which behaved as NC receptor antagonists both in the isolated tissue and in CHONCR cells (pKB 6.1-6.4).  In conclusion, this study demonstrates that chem. requirements for NC receptor agonists are different from those of antagonists.  Moreover, modifications of the steric orientation of the arom. residue Phe1 in the NC sequence as obtained with the pseudopeptide bond between Phe1 and Gly2 or with the displacement of the benzyl side chain by one atom, as in Nphe1, lead resp. to redn. or elimination of efficacy. Indeed, in contrast to [Phe1Ψ(CH2-NH)Gly2]NC(1-13)NH2 which has been reported to exhibit agonist activity in several assays involving either central or recombinant NC receptors, [Nphe1]NC(1-13)NH2 antagonizes the effect of NC at human recombinant NC receptors and in the mouse tail withdrawal assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFZxmx92b-YrVg90H21EOLACvtfcHk0lhC_29wXy_J8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXksFOqsLg%253D&md5=5aa116f7f4d37e32a7aebbbc078ff030</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm990075h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990075h%26sid%3Dliteratum%253Aachs%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DCalo%25E2%2580%2599%26aufirst%3DG.%26aulast%3DBigoni%26aufirst%3DR.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DToth%26aufirst%3DG.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DHashiba%26aufirst%3DE.%26aulast%3DHashimoto%26aufirst%3DY.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DTomatis%26aufirst%3DR.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DRegoli%26aufirst%3DD.%26atitle%3DFurther%2520studies%2520on%2520nociceptin-related%2520peptides%253A%2520discovery%2520of%2520a%2520new%2520chemical%2520template%2520with%2520antagonist%2520activity%2520on%2520the%2520nociceptin%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2805%26epage%3D2813%26doi%3D10.1021%2Fjm990075h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caló, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigoni, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zucchini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashiba, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toth, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borea, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvadori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regoli, D.</span></span> <span> </span><span class="NLM_article-title">Structure-activity studies of the Phe<sup>4</sup> residue of nociceptin(1-13)-NH<sub>2</sub>: identification of highly potent agonists of the nociceptin/orphanin FQ receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">3956</span>– <span class="NLM_lpage">3964</span>, <span class="refDoi"> DOI: 10.1021/jm010221v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm010221v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnsV2ksL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=3956-3964&author=R.+Guerriniauthor=G.+Cal%C3%B3author=R.+Bigoniauthor=D.+Rizziauthor=A.+Rizziauthor=M.+Zucchiniauthor=K.+Varaniauthor=E.+Hashibaauthor=D.+G.+Lambertauthor=G.+Tothauthor=P.+A.+Boreaauthor=S.+Salvadoriauthor=D.+Regoli&title=Structure-activity+studies+of+the+Phe4+residue+of+nociceptin%281-13%29-NH2%3A+identification+of+highly+potent+agonists+of+the+nociceptin%2Forphanin+FQ+receptor&doi=10.1021%2Fjm010221v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Studies of the Phe4 Residue of Nociceptin(1-13)-NH2: Identification of Highly Potent Agonists of the Nociceptin/Orphanin FQ Receptor</span></div><div class="casAuthors">Guerrini, Remo; Calo, Girolamo; Bigoni, Raffaella; Rizzi, Daniela; Rizzi, Anna; Zucchini, Marina; Varani, Katia; Hashiba, Eiji; Lambert, David G.; Toth, Geza; Borea, Pier Andrea; Salvadori, Severo; Regoli, Domenico</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">3956-3964</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A total of 32 compds. was prepd. to investigate the functional role of Phe4 in NC(1-13)-NH2, the minimal sequence maintaining the same activity as the natural peptide nociceptin.  These compds. could be divided into three series in which Phe4 was replaced with residues that would (i) alter aromaticity or side chain length, (ii) introduce steric constraint, and (iii) modify the Ph ring.  Compds. were tested for biol. activity as (a) inhibitors of the elec. stimulated contraction of the mouse vas deferens; (b) competitors of the binding of [3H]-NC-NH2 to mouse brain membranes; and (c) inhibitors of forskolin-stimulated cAMP accumulation in CHO cells expressing the recombinant human OP4 receptor.  Results indicate that all compds. of the first and second series were inactive or very weak with the exception of [N(CH3)Phe4]NC(1-13)-NH2, which was only 3-fold less potent than NC(1-13)-NH2.  Compds. of the third series showed higher, equal, or lower potencies than NC(1-13)-NH2.  In particular, [(pF)Phe4]NC(1-13)-NH2 (pF) and [(pNO2)Phe4]NC(1-13)-NH2 (pNO2) were more active than NC(1-13)-NH2 by a factor of 5.  In the mVD, these compds. showed the following order of potency: (pF) = (pNO2) ≥ (pCN) > (pCl) > (pBr) > (pI) = (pCF3) = (pOCH3) > (pCH3) > (pNH2) = (pOH).  (oF) and esp. (mF) maintained high potencies but were less active than (pF).  Similar orders of potency were obsd. in binding competition and cAMP accumulation studies.  There was a strong (r2 ≥ 0.66) correlation between data obsd. in these assays.  Biol. activity data of compds. of the third series were plotted against some Hansch parameters that are currently used to quantify physicochem. features of the substituents.  In the three biol. assays agonist potency/affinity pos. correlates with the electron withdrawal properties of the groups in the p-position of Phe4 and inversely with their size.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEL-R6_28b97Vg90H21EOLACvtfcHk0lgBeNM04PDdSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnsV2ksL8%253D&md5=3176f57ec89f60f9c35a782a2fdc27c5</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm010221v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010221v%26sid%3Dliteratum%253Aachs%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DCal%25C3%25B3%26aufirst%3DG.%26aulast%3DBigoni%26aufirst%3DR.%26aulast%3DRizzi%26aufirst%3DD.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DZucchini%26aufirst%3DM.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DHashiba%26aufirst%3DE.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26aulast%3DToth%26aufirst%3DG.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DRegoli%26aufirst%3DD.%26atitle%3DStructure-activity%2520studies%2520of%2520the%2520Phe4%2520residue%2520of%2520nociceptin%25281-13%2529-NH2%253A%2520identification%2520of%2520highly%2520potent%2520agonists%2520of%2520the%2520nociceptin%252Forphanin%2520FQ%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D3956%26epage%3D3964%26doi%3D10.1021%2Fjm010221v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calo’, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigoni, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regoli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvadori, S.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship of [Nphe<sup>1</sup>]-NC-(1-13)-NH<sub>2</sub>, a pure and selective nociceptin/orphanin FQ receptor antagonist</span>. <i>J. Pept. Res.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">222</span>, <span class="refDoi"> DOI: 10.1111/j.1399-3011.2001.00820.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1111%2Fj.1399-3011.2001.00820.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=11298922" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BD3MXisVCrsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2001&pages=215-222&author=R.+Guerriniauthor=G.+Calo%E2%80%99author=R.+Bigoniauthor=D.+Rizziauthor=D.+Regoliauthor=S.+Salvadori&title=Structure-activity+relationship+of+%5BNphe1%5D-NC-%281-13%29-NH2%2C+a+pure+and+selective+nociceptin%2Forphanin+FQ+receptor+antagonist&doi=10.1111%2Fj.1399-3011.2001.00820.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship of [Nphe1]-NC-(1-13)-NH2, a pure and selective nociceptin/orphanin FQ receptor antagonist</span></div><div class="casAuthors">Guerrini, R.; Calo', G.; Bigoni, R.; Rizzi, D.; Regoli, D.; Salvadori, S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Peptide Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">215-222</span>CODEN:
                <span class="NLM_cas:coden">JPERFA</span>;
        ISSN:<span class="NLM_cas:issn">1397-002X</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard International Publishers Ltd.</span>)
        </div><div class="casAbstract">A series of analogs of the ORL1 receptor antagonist [Nphe1]-NC(1-13)-NH2 was prepd. and tested for agonistic and antagonistic activities in the mouse vas deferens, a prepn. that shows high sensitivity to nociceptin and related peptides.  The purpose of this study was to det. the role of the arom. residue at the N-terminal for antagonism and eventually identify compds. with improved potency.  Results indicated that all 23 compds. are inactive as agonists, and the antagonistic potency of the initial template [Nphe1]-NC(1-13)-NH2 is high (pKB 6.43) compared with those of all other compds. except [(S)(βMe)Nphe1]NC(1-13)-NH2 (pKB 6.48).  The other 22 compds. can be divided into two groups: 10 show antagonistic potencies (pKB) ranging from 5.30 to 5.86, whereas the other 12 compds. are inactive.  This study clearly shows that the arom. ring of Nphe is very crit. for the interaction with the ORL1 receptor and can not be enlarged or sterically modified without significant loss of antagonistic potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV9CWs5k-Y5bVg90H21EOLACvtfcHk0lgBeNM04PDdSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXisVCrsLs%253D&md5=3bbbed9f8b0017713e54e3f7dd2d4b9b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1111%2Fj.1399-3011.2001.00820.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1399-3011.2001.00820.x%26sid%3Dliteratum%253Aachs%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DCalo%25E2%2580%2599%26aufirst%3DG.%26aulast%3DBigoni%26aufirst%3DR.%26aulast%3DRizzi%26aufirst%3DD.%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DSalvadori%26aufirst%3DS.%26atitle%3DStructure-activity%2520relationship%2520of%2520%255BNphe1%255D-NC-%25281-13%2529-NH2%252C%2520a%2520pure%2520and%2520selective%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520antagonist%26jtitle%3DJ.%2520Pept.%2520Res.%26date%3D2001%26volume%3D57%26spage%3D215%26epage%3D222%26doi%3D10.1111%2Fj.1399-3011.2001.00820.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arduin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spagnolo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calò, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrà, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischetti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapella, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzola, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regoli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvadori, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with Cα,α-dialkylated amino acids</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">4434</span>– <span class="NLM_lpage">4443</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2007.04.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1016%2Fj.bmc.2007.04.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=17490886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlvFSjs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=4434-4443&author=M.+Arduinauthor=B.+Spagnoloauthor=G.+Cal%C3%B2author=R.+Guerriniauthor=G.+Carr%C3%A0author=C.+Fischettiauthor=C.+Trapellaauthor=E.+Marzolaauthor=J.+McDonaldauthor=D.+G.+Lambertauthor=D.+Regoliauthor=S.+Salvadori&title=Synthesis+and+biological+activity+of+nociceptin%2Forphanin+FQ+analogues+substituted+in+position+7+or+11+with+C%CE%B1%2C%CE%B1-dialkylated+amino+acids&doi=10.1016%2Fj.bmc.2007.04.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with Cα,α-dialkylated amino acids</span></div><div class="casAuthors">Arduin, Marika; Spagnolo, Barbara; Calo, Girolamo; Guerrini, Remo; Carra, Giacomo; Fischetti, Carmela; Trapella, Claudio; Marzola, Erika; McDonald, John; Lambert, David G.; Regoli, Domenico; Salvadori, Severo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4434-4443</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Previous structure-activity and NMR studies on nociceptin/orphanin FQ (N/OFQ) demonstrated that Aib substitution of Ala7 and/or Ala11 increases the peptide potency through an alpha helix structure induction mechanism.  On these bases we synthesized and evaluated pharmacol. in the mouse vas deferens assay a series of N/OFQ-NH2 analogs substituted in position 7 and 11 with Cα,α-disubstituted cyclic, linear and branched amino acids.  None of the 20 novel N/OFQ analogs produced better results than [Aib7]N/OFQ-NH2.  Thus, this substitution was combined with other chem. modifications known to modulate peptide potency and/or efficacy generating compd. 21 [Nphe1Aib7Arg14Lys15]N/OFQ-NH2 (coded as UFP-111), compd. 22 [(pF)Phe4Aib7Arg14Lys15]N/OFQ-NH2 (UFP-112) and compd. 23 [Phe1Ψ(CH2-NH)Gly2(pF)Phe4Aib7Arg14Lys15]N/OFQ-NH2 (UFP-113).  These novel peptides behaved as highly potent NOP receptor ligands showing full (UFP-112) and partial (UFP-113) agonist and pure antagonist (UFP-111) activities in a series of in vitro functional assays performed on pharmacol. prepns. expressing native as well as recombinant NOP receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6OBbZI6whX7Vg90H21EOLACvtfcHk0lirmXn8vlTA_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlvFSjs74%253D&md5=79f4cf61ed759bcf4dcdc3cddaec20ac</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.04.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.04.026%26sid%3Dliteratum%253Aachs%26aulast%3DArduin%26aufirst%3DM.%26aulast%3DSpagnolo%26aufirst%3DB.%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DCarr%25C3%25A0%26aufirst%3DG.%26aulast%3DFischetti%26aufirst%3DC.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DMarzola%26aufirst%3DE.%26aulast%3DMcDonald%26aufirst%3DJ.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DSalvadori%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520of%2520nociceptin%252Forphanin%2520FQ%2520analogues%2520substituted%2520in%2520position%25207%2520or%252011%2520with%2520C%25CE%25B1%252C%25CE%25B1-dialkylated%2520amino%2520acids%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D4434%26epage%3D4443%26doi%3D10.1016%2Fj.bmc.2007.04.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenzano, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyle, D. J.</span></span> <span> </span><span class="NLM_article-title">Novel, potent ORL-1 receptor agonist peptides containing alpha-helix-promoting conformational constraints</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">5280</span>– <span class="NLM_lpage">5286</span>, <span class="refDoi"> DOI: 10.1021/jm0202021</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0202021" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BD38Xns1GhsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=5280-5286&author=C.+Zhangauthor=W.+Millerauthor=K.+J.+Valenzanoauthor=D.+J.+Kyle&title=Novel%2C+potent+ORL-1+receptor+agonist+peptides+containing+alpha-helix-promoting+conformational+constraints&doi=10.1021%2Fjm0202021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Novel, potent ORL-1 receptor agonist peptides containing α-helix-promoting conformational constraints</span></div><div class="casAuthors">Zhang, Chongwu; Miller, Wendy; Valenzano, Kenneth J.; Kyle, Donald J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5280-5286</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The ORL-1 receptor has recently been cloned and is implicated in a wide variety of physiol. and pathophysiol. processes.  Toward the goal of elucidating important features of the receptor-bound conformation of the endogenous ligand, nociceptin (NC), several conformationally constrained analogs were prepd.  Either α-aminoisobutyric acid (Aib) or N-methylalanine (MeAla) were inserted as replacement(s) for Ala7, Ala11, or Ala15 in the native NC sequence (FGGFTGARKSARKLANQ).  In vitro assays measuring human ORL-1 receptor affinity (competition binding against [3H] NC), functional potency ([35S]GTPγS), and efficacy (as compared to NC) were performed for each new peptide.  The receptor affinities of the Aib-contg. peptides generally matched NC, showing Ki's in the range of 0.1-0.5 nM.  By comparison, the receptor affinities of the MeAla-contg. peptides were significantly diminished.  Peptide 14 (FGGFTG[Aib]RKS[Aib]RKLANQ-NH2), which contains two constrained alanine residues (positions 7 and 11) and a C-terminal amide modification, was found to be a very potent agonist with Ki = 0.05 nM and EC50 = 0.08 nM in the human ORL-1 assays.  The data support a hypothesis that the receptor-bound form of NC might adopt an amphipathic helix in the "address" segment of the sequence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDAbEqzH3chbVg90H21EOLACvtfcHk0lirmXn8vlTA_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xns1GhsL8%253D&md5=5aa01a2ab064913448cb48e0b440de60</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjm0202021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0202021%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DMiller%26aufirst%3DW.%26aulast%3DValenzano%26aufirst%3DK.%2BJ.%26aulast%3DKyle%26aufirst%3DD.%2BJ.%26atitle%3DNovel%252C%2520potent%2520ORL-1%2520receptor%2520agonist%2520peptides%2520containing%2520alpha-helix-promoting%2520conformational%2520constraints%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D5280%26epage%3D5286%26doi%3D10.1021%2Fjm0202021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zucchini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomatis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regoli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calo’, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvadori, S.</span></span> <span> </span><span class="NLM_article-title">Nociceptin/orphanin FQ(1-13)NH<sub>2</sub> analogues modified in the Phe<sup>1</sup>-Gly<sup>2</sup> peptide bond</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">365</span>– <span class="NLM_lpage">368</span>, <span class="refDoi"> DOI: 10.1016/s0960-894x(02)01004-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1016%2FS0960-894X%2802%2901004-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=12565930" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptFaltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=365-368&author=R.+Guerriniauthor=D.+Rizziauthor=M.+Zucchiniauthor=R.+Tomatisauthor=D.+Regoliauthor=G.+Calo%E2%80%99author=S.+Salvadori&title=Nociceptin%2Forphanin+FQ%281-13%29NH2+analogues+modified+in+the+Phe1-Gly2+peptide+bond&doi=10.1016%2Fs0960-894x%2802%2901004-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Nociceptin/orphanin FQ(1-13)NH2 analogs modified in the Phe1-Gly2 peptide bond</span></div><div class="casAuthors">Guerrini, Remo; Rizzi, Daniela; Zucchini, Marina; Tomatis, Roberto; Regoli, Domenico; Calo', Girolamo; Salvadori, Severo</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">365-368</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">The synthesis and pharmacol. activity of novel nociceptin/orphanin FQ (N/OFQ) analogs modified in the Phe1-Gly2 peptide bond are reported.  The aim of the present work was to elucidate the importance of this peptide bond for the N/OFQ receptor (NOP) interaction.  Our study indicates that the first peptide bond in N/OFQ is important but not crucial for interaction with the N/OFQ receptor; for instance, substitution with a methyleneoxy bond generates an agonist deriv. just 3-fold less potent than the ref. compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGwzawDwsbBLVg90H21EOLACvtfcHk0lhGJNq7S-3QIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptFaltA%253D%253D&md5=37c81781cfed4cda5d40755775046e81</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2901004-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252901004-1%26sid%3Dliteratum%253Aachs%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DRizzi%26aufirst%3DD.%26aulast%3DZucchini%26aufirst%3DM.%26aulast%3DTomatis%26aufirst%3DR.%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DCalo%25E2%2580%2599%26aufirst%3DG.%26aulast%3DSalvadori%26aufirst%3DS.%26atitle%3DNociceptin%252Forphanin%2520FQ%25281-13%2529NH2%2520analogues%2520modified%2520in%2520the%2520Phe1-Gly2%2520peptide%2520bond%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D365%26epage%3D368%26doi%3D10.1016%2Fs0960-894x%2802%2901004-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pacifico, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albanese, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Illuminati, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fantinati, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzola, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neto, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sturaro, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzza, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calò, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span> <span> </span><span class="NLM_article-title">Tetrabranched hetero-conjugated peptides as bifunctional agonists of the NOP and mu opioid receptors</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">2444</span>– <span class="NLM_lpage">2451</span>, <span class="refDoi"> DOI: 10.1021/acs.bioconjchem.9b00519</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.9b00519" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1KksL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2019&pages=2444-2451&author=S.+Pacificoauthor=V.+Albaneseauthor=D.+Illuminatiauthor=A.+Fantinatiauthor=E.+Marzolaauthor=F.+Ferrariauthor=J.+A.+Netoauthor=C.+Sturaroauthor=C.+Ruzzaauthor=G.+Cal%C3%B2author=D.+Pretiauthor=R.+Guerrini&title=Tetrabranched+hetero-conjugated+peptides+as+bifunctional+agonists+of+the+NOP+and+mu+opioid+receptors&doi=10.1021%2Facs.bioconjchem.9b00519"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Tetrabranched Hetero-Conjugated Peptides as Bifunctional Agonists of the NOP and Mu Opioid Receptors</span></div><div class="casAuthors">Pacifico, Salvatore; Albanese, Valentina; Illuminati, Davide; Fantinati, Anna; Marzola, Erika; Ferrari, Federica; Neto, Joaquim Azevedo; Sturaro, Chiara; Ruzza, Chiara; Calo, Girolamo; Preti, Delia; Guerrini, Remo</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2444-2451</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The general aim of the work was the validation of a new synthetic methodol. designed for obtaining bifunctional heterotetrabranched peptide ligands.  Applying an easily accessible synthetic route, we provided a small series of heteromultimeric peptide conjugates targeting the nociceptin/orphanin FQ (N/OFQ) peptide receptors (NOP) and mu opioid receptors.  Among these, H-PWT1-N/OFQ-[Dmt1]dermorphin demonstrated a similar and high agonist potency at the NOP and mu receptors.  The achieved results confirmed the robustness of the approach that is extremely versatile and virtually applicable to different peptide sequences whose pharmacol. activity can be combined for generating dual acting multimeric compds.  These innovative pharmacol. tools will be extremely helpful for investigating the consequences of the simultaneous activation and/or blockage of different peptidergic receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom00_e11aupbVg90H21EOLACvtfcHk0lhGJNq7S-3QIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1KksL3K&md5=643c7bb57212e5eed8193d852eb444fd</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.9b00519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.9b00519%26sid%3Dliteratum%253Aachs%26aulast%3DPacifico%26aufirst%3DS.%26aulast%3DAlbanese%26aufirst%3DV.%26aulast%3DIlluminati%26aufirst%3DD.%26aulast%3DFantinati%26aufirst%3DA.%26aulast%3DMarzola%26aufirst%3DE.%26aulast%3DFerrari%26aufirst%3DF.%26aulast%3DNeto%26aufirst%3DJ.%2BA.%26aulast%3DSturaro%26aufirst%3DC.%26aulast%3DRuzza%26aufirst%3DC.%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26aulast%3DPreti%26aufirst%3DD.%26aulast%3DGuerrini%26aufirst%3DR.%26atitle%3DTetrabranched%2520hetero-conjugated%2520peptides%2520as%2520bifunctional%2520agonists%2520of%2520the%2520NOP%2520and%2520mu%2520opioid%2520receptors%26jtitle%3DBioconjugate%2520Chem.%26date%3D2019%26volume%3D30%26spage%3D2444%26epage%3D2451%26doi%3D10.1021%2Facs.bioconjchem.9b00519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J.</span></span> <span> </span><span class="NLM_article-title">Biased ligands of G protein-coupled receptors (GPCRs): structure-functional selectivity relationships (SFSRs) and therapeutic potential</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">9841</span>– <span class="NLM_lpage">9878</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00435</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00435" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Snu73N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=9841-9878&author=L.+Tanauthor=W.+Yanauthor=J.+D.+McCorvyauthor=J.+Cheng&title=Biased+ligands+of+G+protein-coupled+receptors+%28GPCRs%29%3A+structure-functional+selectivity+relationships+%28SFSRs%29+and+therapeutic+potential&doi=10.1021%2Facs.jmedchem.8b00435"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure-Functional Selectivity Relationships (SFSRs) and Therapeutic Potential</span></div><div class="casAuthors">Tan, Liang; Yan, Wenzhong; McCorvy, John D.; Cheng, Jianjun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9841-9878</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  G protein-coupled receptors (GPCRs) signal through both G-protein-dependent and G-protein-independent pathways, and β-arrestin recruitment is the most recognized one of the latter.  Biased ligands selective for either pathway are expected to regulate biol. functions of GPCRs in a more precise way, therefore providing new drug mols. with superior efficacy and/or reduced side effects.  During the past decade, biased ligands have been discovered and developed for many GPCRs, such as the μ opioid receptor, the angiotensin II receptor type 1, the dopamine D2 receptor, and many others.  In this Perspective, recent advances in this field are reviewed by discussing the structure-functional selectivity relationships (SFSRs) of GPCR biased ligands and the therapeutic potential of these mols.  Further understanding of the biol. functions assocd. with each signaling pathway and structural basis for biased signaling will facilitate future drug design in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNFjkAvar29LVg90H21EOLACvtfcHk0lhGJNq7S-3QIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Snu73N&md5=a7bd605b82666357f5a0a209002225e5</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00435%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DW.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DCheng%26aufirst%3DJ.%26atitle%3DBiased%2520ligands%2520of%2520G%2520protein-coupled%2520receptors%2520%2528GPCRs%2529%253A%2520structure-functional%2520selectivity%2520relationships%2520%2528SFSRs%2529%2520and%2520therapeutic%2520potential%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D9841%26epage%3D9878%26doi%3D10.1021%2Facs.jmedchem.8b00435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gesty-Palmer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flannery, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corsino, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spurney, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefkowitz, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luttrell, L. M.</span></span> <span> </span><span class="NLM_article-title">A beta-arrestin-biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">1ra1</span>, <span class="refDoi"> DOI: 10.1126/scitranslmed.3000071</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1126%2Fscitranslmed.3000071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=20368153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A280%3ADC%252BC3c3jvFSmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2009&pages=1ra1&author=D.+Gesty-Palmerauthor=P.+Flanneryauthor=L.+Yuanauthor=L.+Corsinoauthor=R.+Spurneyauthor=R.+J.+Lefkowitzauthor=L.+M.+Luttrell&title=A+beta-arrestin-biased+agonist+of+the+parathyroid+hormone+receptor+%28PTH1R%29+promotes+bone+formation+independent+of+G+protein+activation&doi=10.1126%2Fscitranslmed.3000071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">A beta-arrestin-biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation</span></div><div class="casAuthors">Gesty-Palmer Diane; Flannery Pat; Yuan Ling; Corsino Leonor; Spurney Robert; Lefkowitz Robert J; Luttrell Louis M</div><div class="citationInfo"><span class="NLM_cas:title">Science translational medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1ra1</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">About 40% of the therapeutic agents in use today exert their effects through seven-transmembrane receptors (7TMRs).  When activated by ligands, these receptors trigger two pathways that independently transduce signals to the cell: one through heterotrimeric GTP-binding proteins (G proteins) and one through beta-arrestins; so-called biased agonists can selectively activate these distinct pathways.  Here, we investigate selective activation of these pathways through the use of a biased agonist for the type 1 parathyroid hormone (PTH)-PTH-related protein receptor (PTH1R), (D-Trp(12),Tyr(34))-PTH(7-34) (PTH-betaarr), which activates beta-arrestin but not classic G protein signaling.  In mice, PTH-betaarr induces anabolic bone formation, as does the nonselective agonist PTH(1-34), which activates both mechanisms.  In beta-arrestin2-null mice, the increase in bone mineral density evoked by PTH(1-34) is attenuated and that stimulated by PTH-betaarr is ablated.  The beta-arrestin2-dependent pathway contributes primarily to trabecular bone formation and does not stimulate bone resorption.  These results show that a biased agonist selective for the beta-arrestin pathway can elicit a response in vivo distinct from that elicited by nonselective agonists.  Ligands with these properties may form the basis for improved 7TMR-directed pharmacologic agents with enhanced therapeutic specificity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSmuM4aCIxthdXdcedVHT5tfW6udTcc2ea1885WWTv1G7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c3jvFSmug%253D%253D&md5=748e4367ded72b6b7e10fd759521ba62</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.3000071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.3000071%26sid%3Dliteratum%253Aachs%26aulast%3DGesty-Palmer%26aufirst%3DD.%26aulast%3DFlannery%26aufirst%3DP.%26aulast%3DYuan%26aufirst%3DL.%26aulast%3DCorsino%26aufirst%3DL.%26aulast%3DSpurney%26aufirst%3DR.%26aulast%3DLefkowitz%26aufirst%3DR.%2BJ.%26aulast%3DLuttrell%26aufirst%3DL.%2BM.%26atitle%3DA%2520beta-arrestin-biased%2520agonist%2520of%2520the%2520parathyroid%2520hormone%2520receptor%2520%2528PTH1R%2529%2520promotes%2520bone%2520formation%2520independent%2520of%2520G%2520protein%2520activation%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2009%26volume%3D1%26spage%3D1ra1%26doi%3D10.1126%2Fscitranslmed.3000071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brame, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maguire, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torella, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheriyan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glen, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, I. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davenport, A. P.</span></span> <span> </span><span class="NLM_article-title">Design, characterization, and first-in-human study of the vascular actions of a novel biased apelin receptor agonist</span>. <i>Hypertension</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">834</span>– <span class="NLM_lpage">840</span>, <span class="refDoi"> DOI: 10.1161/hypertensionaha.114.05099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1161%2FHYPERTENSIONAHA.114.05099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=25712721" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC2MXktVGrtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2015&pages=834-840&author=A.+L.+Brameauthor=J.+J.+Maguireauthor=P.+Yangauthor=A.+Dysonauthor=R.+Torellaauthor=J.+Cheriyanauthor=M.+Singerauthor=R.+C.+Glenauthor=I.+B.+Wilkinsonauthor=A.+P.+Davenport&title=Design%2C+characterization%2C+and+first-in-human+study+of+the+vascular+actions+of+a+novel+biased+apelin+receptor+agonist&doi=10.1161%2Fhypertensionaha.114.05099"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Characterization, and First-In-Human Study of the Vascular Actions of a Novel Biased Apelin Receptor Agonist</span></div><div class="casAuthors">Brame, Aimee L.; Maguire, Janet J.; Yang, Peiran; Dyson, Alex; Torella, Rubben; Cheriyan, Joseph; Singer, Mervyn; Glen, Robert C.; Wilkinson, Ian B.; Davenport, Anthony P.</div><div class="citationInfo"><span class="NLM_cas:title">Hypertension</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">834-840</span>CODEN:
                <span class="NLM_cas:coden">HPRTDN</span>;
        ISSN:<span class="NLM_cas:issn">0194-911X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">[Pyr]apelin-13 is an endogenous vasodilator and inotrope but is downregulated in pulmonary hypertension and heart failure, making the apelin receptor an attractive therapeutic target.  Agonists acting at the same G-protein-coupled receptor can be engineered to stabilize different conformational states and function as biased ligands, selectively stimulating either G-protein or β-arrestin pathways.  We used mol. dynamics simulations of apelin/receptor interactions to design cyclic analogs and identified MM07 as a biased agonist.  In β-arrestin and internalization assays (G-protein-independent), MM07 was 2 orders of magnitude less potent than [Pyr]apelin-13.  In a G-protein-dependent saphenous vein contraction assay, both peptides had comparable potency (pD2:[Pyr]apelin-13 9.93±0.24; MM07 9.54±0.42) and max. responses with a resulting bias for MM07 of ≈350- to 1300-fold for the G-protein pathway.  In rats, systemic infusions of MM07 (10-100 nmol) caused a dose-dependent increase in cardiac output that was significantly greater than the response to [Pyr]apelin-13.  Similarly, in human volunteers, MM07 produced a significant dose-dependent increase in forearm blood flow with a max. dilatation double that is seen with [Pyr]apelin-13.  Addnl., repeated doses of MM07 produced reproducible increases in forearm blood flow.  These responses are consistent with a more efficacious action of the biased agonist.  In human hand vein, both peptides reversed an established norepinephrine constrictor response and significantly increased venous flow.  Our results suggest that MM07 acting as a biased agonist at the apelin receptor can preferentially stimulate the G-protein pathway, which could translate to improved efficacy in the clinic by selectively stimulating vasodilatation and inotropic actions but avoiding activating detrimental β-arrestin-dependent pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVwBeW0p9RgbVg90H21EOLACvtfcHk0lgjKu3a-DhWcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXktVGrtr0%253D&md5=908911768ffa6edcd2ef9b1e80c8826a</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1161%2FHYPERTENSIONAHA.114.05099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FHYPERTENSIONAHA.114.05099%26sid%3Dliteratum%253Aachs%26aulast%3DBrame%26aufirst%3DA.%2BL.%26aulast%3DMaguire%26aufirst%3DJ.%2BJ.%26aulast%3DYang%26aufirst%3DP.%26aulast%3DDyson%26aufirst%3DA.%26aulast%3DTorella%26aufirst%3DR.%26aulast%3DCheriyan%26aufirst%3DJ.%26aulast%3DSinger%26aufirst%3DM.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26aulast%3DWilkinson%26aufirst%3DI.%2BB.%26aulast%3DDavenport%26aufirst%3DA.%2BP.%26atitle%3DDesign%252C%2520characterization%252C%2520and%2520first-in-human%2520study%2520of%2520the%2520vascular%2520actions%2520of%2520a%2520novel%2520biased%2520apelin%2520receptor%2520agonist%26jtitle%3DHypertension%26date%3D2015%26volume%3D65%26spage%3D834%26epage%3D840%26doi%3D10.1161%2Fhypertensionaha.114.05099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Godin, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, S. S. G.</span></span> <span> </span><span class="NLM_article-title">Biased agonism of the angiotensin II type 1 receptor</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">812</span>– <span class="NLM_lpage">816</span>, <span class="refDoi"> DOI: 10.2174/138955712800959134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.2174%2F138955712800959134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=22681254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVGmu7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=812-816&author=C.+M.+Godinauthor=S.+S.+G.+Ferguson&title=Biased+agonism+of+the+angiotensin+II+type+1+receptor&doi=10.2174%2F138955712800959134"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Biased agonism of the angiotensin II type 1 receptor</span></div><div class="casAuthors">Godin, C. M.; Ferguson, S. S. G.</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">812-816</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  G protein-coupled receptors (GPCRs) can be activated by multiple ligands and exhibit the capacity to couple to numerous intracellular signal transduction pathways.  This property allows GPCRs to be modulated by biased agonists that selectively activate specific subsets of GPCR-regulated cellular signaling proteins.  The angiotensin II type 1 receptor (AT1R) is a GPCR that endogenously binds to the peptide ligand angiotensin II.  More recently it has been demonstrated that a modified peptide, [Sar1I-le4-Ile8]-angiotensin II (SII) acts as a biased agonist towards the AT1R.  SII binds to the AT1R without promoting heterotrimeric G protein-coupling, but serves to link the receptor to the beta-arrestin-dependent activation of the mitogen activated protein kinase pathway.  The present mini-review summarize current knowledge regarding the role of biased agonists in stimulating biased AT1R signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqT-Zw0CW9XaLVg90H21EOLACvtfcHk0ljT4WRhkXFQow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVGmu7nP&md5=774a49facf04056047bd3a7acb0e45b9</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.2174%2F138955712800959134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138955712800959134%26sid%3Dliteratum%253Aachs%26aulast%3DGodin%26aufirst%3DC.%2BM.%26aulast%3DFerguson%26aufirst%3DS.%2BS.%2BG.%26atitle%3DBiased%2520agonism%2520of%2520the%2520angiotensin%2520II%2520type%25201%2520receptor%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2012%26volume%3D12%26spage%3D812%26epage%3D816%26doi%3D10.2174%2F138955712800959134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spagnolo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wainford, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischetti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marzola, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldisserotto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvadori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regoli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapusta, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calo, G.</span></span> <span> </span><span class="NLM_article-title">In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor</span>. <i>Peptides</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1240</span>– <span class="NLM_lpage">1251</span>, <span class="refDoi"> DOI: 10.1016/j.peptides.2007.04.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1016%2Fj.peptides.2007.04.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=17532097" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtVaiu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=1240-1251&author=A.+Rizziauthor=B.+Spagnoloauthor=R.+D.+Wainfordauthor=C.+Fischettiauthor=R.+Guerriniauthor=G.+Marzolaauthor=A.+Baldisserottoauthor=S.+Salvadoriauthor=D.+Regoliauthor=D.+R.+Kapustaauthor=G.+Calo&title=In+vitro+and+in+vivo+studies+on+UFP-112%2C+a+novel+potent+and+long+lasting+agonist+selective+for+the+nociceptin%2Forphanin+FQ+receptor&doi=10.1016%2Fj.peptides.2007.04.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor</span></div><div class="casAuthors">Rizzi, Anna; Spagnolo, Barbara; Wainford, Richard D.; Fischetti, Carmela; Guerrini, Remo; Marzola, Giuliano; Baldisserotto, Anna; Salvadori, Severo; Regoli, Domenico; Kapusta, Daniel R.; Calo, Girolamo</div><div class="citationInfo"><span class="NLM_cas:title">Peptides (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1240-1251</span>CODEN:
                <span class="NLM_cas:coden">PPTDD5</span>;
        ISSN:<span class="NLM_cas:issn">0196-9781</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">[(PF)Phe4Aib7Arg14Lys15]N/OFQ-NH2 (UFP-112) has been designed as a novel ligand for the nociceptin/orphanin FQ (N/OFQ) peptide receptor (NOP) by combining into the same peptide different chem. modifications reported to increase N/OFQ potency.  In vitro data obtained in the elec. stimulated mouse vas deferens demonstrated that UFP-112 behaved as a high potency (pEC50 9.43) full agonist at the NOP receptor.  UFP-112 effects were sensitive to the NOP antagonist UFP-101 but not to naloxone and no longer evident in tissues taken from NOP-/- mice.  In vitro half life of UFP-112 in mouse plasma and brain homogenate was 2.6- and 3.5-fold higher than that of N/OFQ.  In vivo, in the mouse tail withdrawal assay, UFP-112 (1-100 pmol, i.c.v.) mimicked the actions of N/OFQ producing pronociceptive effects after i.c.v. administration and antinociceptive effects when given i.t.; in both cases, UFP-112 was approx. 100-fold more potent than the natural peptide and produced longer lasting effects.  UFP-112 also mimicked the hyperphagic effect of N/OFQ producing a bell shaped dose response curve with the max. reached at 10 pmol.  The hyperphagic effects of N/OFQ and UFP-112 were absent in NOP-/- mice.  Equi-effective high doses of UFP-112 (0.1 nmol) and N/OFQ (10 nmol) were injected i.c.v. in mice and spontaneous locomotor activity recorded for 16 h.  N/OFQ produced a clear inhibitory effect which lasted for 60 min while UFP-112 elicited longer lasting effects (>6 h).  In conscious rats, UFP-112 (0.1 and 10 nmol/kg, i.v.) produced a marked and sustained decrease in heart rate, blood pressure, and urinary sodium excretion and a profound increase in urine flow.  Collectively, these findings demonstrate that UFP-112 behaves in vitro and in vivo as a highly potent and selective ligand able to produce full and long lasting activation of NOP receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGombNnEOwl6-bVg90H21EOLACvtfcHk0ljT4WRhkXFQow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtVaiu7o%253D&md5=d1ef96ff0ba18bff8c08d79917dbadc2</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.peptides.2007.04.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.peptides.2007.04.020%26sid%3Dliteratum%253Aachs%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DSpagnolo%26aufirst%3DB.%26aulast%3DWainford%26aufirst%3DR.%2BD.%26aulast%3DFischetti%26aufirst%3DC.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DMarzola%26aufirst%3DG.%26aulast%3DBaldisserotto%26aufirst%3DA.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DKapusta%26aufirst%3DD.%2BR.%26aulast%3DCalo%26aufirst%3DG.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520studies%2520on%2520UFP-112%252C%2520a%2520novel%2520potent%2520and%2520long%2520lasting%2520agonist%2520selective%2520for%2520the%2520nociceptin%252Forphanin%2520FQ%2520receptor%26jtitle%3DPeptides%26date%3D2007%26volume%3D28%26spage%3D1240%26epage%3D1251%26doi%3D10.1016%2Fj.peptides.2007.04.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meunier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mouledous, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Topham, C. M.</span></span> <span> </span><span class="NLM_article-title">The nociceptin (ORL1) receptor: molecular cloning and functional architecture</span>. <i>Peptides</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">893</span>– <span class="NLM_lpage">900</span>, <span class="refDoi"> DOI: 10.1016/s0196-9781(00)00225-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1016%2FS0196-9781%2800%2900225-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10998522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BD3cXms1WrsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=893-900&author=J.+Meunierauthor=L.+Mouledousauthor=C.+M.+Topham&title=The+nociceptin+%28ORL1%29+receptor%3A+molecular+cloning+and+functional+architecture&doi=10.1016%2Fs0196-9781%2800%2900225-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The nociceptin (ORL1) receptor: molecular cloning and functional architecture</span></div><div class="casAuthors">Meunier, J.-C.; Mouledous, L.; Topham, C. M.</div><div class="citationInfo"><span class="NLM_cas:title">Peptides (New York)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">893-900</span>CODEN:
                <span class="NLM_cas:coden">PPTDD5</span>;
        ISSN:<span class="NLM_cas:issn">0196-9781</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review, with 68 refs.  Nociceptin and the ORL1 receptor share high sequence similarity with opioid peptides, particularly dynorphin A, and their receptors.  However, nociceptin and dynorphin A may use distinct mol. pathways to bind and activate their cognate receptors.  Activation of the κ-opioid receptor by dynorphin A is thought to require interactions of its N-terminal hydrophobic domain (Y1GGF) with the receptor opioid binding pocket, located within the transmembrane helix bundle, while activation of the ORL1 receptor appears to require interactions of the pos. charged core (R8KSARK) of nociceptin with the neg. charged second extracellular receptor loop.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgfiMfw8rCDLVg90H21EOLACvtfcHk0ljT4WRhkXFQow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXms1WrsLo%253D&md5=e82a23c14a0aaedaeef0e23470f36dc2</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2FS0196-9781%2800%2900225-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0196-9781%252800%252900225-4%26sid%3Dliteratum%253Aachs%26aulast%3DMeunier%26aufirst%3DJ.%26aulast%3DMouledous%26aufirst%3DL.%26aulast%3DTopham%26aufirst%3DC.%2BM.%26atitle%3DThe%2520nociceptin%2520%2528ORL1%2529%2520receptor%253A%2520molecular%2520cloning%2520and%2520functional%2520architecture%26jtitle%3DPeptides%26date%3D2000%26volume%3D21%26spage%3D893%26epage%3D900%26doi%3D10.1016%2Fs0196-9781%2800%2900225-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tancredi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrà, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arduin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calò, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regoli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvadori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Temussi, P. A.</span></span> <span> </span><span class="NLM_article-title">The interaction of highly helical structural mutants with the NOP receptor discloses the role of the address domain of nociceptin/orphanin FQ</span>. <i>Chemistry</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2061</span>– <span class="NLM_lpage">2070</span>, <span class="refDoi"> DOI: 10.1002/chem.200401095</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1002%2Fchem.200401095" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=15712334" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BD2MXislOgtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=2061-2070&author=T.+Tancrediauthor=G.+Carr%C3%A0author=R.+Guerriniauthor=M.+Arduinauthor=G.+Cal%C3%B2author=D.+Regoliauthor=S.+Salvadoriauthor=P.+A.+Temussi&title=The+interaction+of+highly+helical+structural+mutants+with+the+NOP+receptor+discloses+the+role+of+the+address+domain+of+nociceptin%2Forphanin+FQ&doi=10.1002%2Fchem.200401095"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The interaction of highly helical structural mutants with the NOP receptor discloses the role of the address domain of nociceptin/orphanin FQ</span></div><div class="casAuthors">Tancredi, Teodorico; Carra, Giacomo; Guerrini, Remo; Arduin, Marika; Calo, Girolamo; Regoli, Domenico; Salvadori, Severo; Temussi, Piero Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2061-2070</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Nociceptin is a heptadecapeptide whose sequence is similar to that of Dynorphin A, sharing a message domain characterized by two glycines and two arom. residues, and a highly basic C-terminal address domain but, in spite of these similarities, displays no opioid activity.  Establishing the relative importance of the message and address domains of nociceptin has so far been hampered by its extreme conformational flexibility.  Mutants of this peptide, designed to increase the helical content in the address domain, can be employed to explain the mode of interaction with the NOP receptor.  Nociceptin analogs in which Ala residues are substituted with aminoisobutyric acid (Aib) show a substantial increment of activity in their interaction with the NOP receptor.  The increment of biol. activity was attributed to the well-documented ability of Aib to induce helicity.  Here the authors have verified this working hypothesis by a conformational investigation extended to new analogs in which the role of Aib is taken up by Leu.  The NMR conformational anal. confirms that all Ala/Aib peptides as well as [Leu7,11]-N/OFQ-amide and [Leu11,15]-N/OFQ-amide mutants (N/OFQ=nociceptin/orphanin FQ) have comparable helix content in helix-promoting media.  The authors show that the helical address domain of nociceptin can place key basic residues at an optimal distance from complementary acidic groups of the EL2 loop of the receptor.  The authors' structural data are used to rationalize pharmacol. data which show that although [Leu11,15]-N/OFQ-amide has an activity comparable to those of Ala/Aib peptides, [Leu7,11]-N/OFQ-amide is less active than N/OFQ-amide.  The authors hypothesize that bulky residues cannot be hosted in or near the hinge region (Thr5-Gly6-Ala7) without severe steric clash with the receptor.  This hypothesis is also consistent with previous data on this hinge region obtained by systematic substitution of Thr, Gly, and Ala with Pro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowPRo2dVGzsbVg90H21EOLACvtfcHk0lioweWSeetZDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXislOgtb8%253D&md5=ef65ba54e0e12e43454a95a59e42cffc</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1002%2Fchem.200401095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.200401095%26sid%3Dliteratum%253Aachs%26aulast%3DTancredi%26aufirst%3DT.%26aulast%3DCarr%25C3%25A0%26aufirst%3DG.%26aulast%3DGuerrini%26aufirst%3DR.%26aulast%3DArduin%26aufirst%3DM.%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DSalvadori%26aufirst%3DS.%26aulast%3DTemussi%26aufirst%3DP.%2BA.%26atitle%3DThe%2520interaction%2520of%2520highly%2520helical%2520structural%2520mutants%2520with%2520the%2520NOP%2520receptor%2520discloses%2520the%2520role%2520of%2520the%2520address%2520domain%2520of%2520nociceptin%252Forphanin%2520FQ%26jtitle%3DChemistry%26date%3D2005%26volume%3D11%26spage%3D2061%26epage%3D2070%26doi%3D10.1002%2Fchem.200401095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daga, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaveri, N. T.</span></span> <span> </span><span class="NLM_article-title">Homology modeling and molecular dynamics simulations of the active state of the nociceptin receptor reveal new insights into agonist binding and activation</span>. <i>Proteins</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">1948</span>– <span class="NLM_lpage">1961</span>, <span class="refDoi"> DOI: 10.1002/prot.24077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1002%2Fprot.24077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=22489047" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC38XntFSkur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2012&pages=1948-1961&author=P.+R.+Dagaauthor=N.+T.+Zaveri&title=Homology+modeling+and+molecular+dynamics+simulations+of+the+active+state+of+the+nociceptin+receptor+reveal+new+insights+into+agonist+binding+and+activation&doi=10.1002%2Fprot.24077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Homology modeling and molecular dynamics simulations of the active state of the nociceptin receptor reveal new insights into agonist binding and activation</span></div><div class="casAuthors">Daga, Pankaj R.; Zaveri, Nurulain T.</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Bioinformatics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1948-1961, S1948/1-S1948/8</span>CODEN:
                <span class="NLM_cas:coden">PSFBAF</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The opioid receptor-like receptor, also known as the nociceptin receptor (NOP), is a class A G protein-coupled receptor (GPCR) in the opioid receptor family.  Although NOP shares a significant homol. with the other opioid receptors, it does not bind known opioid ligands and has been shown to have a distinct mechanism of activation compared to the closely related opioid receptors mu, delta, and kappa.  Previously reported homol. models of the NOP receptor, based on the inactive-state GPCR crystal structures, give limited information on the activation and selectivity features of this fourth member of the opioid receptor family.  The authors report the first active-state homol. model of the NOP receptor based on the opsin GPCR crystal structure.  An inactive-state homol. model of NOP was also built using a multiple template approach.  Mol. dynamics simulation of the active-state NOP model and comparison to the inactive-state model suggest that NOP activation involves movements of transmembrane (TM)3 and TM6 and several activation microswitches, consistent with GPCR activation.  Docking of the selective nonpeptidic NOP agonist ligand Ro 64-6198 into the active-state model reveals active-site residues in NOP that play a role in the high selectivity of this ligand for NOP over the other opioid receptors.  Docking the shortest active fragment of endogenous agonist nociceptin/orphaninFQ (residues 1-13) shows that the NOP extracellular loop 2 (EL2) loop interacts with the pos. charged residues (8-13) of N/OFQ.  Both agonists show extensive polar interactions with residues at the extracellular end of the TM domain and EL2 loop, suggesting agonist-induced reorganization of polar networks, during receptor activation.  Proteins 2012; © 2012 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHyKNV6QUesbVg90H21EOLACvtfcHk0lioweWSeetZDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntFSkur0%253D&md5=b239ff210a4b601c46401139c17f8fb5</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2Fprot.24077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.24077%26sid%3Dliteratum%253Aachs%26aulast%3DDaga%26aufirst%3DP.%2BR.%26aulast%3DZaveri%26aufirst%3DN.%2BT.%26atitle%3DHomology%2520modeling%2520and%2520molecular%2520dynamics%2520simulations%2520of%2520the%2520active%2520state%2520of%2520the%2520nociceptin%2520receptor%2520reveal%2520new%2520insights%2520into%2520agonist%2520binding%2520and%2520activation%26jtitle%3DProteins%26date%3D2012%26volume%3D80%26spage%3D1948%26epage%3D1961%26doi%3D10.1002%2Fprot.24077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Della
Longa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arcovito, A.</span></span> <span> </span><span class="NLM_article-title">A dynamic picture of the early events in nociceptin binding to the NOP receptor by metadynamics</span>. <i>Biophys. J.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">1203</span>– <span class="NLM_lpage">1213</span>, <span class="refDoi"> DOI: 10.1016/j.bpj.2016.07.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1016%2Fj.bpj.2016.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=27653479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Sgs7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2016&pages=1203-1213&author=S.+Della%0ALongaauthor=A.+Arcovito&title=A+dynamic+picture+of+the+early+events+in+nociceptin+binding+to+the+NOP+receptor+by+metadynamics&doi=10.1016%2Fj.bpj.2016.07.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">A Dynamic Picture of the Early Events in Nociceptin Binding to the NOP Receptor by Metadynamics</span></div><div class="casAuthors">della Longa, Stefano; Arcovito, Alessandro</div><div class="citationInfo"><span class="NLM_cas:title">Biophysical Journal</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1203-1213</span>CODEN:
                <span class="NLM_cas:coden">BIOJAU</span>;
        ISSN:<span class="NLM_cas:issn">0006-3495</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Nociceptin (NCC, also known as FQ (N/OFQ)) is the 17-amino acid neuropeptide, endogenous ligand for the G-protein-coupled receptor (NOP, also known as ORL-1).  In this study, starting from the recently reported x-ray structure at pH 7 of NOP in complex with an antagonist, new insights, to our knowledge, on the binding geometry of NCC to NOP have been provided in silico.  After a rigid docking of NCC in an α-helix conformation, mol. dynamics (MD) and metadynamics (METAD), a method for the anal. of free-energy surfaces (FES), were performed on the protein-peptide complex.  Free-energy profiles were obtained as a function of the α-helix content of different segments of the 17-mer ligand, and a structural ensemble of conformations of NCC, corresponding to the min. of the FES, was extd., thus representing the NCC bound to the inactive form of NOP.  The structural features were compared with many known exptl. data.  The pose of the "message" domain (residues 1-4) of NCC differs from that of the known NOP antagonists, as being slightly slipped deeper inside the protein core.  A residual α-helix content in the central part of the peptide (residues 4-9) is maintained, whereas the C-terminal segment (residues 13-17) is unstructured and highly flexible.  An important stabilization due to interactions with residues D130 and D110 of the receptor has been found, in agreement with the large decrease in agonist potency reported for the D130A and D110A mutants.  The importance of the extracellular domain 2 (ECL2) in the selectivity toward the endogenous ligand has been confirmed.  A pivotal role for the conserved residue N133 is suggested and further supported by a study of the N133A in silico mutant.  Accordingly, N133 can work as a mol. microswitch driving the change between the inactive and active NOP conformations, in the framework of an extended H-bond and water network rearrangement in the deep binding site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpT4-CBYIpqObVg90H21EOLACvtfcHk0ljtx-Tpc2DuGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Sgs7vL&md5=04150fcde23e790592cbbe14ea4d8b2f</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.bpj.2016.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bpj.2016.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DDella%2BLonga%26aufirst%3DS.%26aulast%3DArcovito%26aufirst%3DA.%26atitle%3DA%2520dynamic%2520picture%2520of%2520the%2520early%2520events%2520in%2520nociceptin%2520binding%2520to%2520the%2520NOP%2520receptor%2520by%2520metadynamics%26jtitle%3DBiophys.%2520J.%26date%3D2016%26volume%3D111%26spage%3D1203%26epage%3D1213%26doi%3D10.1016%2Fj.bpj.2016.07.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Janda, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, K. C.</span></span> <span> </span><span class="NLM_article-title">Wnt acylation and its functional implication in Wnt signalling regulation</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">211</span>– <span class="NLM_lpage">216</span>, <span class="refDoi"> DOI: 10.1042/bst20140249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1042%2FBST20140249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=25849919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlvFSjtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2015&pages=211-216&author=C.+Y.+Jandaauthor=K.+C.+Garcia&title=Wnt+acylation+and+its+functional+implication+in+Wnt+signalling+regulation&doi=10.1042%2Fbst20140249"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt acylation and its functional implication in Wnt signalling regulation</span></div><div class="casAuthors">Janda, Claudia Y.; Garcia, K. Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">211-216</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Wnt proteins are conserved signalling mols. that have an essential role in regulating diverse processes during embryogenesis and adult tissue homoeostasis.  Wnts are post-translationally modified by palmitoylation, which is essential for Wnt secretion and function.  Intriguingly, the crystal structure of XWnt8 in complex with the extracellular domain of the Frizzled 8 cysteine-rich domain (Fzd8-CRD) revealed that Wnts use the fatty acid as a 'hotspot' residue to engage its receptor, which is a unique mode of receptor-ligand recognition.  In addn., there are several lines of evidence suggesting that Wnts engage several signalling modulators and alternative receptors by means of fatty acids as a crit. contact residue.  In the present article, we review our current understanding of Wnt acylation and its functional role in Wnt signalling regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolTAV6vOMoPrVg90H21EOLACvtfcHk0ljtx-Tpc2DuGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlvFSjtrc%253D&md5=1ff3c73e18d01e779f82c039c8a062bb</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1042%2FBST20140249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20140249%26sid%3Dliteratum%253Aachs%26aulast%3DJanda%26aufirst%3DC.%2BY.%26aulast%3DGarcia%26aufirst%3DK.%2BC.%26atitle%3DWnt%2520acylation%2520and%2520its%2520functional%2520implication%2520in%2520Wnt%2520signalling%2520regulation%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2015%26volume%3D43%26spage%3D211%26epage%3D216%26doi%3D10.1042%2Fbst20140249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fredriksson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagerström, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lundin, L.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiöth, H. B.</span></span> <span> </span><span class="NLM_article-title">The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">1256</span>– <span class="NLM_lpage">1272</span>, <span class="refDoi"> DOI: 10.1124/mol.63.6.1256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1124%2Fmol.63.6.1256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=12761335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkt1Shu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=1256-1272&author=R.+Fredrikssonauthor=M.+C.+Lagerstr%C3%B6mauthor=L.-G.+Lundinauthor=H.+B.+Schi%C3%B6th&title=The+G-protein-coupled+receptors+in+the+human+genome+form+five+main+families.+Phylogenetic+analysis%2C+paralogon+groups%2C+and+fingerprints&doi=10.1124%2Fmol.63.6.1256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints</span></div><div class="casAuthors">Fredriksson, Robert; Lagerstrom, Malin C.; Lundin, Lars-Gustav; Schioth, Helgi B.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1256-1272</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The superfamily of G-protein-coupled receptors (GPCRs) is very diverse in structure and function and its members are among the most pursued targets for drug development.  We identified more than 800 human GPCR sequences and simultaneously analyzed 342 unique functional nonolfactory human GPCR sequences with phylogenetic analyses.  Our results show, with high bootstrap support, five main families, named glutamate, rhodopsin, adhesion, frizzled/taste2, and secretin, forming the GRAFS classification system.  The rhodopsin family is the largest and forms four main groups with 13 subbranches.  Positions of the GPCRs in chromosomal paralogons regions indicate the importance of tetraploidizations or local gene duplication events for their creation.  We also searched for "fingerprint" motifs using Hidden Markov Models delineating the putative inter-relationship of the GRAFS families.  We show several common structural features indicating that the human GPCRs in the GRAFS families share a common ancestor.  This study represents the first overall map of the GPCRs in a single mammalian genome.  Our novel approach of analyzing such large and diverse sequence sets may be useful for studies on GPCRs in other genomes and divergent protein families.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdX4VhTsaDzrVg90H21EOLACvtfcHk0ljtx-Tpc2DuGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkt1Shu7k%253D&md5=504ea873ee8469cd0b6016bc94943836</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1124%2Fmol.63.6.1256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.63.6.1256%26sid%3Dliteratum%253Aachs%26aulast%3DFredriksson%26aufirst%3DR.%26aulast%3DLagerstr%25C3%25B6m%26aufirst%3DM.%2BC.%26aulast%3DLundin%26aufirst%3DL.-G.%26aulast%3DSchi%25C3%25B6th%26aufirst%3DH.%2BB.%26atitle%3DThe%2520G-protein-coupled%2520receptors%2520in%2520the%2520human%2520genome%2520form%2520five%2520main%2520families.%2520Phylogenetic%2520analysis%252C%2520paralogon%2520groups%252C%2520and%2520fingerprints%26jtitle%3DMol.%2520Pharmacol.%26date%3D2003%26volume%3D63%26spage%3D1256%26epage%3D1272%26doi%3D10.1124%2Fmol.63.6.1256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carr, R.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benovic, J. L.</span></span> <span> </span><span class="NLM_article-title">From biased signalling to polypharmacology: unlocking unique intracellular signalling using pepducins</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">555</span>– <span class="NLM_lpage">561</span>, <span class="refDoi"> DOI: 10.1042/bst20150230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1042%2FBST20150230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=27068969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlslyqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2016&pages=555-561&author=R.+Carrauthor=J.+L.+Benovic&title=From+biased+signalling+to+polypharmacology%3A+unlocking+unique+intracellular+signalling+using+pepducins&doi=10.1042%2Fbst20150230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">From biased signalling to polypharmacology: unlocking unique intracellular signalling using pepducins</span></div><div class="casAuthors">Carr, Richard, III; Benovic, Jeffrey L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">555-561</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">For over a decade, pepducins have been utilized to develop unique pharmacol. profiles that have been particularly challenging for traditional drug discovery methods.  It is becoming increasingly clear that these cell-penetrating lipopeptides can access receptor conformations that are currently not accessible through orthosteric targeting.  This review addresses the emerging concepts in the development of pepducins including the elicitation of biased signalling, pepducin polypharmacol. and recent insight into their mechanism of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3aZFivLDit7Vg90H21EOLACvtfcHk0ljOAq36XZHcQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlslyqt7g%253D&md5=dcaeb398ab7aee0e6f1712c24828e617</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1042%2FBST20150230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST20150230%26sid%3Dliteratum%253Aachs%26aulast%3DCarr%26aufirst%3DR.%26aulast%3DBenovic%26aufirst%3DJ.%2BL.%26atitle%3DFrom%2520biased%2520signalling%2520to%2520polypharmacology%253A%2520unlocking%2520unique%2520intracellular%2520signalling%2520using%2520pepducins%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2016%26volume%3D44%26spage%3D555%26epage%3D561%26doi%3D10.1042%2Fbst20150230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsuji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirayama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaguchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isono, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagasawa, H.</span></span> <span> </span><span class="NLM_article-title">FRET-based imaging of transbilayer movement of pepducin in living cells by novel intracellular bioreductively activatable fluorescent probes</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">3030</span>– <span class="NLM_lpage">3037</span>, <span class="refDoi"> DOI: 10.1039/c3ob27445d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1039%2Fc3ob27445d" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=23532512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtVWks78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2013&pages=3030-3037&author=M.+Tsujiauthor=S.+Uedaauthor=T.+Hirayamaauthor=K.+Okudaauthor=Y.+Sakaguchiauthor=A.+Isonoauthor=H.+Nagasawa&title=FRET-based+imaging+of+transbilayer+movement+of+pepducin+in+living+cells+by+novel+intracellular+bioreductively+activatable+fluorescent+probes&doi=10.1039%2Fc3ob27445d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">FRET-based imaging of transbilayer movement of pepducin in living cells by novel intracellular bioreductively activatable fluorescent probes</span></div><div class="casAuthors">Tsuji, Mieko; Ueda, Satoshi; Hirayama, Tasuku; Okuda, Kensuke; Sakaguchi, Yoshiaki; Isono, Aoi; Nagasawa, Hideko</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3030-3037</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">To elucidate the mechanisms of direct transmembrane penetration of pepducins, which are artificial lipopeptide G protein-coupled receptor (GPCR) modulators, the authors developed two types of FRET-based probes, Pep13-FL-SS-Dab (13) targeting the inner leaflet of the lipid bilayer and Pep13-Dab-SS-FL (14) targeting the cytosol, resp.  They are composed of a pepducin moiety and a fluorescent switch component consisting of 5(6)-carboxyfluorescein (FAM) as a fluorophore and dabcyl as a quencher connected through disulfide bond linkage.  When they are internalized into the cytosol, intracellular glutathione can cleave the disulfide bond to release the quencher, which results in a turn-on fluorescence signal.  Using these probes, the authors performed live cell imaging of transbilayer movements of pepducins on MCF-7 cells for the first time.  The results suggested that the lipid moiety of the probes facilitated pepducin flipping across and tethering to the membrane.  The present study raises the possibility of applying the probe architecture for direct intracellular drug delivery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosDiFgs14A-rVg90H21EOLACvtfcHk0ljOAq36XZHcQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtVWks78%253D&md5=6abf6bafd05b4eb055bdbae307eda210</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1039%2Fc3ob27445d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3ob27445d%26sid%3Dliteratum%253Aachs%26aulast%3DTsuji%26aufirst%3DM.%26aulast%3DUeda%26aufirst%3DS.%26aulast%3DHirayama%26aufirst%3DT.%26aulast%3DOkuda%26aufirst%3DK.%26aulast%3DSakaguchi%26aufirst%3DY.%26aulast%3DIsono%26aufirst%3DA.%26aulast%3DNagasawa%26aufirst%3DH.%26atitle%3DFRET-based%2520imaging%2520of%2520transbilayer%2520movement%2520of%2520pepducin%2520in%2520living%2520cells%2520by%2520novel%2520intracellular%2520bioreductively%2520activatable%2520fluorescent%2520probes%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2013%26volume%3D11%26spage%3D3030%26epage%3D3037%26doi%3D10.1039%2Fc3ob27445d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quoyer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janz, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armando, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukashova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benovic, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, S. W.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouvier, M.</span></span> <span> </span><span class="NLM_article-title">Pepducin targeting the C-X-C chemokine receptor type 4 acts as a biased agonist favoring activation of the inhibitory G protein</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span>,  <span class="NLM_fpage">E5088</span>– <span class="NLM_lpage">E5097</span>, <span class="refDoi"> DOI: 10.1073/pnas.1312515110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1073%2Fpnas.1312515110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=24309376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC2cXns1SjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=E5088-E5097&author=J.+Quoyerauthor=J.+M.+Janzauthor=J.+Luoauthor=Y.+Renauthor=S.+Armandoauthor=V.+Lukashovaauthor=J.+L.+Benovicauthor=K.+E.+Carlsonauthor=S.+W.+Huntauthor=M.+Bouvier&title=Pepducin+targeting+the+C-X-C+chemokine+receptor+type+4+acts+as+a+biased+agonist+favoring+activation+of+the+inhibitory+G+protein&doi=10.1073%2Fpnas.1312515110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Pepducin targeting the C-X-C chemokine receptor type 4 acts as a biased agonist favoring activation of the inhibitory G protein</span></div><div class="casAuthors">Quoyer, Julie; Janz, Jay M.; Luo, Jiansong; Ren, Yong; Armando, Sylvain; Lukashova, Viktoria; Benovic, Jeffrey L.; Carlson, Kenneth E.; Hunt, Stephen W., III; Bouvier, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">E5088-E5097,SE5088/1-SE5088/6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Short lipidated peptide sequences derived from various intracellular loop regions of G protein-coupled receptors (GPCRs) are named pepducins and act as allosteric modulators of a no. of GPCRs.  Recently, a pepducin selectively targeting the C-X-C chemokine receptor type 4 (CXCR4) was found to be an allosteric agonist, active in both cell-based assays and in vivo.  However, the precise mechanism of action of this class of ligands remains poorly understood.  In particular, given the diversity of signaling effectors that can be engaged by a given receptor, it is not clear whether pepducins can show biased signaling leading to functional selectivity.  To explore the ligand-biased potential of pepducins, the authors assessed the effect of the CXCR4 selective pepducin, ATI-2341, on the ability of the receptor to engage the inhibitory G proteins (Gi1, Gi2 and Gi3), G13, and β-arrestins.  Using bioluminescence resonance energy transfer-based biosensors, the authors found that, in contrast to the natural CXCR4 ligand, stromal cell-derived factor-1α, which promotes the engagement of the three Gi subtypes, G13 and the two β-arrestins, ATI-2341 leads to the engagement of the Gi subtypes but not G13 or the β-arrestins.  Calcn. of the transduction ratio for each pathway revealed a strong neg. bias of ATI-2341 toward G13 and β-arrestins, revealing functional selectivity for the Gi pathways.  The neg. bias toward β-arrestins results from the reduced ability of the pepducin to promote GPCR kinase-mediated phosphorylation of the receptor.  In addn. to revealing ligand-biased signaling of pepducins, these findings shed some light on the mechanism of action of a unique class of allosteric regulators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBOvGh6qLDbLVg90H21EOLACvtfcHk0ljOAq36XZHcQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXns1SjtQ%253D%253D&md5=748ab512167787aa3fe31642f7c244b1</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1312515110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1312515110%26sid%3Dliteratum%253Aachs%26aulast%3DQuoyer%26aufirst%3DJ.%26aulast%3DJanz%26aufirst%3DJ.%2BM.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DArmando%26aufirst%3DS.%26aulast%3DLukashova%26aufirst%3DV.%26aulast%3DBenovic%26aufirst%3DJ.%2BL.%26aulast%3DCarlson%26aufirst%3DK.%2BE.%26aulast%3DHunt%26aufirst%3DS.%2BW.%26aulast%3DBouvier%26aufirst%3DM.%26atitle%3DPepducin%2520targeting%2520the%2520C-X-C%2520chemokine%2520receptor%2520type%25204%2520acts%2520as%2520a%2520biased%2520agonist%2520favoring%2520activation%2520of%2520the%2520inhibitory%2520G%2520protein%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2013%26volume%3D110%26spage%3DE5088%26epage%3DE5097%26doi%3D10.1073%2Fpnas.1312515110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gabl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holdfeldt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundqvist, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lomei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlgren, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forsman, H.</span></span> <span> </span><span class="NLM_article-title">FPR2 signaling without beta-arrestin recruitment alters the functional repertoire of neutrophils</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>145</i></span>,  <span class="NLM_fpage">114</span>– <span class="NLM_lpage">122</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2017.08.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1016%2Fj.bcp.2017.08.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=28855087" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVWmsbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2017&pages=114-122&author=M.+Gablauthor=A.+Holdfeldtauthor=M.+Sundqvistauthor=J.+Lomeiauthor=C.+Dahlgrenauthor=H.+Forsman&title=FPR2+signaling+without+beta-arrestin+recruitment+alters+the+functional+repertoire+of+neutrophils&doi=10.1016%2Fj.bcp.2017.08.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">FPR2 signaling without β-arrestin recruitment alters the functional repertoire of neutrophils</span></div><div class="casAuthors">Gabl, Michael; Holdfeldt, Andre; Sundqvist, Martina; Lomei, Jalal; Dahlgren, Claes; Forsman, Huamei</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">114-122</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">G-protein coupled receptor (GPCR) biased agonism or functional selectivity has become an essential concept in GPCR research over the last years.  Receptor-specific biased agonists selectively trigger one signaling pathway over another and induce a restricted/directed functional response.  In this study, we aimed to characterize the concept of biased agonism for FPR2, a member of the formyl peptide receptor (FPR) subfamily of GPCRs.  We show that the earlier described FPR2-activating pepducin F2Pal10 is a biased FPR2 agonist.  The effects of F2Pal10 on neutrophil function differed in several aspects compared to those mediated by WKYMVM, a conventional FPR2-specific peptide agonist.  Upon interaction with FPR2 expressed by neutrophils both F2Pal10 and WKYMVM activated the PLC-PIP2-Ca2+ signaling pathway and the superoxide-generating NADPH-oxidase, but only WKYMVM activated the receptor to recruit β-arrestin.  The functional consequences linked to a lack of β-arrestin recruitment were further explored, and we demonstrate that FPR2 desensitization occurred independent of β-arrestin.  Despite this, reactivation of desensitized receptors achieved through a disruption of the cytoskeleton and through a novel FPR2 cross-talk mechanism with P2Y2R (the ATP receptor) and PAFR (the receptor for PAF) differed between F2Pal10-desensitized and WKYMVM-desensitized neutrophils.  Further, the inability to recruit β-arrestin was found to be assocd. with a reduced rate of receptor internalization and impaired chemotaxis in neutrophils.  In summary, we provide exptl. evidence of biased agonism for FPR2 and our data disclose crit. roles of β-arrestin in neutrophil chemotaxis and reactivation of desensitized receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqz-stXhQetSbVg90H21EOLACvtfcHk0liwYCicgr9fVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVWmsbzP&md5=1031773a38e0c377d4bf6e251dcb5f7b</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2017.08.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2017.08.018%26sid%3Dliteratum%253Aachs%26aulast%3DGabl%26aufirst%3DM.%26aulast%3DHoldfeldt%26aufirst%3DA.%26aulast%3DSundqvist%26aufirst%3DM.%26aulast%3DLomei%26aufirst%3DJ.%26aulast%3DDahlgren%26aufirst%3DC.%26aulast%3DForsman%26aufirst%3DH.%26atitle%3DFPR2%2520signaling%2520without%2520beta-arrestin%2520recruitment%2520alters%2520the%2520functional%2520repertoire%2520of%2520neutrophils%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2017%26volume%3D145%26spage%3D114%26epage%3D122%26doi%3D10.1016%2Fj.bcp.2017.08.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carr, R.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quoyer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panettieri, R. A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janz, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouvier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobilka, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benovic, J. L.</span></span> <span> </span><span class="NLM_article-title">Development and characterization of pepducins as Gs-biased allosteric agonists</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">35668</span>– <span class="NLM_lpage">35684</span>, <span class="refDoi"> DOI: 10.1074/jbc.m114.618819</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1074%2Fjbc.M114.618819" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=25395624" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitFOhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=35668-35684&author=R.+Carrauthor=Y.+Duauthor=J.+Quoyerauthor=R.+A.+Panettieriauthor=J.+M.+Janzauthor=M.+Bouvierauthor=B.+K.+Kobilkaauthor=J.+L.+Benovic&title=Development+and+characterization+of+pepducins+as+Gs-biased+allosteric+agonists&doi=10.1074%2Fjbc.m114.618819"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Development and Characterization of Pepducins as Gs-biased Allosteric Agonists</span></div><div class="casAuthors">Carr, Richard, III; Du, Yang; Quoyer, Julie; Panettieri, Reynold A., Jr.; Janz, Jay M.; Bouvier, Michel; Kobilka, Brian K.; Benovic, Jeffrey L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">35668-35684</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The β2-adrenergic receptor (β2AR) is a prototypical G protein-coupled receptor that mediates many hormonal responses, including cardiovascular and pulmonary function. β-Agonists used to combat hypercontractility in airway smooth muscle stimulate β2AR-dependent cAMP prodn. that ultimately promotes airway relaxation.  Chronic stimulation of the β2AR by long acting β-agonists used in the treatment of asthma can promote attenuated responsiveness to agonists and an increased frequency of fatal asthmatic attacks. β2AR desensitization to β-agonists is primarily mediated by G protein-coupled receptor kinases and β-arrestins that attenuate receptor-Gs coupling and promote β2AR internalization and degrdn.  A biased agonist that can selectively stimulate Gs signaling without promoting receptor interaction with G protein-coupled receptor kinases and β-arrestins should serve as an advantageous asthma therapeutic.  To identify such mols., we screened ∼50 lipidated peptides derived from the intracellular loops of the β2AR, known as pepducins.  This screen revealed two classes of Gs-biased pepducins, receptor-independent and receptor-dependent, as well as several β-arrestin-biased pepducins.  The receptor-independent Gs-biased pepducins operate by directly stimulating G protein activation.  In contrast, receptor-dependent Gs-biased pepducins appear to stabilize a Gs-biased conformation of the β2AR that couples to Gs but does not undergo G protein-coupled receptor kinase-mediated phosphorylation or β-arrestin-mediated internalization.  Functional studies in primary human airway smooth muscle cells demonstrate that Gs-biased pepducins are not subject to conventional desensitization and thus may be good candidates for the development of next generation asthma therapeutics.  Our study reports the first Gs-biased activator of the β2AR and provides valuable tools for the study of β2AR function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-lWPD7GDCHLVg90H21EOLACvtfcHk0liwYCicgr9fVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitFOhtQ%253D%253D&md5=d50350aa74734b00958e1a09b42e5161</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.618819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.618819%26sid%3Dliteratum%253Aachs%26aulast%3DCarr%26aufirst%3DR.%26aulast%3DDu%26aufirst%3DY.%26aulast%3DQuoyer%26aufirst%3DJ.%26aulast%3DPanettieri%26aufirst%3DR.%2BA.%26aulast%3DJanz%26aufirst%3DJ.%2BM.%26aulast%3DBouvier%26aufirst%3DM.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26aulast%3DBenovic%26aufirst%3DJ.%2BL.%26atitle%3DDevelopment%2520and%2520characterization%2520of%2520pepducins%2520as%2520Gs-biased%2520allosteric%2520agonists%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D35668%26epage%3D35684%26doi%3D10.1074%2Fjbc.m114.618819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carr, R.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynham, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tilley, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benovic, J. L.</span></span> <span> </span><span class="NLM_article-title">Beta-arrestin-biased signaling through the beta2-adrenergic receptor promotes cardiomyocyte contraction</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">E4107</span>– <span class="NLM_lpage">E4116</span>, <span class="refDoi"> DOI: 10.1073/pnas.1606267113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1073%2Fpnas.1606267113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=27354517" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=E4107-E4116&author=R.+Carrauthor=J.+Schillingauthor=J.+Songauthor=R.+L.+Carterauthor=Y.+Duauthor=S.+M.+Yooauthor=C.+J.+Traynhamauthor=W.+J.+Kochauthor=J.+Y.+Cheungauthor=D.+G.+Tilleyauthor=J.+L.+Benovic&title=Beta-arrestin-biased+signaling+through+the+beta2-adrenergic+receptor+promotes+cardiomyocyte+contraction&doi=10.1073%2Fpnas.1606267113"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1606267113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1606267113%26sid%3Dliteratum%253Aachs%26aulast%3DCarr%26aufirst%3DR.%26aulast%3DSchilling%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DJ.%26aulast%3DCarter%26aufirst%3DR.%2BL.%26aulast%3DDu%26aufirst%3DY.%26aulast%3DYoo%26aufirst%3DS.%2BM.%26aulast%3DTraynham%26aufirst%3DC.%2BJ.%26aulast%3DKoch%26aufirst%3DW.%2BJ.%26aulast%3DCheung%26aufirst%3DJ.%2BY.%26aulast%3DTilley%26aufirst%3DD.%2BG.%26aulast%3DBenovic%26aufirst%3DJ.%2BL.%26atitle%3DBeta-arrestin-biased%2520signaling%2520through%2520the%2520beta2-adrenergic%2520receptor%2520promotes%2520cardiomyocyte%2520contraction%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2016%26volume%3D113%26spage%3DE4107%26epage%3DE4116%26doi%3D10.1073%2Fpnas.1606267113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mollereau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parmentier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mailleux, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butour, J.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moisand, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chalon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caput, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vassart, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meunier, J.-C.</span></span> <span> </span><span class="NLM_article-title">ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>341</i></span>,  <span class="NLM_fpage">33</span>– <span class="NLM_lpage">38</span>, <span class="refDoi"> DOI: 10.1016/0014-5793(94)80235-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1016%2F0014-5793%2894%2980235-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=8137918" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADyaK2cXksFamurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=1994&pages=33-38&author=C.+Mollereauauthor=M.+Parmentierauthor=P.+Mailleuxauthor=J.-L.+Butourauthor=C.+Moisandauthor=P.+Chalonauthor=D.+Caputauthor=G.+Vassartauthor=J.-C.+Meunier&title=ORL1%2C+a+novel+member+of+the+opioid+receptor+family.+Cloning%2C+functional+expression+and+localization&doi=10.1016%2F0014-5793%2894%2980235-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization</span></div><div class="casAuthors">Mollereau, Catherine; Parmentier, Marc; Mailleux, Pierre; Butour, Jean Luc; Moisand, Christiane; Chalon, Pascale; Caput, Daniel; Vassart, Gilbert; Meunier, Jean Claude</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-8</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    </div><div class="casAbstract">Selective PCR amplification of human and mouse genomic DNAs with oligonucleotides encoding highly conserved regions of the β-opioid and somatostatin receptors generated a human DNA probe (hOP01, 761 bp) and its murine counterpart (mOP86, 447 bp).  Probe hOP01 was used to screen a cDNA library from human brainstem.  A clone (named hORL1) was isolated, sequenced and found to encode a protein of 370 amino acids whose primary structure displays the seven putative membrane-spanning domains of a G protein-coupled membrane receptor.  The hORL1 receptor is most closely related to opioid receptors not only on structural (sequence) but also on functional grounds: hORL1 is 49-50% identical to the murine μ-, δ- and κ-opioid receptors and, in CHO-K1 cells stably transfected with a pRc/CMV:hORL1 construct, ORL1 mediates inhibition of adenylyl cyclase by etorphine, a universal (nonselective) opiate agonist.  Yet, hORL1 appears not to be a typical opioid receptor.  Neither is it a somatostatin or σ (N-allylnormetazocine) receptor.  The mRNAs hybridizing with synthetic oligonucleotides complementary to mOP86 are present in many regions of the mouse brain and spinal cord, particularly in limbic (amygdala, hippocampus, septum, habenula, ...) and hypothalamic structures.  The authors conclude that the hORL1 receptor is a new member of the opioid receptor family with a potential role in modulating a no. of brain functions, including instinctive behaviors and emotions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWFR7ExrwbJrVg90H21EOLACvtfcHk0lhtGJpJAFQ6fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXksFamurs%253D&md5=7a7190c4703811558b3ce3e60e9df7e8</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2F0014-5793%2894%2980235-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-5793%252894%252980235-1%26sid%3Dliteratum%253Aachs%26aulast%3DMollereau%26aufirst%3DC.%26aulast%3DParmentier%26aufirst%3DM.%26aulast%3DMailleux%26aufirst%3DP.%26aulast%3DButour%26aufirst%3DJ.-L.%26aulast%3DMoisand%26aufirst%3DC.%26aulast%3DChalon%26aufirst%3DP.%26aulast%3DCaput%26aufirst%3DD.%26aulast%3DVassart%26aufirst%3DG.%26aulast%3DMeunier%26aufirst%3DJ.-C.%26atitle%3DORL1%252C%2520a%2520novel%2520member%2520of%2520the%2520opioid%2520receptor%2520family.%2520Cloning%252C%2520functional%2520expression%2520and%2520localization%26jtitle%3DFEBS%2520Lett.%26date%3D1994%26volume%3D341%26spage%3D33%26epage%3D38%26doi%3D10.1016%2F0014-5793%2894%2980235-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zaratin, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrone, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sbacchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garnier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fossati, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrillo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ronzoni, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giardina, G. A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheideler, M. A.</span></span> <span> </span><span class="NLM_article-title">Modification of nociception and morphine tolerance by the selective opiate receptor-like orphan receptor antagonist (-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5<i>H</i>-benzocyclohepten-5-ol (SB-612111)</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>308</i></span>,  <span class="NLM_fpage">454</span>– <span class="NLM_lpage">461</span>, <span class="refDoi"> DOI: 10.1124/jpet.103.055848</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1124%2Fjpet.103.055848" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=14593080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtlSqtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=308&publication_year=2004&pages=454-461&author=P.+F.+Zaratinauthor=G.+Petroneauthor=M.+Sbacchiauthor=M.+Garnierauthor=C.+Fossatiauthor=P.+Petrilloauthor=S.+Ronzoniauthor=G.+A.+M.+Giardinaauthor=M.+A.+Scheideler&title=Modification+of+nociception+and+morphine+tolerance+by+the+selective+opiate+receptor-like+orphan+receptor+antagonist+%28-%29-cis-1-methyl-7-%5B%5B4-%282%2C6-dichlorophenyl%29piperidin-1-yl%5Dmethyl%5D-6%2C7%2C8%2C9-tetrahydro-5H-benzocyclohepten-5-ol+%28SB-612111%29&doi=10.1124%2Fjpet.103.055848"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Modification of nociception and morphine tolerance by the selective opiate receptor-like orphan receptor antagonist (-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol (SB-612111)</span></div><div class="casAuthors">Zaratin, Paola F.; Petrone, Giuseppe; Sbacchi, Massimo; Garnier, Martine; Fossati, Claudia; Petrillo, Paola; Ronzoni, Silvio; Giardina, Giuseppe A. M.; Scheideler, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">308</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">454-461</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">SB-612111 is a novel human opiate receptor-like orphan receptor (ORL-1) antagonist that has high affinity for the clonal human ORL-1 receptor (hORL-1 Ki = 0.33 nM), selectivity vs. μ- (174-fold), δ- (6391-fold), and κ (486-fold)-opioid receptors and is able to inhibit nociceptin signaling via hORL-1 in a whole cell gene reporter assay.  SB-612111 has no measurable antinociceptive effects in vivo in the mouse hot-plate test after i.v. administration but is able to antagonize the antimorphine action of nociceptin [ED50 = 0.69 mg/kg, 95% confidence limit (CL) = 0.34-1.21].  SB-62111 administration can also reverse tolerance to morphine in this model, established via repeated morphine administration.  In addn., i.v. SB-612111 can antagonize nociceptin-induced thermal hyperalgesia in a dose-dependent manner (ED50 = 0.62 mg/kg i.v., 95% CL = 0.22-1.89) and is effective per se at reversing thermal hyperalgesia in the rat carrageenan inflammatory pain model.  These data show that an ORL-1 receptor antagonist may be a useful adjunct to chronic pain therapy with opioids and can be used to treat conditions in which thermal hyperalgesia is a significant component of the pain response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZbUKJ64ZkmbVg90H21EOLACvtfcHk0lhtGJpJAFQ6fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtlSqtLo%253D&md5=c56ae72c9113af5aeb7168b9a1646b7b</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.055848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.055848%26sid%3Dliteratum%253Aachs%26aulast%3DZaratin%26aufirst%3DP.%2BF.%26aulast%3DPetrone%26aufirst%3DG.%26aulast%3DSbacchi%26aufirst%3DM.%26aulast%3DGarnier%26aufirst%3DM.%26aulast%3DFossati%26aufirst%3DC.%26aulast%3DPetrillo%26aufirst%3DP.%26aulast%3DRonzoni%26aufirst%3DS.%26aulast%3DGiardina%26aufirst%3DG.%2BA.%2BM.%26aulast%3DScheideler%26aufirst%3DM.%2BA.%26atitle%3DModification%2520of%2520nociception%2520and%2520morphine%2520tolerance%2520by%2520the%2520selective%2520opiate%2520receptor-like%2520orphan%2520receptor%2520antagonist%2520%2528-%2529-cis-1-methyl-7-%255B%255B4-%25282%252C6-dichlorophenyl%2529piperidin-1-yl%255Dmethyl%255D-6%252C7%252C8%252C9-tetrahydro-5H-benzocyclohepten-5-ol%2520%2528SB-612111%2529%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2004%26volume%3D308%26spage%3D454%26epage%3D461%26doi%3D10.1124%2Fjpet.103.055848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spagnolo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrà, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fantin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischetti, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hebbes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trapella, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanton, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morari, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regoli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calò, G.</span></span> <span> </span><span class="NLM_article-title">Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5<i>H</i>-benzocyclohepten-5-ol]: in vitro studies</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>321</i></span>,  <span class="NLM_fpage">961</span>– <span class="NLM_lpage">967</span>, <span class="refDoi"> DOI: 10.1124/jpet.106.116764</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1124%2Fjpet.106.116764" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=17329552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFeqsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=321&publication_year=2007&pages=961-967&author=B.+Spagnoloauthor=G.+Carr%C3%A0author=M.+Fantinauthor=C.+Fischettiauthor=C.+Hebbesauthor=J.+McDonaldauthor=T.+A.+Barnesauthor=A.+Rizziauthor=C.+Trapellaauthor=G.+Fantonauthor=M.+Morariauthor=D.+G.+Lambertauthor=D.+Regoliauthor=G.+Cal%C3%B2&title=Pharmacological+characterization+of+the+nociceptin%2Forphanin+FQ+receptor+antagonist+SB-612111+%5B%28-%29-cis-1-methyl-7-%5B%5B4-%282%2C6-dichlorophenyl%29piperidin-1-yl%5Dmethyl%5D-6%2C7%2C8%2C9-tetrahydro-5H-benzocyclohepten-5-ol%5D%3A+in+vitro+studies&doi=10.1124%2Fjpet.106.116764"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vitro studies</span></div><div class="casAuthors">Spagnolo, Barbara; Carra, Giacomo; Fantin, Martina; Fischetti, Carmela; Hebbes, Chris; McDonald, John; Barnes, Timothy A.; Rizzi, Anna; Trapella, Claudio; Fanton, Giulia; Morari, Michele; Lambert, Dave G.; Regoli, Domenico; Calo, Girolamo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">321</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">961-967</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The compd. SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol] was recently identified as a selective antagonist for the nociceptin/orphanin FQ (N/OFQ) peptide receptor (NOP).  In the present study, the in vitro pharmacol. profile of SB-612111 at human recombinant NOP receptors expressed in Chinese hamster ovary (CHO) cells [receptor binding, guanosine 5'-O-(3-[35S]thio)triphosphate (GTPγ[35S]) binding, and cAMP level expts.] as well as at native NOP receptors expressed in peripheral (mouse and rat vas deferens, guinea pig ileum) and central (mouse cerebral cortex synaptosomes releasing [3H]5-HT) prepns. was evaluated and compared with that of the std. nonpeptide antagonist (±)J-113397 [(±)-trans-1-[1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one].  SB-612111 produced a concn.-dependent displacement of [3H]N/OFQ binding to CHOhNOP cell membranes, showing higher affinity and NOP selectivity over classical opioid receptors than (±)J-113397.  SB-612111 and (±)J-113397 competitively antagonized the effects of N/OFQ on GTPγ[35S] binding in CHOhNOP cell membranes (pKB, 9.70 and 8.71, resp.) and on cAMP accumulation in CHOhNOP cells (pKB, 8.63 and 7.95, resp.), being per se inactive.  In isolated peripheral tissues of mice, rats, and guinea pigs and in mouse cerebral cortex synaptosomes preloaded with [3H]5-HT, SB-612111 competitively antagonized the inhibitory effects of N/OFQ, with pA2 values in the range of 8.20 to 8.50.  In parallel expts., (±)J-113397 was found to be 2- to 9-fold less potent than SB-612111.  In the elec. stimulated tissues, 1 μM SB-612111 did not modify the effects of classical opioid receptor agonists.  In conclusion, the results of the present study demonstrated that SB-612111 is among the most potent and NOP-selective nonpeptide antagonists identified to date.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozelFgTfoi5rVg90H21EOLACvtfcHk0lhXFdMi964YKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFeqsrw%253D&md5=49c903afa586c64284535b50692bb877</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.116764&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.116764%26sid%3Dliteratum%253Aachs%26aulast%3DSpagnolo%26aufirst%3DB.%26aulast%3DCarr%25C3%25A0%26aufirst%3DG.%26aulast%3DFantin%26aufirst%3DM.%26aulast%3DFischetti%26aufirst%3DC.%26aulast%3DHebbes%26aufirst%3DC.%26aulast%3DMcDonald%26aufirst%3DJ.%26aulast%3DBarnes%26aufirst%3DT.%2BA.%26aulast%3DRizzi%26aufirst%3DA.%26aulast%3DTrapella%26aufirst%3DC.%26aulast%3DFanton%26aufirst%3DG.%26aulast%3DMorari%26aufirst%3DM.%26aulast%3DLambert%26aufirst%3DD.%2BG.%26aulast%3DRegoli%26aufirst%3DD.%26aulast%3DCal%25C3%25B2%26aufirst%3DG.%26atitle%3DPharmacological%2520characterization%2520of%2520the%2520nociceptin%252Forphanin%2520FQ%2520receptor%2520antagonist%2520SB-612111%2520%255B%2528-%2529-cis-1-methyl-7-%255B%255B4-%25282%252C6-dichlorophenyl%2529piperidin-1-yl%255Dmethyl%255D-6%252C7%252C8%252C9-tetrahydro-5H-benzocyclohepten-5-ol%255D%253A%2520in%2520vitro%2520studies%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D321%26spage%3D961%26epage%3D967%26doi%3D10.1124%2Fjpet.106.116764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferrari, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzza, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calo, G.</span></span> <span> </span><span class="NLM_article-title">Detailed in vitro pharmacological characterization of the clinically viable nociceptin/orphanin FQ peptide receptor antagonist BTRX-246040</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>373</i></span>,  <span class="NLM_fpage">34</span>– <span class="NLM_lpage">43</span>, <span class="refDoi"> DOI: 10.1124/jpet.119.262865</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1124%2Fjpet.119.262865" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=31937563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BB3cXovV2rs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2020&pages=34-43&author=F.+Ferrariauthor=S.+Rizzoauthor=C.+Ruzzaauthor=G.+Calo&title=Detailed+in+vitro+pharmacological+characterization+of+the+clinically+viable+nociceptin%2Forphanin+FQ+peptide+receptor+antagonist+BTRX-246040&doi=10.1124%2Fjpet.119.262865"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Detailed in vitro pharmacological characterization of the clinically viable nociceptin/orphanin FQ peptide receptor antagonist BTRX-246040</span></div><div class="casAuthors">Ferrari, Federica; Rizzo, Sabrina; Ruzza, Chiara; Calo, Girolamo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">373</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">34-43</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The peptide nociceptin/orphanin FQ (N/OFQ) is the natural ligand of the N/OFQ receptor (NOP), which is widely expressed in the central and peripheral nervous system.  Selective NOP antagonists are worthy of testing as innovative drugs to treat depression, Parkinson disease, and drug abuse.  The aim of this study was to perform a detailed in vitro characterization of BTRX-246040 (also known as LY2940094, [2-[4-[(2-chloro-4,4-difluoro-spiro[5H-thieno [2,3-c]pyran-7,4'-piperidine]-1'-yl)methyl]-3-methyl-pyrazol-1-yl]-3-pyridyl]methanol), a novel NOP antagonist that has been already studied in humans.  BTRX-246040 has been tested in vitro in the following assays: calcium mobilization in cells expressing NOP and classic opioid receptors and chimeric G proteins, bioluminescence resonance energy transfer assay measuring NOP interaction with G proteins and β-arrestins, the label-free dynamic mass redistribution assay, and the elec. stimulated mouse vas deferens.  BTRX-246040 was systematically compared with the std. NOP antagonist SB-612111.  In all assays, BTRX-246040 behaves as a pure and selective antagonist at human recombinant and murine nativeNOP receptors displaying 3-10-fold higher potency than the std. antagonist SB-612111.  BTRX-246040 is an essential pharmacol. tool to further investigate the therapeutic potential of NOP antagonists in preclin. and clin. studies.  SIGNIFICANCE STATEMENT NOP antagonists may be innovative antidepressant drugs.  In this research, the novel clin. viable NOP antagonist BTRX-246040 has been deeply characterized in vitro in a panel of assays.  BTRX-246040 resulted a pure, potent, and selective NOP antagonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF6Ni0I1ikg7Vg90H21EOLACvtfcHk0lhXFdMi964YKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXovV2rs70%253D&md5=6db0fa782a8f9cede1d4eef10b0a9ddd</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1124%2Fjpet.119.262865&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.119.262865%26sid%3Dliteratum%253Aachs%26aulast%3DFerrari%26aufirst%3DF.%26aulast%3DRizzo%26aufirst%3DS.%26aulast%3DRuzza%26aufirst%3DC.%26aulast%3DCalo%26aufirst%3DG.%26atitle%3DDetailed%2520in%2520vitro%2520pharmacological%2520characterization%2520of%2520the%2520clinically%2520viable%2520nociceptin%252Forphanin%2520FQ%2520peptide%2520receptor%2520antagonist%2520BTRX-246040%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2020%26volume%3D373%26spage%3D34%26epage%3D43%26doi%3D10.1124%2Fjpet.119.262865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Negri, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melchiorri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lattanzi, R.</span></span> <span> </span><span class="NLM_article-title">Pharmacology of amphibian opiate peptides</span>. <i>Peptides</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1639</span>– <span class="NLM_lpage">1647</span>, <span class="refDoi"> DOI: 10.1016/s0196-9781(00)00295-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1016%2FS0196-9781%2800%2900295-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=11090917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BD3cXot1ygs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=1639-1647&author=L.+Negriauthor=P.+Melchiorriauthor=R.+Lattanzi&title=Pharmacology+of+amphibian+opiate+peptides&doi=10.1016%2Fs0196-9781%2800%2900295-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology of Amphibian Opiate Peptides</span></div><div class="casAuthors">Negri, L.; Melchiorri, P.; Lattanzi, R.</div><div class="citationInfo"><span class="NLM_cas:title">Peptides (New York)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1639-1647</span>CODEN:
                <span class="NLM_cas:coden">PPTDD5</span>;
        ISSN:<span class="NLM_cas:issn">0196-9781</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review, with 116 refs., on dermorphin and deltorphin, opiate peptides found only in the skin of South American frogs belonging to the subfamily Phyllomedusinae.  The authors presented a brief history of the discovery of these opiate peptides; their distinctive feature of the presence of a naturally occurring D-enantiomer at the 2nd position of their common N-terminal sequence; their structure-activity relationship; brain opiate receptors binding these peptides; pharmacokinetics; and pharmacol. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoa8bAEZow_ObVg90H21EOLACvtfcHk0lgWSCHjuM3E7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXot1ygs70%253D&md5=ca0ac8c7493512e26185c20f7fcba6de</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2FS0196-9781%2800%2900295-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0196-9781%252800%252900295-3%26sid%3Dliteratum%253Aachs%26aulast%3DNegri%26aufirst%3DL.%26aulast%3DMelchiorri%26aufirst%3DP.%26aulast%3DLattanzi%26aufirst%3DR.%26atitle%3DPharmacology%2520of%2520amphibian%2520opiate%2520peptides%26jtitle%3DPeptides%26date%3D2000%26volume%3D21%26spage%3D1639%26epage%3D1647%26doi%3D10.1016%2Fs0196-9781%2800%2900295-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosterlitz, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fothergill, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morris, H. R.</span></span> <span> </span><span class="NLM_article-title">Identification of two related pentapeptides from the brain with potent opiate agonist activity</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>258</i></span>,  <span class="NLM_fpage">577</span>– <span class="NLM_lpage">580</span>, <span class="refDoi"> DOI: 10.1038/258577a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1038%2F258577a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1207728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADyaE28XhtVWjurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=258&publication_year=1975&pages=577-580&author=J.+Hughesauthor=T.+W.+Smithauthor=H.+W.+Kosterlitzauthor=L.+A.+Fothergillauthor=B.+A.+Morganauthor=H.+R.+Morris&title=Identification+of+two+related+pentapeptides+from+the+brain+with+potent+opiate+agonist+activity&doi=10.1038%2F258577a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of two related pentapeptides from the brain with potent opiate agonist activity</span></div><div class="casAuthors">Hughes, J.; Smith, T. W.; Kosterlitz, H. W.; Fothergill, Linda A.; Morgan, B. A.; Morris, H. R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">258</span>
        (<span class="NLM_cas:issue">5536</span>),
    <span class="NLM_cas:pages">577-9</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Dansyl-Edman sequencing and mass spectrometry showed that enkephalin, a natural ligand for opiate receptors, is composed of Tyr-Gly-Gly-Phe-Met and Tyr-Gly-Gly-Phe-Leu.  The biol. potencies of the sep. synthetic pentapeptides compared well with natural enkephalin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ8eTondwYrLVg90H21EOLACvtfcHk0lgWSCHjuM3E7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XhtVWjurw%253D&md5=4db35634178f0a60d35bf3cf0b92a3fc</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2F258577a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F258577a0%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DT.%2BW.%26aulast%3DKosterlitz%26aufirst%3DH.%2BW.%26aulast%3DFothergill%26aufirst%3DL.%2BA.%26aulast%3DMorgan%26aufirst%3DB.%2BA.%26aulast%3DMorris%26aufirst%3DH.%2BR.%26atitle%3DIdentification%2520of%2520two%2520related%2520pentapeptides%2520from%2520the%2520brain%2520with%2520potent%2520opiate%2520agonist%2520activity%26jtitle%3DNature%26date%3D1975%26volume%3D258%26spage%3D577%26epage%3D580%26doi%3D10.1038%2F258577a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Michel, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charlton, S. J.</span></span> <span> </span><span class="NLM_article-title">Biased agonism in drug discovery-is it too soon to choose a path?</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>93</i></span>,  <span class="NLM_fpage">259</span>– <span class="NLM_lpage">265</span>, <span class="refDoi"> DOI: 10.1124/mol.117.110890</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1124%2Fmol.117.110890" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=29326242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs12qsr3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=2018&pages=259-265&author=M.+C.+Michelauthor=S.+J.+Charlton&title=Biased+agonism+in+drug+discovery-is+it+too+soon+to+choose+a+path%3F&doi=10.1124%2Fmol.117.110890"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Biased agonism in drug discovery-is it too soon to choose a path?</span></div><div class="casAuthors">Michel, Martin C.; Charlton, Steven J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">259-265</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A single receptor can activate multiple signaling pathways that have distinct or even opposite effects on cell function.  Biased agonists stabilize receptor conformations preferentially stimulating one of these pathways, and therefore allow a more targeted modulation of cell function and treatment of disease.  Dedicated development of biased agonists has led to promising drug candidates in clin. development, such as the G proteinbiased μ opioid receptor agonist oliceridine.  However, leveraging the theor. potential of biased agonism for drug discovery faces several challenges.  Some of these challenges are tech., such as techniques for quant. anal. of bias and development of suitable screening assays; others are more fundamental, such as the need to robustly identify in a very early phase which cell type harbors the cellular target of the drug candidate, which signaling pathway leads to the desired therapeutic effect, and how these pathways may be modulated in the disease to be treated.  We conclude that biased agonism has potential mainly in the treatment of conditions with a wellunderstood pathophysiol.; in contrast, it may increase effort and com. risk under circumstances where the pathophysiol. has been less well defined, as is the case with many highly innovative treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC0JJ5dRicyLVg90H21EOLACvtfcHk0lgWSCHjuM3E7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs12qsr3K&md5=a975e0fedbb29ba2059fe14c5be5d434</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1124%2Fmol.117.110890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.117.110890%26sid%3Dliteratum%253Aachs%26aulast%3DMichel%26aufirst%3DM.%2BC.%26aulast%3DCharlton%26aufirst%3DS.%2BJ.%26atitle%3DBiased%2520agonism%2520in%2520drug%2520discovery-is%2520it%2520too%2520soon%2520to%2520choose%2520a%2520path%253F%26jtitle%3DMol.%2520Pharmacol.%26date%3D2018%26volume%3D93%26spage%3D259%26epage%3D265%26doi%3D10.1124%2Fmol.117.110890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benoiton, N. L.</span></span> <i>Chemistry of Peptide Synthesis</i>; <span class="NLM_publisher-name">Taylor & Francis Group</span>: <span class="NLM_publisher-loc">6000 Broken Sound Parkway NW, Suite 300, Boca Raton, FL, 33487-2742, USA</span>, <span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=N.+L.+Benoiton&title=Chemistry+of+Peptide+Synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBenoiton%26aufirst%3DN.%2BL.%26btitle%3DChemistry%2520of%2520Peptide%2520Synthesis%26pub%3DTaylor%2520%2526%2520Francis%2520Group%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rich, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gesellchen, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckner, C. K.</span></span> <span> </span><span class="NLM_article-title">Alkylating derivatives of amino acids and peptides. Synthesis of N-maleoylamino acids, [1-(N-maleoylglycyl)cysteinyl]oxytocin. Effects on vasopressin-stimulated water loss from isolated toad bladder</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1004</span>– <span class="NLM_lpage">1010</span>, <span class="refDoi"> DOI: 10.1021/jm00244a011</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00244a011" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADyaE2MXmtVajur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1975&pages=1004-1010&author=D.+H.+Richauthor=P.+D.+Gesellchenauthor=A.+Tongauthor=A.+Cheungauthor=C.+K.+Buckner&title=Alkylating+derivatives+of+amino+acids+and+peptides.+Synthesis+of+N-maleoylamino+acids%2C+%5B1-%28N-maleoylglycyl%29cysteinyl%5Doxytocin.+Effects+on+vasopressin-stimulated+water+loss+from+isolated+toad+bladder&doi=10.1021%2Fjm00244a011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Alkylating derivatives of amino acids and peptides.  Synthesis of N-maleoylamino acids, [1-(N-maleoylglycyl)cysteinyl]oxytocin, and [1-(N-maleoyl-11-aminoundecanoyl)cysteinyl]oxytocin.  Effects on vasopressin-stimulated water loss from isolated toad bladder</span></div><div class="casAuthors">Rich, Daniel H.; Gesellchen, Paul D.; Tong, Alex; Cheung, Al; Buckner, Carl K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1004-10</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Eight N-maleoylamino acids were prepd. by cyclization of the corresponding maleamic acids, while 5 N-maleoylamino acid esters were prepd. by the reaction of the ester with maleic anhydride [108-31-6].  These compds. inhibited both the oxytocin-induced contraction in the isolated rat uterus and vasopressin-induced water loss from the isolated toad bladder.  Acylation of oxytocin acetate [6233-83-6] with the appropriate maleoylamino acid gave N-maleoylglycyloxytocin (I) [57078-96-3] and N-maleoyl-11-aminoundecanoyloxytocin (II) [57078-97-4].  I and II were inactive in the rat uterus assay ≤3 × 10-5M, and had inhibitory activity only on the mucosal surface in the toad bladder assay.  Structure-activity relations, the relation of activity to partition coeff., and the role of sulfhydryl group binding at neurohypophyseal receptors are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYXqdsVEXQrbVg90H21EOLACvtfcHk0lgUzOC5p1zGwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXmtVajur4%253D&md5=51a9d1485560c7a67f5df39eb2d634d5</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjm00244a011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00244a011%26sid%3Dliteratum%253Aachs%26aulast%3DRich%26aufirst%3DD.%2BH.%26aulast%3DGesellchen%26aufirst%3DP.%2BD.%26aulast%3DTong%26aufirst%3DA.%26aulast%3DCheung%26aufirst%3DA.%26aulast%3DBuckner%26aufirst%3DC.%2BK.%26atitle%3DAlkylating%2520derivatives%2520of%2520amino%2520acids%2520and%2520peptides.%2520Synthesis%2520of%2520N-maleoylamino%2520acids%252C%2520%255B1-%2528N-maleoylglycyl%2529cysteinyl%255Doxytocin.%2520Effects%2520on%2520vasopressin-stimulated%2520water%2520loss%2520from%2520isolated%2520toad%2520bladder%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1975%26volume%3D18%26spage%3D1004%26epage%3D1010%26doi%3D10.1021%2Fjm00244a011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ngai, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacAry, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lear, M. J.</span></span> <span> </span><span class="NLM_article-title">Practical synthesis of maleimides and coumarin-linked probes for protein and antibody labelling via reduction of native disulfides</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">3400</span>– <span class="NLM_lpage">3406</span>, <span class="refDoi"> DOI: 10.1039/b904060a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1039%2Fb904060a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=19675893" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpsl2itrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=3400-3406&author=H.+Y.+Songauthor=M.+H.+Ngaiauthor=Z.+Y.+Songauthor=P.+A.+MacAryauthor=J.+Hobleyauthor=M.+J.+Lear&title=Practical+synthesis+of+maleimides+and+coumarin-linked+probes+for+protein+and+antibody+labelling+via+reduction+of+native+disulfides&doi=10.1039%2Fb904060a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Practical synthesis of maleimides and coumarin-linked probes for protein and antibody labelling via reduction of native disulfides</span></div><div class="casAuthors">Song, Hong Y.; Ngai, Mun H.; Song, Zhen Y.; MacAry, Paul A.; Hobley, Jonathan; Lear, Martin J.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3400-3406</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">The cellular tracking, detection and sensing of protein or antibody movement are important aspects to advance the understanding of biomol. interactions and activity.  Antibodies modified with fluorescent dyes are also valuable tools, esp. in immunol. research.  The authors describe here a proof-of-principle study of a new water-sol. coumarin probe with a maleimide thiol-reacting unit to fluorescently tag biomols.  Highlights include: (1) a convenient water-based prepn. of N-substituted maleimides, (2) a one-pot prepn. of activated maleimido-esters, and (3) a bio-conjugation protocol for the selenol-promoted redn. of native disulfide bonds and the 'site-specific' labeling of antibodies with no significant loss of activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqejqbTih3MJrVg90H21EOLACvtfcHk0lgUzOC5p1zGwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpsl2itrw%253D&md5=8dabf1f4827e7b1bafbf7de2c9345fbf</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1039%2Fb904060a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb904060a%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DH.%2BY.%26aulast%3DNgai%26aufirst%3DM.%2BH.%26aulast%3DSong%26aufirst%3DZ.%2BY.%26aulast%3DMacAry%26aufirst%3DP.%2BA.%26aulast%3DHobley%26aufirst%3DJ.%26aulast%3DLear%26aufirst%3DM.%2BJ.%26atitle%3DPractical%2520synthesis%2520of%2520maleimides%2520and%2520coumarin-linked%2520probes%2520for%2520protein%2520and%2520antibody%2520labelling%2520via%2520reduction%2520of%2520native%2520disulfides%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2009%26volume%3D7%26spage%3D3400%26epage%3D3406%26doi%3D10.1039%2Fb904060a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vachon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herz, A.</span></span> <span> </span><span class="NLM_article-title">Opioid receptor desensitization in NG 108-15 cells. Differential effects of a full and a partial agonist on the opioid-dependent GTPase</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">2889</span>– <span class="NLM_lpage">2897</span>, <span class="refDoi"> DOI: 10.1016/0006-2952(87)90199-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1016%2F0006-2952%2887%2990199-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=2820424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADyaL2sXlvFWgsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1987&pages=2889-2897&author=L.+Vachonauthor=T.+Costaauthor=A.+Herz&title=Opioid+receptor+desensitization+in+NG+108-15+cells.+Differential+effects+of+a+full+and+a+partial+agonist+on+the+opioid-dependent+GTPase&doi=10.1016%2F0006-2952%2887%2990199-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Opioid receptor desensitization in NG 108-15 cells.  Differential effects of a full and a partial agonist on the opioid-dependent GTPase</span></div><div class="casAuthors">Vachon, Luc; Costa, Tommaso; Herz, Albert</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2889-97</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    </div><div class="casAbstract">Opioid receptor binding and the opioid-mediated stimulation of low Km GTPase and inhibition of adenylate cyclase were studied in membranes derived from NG 108-15 cells pretreated with either the opioid peptide [L-Ala2,L-Leu5]enkephalin (DADLE) or morphine.  Pretreatment with DADLE resulted in a concn.-dependent loss of responsiveness of GTPase to the peptide; this effect was entirely accounted for by a redn. in the maximal stimulation produced acutely by DADLE, without changes in the 50% effective concn. of the peptide, indicating a non-competitive type of desensitization.  The degree of desensitization of GTPase was similar after 1 and 24 h of pretreatment with DADLE, indicating that the process occurs rapidly.  In contrast, morphine, which was 70-80% as potent as DADLE in stimulating GTPase and inhibiting adenylate cyclase in acute conditions, induced only a minimal desensitization of the opioid-GTPase system and, in contrast to DADLE, did not desensitize adenylate cyclase.  Pretreatment with DADLE for 1 h decreased opioid receptor d. which was quant. similar to the degree of desensitization of GTPase: both these effects of DADLE were antagonized to a similar extent when morphine was also present in the pretreatment.  Thus, desensitization of the opioid-stimulated GTPase appears to be correlated with down-regulation of the opioid receptor.  Moreover, these findings suggest that partial agonists cannot induce this process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs0YtHkrztmbVg90H21EOLACvtfcHk0lgrn9yrON0evw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXlvFWgsr4%253D&md5=be4ca5176c9c32d4aae6c573608b2dc2</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2F0006-2952%2887%2990199-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-2952%252887%252990199-7%26sid%3Dliteratum%253Aachs%26aulast%3DVachon%26aufirst%3DL.%26aulast%3DCosta%26aufirst%3DT.%26aulast%3DHerz%26aufirst%3DA.%26atitle%3DOpioid%2520receptor%2520desensitization%2520in%2520NG%2520108-15%2520cells.%2520Differential%2520effects%2520of%2520a%2520full%2520and%2520a%2520partial%2520agonist%2520on%2520the%2520opioid-dependent%2520GTPase%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1987%26volume%3D36%26spage%3D2889%26epage%3D2897%26doi%3D10.1016%2F0006-2952%2887%2990199-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neubig, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spedding, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenakin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span> <span> </span><span class="NLM_article-title">International union of pharmacology committee on receptor nomenclature and drug classification. XXXVIII. Update on terms and symbols in quantitative pharmacology</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">597</span>– <span class="NLM_lpage">606</span>, <span class="refDoi"> DOI: 10.1124/pr.55.4.4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1124%2Fpr.55.4.4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=14657418" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtlWkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2003&pages=597-606&author=R.+R.+Neubigauthor=M.+Speddingauthor=T.+Kenakinauthor=A.+Christopoulos&title=International+union+of+pharmacology+committee+on+receptor+nomenclature+and+drug+classification.+XXXVIII.+Update+on+terms+and+symbols+in+quantitative+pharmacology&doi=10.1124%2Fpr.55.4.4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology</span></div><div class="casAuthors">Neubig, Richard R.; Spedding, Michael; Kenakin, Terry; Christopoulos, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">597-606</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The recommendations that follow have been updated from the proposals of a Tech. Subcommittee set up by the International Union of Pharmacol. Committee on Receptor Nomenclature and Drug Classification.  International Union of Pharmacol. Committee on Receptor Nomenclature and Drug Classification. IX.  Recommendations on terms and symbols in quant. pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobvkWoNCTvu7Vg90H21EOLACvtfcHk0lgrn9yrON0evw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtlWkuw%253D%253D&md5=8a467ff5e3812d34d42179491555793d</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1124%2Fpr.55.4.4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.55.4.4%26sid%3Dliteratum%253Aachs%26aulast%3DNeubig%26aufirst%3DR.%2BR.%26aulast%3DSpedding%26aufirst%3DM.%26aulast%3DKenakin%26aufirst%3DT.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DInternational%2520union%2520of%2520pharmacology%2520committee%2520on%2520receptor%2520nomenclature%2520and%2520drug%2520classification.%2520XXXVIII.%2520Update%2520on%2520terms%2520and%2520symbols%2520in%2520quantitative%2520pharmacology%26jtitle%3DPharmacol.%2520Rev.%26date%3D2003%26volume%3D55%26spage%3D597%26epage%3D606%26doi%3D10.1124%2Fpr.55.4.4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kenakin, T. A.</span></span> <i>Pharmacology Primer. Techniques for More Effective and Strategic Drug Discovery</i>, <span class="NLM_edition">4</span>th ed.; <span class="NLM_publisher-name">Elsevier Science Publishing Co Inc.</span>: <span class="NLM_publisher-loc">525 B Street, Suite 1800, San Diego, CA, 92101-4495, USA</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=T.+A.+Kenakin&title=Pharmacology+Primer.+Techniques+for+More+Effective+and+Strategic+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DKenakin%26aufirst%3DT.%2BA.%26btitle%3DPharmacology%2520Primer.%2520Techniques%2520for%2520More%2520Effective%2520and%2520Strategic%2520Drug%2520Discovery%26pub%3DElsevier%2520Science%2520Publishing%2520Co%2520Inc%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pineyro, G.</span></span> <span> </span><span class="NLM_article-title">Practical guide for calculating and representing biased signaling by GPCR ligands: A stepwise approach</span>. <i>Methods</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">78</span>– <span class="NLM_lpage">86</span>, <span class="refDoi"> DOI: 10.1016/j.ymeth.2015.09.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=10.1016%2Fj.ymeth.2015.09.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=26364590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFShsrjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2016&pages=78-86&author=K.+Nagiauthor=G.+Pineyro&title=Practical+guide+for+calculating+and+representing+biased+signaling+by+GPCR+ligands%3A+A+stepwise+approach&doi=10.1016%2Fj.ymeth.2015.09.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Practical guide for calculating and representing biased signaling by GPCR ligands: A stepwise approach</span></div><div class="casAuthors">Nagi, Karim; Pineyro, Graciela</div><div class="citationInfo"><span class="NLM_cas:title">Methods (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">78-86</span>CODEN:
                <span class="NLM_cas:coden">MTHDE9</span>;
        ISSN:<span class="NLM_cas:issn">1046-2023</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Signaling bias makes ref. to the capacity of G-protein coupled receptor (GPCR) ligands to direct pharmacol. stimuli to a subset of effectors among all of those controlled by the receptor.  This new signaling modality has added texture to the classical notion of efficacy.  In doing so, it has opened new avenues for the development of therapeutic GPCR ligands that specifically modulate signals underlying desired effects while sparing those that support undesired drug actions.  Essential to taking advantage of this texture is the ability to identify, quantify and represent bias in a reliable and intuitive manner that ensures comparison among ligands.  Here, we present a practical guide on how the operational model may be used to evaluate ligand efficiency to induce different responses, how differences in response may be used to est. bias and how quant. information derived from this anal. may be graphically represented to recreate a drug's unique signaling footprint.  The approach used is discussed in terms of data interpretation and limitations that may influence the conclusions drawn from the anal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs73ewRZinOLVg90H21EOLACvtfcHk0lj1sJCVPO_NfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFShsrjI&md5=8f8cf53cb073bdc0815452dc5b231eb0</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.ymeth.2015.09.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ymeth.2015.09.010%26sid%3Dliteratum%253Aachs%26aulast%3DNagi%26aufirst%3DK.%26aulast%3DPineyro%26aufirst%3DG.%26atitle%3DPractical%2520guide%2520for%2520calculating%2520and%2520representing%2520biased%2520signaling%2520by%2520GPCR%2520ligands%253A%2520A%2520stepwise%2520approach%26jtitle%3DMethods%26date%3D2016%26volume%3D92%26spage%3D78%26epage%3D86%26doi%3D10.1016%2Fj.ymeth.2015.09.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i33"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b02057">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_61757"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.9b02057?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b02057</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">ESI mass spectra of compounds <b>62a–c</b>, <b>65d–m</b>, <b>67</b>, and <b>39–59</b>; HPLC chromatograms of compounds <b>67</b> and <b>39–59</b>; HRMS profiles of final compounds; concentration–response curves to N/OFQ(1–13)-NH<sub>2</sub>, compounds <b>40</b> and <b>43</b> in the absence and presence of the NOP antagonist SB-612111; and chemical structures of unusual amino acids (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b02057/suppl_file/jm9b02057_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b02057/suppl_file/jm9b02057_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02057/suppl_file/jm9b02057_si_001.pdf">jm9b02057_si_001.pdf (3.75 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b02057/suppl_file/jm9b02057_si_002.csv">jm9b02057_si_002.csv (17.04 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b02057&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-19%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b02057%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b02057" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799840dab9125a5","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
